"Molecule ChEMBL ID";"Molecule Name";"Molecule Max Phase";"Molecular Weight";"#RO5 Violations";"AlogP";"Compound Key";"Smiles";"Standard Type";"Standard Relation";"Standard Value";"Standard Units";"pChEMBL Value";"Data Validity Comment";"Comment";"Uo Units";"Ligand Efficiency BEI";"Ligand Efficiency LE";"Ligand Efficiency LLE";"Ligand Efficiency SEI";"Potential Duplicate";"Assay ChEMBL ID";"Assay Description";"Assay Type";"BAO Format ID";"BAO Label";"Assay Organism";"Assay Tissue ChEMBL ID";"Assay Tissue Name";"Assay Cell Type";"Assay Subcellular Fraction";"Assay Parameters";"Assay Variant Accession";"Assay Variant Mutation";"Target ChEMBL ID";"Target Name";"Target Organism";"Target Type";"Document ChEMBL ID";"Source ID";"Source Description";"Document Journal";"Document Year";"Cell ChEMBL ID";"Properties";"Action Type";"Standard Text Value"
"CHEMBL628";"PENTOXIFYLLINE";"4.0";"278.31";"0";"0.19";"PENTOXIFYLLINE";"CC(=O)CCCCn1c(=O)c2c(ncn2C)n(C)c1=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL945";"AMILORIDE";"4.0";"229.63";"0";"-1.08";"AMILORIDE";"N=C(N)NC(=O)c1nc(Cl)c(N)nc1N";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL63560";"(R)-BICALUTAMIDE";"None";"430.38";"0";"2.88";"(R)-BICALUTAMIDE";"C[C@](O)(CS(=O)(=O)c1ccc(F)cc1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL193";"NIFEDIPINE";"4.0";"346.34";"0";"2.18";"NIFEDIPINE";"COC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1c1ccccc1[N+](=O)[O-]";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL475534";"NITRENDIPINE";"4.0";"360.37";"0";"2.57";"NITRENDIPINE";"CCOC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1c1cccc([N+](=O)[O-])c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL425095";"";"None";"1849.18";"None";"None";"36";"CC(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O)C(C)C";"IC50";"'='";"3.84";"nM";"8.42";"";"";"UO_0000065";"4.55";"None";"None";"None";"0";"CHEMBL755164";"Affinity against Neuropeptide Y receptor Y2 in SK-N-BE2 cell line";"B";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133640";"1";"Scientific Literature";"J Med Chem";"2000";"None";"";"";""
"CHEMBL179166";"SODIUM ORTHOVANAD";"None";"183.91";"None";"None";"SODIUM ORTHOVANADATE";"";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1149";"LEVOCARNITINE";"4.0";"161.20";"0";"-1.81";"LEVOCARNITINE";"C[N+](C)(C)C[C@H](O)CC(=O)[O-]";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL689";"MANNITOL";"4.0";"182.17";"1";"-3.59";"MANNITOL";"OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL154111";"SALSALATE";"4.0";"258.23";"0";"2.31";"SALSALATE";"O=C(Oc1ccccc1C(=O)O)c1ccccc1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL428";"TROVAFLOXACIN";"4.0";"416.36";"0";"1.89";"TROVAFLOXACIN";"N[C@@H]1[C@H]2CN(c3nc4c(cc3F)c(=O)c(C(=O)O)cn4-c3ccc(F)cc3F)C[C@@H]12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL4063306";"";"None";"1865.27";"None";"None";"7";"CC(=O)N[C@@H](CO)C(=O)N1CCC[C@@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](CC1CCCCC1)C(=O)N[C@@H](CC1CCCCC1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)NC(C)(C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC1CCCCC1)C(N)=O)[C@@H](C)O";"IC50";"'='";"0.55";"nM";"9.26";"";"";"UO_0000065";"4.96";"None";"None";"None";"0";"CHEMBL4056968";"Displacement of [125I]peptide YY from human Y2 receptor expressed in CHO cell membranes after 60 mins by TopCount scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4052740";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";""
"CHEMBL17645";"CGP-71683A";"None";"475.62";"0";"4.56";"8, (CGP-71683A)";"Nc1nc(NC[C@H]2CC[C@H](CNS(=O)(=O)c3cccc4ccccc34)CC2)nc2ccccc12";"IC50";"'='";"1890.0";"nM";"5.72";"";"";"UO_0000065";"12.03";"0.23";"1.16";"5.20";"0";"CHEMBL747055";"Compound was tested for human Neuropeptide Y receptor type 2";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1132894";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2000";"None";"";"";""
"CHEMBL1784130";"";"None";"416.38";"0";"3.60";"7m";"C[C@@H]1NC(c2ccc(=O)n(C(F)F)c2)=N[C@@]1(c1ccc(F)cc1)c1ccc(F)nc1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1787182";"Binding affinity to human NPYY2";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1781958";"1";"Scientific Literature";"Bioorg Med Chem";"2009";"None";"";"";""
"CHEMBL491762";"";"None";"366.46";"1";"5.01";"(RS)-1";"CC1(C)CC(=O)C(C2C3=C(CC(C)(C)CC3=O)Oc3ccccc32)=C(O)C1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL997871";"Inhibition of human neuropeptide Y2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1155895";"1";"Scientific Literature";"J Med Chem";"2008";"None";"";"";""
"CHEMBL1823343";"";"None";"506.61";"2";"5.04";"6";"COC(=O)C(c1ccccc1)N1CCN(c2ccc(NC(=O)c3ccccc3-c3ccncc3)cc2)CC1";"IC50";"'='";"240.0";"nM";"6.62";"";"";"UO_0000065";"13.07";"0.24";"1.58";"8.85";"0";"CHEMBL1827365";"Displacement of [125I]PYY from human NPY Y2 receptor expressed endogenously in KAN-Ts cells by scintillation counting";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"KAN-Ts";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1821563";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";"";""
"CHEMBL1823358";"";"None";"461.61";"0";"3.93";"27";"CCNC(=O)C(c1ccccc1)N1CCN(c2ccc(NC(=O)C(CC)CC)cc2C#N)CC1";"IC50";"'='";"150.0";"nM";"6.82";"";"";"UO_0000065";"14.78";"0.27";"2.89";"7.71";"0";"CHEMBL1827365";"Displacement of [125I]PYY from human NPY Y2 receptor expressed endogenously in KAN-Ts cells by scintillation counting";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"KAN-Ts";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1821563";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";"";""
"CHEMBL1823575";"";"None";"489.66";"0";"4.66";"32";"CCC(CC)C(=O)Nc1ccc(N2CCN(C(C(=O)N(CC)CC)c3ccccc3)CC2)c(C#N)c1";"IC50";"'='";"200.0";"nM";"6.70";"";"";"UO_0000065";"13.68";"0.25";"2.04";"8.41";"0";"CHEMBL1827365";"Displacement of [125I]PYY from human NPY Y2 receptor expressed endogenously in KAN-Ts cells by scintillation counting";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"KAN-Ts";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1821563";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";"";""
"CHEMBL1984816";"";"None";"324.30";"0";"2.78";"SID24788030";"COc1ccc(C(=O)/C(C#N)=N/Nc2cccc([N+](=O)[O-])c2)cc1";"IC50";"'>'";"35000.0";"nM";"";"";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1613986";"PUBCHEM_BIOASSAY: Dose response counterscreen assay for neuropeptide Y receptor Y1 (NPY-Y1): Cell-based high throughput assay to measure NPY-Y2 antagonism. (Class of assay: confirmatory) [Related pubchem assays: 793, 1040, 1255, 1254 ]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1414494";"";"None";"416.52";"0";"4.45";"SID24796623";"CC1=CC(C)(C)N(C(=O)CNC2CCCCC2)c2cc(C)ccc21.O=C(O)C(=O)O";"IC50";"'='";"12280.0";"nM";"4.91";"";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1613986";"PUBCHEM_BIOASSAY: Dose response counterscreen assay for neuropeptide Y receptor Y1 (NPY-Y1): Cell-based high throughput assay to measure NPY-Y2 antagonism. (Class of assay: confirmatory) [Related pubchem assays: 793, 1040, 1255, 1254 ]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1426722";"";"None";"403.51";"0";"4.59";"SID24800554";"Cc1ccc(-n2cc(CNCCn3nc(C)cc3C)c(-c3ccc(F)cc3)n2)cc1";"IC50";"'>'";"35000.0";"nM";"";"";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1613986";"PUBCHEM_BIOASSAY: Dose response counterscreen assay for neuropeptide Y receptor Y1 (NPY-Y1): Cell-based high throughput assay to measure NPY-Y2 antagonism. (Class of assay: confirmatory) [Related pubchem assays: 793, 1040, 1255, 1254 ]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1545811";"";"None";"410.52";"0";"3.86";"SID14737860";"O=C(c1cnccn1)N(Cc1ccco1)C1(C(=O)NC2CCCCC2)CCCCC1";"IC50";"'>'";"35000.0";"nM";"";"";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1613986";"PUBCHEM_BIOASSAY: Dose response counterscreen assay for neuropeptide Y receptor Y1 (NPY-Y1): Cell-based high throughput assay to measure NPY-Y2 antagonism. (Class of assay: confirmatory) [Related pubchem assays: 793, 1040, 1255, 1254 ]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1468579";"";"None";"312.33";"0";"3.60";"SID865285";"COc1ccc(Oc2c(C)n[nH]c2-c2ccc(O)cc2O)cc1";"IC50";"'>'";"35000.0";"nM";"";"";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1613986";"PUBCHEM_BIOASSAY: Dose response counterscreen assay for neuropeptide Y receptor Y1 (NPY-Y1): Cell-based high throughput assay to measure NPY-Y2 antagonism. (Class of assay: confirmatory) [Related pubchem assays: 793, 1040, 1255, 1254 ]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1909055";"COBALTOUS CHLORIDE";"4.0";"129.84";"None";"None";"COBALT (II) CHLORIDE";"";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL118";"CELECOXIB";"4.0";"381.38";"0";"3.51";"CELECOXIB";"Cc1ccc(-c2cc(C(F)(F)F)nn2-c2ccc(S(N)(=O)=O)cc2)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL105";"MITOMYCIN";"4.0";"334.33";"0";"-1.65";"MITOMYCIN C";"CO[C@@]12[C@H](COC(N)=O)C3=C(C(=O)C(C)=C(N)C3=O)N1C[C@@H]1N[C@@H]12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL459";"METHYLDOPA";"4.0";"211.22";"0";"0.44";"METHYLDOPA";"C[C@](N)(Cc1ccc(O)c(O)c1)C(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1243";"SULFABENZAMIDE";"4.0";"276.32";"0";"1.39";"SULFABENZAMIDE";"Nc1ccc(S(=O)(=O)NC(=O)c2ccccc2)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL18701";"RO-201724";"None";"278.35";"0";"2.10";"Ro-201724";"CCCCOc1cc(CC2CNC(=O)N2)ccc1OC";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL319562";"";"None";"446.64";"1";"6.40";"16";"CN(C)CCN(C(=O)c1cc2ccccc2s1)c1ccccc1SCc1ccccc1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL747054";"Binding affinity against SMS-KAN cell membranes endogenously expressing Neuropeptide Y receptor type 2 using [125I]PYY as radioligand";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"SMS-KAN";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1136181";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2003";"None";"";"";""
"CHEMBL114";"SAQUINAVIR";"4.0";"670.86";"1";"3.09";"SAQUINAVIR";"CC(C)(C)NC(=O)[C@@H]1C[C@@H]2CCCC[C@@H]2CN1C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)c1ccc2ccccc2n1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL412704";"";"None";"1917.26";"None";"None";"23";"CC(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)CN[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O)C(C)C";"IC50";"'='";"1.32";"nM";"8.88";"";"";"UO_0000065";"4.63";"None";"None";"None";"0";"CHEMBL755164";"Affinity against Neuropeptide Y receptor Y2 in SK-N-BE2 cell line";"B";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133640";"1";"Scientific Literature";"J Med Chem";"2000";"None";"";"";""
"CHEMBL1909076";"";"None";"270.38";"0";"1.21";"S-(N-BENZYLTHIOCARBAMOYL)-L-CYSTEINE";"N[C@H](CSC(=S)NCc1ccccc1)C(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1220";"TINIDAZOLE";"4.0";"247.28";"0";"0.53";"TINIDAZOLE";"CCS(=O)(=O)CCn1c([N+](=O)[O-])cnc1C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1504";"TRIAMCINOLONE ACETONIDE";"4.0";"434.50";"0";"2.42";"TRIAMCINOLONE ACETONIDE";"CC1(C)O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO)O1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL14";"CARBACHOL";"4.0";"182.65";"0";"-0.21";"CARBACHOL";"C[N+](C)(C)CCOC(N)=O.[Cl-]";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL5314404";"AJMALINE";"3.0";"326.44";"0";"1.55";"AJMALINE";"CC[C@H]1[C@@H]2C[C@H]3[C@@H]4N(C)c5ccccc5[C@]45C[C@@H]([C@@H]2[C@H]5O)N3[C@@H]1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1006";"AMIFOSTINE";"4.0";"214.23";"0";"-0.25";"AMIFOSTINE";"NCCCNCCSP(=O)(O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1046";"AMINOCAPROIC ACID";"4.0";"131.18";"0";"0.59";"AMINOCAPROIC ACID";"NCCCCCC(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL12856";"INAMRINONE";"4.0";"187.20";"0";"1.02";"AMRINONE";"Nc1cc(-c2ccncc2)c[nH]c1=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL695";"TRIMETHADIONE";"4.0";"143.14";"0";"0.37";"TRIMETHADIONE";"CN1C(=O)OC(C)(C)C1=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1515";"METHIMAZOLE";"4.0";"114.17";"0";"0.71";"METHIMAZOLE";"Cn1ccnc1S";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL608";"PROBUCOL";"4.0";"516.86";"2";"9.91";"PROBUCOL";"CC(C)(Sc1cc(C(C)(C)C)c(O)c(C(C)(C)C)c1)Sc1cc(C(C)(C)C)c(O)c(C(C)(C)C)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL802";"MINOXIDIL";"4.0";"209.25";"0";"-0.13";"MINOXIDIL";"Nc1cc(N2CCCCC2)nc(N)[n+]1[O-]";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL444633";"RIFABUTIN";"4.0";"847.02";"2";"4.62";"RIFABUTIN";"CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C)c(O)c4c(c3C2=O)C2=NC3(CCN(CC(C)C)CC3)NC2=C(NC(=O)/C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C4=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL410792";"";"None";"2015.32";"None";"None";"20";"CC(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1cccc2ccccc12)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O)C(C)C";"IC50";"'='";"1.09";"nM";"8.96";"";"";"UO_0000065";"4.45";"None";"None";"None";"0";"CHEMBL755164";"Affinity against Neuropeptide Y receptor Y2 in SK-N-BE2 cell line";"B";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133640";"1";"Scientific Literature";"J Med Chem";"2000";"None";"";"";""
"CHEMBL100162";"";"None";"446.64";"1";"6.45";"19";"CNCCCN(C(=O)c1cc2ccccc2s1)c1ccccc1SCc1ccccc1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL747054";"Binding affinity against SMS-KAN cell membranes endogenously expressing Neuropeptide Y receptor type 2 using [125I]PYY as radioligand";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"SMS-KAN";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1136181";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2003";"None";"";"";""
"CHEMBL127";"MEROPENEM";"4.0";"383.47";"0";"-0.31";"MEROPENEM";"C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL78109";"";"None";"410.90";"1";"5.72";"44d";"C[C@H]([C@@H](O)c1ccccc1)N(C)C(=O)Nc1ccc(Oc2ccc(Cl)cc2)cc1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL749564";"Inhibitory activity tested against Human Neuropeptide Y2 Receptor.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1134441";"1";"Scientific Literature";"J Med Chem";"2001";"None";"";"";""
"CHEMBL1566249";"AMPIROXICAM";"2.0";"447.47";"0";"2.56";"AMPIROXICAM";"CCOC(=O)OC(C)OC1=C(C(=O)Nc2ccccn2)N(C)S(=O)(=O)c2ccccc21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1572";"NETILMICIN";"4.0";"475.59";"2";"-3.20";"7 (Netilmicin)";"CCN[C@@H]1C[C@H](N)[C@@H](O[C@H]2OC(CN)=CC[C@H]2N)[C@H](O)[C@H]1O[C@H]1OC[C@](C)(O)[C@H](NC)[C@H]1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1200862";"METYROSINE";"4.0";"195.22";"0";"0.74";"METYROSINE";"C[C@](N)(Cc1ccc(O)cc1)C(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL717";"MEDROXYPROGESTERONE ACETATE";"4.0";"386.53";"0";"4.66";"MEDROXYPROGESTERONE ACETATE";"CC(=O)O[C@]1(C(C)=O)CC[C@H]2[C@@H]3C[C@H](C)C4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL21";"SULFANILAMIDE";"4.0";"172.21";"0";"-0.08";"SULFANILAMIDE";"Nc1ccc(S(N)(=O)=O)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1196";"PROPARACAINE";"4.0";"294.39";"0";"2.56";"PROPARACAINE";"CCCOc1ccc(C(=O)OCCN(CC)CC)cc1N";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL445";"NORTRIPTYLINE";"4.0";"263.38";"0";"3.83";"NORTRIPTYLINE";"CNCCC=C1c2ccccc2CCc2ccccc21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL476";"DACARBAZINE";"4.0";"182.19";"0";"0.07";"DACARBAZINE";"CN(C)/N=N/c1[nH]cnc1C(N)=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1754";"DOXAPRAM";"4.0";"378.52";"0";"3.17";"DOXAPRAM";"CCN1CC(CCN2CCOCC2)C(c2ccccc2)(c2ccccc2)C1=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL97046";"";"None";"444.60";"1";"6.32";"13";"CN(C)CCCN(C(=O)c1cc2ccccc2o1)c1ccccc1SCc1ccccc1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL747054";"Binding affinity against SMS-KAN cell membranes endogenously expressing Neuropeptide Y receptor type 2 using [125I]PYY as radioligand";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"SMS-KAN";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1136181";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2003";"None";"";"";""
"CHEMBL832";"SULFINPYRAZONE";"4.0";"404.49";"0";"3.80";"SULFINPYRAZONE";"O=C1C(CC[S+]([O-])c2ccccc2)C(=O)N(c2ccccc2)N1c1ccccc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL161724";"";"None";"362.43";"0";"4.20";"1";"CC(C)(C)OCCOc1ccc(-c2nc(-c3cccc(C#N)c3)c[nH]2)cn1";"IC50";"'>>'";"1000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL747210";"Inhibitory activity against Neuropeptide Y receptor type 2";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1145972";"1";"Scientific Literature";"J Med Chem";"2003";"None";"";"";""
"CHEMBL82374";"";"None";"417.55";"0";"4.72";"68";"CCCCC(=O)N1CCC(CNc2nc3c(s2)CCOc2ccc(F)cc2-3)CC1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL750763";"In vitro binding affinity against rat neuropeptide Y2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1146725";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2004";"None";"";"";""
"CHEMBL417100";"";"None";"507.68";"2";"5.74";"48";"CC(=O)N1CCc2ccc(N(C(=O)/C=C/c3ccccc3)C3CCN(CCCc4ccccc4)CC3)cc21";"IC50";"'='";"2300.0";"nM";"5.64";"";"";"UO_0000065";"11.11";"0.20";"-0.10";"12.86";"0";"CHEMBL750768";"Binding affinity towards the NPY Y2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147599";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2004";"None";"";"";""
"CHEMBL334255";"CETYLPYRIDINIUM BROMIDE";"None";"384.45";"1";"6.46";"CETYLPYRIDINIUM BROMIDE";"CCCCCCCCCCCCCCCC[n+]1ccccc1.[Br-]";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1774344";"";"None";"1076.26";"3";"7.39";"66, UR-MK131";"CN(C)c1ccc(/C=C/C=C/c2sc3ccccc3[n+]2CCCC(=O)NCCCCNC(=O)/N=C(/N)NCCC[C@@H](NC(=O)C(c2ccccc2)c2ccccc2)C(=O)NCc2ccc(O)cc2)cc1.O=C([O-])C(F)(F)F";"IC50";"'>'";"1000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1777149";"Displacement of Dy-635-pNPY from human Y2R expressed in CHO cells by flow cytometry";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1773009";"1";"Scientific Literature";"Bioorg Med Chem";"2011";"CHEMBL3308072";"";"";""
"CHEMBL20773";"";"None";"547.62";"2";"6.33";"34";"CC(=O)N1CCc2ccc(N(C(=O)/C=C/c3ccc(C(F)(F)F)cc3)C3CCN(Cc4ccccc4)CC3)cc21";"IC50";"'='";"2800.0";"nM";"5.55";"";"";"UO_0000065";"10.14";"0.19";"-0.78";"12.66";"0";"CHEMBL750768";"Binding affinity towards the NPY Y2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147599";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2004";"None";"";"";""
"CHEMBL77769";"";"None";"376.46";"1";"5.06";"44i";"C[C@H]([C@@H](O)c1ccccc1)N(C)C(=O)Nc1cccc(Oc2ccccc2)c1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL749564";"Inhibitory activity tested against Human Neuropeptide Y2 Receptor.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1134441";"1";"Scientific Literature";"J Med Chem";"2001";"None";"";"";""
"CHEMBL311229";"";"None";"427.57";"0";"3.88";"6";"Cc1ccc2c(c1)-c1nc(NCC3CCN(C(=O)[C@H]4CCCO4)CC3)sc1CCO2";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL750763";"In vitro binding affinity against rat neuropeptide Y2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1146725";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2004";"None";"";"";""
"CHEMBL1823347";"";"None";"530.63";"2";"5.51";"16";"COC(=O)C(c1ccccc1)N1CCN(c2ccc(NC(=O)c3ccccc3-c3ccccc3)cc2C#N)CC1";"IC50";"'='";"25.0";"nM";"7.60";"";"";"UO_0000065";"14.33";"0.26";"2.09";"8.87";"0";"CHEMBL1827365";"Displacement of [125I]PYY from human NPY Y2 receptor expressed endogenously in KAN-Ts cells by scintillation counting";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"KAN-Ts";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1821563";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";"";""
"CHEMBL1823359";"";"None";"571.73";"2";"6.21";"28";"CCN(CC)C(=O)C(c1ccccc1)N1CCN(c2ccc(NC(=O)c3ccccc3-c3ccccc3)cc2C#N)CC1";"IC50";"'='";"37.0";"nM";"7.43";"";"";"UO_0000065";"13.00";"0.24";"1.22";"9.33";"0";"CHEMBL1827365";"Displacement of [125I]PYY from human NPY Y2 receptor expressed endogenously in KAN-Ts cells by scintillation counting";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"KAN-Ts";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1821563";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";"";""
"CHEMBL1823360";"";"None";"564.71";"2";"6.48";"29";"CCN(CC)C(=O)C(c1ccccc1)N1CCN(c2ccc(NC(=O)c3ccccc3-c3ccccc3)cc2F)CC1";"IC50";"'='";"10.0";"nM";"8.00";"";"";"UO_0000065";"14.17";"0.26";"1.52";"14.31";"0";"CHEMBL1827365";"Displacement of [125I]PYY from human NPY Y2 receptor expressed endogenously in KAN-Ts cells by scintillation counting";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"KAN-Ts";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1821563";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";"";""
"CHEMBL1836316";"";"None";"491.73";"1";"5.47";"14";"O=S(=O)(NC[C@H]1CC[C@H](Nc2nc3c(s2)CCSc2ccccc2-3)CC1)c1cccs1";"IC50";"'>'";"1000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1837822";"Antagonist activity at human NPY2 receptor assessed as calcium mobilization by FLIPR assay";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1833793";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";"";""
"CHEMBL78040";"";"None";"401.51";"1";"5.40";"47";"CCn1c2ccccc2c2cc(NC(=O)N(C)[C@H](C)[C@@H](O)c3ccccc3)ccc21";"IC50";"'='";"1101.0";"nM";"5.96";"";"";"UO_0000065";"14.84";"0.27";"0.56";"10.36";"0";"CHEMBL749564";"Inhibitory activity tested against Human Neuropeptide Y2 Receptor.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1134441";"1";"Scientific Literature";"J Med Chem";"2001";"None";"";"";""
"CHEMBL22174";"";"None";"403.53";"0";"3.78";"25";"C=CC(=O)N(c1ccc2c(c1)N(C(C)=O)CC2)C1CCN(Cc2ccccc2)CC1";"IC50";"'='";"30000.0";"nM";"4.52";"";"";"UO_0000065";"11.21";"0.21";"0.74";"10.31";"0";"CHEMBL750768";"Binding affinity towards the NPY Y2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147599";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2004";"None";"";"";""
"CHEMBL268351";"";"None";"1727.01";"None";"None";"Ac-25-36[Cha30,Cha31]";"CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCN=C(N)N)NC(C)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)C1CCCCC1)C1CCCCC1";"IC50";"'='";"3.0";"nM";"8.52";"";"";"UO_0000065";"4.94";"None";"None";"None";"0";"CHEMBL750762";"Compound was evaluated for its inhibitory activity against human neuropeptide Y2 receptor expressing LN319 cells";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"LN319";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1126482";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1993";"None";"";"";""
"CHEMBL21992";"";"None";"493.61";"0";"4.95";"46";"CC(=O)N1CCc2ccc(N(C(=O)/C=C/c3ccccc3)C3CCN(C(=O)c4ccccc4)CC3)cc21";"IC50";"'='";"29000.0";"nM";"4.54";"";"";"UO_0000065";"9.19";"0.17";"-0.41";"7.45";"0";"CHEMBL750768";"Binding affinity towards the NPY Y2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147599";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2004";"None";"";"";""
"CHEMBL311552";"";"None";"378.45";"1";"5.71";"40k";"CC(Cc1ccc(F)cc1)N(C)C(=O)Nc1ccc(Oc2ccccc2)cc1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL749564";"Inhibitory activity tested against Human Neuropeptide Y2 Receptor.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1134441";"1";"Scientific Literature";"J Med Chem";"2001";"None";"";"";""
"CHEMBL77333";"";"None";"374.44";"1";"5.17";"46";"C[C@H]([C@@H](O)c1ccccc1)N(C)C(=O)Nc1ccc2oc3ccccc3c2c1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL749564";"Inhibitory activity tested against Human Neuropeptide Y2 Receptor.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1134441";"1";"Scientific Literature";"J Med Chem";"2001";"None";"";"";""
"CHEMBL1423799";"";"None";"372.28";"1";"5.61";"SID17503768";"N#Cc1ccc(-c2cccnc2)nc1SCc1ccc(Cl)c(Cl)c1";"IC50";"'='";"5194.0";"nM";"5.28";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614345";"PUBCHEM_BIOASSAY: Dose response cell-based screening assay for antagonists of neuropeptide Y receptor Y2 (NPY-Y2). (Class of assay: confirmatory) [Related pubchem assays: 793, 1257, 1256 ]";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL3199632";"";"None";"370.41";"0";"2.33";"SID22404679";"COc1cc(/C=N/NC(N)=O)ccc1OCC(=O)Nc1ccc(C)c(C)c1";"IC50";"'='";"9830.0";"nM";"5.01";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614345";"PUBCHEM_BIOASSAY: Dose response cell-based screening assay for antagonists of neuropeptide Y receptor Y2 (NPY-Y2). (Class of assay: confirmatory) [Related pubchem assays: 793, 1257, 1256 ]";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1451";"TRIAMCINOLONE";"4.0";"394.44";"0";"0.62";"TRIAMCINOLONE";"C[C@]12C=CC(=O)C=C1CC[C@H]1[C@@H]3C[C@@H](O)[C@](O)(C(=O)CO)[C@@]3(C)C[C@H](O)[C@@]12F";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL621";"TRAZODONE";"4.0";"371.87";"0";"2.36";"Trazodone";"O=c1n(CCCN2CCN(c3cccc(Cl)c3)CC2)nc2ccccn12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1433";"DOXYCYCLINE ANHYDROUS";"4.0";"444.44";"1";"-0.35";"DOXYCYCLINE";"C[C@H]1c2cccc(O)c2C(=O)C2=C(O)[C@]3(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@@H]3[C@@H](O)[C@@H]21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL461727";"AMYGDALIN";"None";"457.43";"2";"-3.11";"AMYGDALIN(D)";"N#C[C@H](O[C@@H]1O[C@H](CO[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@@H](O)[C@H](O)[C@H]1O)c1ccccc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL87285";"ANDROSTERONE";"None";"290.45";"0";"3.96";"ANDROSTERONE";"C[C@]12CC[C@@H](O)C[C@@H]1CC[C@@H]1[C@@H]2CC[C@]2(C)C(=O)CC[C@@H]12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL86";"METOCLOPRAMIDE";"4.0";"299.80";"0";"2.00";"METOCLOPRAMIDE";"CCN(CC)CCNC(=O)c1cc(Cl)c(N)cc1OC";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL414804";"OXALIPLATIN";"4.0";"395.27";"None";"None";"OXALIPLATIN";"";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1601669";"ALFACALCIDOL";"4.0";"400.65";"1";"6.59";"ALFACALCIDOL";"C=C1/C(=C\C=C2/CCC[C@]3(C)[C@@H]([C@H](C)CCCC(C)C)CC[C@@H]23)C[C@@H](O)C[C@@H]1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL878";"METOLAZONE";"4.0";"365.84";"0";"2.71";"METOLAZONE";"Cc1ccccc1N1C(=O)c2cc(S(N)(=O)=O)c(Cl)cc2NC1C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL267894";"AMOBARBITAL";"4.0";"226.28";"0";"1.18";"AMOBARBITAL";"CCC1(CCC(C)C)C(=O)NC(=O)NC1=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL417641";"";"None";"477.61";"0";"4.64";"22";"CC(=O)N1CCc2ccc(N(C(=O)C#Cc3ccccc3)C3CCN(Cc4ccccc4)CC3)cc21";"IC50";"'='";"9200.0";"nM";"5.04";"";"";"UO_0000065";"10.54";"0.19";"0.40";"11.48";"0";"CHEMBL750768";"Binding affinity towards the NPY Y2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147599";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2004";"None";"";"";""
"CHEMBL414482";"";"None";"1700.97";"None";"None";"Ac-25-36[Cha31]";"CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCN=C(N)N)NC(C)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)C1CCCCC1";"IC50";"'='";"18.0";"nM";"7.75";"";"";"UO_0000065";"4.55";"None";"None";"None";"0";"CHEMBL750765";"Compound was evaluated for its inhibitory activity against Y2 receptor of rabbit kidney membrane";"B";"BAO_0000019";"assay format";"Oryctolagus cuniculus";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1126482";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1993";"None";"";"";""
"CHEMBL1774211";"";"None";"1031.19";"3";"6.30";"54";"Cc1cc(/C=C/c2cc3c4c(c2)CCCN4CCC3)cc(C)[n+]1CCNC(=O)CCCC(=O)/N=C(/N)NCCC[C@@H](NC(=O)C(c1ccccc1)c1ccccc1)C(=O)NCc1ccc(O)cc1.O=C([O-])C(F)(F)F";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1777149";"Displacement of Dy-635-pNPY from human Y2R expressed in CHO cells by flow cytometry";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1773009";"1";"Scientific Literature";"Bioorg Med Chem";"2011";"CHEMBL3308072";"";"";""
"CHEMBL281387";"";"None";"493.65";"1";"5.62";"39";"CC(=O)N1CCc2ccc(N(C(=O)/C=C/c3cccc(C)c3)C3CCN(Cc4ccccc4)CC3)cc21";"IC50";"'='";"1400.0";"nM";"5.85";"";"";"UO_0000065";"11.86";"0.22";"0.23";"13.35";"0";"CHEMBL750768";"Binding affinity towards the NPY Y2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147599";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2004";"None";"";"";""
"CHEMBL20400";"";"None";"480.61";"0";"4.70";"29";"CC(=O)N1CCc2ccc(N(C(=O)/C=C/c3ccncc3)C3CCN(Cc4ccccc4)CC3)cc21";"IC50";"'='";"12000.0";"nM";"4.92";"";"";"UO_0000065";"10.24";"0.19";"0.22";"8.67";"0";"CHEMBL750768";"Binding affinity towards the NPY Y2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147599";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2004";"None";"";"";""
"CHEMBL21071";"";"None";"493.65";"1";"5.70";"15";"CC(=O)N1CCCc2ccc(N(C(=O)/C=C/c3ccccc3)C3CCN(Cc4ccccc4)CC3)cc21";"IC50";"'='";"10000.0";"nM";"5.00";"";"";"UO_0000065";"10.13";"0.18";"-0.70";"11.40";"0";"CHEMBL750768";"Binding affinity towards the NPY Y2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147599";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2004";"None";"";"";""
"CHEMBL266077";"";"None";"1674.93";"None";"None";"NPY Ac 25-36";"CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCN=C(N)N)NC(C)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)[C@@H](C)CC";"IC50";"'='";"160.0";"nM";"6.80";"";"";"UO_0000065";"4.06";"None";"None";"None";"0";"CHEMBL750765";"Compound was evaluated for its inhibitory activity against Y2 receptor of rabbit kidney membrane";"B";"BAO_0000019";"assay format";"Oryctolagus cuniculus";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1126482";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1993";"None";"";"";""
"CHEMBL1458887";"";"None";"362.74";"0";"4.66";"SID24796859";"CC(C)(C)NCc1cc(Br)ccc1OC1CCCC1.Cl";"IC50";"'='";"11220.0";"nM";"4.95";"";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1613986";"PUBCHEM_BIOASSAY: Dose response counterscreen assay for neuropeptide Y receptor Y1 (NPY-Y1): Cell-based high throughput assay to measure NPY-Y2 antagonism. (Class of assay: confirmatory) [Related pubchem assays: 793, 1040, 1255, 1254 ]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL41543";"";"None";"238.29";"0";"3.00";"10,11-DIHYDRO-CARBAMAZEPINE";"NC(=O)N1c2ccccc2CCc2ccccc21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1489";"AZACITIDINE";"4.0";"244.21";"0";"-3.17";"AZACITIDINE";"Nc1ncn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c(=O)n1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL640";"PROCAINAMIDE";"4.0";"235.33";"0";"1.34";"PROCAINAMIDE";"CCN(CC)CCNC(=O)c1ccc(N)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1200528";"CHROMIC CHLORIDE";"4.0";"158.36";"None";"None";"CHROMIUM(III) CHLORIDE";"";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL404811";"DIGITONIN";"None";"1229.32";"None";"None";"DIGITONIN";"C[C@@H]1CC[C@@]2(OC1)O[C@H]1[C@@H](O)[C@H]3[C@@H]4CC[C@H]5C[C@@H](O[C@@H]6O[C@H](CO)[C@H](O[C@@H]7O[C@H](CO)C(O)[C@H](O[C@@H]8OC[C@@H](O)[C@H](O)[C@H]8O)[C@H]7O[C@@H]7O[C@H](CO)[C@H](O)[C@H](O[C@@H]8O[C@H](CO)[C@@H](O)[C@H](O)[C@H]8O)[C@H]7O)[C@H](O)[C@H]6O)[C@H](O)C[C@]5(C)[C@H]4CC[C@]3(C)[C@H]1[C@@H]2C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL248702";"DEXFENFLURAMINE";"4.0";"231.26";"0";"3.25";"DEXFENFLURAMINE";"CCN[C@@H](C)Cc1cccc(C(F)(F)F)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL564";"PROMAZINE";"4.0";"284.43";"0";"4.24";"PROMAZINE";"CN(C)CCCN1c2ccccc2Sc2ccccc21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1555711";"";"None";"368.84";"0";"3.85";"SID17407295";"CCCCNC(=O)c1onc(CSc2ccc(Cl)cc2)c1C(=O)O";"IC50";"'='";"9926.0";"nM";"5.00";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1613986";"PUBCHEM_BIOASSAY: Dose response counterscreen assay for neuropeptide Y receptor Y1 (NPY-Y1): Cell-based high throughput assay to measure NPY-Y2 antagonism. (Class of assay: confirmatory) [Related pubchem assays: 793, 1040, 1255, 1254 ]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL990";"BUTENAFINE";"4.0";"317.48";"1";"5.77";"BUTENAFINE";"CN(Cc1ccc(C(C)(C)C)cc1)Cc1cccc2ccccc12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL698";"TETRACAINE";"4.0";"264.37";"0";"2.62";"TETRACAINE";"CCCCNc1ccc(C(=O)OCCN(C)C)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1909079";"STANNOUS FLUORIDE";"4.0";"156.71";"None";"None";"STANNOUS FLUORIDE";"";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL2079587";"STANOZOLOL";"4.0";"328.50";"0";"4.12";"STANOZOLOL";"C[C@]12Cc3c[nH]nc3C[C@@H]1CC[C@@H]1[C@@H]2CC[C@@]2(C)[C@H]1CC[C@]2(C)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL415324";"TRANILAST";"3.0";"327.34";"0";"3.05";"TRANILAST";"COc1ccc(/C=C/C(=O)Nc2ccccc2C(=O)O)cc1OC";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL421";"SULFASALAZINE";"4.0";"398.40";"0";"3.70";"SULFASALAZINE";"O=C(O)c1cc(/N=N/c2ccc(S(=O)(=O)Nc3ccccn3)cc2)ccc1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL726";"FLUPHENAZINE";"4.0";"437.53";"0";"4.31";"FLUPHENAZINE";"OCCN1CCN(CCCN2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL891";"CLOXACILLIN";"4.0";"435.89";"0";"2.55";"CLOXACILLIN";"Cc1onc(-c2ccccc2Cl)c1C(=O)N[C@@H]1C(=O)N2[C@@H]1SC(C)(C)[C@@H]2C(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1201139";"MEGESTROL ACETATE";"4.0";"384.52";"0";"4.58";"MEGESTROL ACETATE";"CC(=O)O[C@]1(C(C)=O)CC[C@H]2[C@@H]3C=C(C)C4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1201024";"METHSCOPOLAMINE BROMIDE";"None";"398.30";"0";"1.06";"METHSCOPOLAMINE BROMIDE";"C[N+]1(C)[C@H]2C[C@H](OC(=O)[C@H](CO)c3ccccc3)C[C@H]1[C@H]1O[C@H]12.[Br-]";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL817";"TOLAZAMIDE";"4.0";"311.41";"0";"1.77";"TOLAZAMIDE";"Cc1ccc(S(=O)(=O)NC(=O)NN2CCCCCC2)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL21652";"";"None";"507.68";"2";"5.92";"44";"CC(=O)N1CCc2ccc(N(C(=O)/C=C/c3cc(C)cc(C)c3)C3CCN(Cc4ccccc4)CC3)cc21";"IC50";"'='";"3900.0";"nM";"5.41";"";"";"UO_0000065";"10.65";"0.19";"-0.51";"12.33";"0";"CHEMBL750768";"Binding affinity towards the NPY Y2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147599";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2004";"None";"";"";""
"CHEMBL2403024";"";"None";"506.62";"2";"5.55";"9b";"CCN(CC)C(=O)C(c1ccccc1)C1CCN(c2ccc(NC(=O)c3c(C)noc3C)cc2F)CC1";"IC50";"'='";"37.0";"nM";"7.43";"";"";"UO_0000065";"14.67";"0.27";"1.88";"9.45";"0";"CHEMBL2404394";"Displacement of [125I]PYY from NPY-Y2 receptor in human KAN-TS cell membranes after 1 hr by scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"KAN-TS";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2401643";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"None";"";"";""
"CHEMBL2402906";"";"None";"536.65";"2";"6.28";"8b";"CCNC(=O)C(c1ccccc1)C1CCN(c2ccc(NC(=O)c3ccccc3-c3cccnc3)cc2F)CC1";"IC50";"'='";"24.0";"nM";"7.62";"";"";"UO_0000065";"14.20";"0.26";"1.34";"10.25";"0";"CHEMBL2404394";"Displacement of [125I]PYY from NPY-Y2 receptor in human KAN-TS cell membranes after 1 hr by scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"KAN-TS";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2401643";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"None";"";"";""
"CHEMBL22131";"";"None";"493.65";"1";"5.72";"55";"C=CCN(CCCN(C(=O)/C=C/c1ccccc1)c1ccc2c(c1)N(C(C)=O)CC2)Cc1ccccc1";"IC50";"'='";"12000.0";"nM";"4.92";"";"";"UO_0000065";"9.97";"0.18";"-0.80";"11.22";"0";"CHEMBL750768";"Binding affinity towards the NPY Y2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147599";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2004";"None";"";"";""
"CHEMBL328860";"";"None";"430.62";"1";"5.98";"10";"CN(C)CCCN(C(=O)/C=C/c1ccccc1)c1ccccc1SCc1ccccc1";"IC50";"'='";"10000.0";"nM";"5.00";"";"";"UO_0000065";"11.61";"0.22";"-0.98";"21.23";"0";"CHEMBL747054";"Binding affinity against SMS-KAN cell membranes endogenously expressing Neuropeptide Y receptor type 2 using [125I]PYY as radioligand";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"SMS-KAN";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1136181";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2003";"None";"";"";""
"CHEMBL567112";"";"None";"473.64";"1";"5.01";"2o";"CCc1sc(SCc2cc(N3CCOCC3)cc(NCc3cccc(C)n3)n2)nc1CF";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1042014";"Displacement of [125I]-PYY from human NPYY2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1155324";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"None";"";"";""
"CHEMBL95327";"";"None";"457.60";"1";"5.75";"24";"CN(C)CCCN(C(=O)c1cc2ccccc2s1)c1ccccc1NC(=O)c1ccccc1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL747054";"Binding affinity against SMS-KAN cell membranes endogenously expressing Neuropeptide Y receptor type 2 using [125I]PYY as radioligand";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"SMS-KAN";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1136181";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2003";"None";"";"";""
"CHEMBL282468";"CHOLINE CHLORIDE";"4.0";"139.63";"None";"None";"CHOLINE CHLORIDE";"C[N+](C)(C)CCO.[Cl-]";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL411637";"";"None";"2077.35";"None";"None";"37";"CC(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O)C(C)C";"IC50";"'='";"3.17";"nM";"8.50";"";"";"UO_0000065";"4.09";"None";"None";"None";"0";"CHEMBL755164";"Affinity against Neuropeptide Y receptor Y2 in SK-N-BE2 cell line";"B";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133640";"1";"Scientific Literature";"J Med Chem";"2000";"None";"";"";""
"CHEMBL1538792";"";"None";"440.57";"0";"4.19";"SID24819695";"CCOC(=O)c1c(CSc2ccccc2)n(C)c2ccc(O)c(CN3CCOCC3)c12";"IC50";"'>'";"35000.0";"nM";"";"";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1613986";"PUBCHEM_BIOASSAY: Dose response counterscreen assay for neuropeptide Y receptor Y1 (NPY-Y1): Cell-based high throughput assay to measure NPY-Y2 antagonism. (Class of assay: confirmatory) [Related pubchem assays: 793, 1040, 1255, 1254 ]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL452861";"(-)-PROPANOLOL ";"2.0";"259.35";"0";"2.58";"S-(-)-PROPRANOLOL";"CC(C)NC[C@H](O)COc1cccc2ccccc12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1427664";"";"None";"226.11";"0";"0.26";"SID855511";"CC(=O)OCC[N+](C)(C)C.[Br-]";"IC50";"'>'";"35000.0";"nM";"";"";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1613986";"PUBCHEM_BIOASSAY: Dose response counterscreen assay for neuropeptide Y receptor Y1 (NPY-Y1): Cell-based high throughput assay to measure NPY-Y2 antagonism. (Class of assay: confirmatory) [Related pubchem assays: 793, 1040, 1255, 1254 ]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1359108";"";"None";"674.70";"2";"5.89";"SID24708168";"COC(=O)[C@@]1(Cc2ccc(F)cc2)[C@H]2c3cc(C(=O)N4CCCC4)n(Cc4ccc(C(F)(F)F)nc4)c3C[C@H]2CN1C(=O)c1ccccc1";"IC50";"'>'";"35000.0";"nM";"";"";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1613986";"PUBCHEM_BIOASSAY: Dose response counterscreen assay for neuropeptide Y receptor Y1 (NPY-Y1): Cell-based high throughput assay to measure NPY-Y2 antagonism. (Class of assay: confirmatory) [Related pubchem assays: 793, 1040, 1255, 1254 ]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1471370";"";"None";"411.53";"0";"3.51";"SID24831665";"Cc1cc(C(=O)CSc2nc3ccccc3c(=O)n2C)c(C)n1CC1CCCO1";"IC50";"'>'";"35000.0";"nM";"";"";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1613986";"PUBCHEM_BIOASSAY: Dose response counterscreen assay for neuropeptide Y receptor Y1 (NPY-Y1): Cell-based high throughput assay to measure NPY-Y2 antagonism. (Class of assay: confirmatory) [Related pubchem assays: 793, 1040, 1255, 1254 ]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1368744";"";"None";"309.35";"0";"3.76";"SID24816175";"Oc1ccc(-c2n[nH]cc2-c2nc3ccccc3s2)c(O)c1";"IC50";"'>'";"35000.0";"nM";"";"";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1613986";"PUBCHEM_BIOASSAY: Dose response counterscreen assay for neuropeptide Y receptor Y1 (NPY-Y1): Cell-based high throughput assay to measure NPY-Y2 antagonism. (Class of assay: confirmatory) [Related pubchem assays: 793, 1040, 1255, 1254 ]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL491930";"";"None";"400.44";"0";"3.84";"5c";"O=C1OC2(CCN(C(=O)Nc3cnc(-c4ccccc4)cn3)CC2)c2ccccc21";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1008339";"Inhibition of human NPY Y2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1136978";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"None";"";"";""
"CHEMBL279493";"";"None";"451.57";"0";"4.89";"16";"O=C1Cc2ccc(N(C(=O)/C=C/c3ccccc3)C3CCN(Cc4ccccc4)CC3)cc2N1";"IC50";"'='";"30000.0";"nM";"4.52";"";"";"UO_0000065";"10.02";"0.18";"-0.37";"8.59";"0";"CHEMBL750768";"Binding affinity towards the NPY Y2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147599";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2004";"None";"";"";""
"CHEMBL1110";"ALOSETRON";"4.0";"294.36";"0";"2.41";"ALOSETRON";"Cc1[nH]cnc1CN1CCc2c(c3ccccc3n2C)C1=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL411";"DIETHYLSTILBESTROL";"4.0";"268.36";"0";"4.83";"DIETHYLSTILBESTROL";"CC/C(=C(/CC)c1ccc(O)cc1)c1ccc(O)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL205596";"CHOLIC ACID";"4.0";"408.58";"0";"3.45";"CHOLIC ACID";"C[C@H](CCC(=O)O)[C@H]1CC[C@H]2[C@@H]3[C@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3C[C@H](O)[C@]12C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL504760";"CAMPHOR";"4.0";"152.24";"0";"2.40";"CAMPHRE";"CC1(C)[C@@H]2CC[C@@]1(C)C(=O)C2";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL648";"CYCLIZINE";"4.0";"266.39";"0";"3.02";"CYCLIZINE";"CN1CCN(C(c2ccccc2)c2ccccc2)CC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1389982";"";"None";"311.38";"1";"5.25";"SID17386276";"Oc1cccc(-c2nc3ccc4ccccc4c3c3c2CCC3)c1";"IC50";"'='";"5224.0";"nM";"5.28";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614345";"PUBCHEM_BIOASSAY: Dose response cell-based screening assay for antagonists of neuropeptide Y receptor Y2 (NPY-Y2). (Class of assay: confirmatory) [Related pubchem assays: 793, 1257, 1256 ]";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1503";"OMEPRAZOLE";"4.0";"345.42";"0";"2.90";"OMEPRAZOLE";"COc1ccc2[nH]c([S+]([O-])Cc3ncc(C)c(OC)c3C)nc2c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL871";"ETIDRONIC ACID";"4.0";"206.03";"0";"-0.99";"ETIDRONATE";"CC(O)(P(=O)(O)O)P(=O)(O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL413965";"FELBINAC";"4.0";"212.25";"0";"2.98";"SID11112568";"O=C(O)Cc1ccc(-c2ccccc2)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1140";"NIACINAMIDE";"4.0";"122.13";"0";"0.18";"NIACINAMIDE";"NC(=O)c1cccnc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL826";"ENOXACIN";"4.0";"320.32";"0";"0.66";"ENOXACIN";"CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)nc21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL710";"FINASTERIDE";"4.0";"372.55";"0";"3.81";"FINASTERIDE";"CC(C)(C)NC(=O)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4NC(=O)C=C[C@]4(C)[C@H]3CC[C@]12C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL290106";"BITHIONOL";"4.0";"356.06";"1";"5.86";"BITHIONOL";"Oc1c(Cl)cc(Cl)cc1Sc1cc(Cl)cc(Cl)c1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL2";"PRAZOSIN";"4.0";"383.41";"0";"1.78";"Prazosin";"COc1cc2nc(N3CCN(C(=O)c4ccco4)CC3)nc(N)c2cc1OC";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1200656";"NATAMYCIN";"4.0";"665.73";"3";"0.12";"PIMARICIN";"C[C@@H]1C/C=C/C=C/C=C/C=C/[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)C[C@H]3O[C@@H]3/C=C/C(=O)O1)C[C@H](O)[C@H]2C(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL838";"BENAZEPRIL";"4.0";"424.50";"0";"2.57";"BENAZEPRIL";"CCOC(=O)[C@H](CCc1ccccc1)N[C@H]1CCc2ccccc2N(CC(=O)O)C1=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1455";"ALTRETAMINE";"4.0";"210.28";"0";"0.07";"ALTRETAMINE";"CN(C)c1nc(N(C)C)nc(N(C)C)n1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1480";"FELODIPINE";"4.0";"384.26";"0";"3.96";"FELODIPINE";"CCOC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1c1cccc(Cl)c1Cl";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1481";"GLIMEPIRIDE";"4.0";"490.63";"0";"3.07";"GLIMEPIRIDE";"CCC1=C(C)CN(C(=O)NCCc2ccc(S(=O)(=O)NC(=O)N[C@H]3CC[C@H](C)CC3)cc2)C1=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL289469";"GRANISETRON";"4.0";"312.42";"0";"2.32";"GRANISETRON";"CN1C2CCCC1CC(NC(=O)c1nn(C)c3ccccc13)C2";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL29";"BENZYLPENICILLIN";"4.0";"334.40";"0";"0.86";"PENICILLINE";"CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1480987";"CYCLANDELATE";"4.0";"276.38";"0";"3.48";"CYCLANDELATE";"CC1CC(OC(=O)C(O)c2ccccc2)CC(C)(C)C1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL31184";"BENZO[DEF]CHRYSENE";"0.5";"252.32";"1";"5.74";"BENZO[A]PYRENE";"c1ccc2c(c1)cc1ccc3cccc4ccc2c1c34";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL566534";"ARTEMETHER";"4.0";"298.38";"0";"2.84";"ARTEMETHER";"CO[C@H]1O[C@@H]2O[C@@]3(C)CC[C@H]4[C@H](C)CC[C@@H]([C@H]1C)[C@@]24OO3";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1487";"ATORVASTATIN";"4.0";"558.65";"2";"6.31";"ATORVASTATIN";"CC(C)c1c(C(=O)Nc2ccccc2)c(-c2ccccc2)c(-c2ccc(F)cc2)n1CC[C@@H](O)C[C@@H](O)CC(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL498";"CHLORPROPAMIDE";"4.0";"276.75";"0";"1.74";"CHLORPROPAMIDE";"CCCNC(=O)NS(=O)(=O)c1ccc(Cl)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL53463";"DOXORUBICIN";"4.0";"543.53";"3";"0.00";"DOX";"COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL254219";"DIGITOXIN";"4.0";"764.95";"2";"3.25";"DIGITOXIN";"C[C@H]1O[C@@H](O[C@H]2[C@@H](O)C[C@H](O[C@H]3[C@@H](O)C[C@H](O[C@H]4CC[C@@]5(C)[C@H](CC[C@@H]6[C@@H]5CC[C@]5(C)[C@@H](C7=CC(=O)OC7)CC[C@]65O)C4)O[C@@H]3C)O[C@@H]2C)C[C@H](O)[C@@H]1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL47";"ALPHA-TOCOPHEROL";"None";"430.72";"1";"8.84";"ALPHA-TOCOPHEROL";"Cc1c(C)c2c(c(C)c1O)CC[C@@](C)(CCC[C@H](C)CCC[C@H](C)CCCC(C)C)O2";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1353428";"";"None";"377.51";"0";"4.56";"SID17514938";"Cc1cccc(-n2ccnc2SCC(=O)N2CCCc3ccccc32)c1C";"IC50";"'='";"1564.0";"nM";"5.81";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614345";"PUBCHEM_BIOASSAY: Dose response cell-based screening assay for antagonists of neuropeptide Y receptor Y2 (NPY-Y2). (Class of assay: confirmatory) [Related pubchem assays: 793, 1257, 1256 ]";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1870697";"";"None";"464.11";"1";"5.51";"SID17503795";"O=C(Nc1cccc(/N=C/c2cc(Br)cc(Br)c2O)c1)c1ccco1";"IC50";"'>'";"35000.0";"nM";"";"";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614345";"PUBCHEM_BIOASSAY: Dose response cell-based screening assay for antagonists of neuropeptide Y receptor Y2 (NPY-Y2). (Class of assay: confirmatory) [Related pubchem assays: 793, 1257, 1256 ]";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1771259";"";"None";"464.40";"0";"4.51";"2f, CP-671906";"COc1cc(Cl)c(-c2c(C)nn3c(NCCNC4CCOCC4)cc(C)nc23)c(Cl)c1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1772030";"Binding affinity to human NPY Y2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1770105";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";"";""
"CHEMBL7568";"QUINACRINE";"2.0";"399.97";"1";"5.97";"QUINACRINE";"CCN(CC)CCCC(C)Nc1c2ccc(Cl)cc2nc2ccc(OC)cc12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL959";"RIMANTADINE";"4.0";"179.31";"0";"2.55";"RIMANTADINE";"CC(N)C12CC3CC(CC(C3)C1)C2";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL549";"CITALOPRAM";"4.0";"324.40";"0";"3.81";"CITALOPRAM";"CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL83";"TAMOXIFEN";"4.0";"371.52";"1";"6.00";"2";"CC/C(=C(\c1ccccc1)c1ccc(OCCN(C)C)cc1)c1ccccc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL498847";"SECNIDAZOLE";"4.0";"185.18";"0";"0.48";"SECNIDAZOLE";"Cc1ncc([N+](=O)[O-])n1CC(C)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1419";"SIBUTRAMINE";"4.0";"279.86";"0";"4.74";"SIBUTRAMINE";"CC(C)CC(N(C)C)C1(c2ccc(Cl)cc2)CCC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1200748";"CARBIDOPA";"4.0";"244.25";"0";"-0.05";"S(-)-CARBIDOPA";"C[C@@](Cc1ccc(O)c(O)c1)(NN)C(=O)O.O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL37858";"SARAFLOXACIN";"-1.0";"385.37";"0";"2.38";"SARAFLOXACIN";"O=C(O)c1cn(-c2ccc(F)cc2)c2cc(N3CCNCC3)c(F)cc2c1=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL866";"MYCOPHENOLIC ACID";"4.0";"320.34";"0";"2.73";"MYCOPHENOLIC ACID";"COc1c(C)c2c(c(O)c1C/C=C(\C)CCC(=O)O)C(=O)OC2";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL262777";"VANCOMYCIN";"4.0";"1449.27";"None";"None";"vancomycin";"CN[C@H](CC(C)C)C(=O)N[C@H]1C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]2C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c4cc(O)cc(O)c4-c4cc3ccc4O)[C@H](O)c3ccc(c(Cl)c3)Oc3cc2cc(c3O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O[C@H]2C[C@](C)(N)[C@H](O)[C@H](C)O2)Oc2ccc(cc2Cl)[C@H]1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL24441";"BETAHISTINE";"4.0";"136.20";"0";"0.84";"BETAHISTINE";"CNCCc1ccccn1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL44";"GENISTEIN";"2.0";"270.24";"0";"2.58";"genistein";"O=c1c(-c2ccc(O)cc2)coc2cc(O)cc(O)c12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL559147";"Y-27632";"None";"247.34";"0";"2.17";"Y-27632";"C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1670";"MITOTANE";"4.0";"320.05";"1";"5.93";"MITOTANE";"Clc1ccc(C(c2ccccc2Cl)C(Cl)Cl)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL22056";"";"None";"514.07";"2";"5.96";"32";"CC(=O)N1CCc2ccc(N(C(=O)/C=C/c3cccc(Cl)c3)C3CCN(Cc4ccccc4)CC3)cc21";"IC50";"'='";"3000.0";"nM";"5.52";"";"";"UO_0000065";"10.74";"0.20";"-0.44";"12.59";"0";"CHEMBL750768";"Binding affinity towards the NPY Y2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147599";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2004";"None";"";"";""
"CHEMBL5315124";"LEVOFLOXACIN";"4.0";"740.76";"0";"1.54";"LEVOFLOXACIN";"C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1630579";"MYRTECAINE";"2.0";"265.44";"0";"3.73";"MYRTECAINE";"CCN(CC)CCOCCC1=CCC2CC1C2(C)C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL3208997";"";"None";"322.37";"0";"3.06";"SID14739316";"COc1cc(/C=N/n2cnnc2)ccc1OCc1ccc(C)cc1";"IC50";"'='";"4180.0";"nM";"5.38";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614345";"PUBCHEM_BIOASSAY: Dose response cell-based screening assay for antagonists of neuropeptide Y receptor Y2 (NPY-Y2). (Class of assay: confirmatory) [Related pubchem assays: 793, 1257, 1256 ]";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1462447";"";"None";"280.26";"0";"1.64";"SID14722665";"O=C(O)CSc1nnc(-c2ccc3c(c2)OCO3)o1";"IC50";"'>'";"35000.0";"nM";"";"";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614345";"PUBCHEM_BIOASSAY: Dose response cell-based screening assay for antagonists of neuropeptide Y receptor Y2 (NPY-Y2). (Class of assay: confirmatory) [Related pubchem assays: 793, 1257, 1256 ]";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1579872";"";"None";"379.28";"0";"4.10";"SID7967138";"Cc1cccc(CSC2=NCCN2C(=O)c2ccc(Br)o2)c1";"IC50";"'='";"12810.0";"nM";"4.89";"";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614345";"PUBCHEM_BIOASSAY: Dose response cell-based screening assay for antagonists of neuropeptide Y receptor Y2 (NPY-Y2). (Class of assay: confirmatory) [Related pubchem assays: 793, 1257, 1256 ]";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL3190644";"";"None";"295.34";"0";"3.71";"SID14727976";"CC(C)COC(=O)c1cccc2c1-c1ccccc1/C2=N\O";"IC50";"'='";"4958.0";"nM";"5.30";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614345";"PUBCHEM_BIOASSAY: Dose response cell-based screening assay for antagonists of neuropeptide Y receptor Y2 (NPY-Y2). (Class of assay: confirmatory) [Related pubchem assays: 793, 1257, 1256 ]";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1456185";"";"None";"254.34";"0";"2.83";"SID4259551";"C=CCNc1nc(N2CCCC2)nc2ccccc12";"IC50";"'>'";"35000.0";"nM";"";"";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614345";"PUBCHEM_BIOASSAY: Dose response cell-based screening assay for antagonists of neuropeptide Y receptor Y2 (NPY-Y2). (Class of assay: confirmatory) [Related pubchem assays: 793, 1257, 1256 ]";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1600727";"";"None";"357.49";"1";"5.21";"SID3716518";"c1ccc(-c2nc(CSc3nnc(-c4cccs4)o3)cs2)cc1";"IC50";"'='";"17320.0";"nM";"4.76";"";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614345";"PUBCHEM_BIOASSAY: Dose response cell-based screening assay for antagonists of neuropeptide Y receptor Y2 (NPY-Y2). (Class of assay: confirmatory) [Related pubchem assays: 793, 1257, 1256 ]";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1585652";"";"None";"377.48";"0";"4.62";"SID17412688";"COc1ccccc1CCNCc1ccc(OC)c(OCc2ccccc2)c1";"IC50";"'='";"1974.0";"nM";"5.71";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614345";"PUBCHEM_BIOASSAY: Dose response cell-based screening assay for antagonists of neuropeptide Y receptor Y2 (NPY-Y2). (Class of assay: confirmatory) [Related pubchem assays: 793, 1257, 1256 ]";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL181";"DIAZOXIDE";"4.0";"230.68";"0";"1.68";"DIAZOXIDE";"CC1=Nc2ccc(Cl)cc2S(=O)(=O)N1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL521606";"NADOLOL";"4.0";"309.41";"0";"0.63";"NADOLOL";"CC(C)(C)NCC(O)COc1cccc2c1CC(O)C(O)C2";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL398440";"CHLOROXYLENOL";"4.0";"156.61";"0";"2.66";"CHLOROXYLENOL";"Cc1cc(O)cc(C)c1Cl";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL115769";"";"None";"334.35";"0";"3.97";"RWJ-68354";"COc1cc(N)[nH]c2nc(-c3ccc(F)cc3)c(-c3ccncc3)c1-2";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1214185";"ROXITHROMYCIN";"4.0";"837.06";"2";"2.21";"ROXITHROMYCIN";"CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)/C(=N\OCOCCOC)[C@H](C)[C@@H](O)[C@]1(C)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL288355";"";"None";"487.60";"0";"2.94";"10 (RS)";"CC(NC(=O)C(CCCN=C(N)N)NC(=O)C(c1ccccc1)c1ccccc1)c1ccc(O)cc1";"IC50";"'='";"575000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL747056";"Inhibition of binding of [3H]propionyl-NPY (1 nM) to Neuropeptide Y receptor type 2 in SMS-KAN cell membranes";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"SMS-KAN";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133238";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2000";"None";"";"";""
"CHEMBL799";"CILOSTAZOL";"4.0";"369.47";"0";"3.46";"CILOSTAZOL";"O=C1CCc2cc(OCCCCc3nnnn3C3CCCCC3)ccc2N1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL64894";"GENTIAN VIOLET";"4.0";"407.99";"0";"4.46";"GENTIAN VIOLET";"CN(C)c1ccc(C(=C2C=CC(=[N+](C)C)C=C2)c2ccc(N(C)C)cc2)cc1.[Cl-]";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1201356";"METHYLERGONOVINE";"4.0";"339.44";"0";"1.92";"METHYLERGONOVINE";"CC[C@@H](CO)NC(=O)[C@@H]1C=C2c3cccc4[nH]cc(c34)C[C@H]2N(C)C1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1360997";"";"None";"440.59";"0";"3.54";"SID14722452";"CCN(CC)S(=O)(=O)c1ccc(Oc2ccc(S(=O)(=O)N(CC)CC)cc2)cc1";"IC50";"'>'";"35000.0";"nM";"";"";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1613986";"PUBCHEM_BIOASSAY: Dose response counterscreen assay for neuropeptide Y receptor Y1 (NPY-Y1): Cell-based high throughput assay to measure NPY-Y2 antagonism. (Class of assay: confirmatory) [Related pubchem assays: 793, 1040, 1255, 1254 ]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1412538";"";"None";"324.34";"0";"3.45";"SID3717588";"CCc1cc(-c2[nH]ncc2-c2ccc3c(c2)OCO3)c(O)cc1O";"IC50";"'<'";"35000.0";"nM";"";"";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1613986";"PUBCHEM_BIOASSAY: Dose response counterscreen assay for neuropeptide Y receptor Y1 (NPY-Y1): Cell-based high throughput assay to measure NPY-Y2 antagonism. (Class of assay: confirmatory) [Related pubchem assays: 793, 1040, 1255, 1254 ]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL21283";"";"None";"510.68";"2";"5.56";"60";"CC(=O)N1CCc2ccc(N(C(=O)/C=C/c3cccc(C#N)c3)C3CCN(CCC4CCCC4)CC3)cc21";"IC50";"'='";"100.0";"nM";"7.00";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL750761";"Binding affinity towards human NPY Y2 receptor was determined using [35S]GTP-gamma-S, radioligand";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147599";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2004";"None";"";"";""
"CHEMBL1201010";"FLUDROCORTISONE ACETATE";"4.0";"422.49";"0";"2.44";"FLUDROCORTISONE ACETATE";"CC(=O)OCC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1836318";"";"None";"437.66";"0";"4.37";"16";"CCS(=O)(=O)NC[C@H]1CC[C@H](Nc2nc3c(s2)CCSc2ccccc2-3)CC1";"IC50";"'>'";"1000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1837822";"Antagonist activity at human NPY2 receptor assessed as calcium mobilization by FLIPR assay";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1833793";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";"";""
"CHEMBL488025";"EXISULIND";"3.0";"372.42";"0";"4.03";"SULINDAC SULFONE";"CC1=C(CC(=O)O)c2cc(F)ccc2/C1=C\c1ccc(S(C)(=O)=O)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL58";"MITOXANTRONE";"4.0";"444.49";"1";"-0.14";"MITOXANTRONE";"O=C1c2c(O)ccc(O)c2C(=O)c2c(NCCNCCO)ccc(NCCNCCO)c21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL534";"KETOTIFEN";"4.0";"309.43";"0";"4.01";"KETOTIFEN";"CN1CCC(=C2c3ccccc3CC(=O)c3sccc32)CC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL976";"PRAZIQUANTEL";"4.0";"312.41";"0";"2.53";"PRAZIQUANTEL";"O=C(C1CCCCC1)N1CC(=O)N2CCc3ccccc3C2C1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL783";"NATEGLINIDE";"4.0";"317.43";"0";"3.26";"NATEGLINIDE";"CC(C)[C@H]1CC[C@H](C(=O)N[C@H](Cc2ccccc2)C(=O)O)CC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1064";"SIMVASTATIN";"4.0";"418.57";"0";"4.59";"SIMVASTATIN";"CCC(C)(C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@H]21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL267648";"PEFLOXACIN";"4.0";"333.36";"0";"1.61";"PEFLOXACIN";"CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCN(C)CC3)cc21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL19299";"LOXOPROFEN";"4.0";"246.31";"0";"2.79";"LOXOPROFEN";"CC(C(=O)O)c1ccc(CC2CCCC2=O)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1908847";"SPARTEINE";"4.0";"234.39";"0";"2.35";"SPARTEINE";"C1CCN2C[C@@H]3C[C@@H](CN4CCCC[C@@H]34)[C@H]2C1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL122";"ROFECOXIB";"4.0";"314.36";"0";"2.56";"ROFECOXIB";"CS(=O)(=O)c1ccc(C2=C(c3ccccc3)C(=O)OC2)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1395";"METHYLTESTOSTERONE";"4.0";"302.46";"0";"4.27";"SID56463771";"C[C@]12CCC(=O)C=C1CC[C@@H]1[C@@H]2CC[C@@]2(C)[C@H]1CC[C@]2(C)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1544";"LIOTHYRONINE";"4.0";"650.98";"1";"3.95";"3,3',5-TRIIODO-L-THYRONINE";"N[C@@H](Cc1cc(I)c(Oc2ccc(O)c(I)c2)c(I)c1)C(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL32749";"FERULATE";"-1.0";"194.19";"0";"1.50";"FERULIC ACID";"COc1cc(/C=C/C(=O)O)ccc1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL12";"DIAZEPAM";"4.0";"284.75";"0";"3.15";"DIAZEPAM";"CN1C(=O)CN=C(c2ccccc2)c2cc(Cl)ccc21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL508102";"CARBIMAZOLE";"4.0";"186.24";"0";"1.56";"CARBIMAZOLE";"CCOC(=O)n1ccn(C)c1=S";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL30";"CIMETIDINE";"4.0";"252.35";"0";"0.60";"CIMETIDINE";"CN/C(=N\CCSCc1nc[nH]c1C)NC#N";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL18797";"SULINDAC SULFIDE";"-1.0";"340.42";"1";"5.35";"SULINDAC SULFIDE";"CSc1ccc(/C=C2/C(C)=C(CC(=O)O)c3cc(F)ccc32)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1790041";"RANITIDINE";"4.0";"314.41";"0";"1.46";"RANITIDINE";"CNC(=C[N+](=O)[O-])NCCSCc1ccc(CN(C)C)o1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL338790";"";"None";"212.21";"0";"1.31";"4-AMINO-1,8-NAPHTHALIMIDE";"Nc1ccc2c3c(cccc13)C(=O)NC2=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1908355";"TENIDAP";"2.0";"320.76";"0";"3.25";"TENIDAP";"NC(=O)N1C(=O)/C(=C(\O)c2cccs2)c2cc(Cl)ccc21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL21935";"";"None";"534.14";"2";"6.73";"56";"CC(=O)N1CCc2ccc(N(C(=O)/C=C/c3ccc(Cl)cc3)C3CCN(CCC4CCCCC4)CC3)cc21";"IC50";"'='";"1100.0";"nM";"5.96";"";"";"UO_0000065";"11.16";"0.21";"-0.77";"13.59";"0";"CHEMBL750768";"Binding affinity towards the NPY Y2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147599";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2004";"None";"";"";""
"CHEMBL441687";"GLYCYRRHIZIN";"2.0";"822.94";"3";"2.25";"GLYCYRRHIZIN";"CC1(C)[C@@H](O[C@H]2O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]2O[C@@H]2O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]2O)CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@@](C)(C(=O)O)CC[C@]5(C)CC[C@@]4(C)[C@]3(C)CC[C@@H]12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL278795";"";"None";"480.61";"0";"4.70";"28";"CC(=O)N1CCc2ccc(N(C(=O)/C=C/c3cccnc3)C3CCN(Cc4ccccc4)CC3)cc21";"IC50";"'='";"30000.0";"nM";"4.52";"";"";"UO_0000065";"9.41";"0.17";"-0.18";"7.97";"0";"CHEMBL750768";"Binding affinity towards the NPY Y2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147599";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2004";"None";"";"";""
"CHEMBL517712";"ATROPINE";"4.0";"289.38";"0";"1.93";"ATROPINE";"CN1[C@@H]2CC[C@H]1C[C@@H](OC(=O)C(CO)c1ccccc1)C2";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL415";"CLOMIPRAMINE";"4.0";"314.86";"0";"4.53";"CLOMIPRAMINE";"CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL4";"OFLOXACIN";"4.0";"361.37";"0";"1.54";"OFLOXACIN";"CC1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL748";"PRALIDOXIME CHLORIDE";"4.0";"172.62";"0";"0.32";"PRALIDOXIME CHLORIDE";"C[n+]1ccccc1/C=N/O.[Cl-]";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL597";"PHENTOLAMINE";"4.0";"281.36";"0";"2.84";"PHENTOLAMINE";"Cc1ccc(N(CC2=NCCN2)c2cccc(O)c2)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL456";"ETHACRYNIC ACID";"4.0";"303.14";"0";"3.61";"ETHACRYNIC ACID";"C=C(CC)C(=O)c1ccc(OCC(=O)O)c(Cl)c1Cl";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL139835";"CYPROTERONE ACETATE";"4.0";"416.95";"0";"4.61";"CYPROTERONE ACETATE";"CC(=O)O[C@]1(C(C)=O)CC[C@H]2[C@@H]3C=C(Cl)C4=CC(=O)[C@@H]5C[C@@H]5[C@]4(C)[C@H]3CC[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1055";"CHLORTHALIDONE";"4.0";"338.77";"0";"0.92";"CHLORTHALIDONE";"NS(=O)(=O)c1cc(C2(O)NC(=O)c3ccccc32)ccc1Cl";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL110691";"CHLORMADINONE ACETATE";"4.0";"404.93";"0";"4.75";"CHLORMADINONE ACETATE";"CC(=O)O[C@]1(C(C)=O)CC[C@H]2[C@@H]3C=C(Cl)C4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1282";"IMIQUIMOD";"4.0";"240.31";"0";"2.82";"IMIQUIMOD";"CC(C)Cn1cnc2c(N)nc3ccccc3c21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1385840";"ERGOCORNINE";"None";"561.68";"1";"2.04";"ERGOCORNINE";"CC(C)[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C=C4c5cccc6[nH]cc(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL134";"CLONIDINE";"4.0";"230.10";"0";"2.36";"CLONIDINE";"Clc1cccc(Cl)c1NC1=NCCN1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL894";"BUPROPION";"4.0";"239.75";"0";"3.30";"BUPROPION";"CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL294199";"CAPSAICIN";"4.0";"305.42";"0";"3.79";"CAPSAICIN";"COc1cc(CNC(=O)CCCC/C=C/C(C)C)ccc1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL567597";"ARTEMISININ";"4.0";"282.34";"0";"2.39";"ARTEMISININ";"C[C@@H]1CC[C@H]2[C@@H](C)C(=O)O[C@@H]3O[C@]4(C)CC[C@@H]1[C@]32OO4";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL445206";"ISOEUGENOL";"None";"164.20";"0";"2.43";"ISOEUGENOL";"C/C=C\c1ccc(O)c(OC)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL395110";"MEPAZINE";"4.0";"310.47";"0";"4.63";"MEPAZINE";"CN1CCCC(CN2c3ccccc3Sc3ccccc32)C1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL415176";"";"None";"1700.97";"None";"None";"Ac-25-36[Cha30]";"CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCN=C(N)N)NC(C)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)[C@@H](C)CC)C1CCCCC1";"IC50";"'='";"16.0";"nM";"7.80";"";"";"UO_0000065";"4.58";"None";"None";"None";"0";"CHEMBL750765";"Compound was evaluated for its inhibitory activity against Y2 receptor of rabbit kidney membrane";"B";"BAO_0000019";"assay format";"Oryctolagus cuniculus";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1126482";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1993";"None";"";"";""
"CHEMBL415176";"";"None";"1700.97";"None";"None";"Ac-25-36[Cha30]";"CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCN=C(N)N)NC(C)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)[C@@H](C)CC)C1CCCCC1";"IC50";"'='";"8.0";"nM";"8.10";"";"";"UO_0000065";"4.76";"None";"None";"None";"0";"CHEMBL750762";"Compound was evaluated for its inhibitory activity against human neuropeptide Y2 receptor expressing LN319 cells";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"LN319";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1126482";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1993";"None";"";"";""
"CHEMBL1308";"FOMEPIZOLE";"4.0";"82.11";"0";"0.72";"4-METHYLPYRAZOLE";"Cc1cn[nH]c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1752";"DYPHYLLINE";"4.0";"254.25";"0";"-2.21";"DYPHYLLINE";"Cn1c(=O)c2c(ncn2CC(O)CO)n(C)c1=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL241694";"ETHISTERONE";"3.0";"312.45";"0";"3.88";"ETHISTERONE";"C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1909050";"";"None";"293.41";"0";"4.09";"1-(2-METHYLBENZOYL)-4-(PHENYLMETHYL)-PIPERIDINE";"Cc1ccccc1C(=O)N1CCC(Cc2ccccc2)CC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL428880";"CROMOLYN";"4.0";"468.37";"0";"2.11";"CROMOLYN";"O=C(O)c1cc(=O)c2c(OCC(O)COc3cccc4oc(C(=O)O)cc(=O)c34)cccc2o1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1471779";"";"None";"500.53";"2";"5.11";"SID17514496";"COC(=O)c1c(C)oc2ccc(N(C(=O)c3ccncc3)S(=O)(=O)c3ccc4ccccc4c3)cc12";"IC50";"'='";"7936.0";"nM";"5.10";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614345";"PUBCHEM_BIOASSAY: Dose response cell-based screening assay for antagonists of neuropeptide Y receptor Y2 (NPY-Y2). (Class of assay: confirmatory) [Related pubchem assays: 793, 1257, 1256 ]";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1393538";"";"None";"458.61";"0";"3.58";"SID14734196";"Cc1ccccc1C(=O)c1cccn1CC(=O)NCCN1CCN(c2cccc(C)c2C)CC1";"IC50";"'='";"13200.0";"nM";"4.88";"";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614345";"PUBCHEM_BIOASSAY: Dose response cell-based screening assay for antagonists of neuropeptide Y receptor Y2 (NPY-Y2). (Class of assay: confirmatory) [Related pubchem assays: 793, 1257, 1256 ]";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL508338";"THIMEROSAL";"4.0";"404.82";"None";"None";"THIMEROSAL";"";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1660";"RIFAPENTINE";"4.0";"877.04";"4";"5.65";"RIFAPENTINE";"CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C)c(O)c4c(O)c(c(/C=N/N5CCN(C6CCCC6)CC5)c(O)c4c3C2=O)NC(=O)/C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL15245";"YOHIMBINE";"4.0";"354.45";"0";"2.65";"YOHIMBINE";"COC(=O)[C@@H]1[C@H]2C[C@H]3c4[nH]c5ccccc5c4CCN3C[C@@H]2CC[C@@H]1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL496";"HEXACHLOROPHENE";"4.0";"406.91";"1";"6.61";"SID26752933";"Oc1c(Cl)cc(Cl)c(Cl)c1Cc1c(O)c(Cl)cc(Cl)c1Cl";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1836317";"";"None";"423.63";"0";"3.98";"15, Lu AA33810";"CS(=O)(=O)NC[C@H]1CC[C@H](Nc2nc3c(s2)CCSc2ccccc2-3)CC1";"IC50";"'>'";"1000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1837822";"Antagonist activity at human NPY2 receptor assessed as calcium mobilization by FLIPR assay";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1833793";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";"";""
"CHEMBL25719";"GERANIOL";"None";"154.25";"0";"2.67";"GERANIOL";"CC(C)=CCC/C(C)=C/CO";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1823345";"";"None";"505.62";"2";"5.64";"14";"COC(=O)C(c1ccccc1)N1CCN(c2ccc(NC(=O)c3ccccc3-c3ccccc3)cc2)CC1";"IC50";"'='";"530.0";"nM";"6.28";"";"";"UO_0000065";"12.41";"0.23";"0.64";"10.14";"0";"CHEMBL1827365";"Displacement of [125I]PYY from human NPY Y2 receptor expressed endogenously in KAN-Ts cells by scintillation counting";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"KAN-Ts";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1821563";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";"";""
"CHEMBL1823576";"";"None";"482.64";"0";"4.93";"33";"CCC(CC)C(=O)Nc1ccc(N2CCN(C(C(=O)N(CC)CC)c3ccccc3)CC2)c(F)c1";"IC50";"'='";"50.0";"nM";"7.30";"";"";"UO_0000065";"15.13";"0.28";"2.37";"13.06";"0";"CHEMBL1827365";"Displacement of [125I]PYY from human NPY Y2 receptor expressed endogenously in KAN-Ts cells by scintillation counting";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"KAN-Ts";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1821563";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";"";""
"CHEMBL424";"SALICYLIC ACID";"4.0";"138.12";"0";"1.09";"SALICYLIC ACID";"O=C(O)c1ccccc1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1200396";"BUPIVACAINE HYDROCHLORIDE";"4.0";"324.90";"0";"3.90";"BUPIVACAINE HYDROCHLORIDE";"CCCCN1CCCCC1C(=O)Nc1c(C)cccc1C.Cl";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL4649901";"";"None";"1495.48";"None";"None";"BLEOMYCIN A2";"Cc1c(N)nc([C@H](CC(N)=O)NC[C@H](N)C(N)=O)nc1C(=O)N[C@H](C(=O)N[C@H](C)[C@@H](O)[C@H](C)C(=O)N[C@H](C(=O)NCCc1nc(-c2nc(C(=O)NCCC[S+](C)C)cs2)cs1)[C@@H](C)O)[C@@H](O[C@@H]1O[C@@H](CO)[C@@H](O)[C@H](O)[C@@H]1O[C@H]1O[C@H](CO)[C@@H](O)[C@H](OC(N)=O)[C@@H]1O)c1c[nH]cn1.[Br-]";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1109";"SULFAPHENAZOLE";"4.0";"314.37";"0";"2.26";"SULFAPHENAZOLE";"Nc1ccc(S(=O)(=O)Nc2ccnn2-c2ccccc2)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1741";"CLARITHROMYCIN";"4.0";"747.96";"2";"2.44";"CLARITHROMYCIN";"CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL191";"LOSARTAN";"4.0";"422.92";"0";"4.27";"LOSARTAN";"CCCCc1nc(Cl)c(CO)n1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1231107";"CYROMAZINE";"2.0";"166.19";"0";"-0.39";"CYROMAZINE";"Nc1nc(N)nc(NC2CC2)n1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL469912";"PUROMYCIN";"2.0";"471.52";"1";"-0.79";"PUROMYCIN";"COc1ccc(C[C@H](N)C(=O)N[C@H]2[C@@H](O)[C@H](n3cnc4c(N(C)C)ncnc43)O[C@@H]2CO)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1753";"CLINDAMYCIN";"4.0";"424.99";"0";"0.39";"CLINDAMYCIN";"CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1321";"PROCARBAZINE";"4.0";"221.30";"0";"1.05";"PROCARBAZINE";"CNNCc1ccc(C(=O)NC(C)C)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL136478";"SODIUM NITROPRUSSIDE";"4.0";"261.92";"None";"None";"SODIUM NITROPRUSSIDE";"";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL685";"MEBENDAZOLE";"4.0";"295.30";"0";"2.97";"MEBENDAZOLE";"COC(=O)Nc1nc2cc(C(=O)c3ccccc3)ccc2[nH]1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1201631";"INSULIN HUMAN";"4.0";"None";"None";"None";"INSULIN";"";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1177";"PEMOLINE";"4.0";"176.18";"0";"0.60";"PEMOLINE";"NC1=NC(=O)C(c2ccccc2)O1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1650";"CORTISONE ACETATE";"4.0";"402.49";"0";"2.56";"CORTISONE ACETATE";"CC(=O)OCC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3C(=O)C[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL280372";"";"None";"479.62";"1";"5.31";"23";"CC(=O)N1CCc2ccc(N(C(=O)/C=C\c3ccccc3)C3CCN(Cc4ccccc4)CC3)cc21";"IC50";"'='";"22000.0";"nM";"4.66";"";"";"UO_0000065";"9.71";"0.18";"-0.65";"10.62";"0";"CHEMBL750768";"Binding affinity towards the NPY Y2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147599";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2004";"None";"";"";""
"CHEMBL22046";"";"None";"505.66";"2";"5.86";"24";"CC(=O)N1CCc2ccc(N(C(=O)/C=C/C=C/c3ccccc3)C3CCN(Cc4ccccc4)CC3)cc21";"IC50";"'='";"2800.0";"nM";"5.55";"";"";"UO_0000065";"10.98";"0.20";"-0.31";"12.66";"0";"CHEMBL750768";"Binding affinity towards the NPY Y2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147599";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2004";"None";"";"";""
"CHEMBL20553";"";"None";"524.62";"2";"5.21";"40";"CC(=O)N1CCc2ccc(N(C(=O)/C=C/c3cccc([N+](=O)[O-])c3)C3CCN(Cc4ccccc4)CC3)cc21";"IC50";"'='";"1900.0";"nM";"5.72";"";"";"UO_0000065";"10.91";"0.20";"0.51";"6.58";"0";"CHEMBL750768";"Binding affinity towards the NPY Y2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147599";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2004";"None";"";"";""
"CHEMBL1342624";"";"None";"460.41";"1";"5.52";"SID17401411";"Cc1cccc(OCCNC(=O)c2ccc(Oc3ccc(C(F)(F)F)cc3[N+](=O)[O-])cc2)c1";"IC50";"'>'";"35000.0";"nM";"";"";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1613986";"PUBCHEM_BIOASSAY: Dose response counterscreen assay for neuropeptide Y receptor Y1 (NPY-Y1): Cell-based high throughput assay to measure NPY-Y2 antagonism. (Class of assay: confirmatory) [Related pubchem assays: 793, 1040, 1255, 1254 ]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL55";"PENTAMIDINE";"4.0";"340.43";"0";"2.88";"PENTAMIDINE";"N=C(N)c1ccc(OCCCCCOc2ccc(C(=N)N)cc2)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1766";"DESOXIMETASONE";"4.0";"376.47";"0";"2.78";"DESOXIMETASONE";"C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@H]1C(=O)CO";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1321154";"ROXARSONE";"None";"263.04";"None";"None";"ROXARSONE";"O=[N+]([O-])c1cc([As](=O)(O)O)ccc1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL37161";"FENBENDAZOLE";"2.0";"299.36";"0";"3.89";"FENBENDAZOLE";"COC(=O)Nc1nc2cc(Sc3ccccc3)ccc2[nH]1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1200845";"HALCINONIDE";"4.0";"454.97";"0";"3.89";"HALCINONIDE";"CC1(C)O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)CC[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@]2(C(=O)CCl)O1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1351";"CARBOPLATIN";"4.0";"371.25";"None";"None";"CARBOPLATIN";"";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL567";"PERPHENAZINE";"4.0";"403.98";"0";"3.94";"PERPHENAZINE";"OCCN1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL508112";"BENZOTHIAZYL DISULFIDE";"None";"332.50";"1";"5.71";"BENZOTHIAZYL DISULFIDE";"c1ccc2sc(SSc3nc4ccccc4s3)nc2c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL529";"AZITHROMYCIN";"4.0";"749.00";"2";"1.90";"1";"CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL500";"PINDOLOL";"4.0";"248.33";"0";"1.91";"PINDOLOL";"CC(C)NCC(O)COc1cccc2[nH]ccc12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL84158";"TIAPRIDE";"3.0";"328.43";"0";"1.17";"TIAPRIDE";"CCN(CC)CCNC(=O)c1cc(S(C)(=O)=O)ccc1OC";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL44814";"CARBON TETRACHLORIDE";"-1.0";"153.82";"0";"2.55";"CARBON TETRACHLORIDE";"ClC(Cl)(Cl)Cl";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL659";"GALANTAMINE";"4.0";"287.36";"0";"1.85";"GALANTAMINE";"COc1ccc2c3c1O[C@H]1C[C@@H](O)C=C[C@@]31CCN(C)C2";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL43064";"CINNARIZINE";"4.0";"368.52";"1";"5.11";"CINNARIZINE";"C(=C/c1ccccc1)\CN1CCN(C(c2ccccc2)c2ccccc2)CC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1376342";"";"None";"289.33";"0";"4.85";"SID14727415";"O=C(O)c1ccc(N(c2ccccc2)c2ccccc2)cc1";"IC50";"'>'";"35000.0";"nM";"";"";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1613986";"PUBCHEM_BIOASSAY: Dose response counterscreen assay for neuropeptide Y receptor Y1 (NPY-Y1): Cell-based high throughput assay to measure NPY-Y2 antagonism. (Class of assay: confirmatory) [Related pubchem assays: 793, 1040, 1255, 1254 ]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1482513";"";"None";"967.16";"3";"3.13";"SID24841414";"CC(=O)OC1COC(OC2C(O)C(C)OC(OC3C(OC4CCC5(C)C(CCC6(C)C5CC=C5C7CC(C)(C)CCC7(C(=O)O)CCC56C)C4(C)CO)OCC(O)C3O)C2O)C(O)C1OC(C)=O";"IC50";"'>'";"35000.0";"nM";"";"";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1613986";"PUBCHEM_BIOASSAY: Dose response counterscreen assay for neuropeptide Y receptor Y1 (NPY-Y1): Cell-based high throughput assay to measure NPY-Y2 antagonism. (Class of assay: confirmatory) [Related pubchem assays: 793, 1040, 1255, 1254 ]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1307319";"";"None";"420.54";"0";"4.30";"SID847305";"CCN(C(=O)c1ccc(C(C)(C)C)cc1)c1nnc(Cn2nnc3ccccc32)s1";"IC50";"'='";"7737.0";"nM";"5.11";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1613986";"PUBCHEM_BIOASSAY: Dose response counterscreen assay for neuropeptide Y receptor Y1 (NPY-Y1): Cell-based high throughput assay to measure NPY-Y2 antagonism. (Class of assay: confirmatory) [Related pubchem assays: 793, 1040, 1255, 1254 ]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL468";"THALIDOMIDE";"4.0";"258.23";"0";"0.09";"THALIDOMIDE";"O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1231";"OXYBUTYNIN";"4.0";"357.49";"0";"3.34";"OXYBUTYNIN";"CCN(CC)CC#CCOC(=O)C(O)(c1ccccc1)C1CCCCC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1076211";"TOLPERISONE";"3.0";"245.37";"0";"3.30";"TOLPERISONE";"Cc1ccc(C(=O)C(C)CN2CCCCC2)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1457690";"";"None";"467.79";"1";"5.18";"SID24826569";"COc1ccc(-[n+]2c(-c3ccc(Cl)cc3)cn3c2CCc2ccccc2-3)cc1.[Br-]";"IC50";"'='";"10260.0";"nM";"4.99";"";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1613986";"PUBCHEM_BIOASSAY: Dose response counterscreen assay for neuropeptide Y receptor Y1 (NPY-Y1): Cell-based high throughput assay to measure NPY-Y2 antagonism. (Class of assay: confirmatory) [Related pubchem assays: 793, 1040, 1255, 1254 ]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1651906";"STREPTOZOCIN";"4.0";"265.22";"0";"-2.89";"STREPTOZOTOCIN";"CN(N=O)C(=O)N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1333512";"N,N'-DIPHENYL-P-PHENYLENEDIAMINE";"None";"260.34";"1";"5.17";"N,N'-DIPHENYL-P-PHENYLENEDIAMINE";"c1ccc(Nc2ccc(Nc3ccccc3)cc2)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL108545";"METHYL SALICYLATE";"4.0";"152.15";"0";"1.18";"METHYL SALICYLATE";"COC(=O)c1ccccc1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL991";"STAVUDINE";"4.0";"224.22";"0";"-0.71";"STAVUDINE";"Cc1cn([C@H]2C=C[C@@H](CO)O2)c(=O)[nH]c1=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL2367892";"TEICOPLANIN";"None";"1767.46";"None";"None";"TEICOPLANIN";"CC(=O)N[C@@H]1[C@H](Oc2c3cc4cc2Oc2ccc(cc2Cl)[C@@H](O[C@@H]2O[C@@H](CO)[C@@H](O)[C@H](O)[C@@H]2NC(C)=O)[C@@H]2NC(=O)[C@H](NC(=O)[C@@H]4NC(=O)[C@H]4NC(=O)[C@@H](Cc5ccc(c(Cl)c5)O3)NC(=O)[C@H](N)c3ccc(O)c(c3)Oc3cc(O)cc4c3)c3ccc(O)c(c3)-c3c(O[C@H]4O[C@H](CO)[C@@H](O)[C@@H](O)[C@@H]4O)cc(O)cc3[C@@H](C(=O)O)NC2=O)O[C@@H](CO)[C@@H](O)[C@@H]1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL95";"TACRINE";"4.0";"198.27";"0";"2.70";"TACRINE";"Nc1c2c(nc3ccccc13)CCCC2";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL504";"DIMETHYL SULFOXIDE";"4.0";"78.14";"0";"-0.01";"DIMETHYL SULFOXIDE";"C[S+](C)[O-]";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL803";"CYTARABINE";"4.0";"243.22";"0";"-2.56";"CYTARABINE";"Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)[C@@H]2O)c(=O)n1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1823354";"";"None";"543.67";"2";"5.48";"23";"CCNC(=O)C(c1ccccc1)N1CCN(c2ccc(NC(=O)c3ccccc3-c3ccccc3)cc2C#N)CC1";"IC50";"'='";"11.0";"nM";"7.96";"";"";"UO_0000065";"14.64";"0.27";"2.48";"9.00";"0";"CHEMBL1827365";"Displacement of [125I]PYY from human NPY Y2 receptor expressed endogenously in KAN-Ts cells by scintillation counting";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"KAN-Ts";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1821563";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";"";""
"CHEMBL1823359";"";"None";"571.73";"2";"6.21";"30";"CCN(CC)C(=O)C(c1ccccc1)N1CCN(c2ccc(NC(=O)c3ccccc3-c3ccccc3)cc2C#N)CC1";"IC50";"'='";"8.0";"nM";"8.10";"";"";"UO_0000065";"14.16";"0.26";"1.89";"10.16";"0";"CHEMBL1827365";"Displacement of [125I]PYY from human NPY Y2 receptor expressed endogenously in KAN-Ts cells by scintillation counting";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"KAN-Ts";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1821563";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";"";""
"CHEMBL1823575";"";"None";"489.66";"0";"4.66";"34";"CCC(CC)C(=O)Nc1ccc(N2CCN(C(C(=O)N(CC)CC)c3ccccc3)CC2)c(C#N)c1";"IC50";"'='";"13.0";"nM";"7.89";"";"";"UO_0000065";"16.11";"0.30";"3.23";"9.90";"0";"CHEMBL1827365";"Displacement of [125I]PYY from human NPY Y2 receptor expressed endogenously in KAN-Ts cells by scintillation counting";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"KAN-Ts";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1821563";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";"";""
"CHEMBL527";"PIROXICAM";"4.0";"331.35";"0";"1.58";"PIROXICAM";"CN1C(C(=O)Nc2ccccn2)=C(O)c2ccccc2S1(=O)=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL19215";"METERGOLINE";"4.0";"403.53";"0";"4.06";"METERGOLINE";"CN1C[C@H](CNC(=O)OCc2ccccc2)C[C@@H]2c3cccc4c3c(cn4C)C[C@H]21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL2030152";"";"None";"473.64";"0";"4.78";"13";"CCNC(=O)c1ccc(NC(=S)N2CCC(C(O)(c3ccccc3)c3ccccc3)CC2)cc1";"IC50";"'='";"206.0";"nM";"6.69";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2032840";"Antagonist activity at neuropeptide Y receptor Y2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2029318";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";"";""
"CHEMBL432651";"";"None";"453.59";"0";"4.82";"54";"CC(=O)N1CCc2ccc(N(CCCNCc3ccccc3)C(=O)/C=C/c3ccccc3)cc21";"IC50";"'='";"12000.0";"nM";"4.92";"";"";"UO_0000065";"10.85";"0.20";"0.10";"9.35";"0";"CHEMBL750768";"Binding affinity towards the NPY Y2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147599";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2004";"None";"";"";""
"CHEMBL515";"CHLORAMBUCIL";"4.0";"304.22";"0";"3.38";"CHLORAMBUCIL";"O=C(O)CCCc1ccc(N(CCCl)CCCl)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL95764";"GLYPHOSATE";"None";"169.07";"0";"-1.20";"GLYPHOSATE";"O=C(O)CNCP(=O)(O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1198";"PRAMOXINE";"4.0";"293.41";"0";"2.97";"PRAMOXINE";"CCCCOc1ccc(OCCCN2CCOCC2)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1071";"OXAPROZIN";"4.0";"293.32";"0";"4.03";"OXAPROZIN";"O=C(O)CCc1nc(-c2ccccc2)c(-c2ccccc2)o1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL580";"LORAZEPAM";"4.0";"321.16";"0";"3.10";"LORAZEPAM";"O=C1Nc2ccc(Cl)cc2C(c2ccccc2Cl)=NC1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL485259";"EUCALYPTOL";"3.0";"154.25";"0";"2.74";"EUCALYPTOL";"CC12CCC(CC1)C(C)(C)O2";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL720";"BENZYL ALCOHOL";"4.0";"108.14";"0";"1.18";"BENZYL ALCOHOL";"OCc1ccccc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL93645";"ACECLOFENAC";"4.0";"354.19";"0";"3.91";"ACECLOFENAC";"O=C(O)COC(=O)Cc1ccccc1Nc1c(Cl)cccc1Cl";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL174";"AMPICILLIN";"4.0";"349.41";"0";"0.32";"A";"CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](N)c3ccccc3)C(=O)N2[C@H]1C(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1200545";"DIFLORASONE DIACETATE";"4.0";"494.53";"0";"2.99";"DIFLORASONE DIACETATE";"CC(=O)OCC(=O)[C@@]1(OC(C)=O)[C@@H](C)C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL467";"HYDROXYUREA";"4.0";"76.05";"0";"-0.96";"HYDROXYUREA";"NC(=O)NO";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1535";"HYDROXYCHLOROQUINE";"4.0";"335.88";"0";"3.78";"HYDROXYCHLOROQUINE";"CCN(CCO)CCCC(C)Nc1ccnc2cc(Cl)ccc12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL2108139";"POVIDONE";"4.0";"None";"None";"None";"POLYVINYLPYRROLIDONE";"";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1262";"OXICONAZOLE";"4.0";"429.13";"1";"6.12";"OXICONAZOLE";"Clc1ccc(CO/N=C(\Cn2ccnc2)c2ccc(Cl)cc2Cl)c(Cl)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL42442";"OXFENDAZOLE";"2.0";"315.35";"0";"2.91";"OXFENDAZOLE";"COC(=O)Nc1nc2cc([S+]([O-])c3ccccc3)ccc2[nH]1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL21753";"";"None";"514.07";"2";"5.96";"33";"CC(=O)N1CCc2ccc(N(C(=O)/C=C/c3ccc(Cl)cc3)C3CCN(Cc4ccccc4)CC3)cc21";"IC50";"'='";"3600.0";"nM";"5.44";"";"";"UO_0000065";"10.59";"0.20";"-0.52";"12.41";"0";"CHEMBL750768";"Binding affinity towards the NPY Y2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147599";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2004";"None";"";"";""
"CHEMBL4101589";"";"None";"1782.13";"None";"None";"13";"CC(=O)N[C@@H](CO)C(=O)N1CCC[C@@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](CC1CCCCC1)C(=O)NC(C)(C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)NC(C)(C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC1CCCCC1)C(N)=O)[C@@H](C)O";"IC50";"'='";"1.4";"nM";"8.85";"";"";"UO_0000065";"4.97";"None";"None";"None";"0";"CHEMBL4056968";"Displacement of [125I]peptide YY from human Y2 receptor expressed in CHO cell membranes after 60 mins by TopCount scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4052740";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";""
"CHEMBL113";"CAFFEINE";"4.0";"194.19";"0";"-1.03";"CAFFEINE";"Cn1c(=O)c2c(ncn2C)n(C)c1=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL24";"ATENOLOL";"4.0";"266.34";"0";"0.45";"ATENOLOL";"CC(C)NCC(O)COc1ccc(CC(N)=O)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1077";"BROMFENAC";"4.0";"334.17";"0";"2.89";"BROMFENAC";"Nc1c(CC(=O)O)cccc1C(=O)c1ccc(Br)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL672";"FENOFIBRATE";"4.0";"360.84";"0";"4.68";"FENOFIBRATE";"CC(C)OC(=O)C(C)(C)Oc1ccc(C(=O)c2ccc(Cl)cc2)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL429698";"";"None";"1965.30";"None";"None";"11";"CC(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1cccc2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O)C(C)C";"IC50";"'='";"7.08";"nM";"8.15";"";"";"UO_0000065";"4.15";"None";"None";"None";"0";"CHEMBL755164";"Affinity against Neuropeptide Y receptor Y2 in SK-N-BE2 cell line";"B";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133640";"1";"Scientific Literature";"J Med Chem";"2000";"None";"";"";""
"CHEMBL429905";"";"None";"1899.24";"None";"None";"33";"CC(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccccc1)C(N)=O)[C@@H](C)O)C(C)C";"IC50";"'='";"1.16";"nM";"8.94";"";"";"UO_0000065";"4.70";"None";"None";"None";"0";"CHEMBL755164";"Affinity against Neuropeptide Y receptor Y2 in SK-N-BE2 cell line";"B";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133640";"1";"Scientific Literature";"J Med Chem";"2000";"None";"";"";""
"CHEMBL443";"SULFAMETHOXAZOLE";"4.0";"253.28";"0";"1.37";"SULFAMETHOXAZOLE";"Cc1cc(NS(=O)(=O)c2ccc(N)cc2)no1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1221";"SULCONAZOLE";"4.0";"397.76";"1";"6.52";"SULCONAZOLE";"Clc1ccc(CSC(Cn2ccnc2)c2ccc(Cl)cc2Cl)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL119385";"NEFLAMAPIMOD";"2.0";"436.27";"1";"5.49";"VX-745";"O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1543306";"";"None";"446.62";"1";"5.43";"3, SF-11";"CCOc1ccc(NC(=S)N2CCC(C(O)(c3ccccc3)c3ccccc3)CC2)cc1";"IC50";"'='";"200.0";"nM";"6.70";"";"";"UO_0000065";"15.00";"0.29";"1.27";"14.98";"0";"CHEMBL1827365";"Displacement of [125I]PYY from human NPY Y2 receptor expressed endogenously in KAN-Ts cells by scintillation counting";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"KAN-Ts";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1821563";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";"";""
"CHEMBL1836314";"";"None";"535.76";"2";"6.56";"12";"O=S(=O)(NC[C@H]1CC[C@H](Nc2nc3c(s2)CCSc2ccccc2-3)CC1)c1cccc2ccccc12";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1837822";"Antagonist activity at human NPY2 receptor assessed as calcium mobilization by FLIPR assay";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1833793";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";"";""
"CHEMBL1836315";"";"None";"489.69";"0";"4.14";"13";"Cn1cnc(S(=O)(=O)NC[C@H]2CC[C@H](Nc3nc4c(s3)CCSc3ccccc3-4)CC2)c1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1837822";"Antagonist activity at human NPY2 receptor assessed as calcium mobilization by FLIPR assay";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1833793";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";"";""
"CHEMBL491288";"";"None";"375.38";"0";"3.31";"2a";"C[C@@H]1NC(c2cc(C#N)ccn2)=N[C@@]1(c1ccc(F)cc1)c1ccc(F)nc1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1022824";"Binding affinity to human neuropeptide Y2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1138528";"1";"Scientific Literature";"J Med Chem";"2009";"None";"";"";""
"CHEMBL319244";"CAFFEIC ACID PHENETHYL ESTER";"None";"284.31";"0";"2.90";"CAFFEIC ACID PHENETHYL ESTER";"O=C(/C=C/c1ccc(O)c(O)c1)OCCc1ccccc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL900";"ORPHENADRINE";"4.0";"269.39";"0";"3.66";"ORPHENADRINE";"Cc1ccccc1C(OCCN(C)C)c1ccccc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1255834";"BW-723C86";"None";"286.40";"0";"3.70";"BW-723C86";"CC(N)Cc1c[nH]c2ccc(OCc3cccs3)cc12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL95327";"";"None";"457.60";"1";"5.75";"7";"CN(C)CCCN(C(=O)c1cc2ccccc2s1)c1ccccc1NC(=O)c1ccccc1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"1";"CHEMBL3107075";"Displacement of [125I]-PYY from NPYY2 receptor (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3102719";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL427594";"";"None";"2007.34";"None";"None";"35";"CC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O)C(C)C";"IC50";"'='";"2.68";"nM";"8.57";"";"";"UO_0000065";"4.27";"None";"None";"None";"0";"CHEMBL755164";"Affinity against Neuropeptide Y receptor Y2 in SK-N-BE2 cell line";"B";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133640";"1";"Scientific Literature";"J Med Chem";"2000";"None";"";"";""
"CHEMBL2030149";"";"None";"485.70";"1";"6.02";"10";"OC(c1ccccc1)(c1ccccc1)C1CCN(C(=S)Nc2ccc(N3CCCCC3)cc2)CC1";"IC50";"'='";"271.0";"nM";"6.57";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2032842";"Partial antagonist activity at neuropeptide Y receptor Y2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2029318";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";"";""
"CHEMBL158";"AZTREONAM";"4.0";"435.44";"0";"-1.17";"AZTREONAM";"C[C@H]1[C@H](NC(=O)/C(=N\OC(C)(C)C(=O)O)c2csc(N)n2)C(=O)N1S(=O)(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL8";"CIPROFLOXACIN";"4.0";"331.35";"0";"1.58";"CIPROFLOXACIN";"O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL406";"INDAPAMIDE";"4.0";"365.84";"0";"2.08";"INDAPAMIDE";"CC1Cc2ccccc2N1NC(=O)c1ccc(Cl)c(S(N)(=O)=O)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL282575";"ESTRADIOL BENZOATE";"4.0";"376.50";"1";"5.12";"BETA-ESTRADIOL 3-BENZOATE";"C[C@]12CC[C@@H]3c4ccc(OC(=O)c5ccccc5)cc4CC[C@H]3[C@@H]1CC[C@@H]2O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL3215298";"ABAMECTIN";"3.0";"1732.15";"None";"None";"ABAMECTIN";"CC[C@H](C)[C@H]1O[C@]2(C=C[C@@H]1C)C[C@@H]1C[C@@H](C/C=C(\C)[C@@H](O[C@H]3C[C@H](OC)[C@@H](O[C@H]4C[C@H](OC)[C@@H](O)[C@H](C)O4)[C@H](C)O3)[C@@H](C)/C=C/C=C3\CO[C@@H]4[C@H](O)C(C)=C[C@@H](C(=O)O1)[C@]34O)O2.CO[C@H]1C[C@H](O[C@H]2[C@H](C)O[C@@H](O[C@@H]3/C(C)=C/C[C@@H]4C[C@@H](C[C@]5(C=C[C@H](C)[C@@H](C(C)C)O5)O4)OC(=O)[C@@H]4C=C(C)[C@@H](O)[C@H]5OC/C(=C\C=C\[C@@H]3C)[C@]54O)C[C@@H]2OC)O[C@@H](C)[C@@H]1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL20";"ACETAZOLAMIDE";"4.0";"222.25";"0";"-0.86";"ACETAZOLAMIDE";"CC(=O)Nc1nnc(S(N)(=O)=O)s1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1762";"TOCAINIDE";"4.0";"192.26";"0";"1.59";"TOCAINIDE";"Cc1cccc(C)c1NC(=O)C(C)N";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1201346";"BALSALAZIDE";"4.0";"357.32";"0";"2.71";"BALSALAZIDE";"O=C(O)CCNC(=O)c1ccc(/N=N/c2ccc(O)c(C(=O)O)c2)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1909075";"";"None";"None";"None";"None";"QUINOLONE, CHEMI-LINZ ; CYANAMID";"";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL918";"PHENACEMIDE";"4.0";"178.19";"0";"0.42";"PHENACEMIDE";"NC(=O)NC(=O)Cc1ccccc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL4099784";"";"None";"1838.24";"None";"None";"13";"CC(=O)N[C@@H](CO)C(=O)N(C)[C@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)NC(CC1CCCCC1)C(=O)NC(CC1CCCCC1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)NC(C)(C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NC(CC1CCCCC1)C(N)=O)[C@@H](C)O";"IC50";"'='";"2.8";"nM";"8.55";"";"";"UO_0000065";"4.65";"None";"None";"None";"0";"CHEMBL4036757";"Displacement of [125I]-PYY from human Y2R expressed in CHO cell membranes after 60 mins by liquid scintillation method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4033754";"1";"Scientific Literature";"ACS Med Chem Lett";"2017";"None";"";"";""
"CHEMBL4064778";"";"None";"1808.17";"None";"None";"22";"CC(=O)N[C@@H](CO)C(=O)N1CCC[C@@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccncc1)C(=O)N[C@@H](CC1CCCCC1)C(=O)NC(C)(C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)NC(C)(C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC1CCCCC1)C(N)=O)[C@@H](C)O";"IC50";"'='";"0.92";"nM";"9.04";"";"";"UO_0000065";"5.00";"None";"None";"None";"0";"CHEMBL4056968";"Displacement of [125I]peptide YY from human Y2 receptor expressed in CHO cell membranes after 60 mins by TopCount scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4052740";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";""
"CHEMBL4090786";"";"None";"1800.19";"None";"None";"20";"CC(=O)N[C@@H](CO)C(=O)N1CCC[C@@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC1CCCCC1)C(=O)N[C@@H](CC1CCCCC1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)NC(C)(C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC1CCCCC1)C(N)=O)[C@@H](C)O";"IC50";"'='";"0.97";"nM";"9.01";"";"";"UO_0000065";"5.01";"None";"None";"None";"0";"CHEMBL4056968";"Displacement of [125I]peptide YY from human Y2 receptor expressed in CHO cell membranes after 60 mins by TopCount scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4052740";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";""
"CHEMBL4085697";"";"None";"1824.22";"None";"None";"10";"CC(=O)N[C@@H](CO)C(=O)N1CCC[C@@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](CC1CCCCC1)C(=O)N[C@@](C)(CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)NC(C)(C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC1CCCCC1)C(N)=O)[C@@H](C)O";"IC50";"'='";"0.94";"nM";"9.03";"";"";"UO_0000065";"4.95";"None";"None";"None";"0";"CHEMBL4056968";"Displacement of [125I]peptide YY from human Y2 receptor expressed in CHO cell membranes after 60 mins by TopCount scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4052740";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";""
"CHEMBL415690";"BETADEX";"3.0";"1134.99";"None";"None";"BETA CYCLODEXTRIN";"OC[C@H]1O[C@@H]2O[C@H]3[C@H](O)[C@@H](O)[C@@H](O[C@H]4[C@H](O)[C@@H](O)[C@@H](O[C@H]5[C@H](O)[C@@H](O)[C@@H](O[C@H]6[C@H](O)[C@@H](O)[C@@H](O[C@H]7[C@H](O)[C@@H](O)[C@@H](O[C@H]8[C@H](O)[C@@H](O)[C@@H](O[C@H]1[C@H](O)[C@H]2O)O[C@@H]8CO)O[C@@H]7CO)O[C@@H]6CO)O[C@@H]5CO)O[C@@H]4CO)O[C@@H]3CO";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL2105807";"MADURAMICIN";"2.0";"934.17";"2";"4.32";"MADURAMICIN";"CO[C@@H]1[C@@H](OC)[C@H](C)[C@@](O)(CC(=O)O)O[C@H]1[C@H](C)[C@H]1O[C@@]2(CC[C@@](C)([C@H]3CC[C@@](C)([C@@H]4O[C@@H]([C@H]5O[C@](C)(O)[C@H](C)C[C@@H]5C)C[C@@H]4O[C@@H]4C[C@H](OC)[C@@H](OC)[C@H](C)O4)O3)O2)C[C@H](O)[C@H]1C.N";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL28079";"ZAPRINAST";"2.0";"271.28";"0";"1.50";"92125335";"CCCOc1ccccc1-c1nc2[nH]nnc2c(=O)[nH]1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1306";"TERCONAZOLE";"4.0";"532.47";"1";"4.46";"TERCONAZOLE";"CC(C)N1CCN(c2ccc(OC[C@H]3CO[C@](Cn4cncn4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL203266";"TRIMETAZIDINE";"4.0";"266.34";"0";"1.12";"TRIMETAZIDINE";"COc1ccc(CN2CCNCC2)c(OC)c1OC";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL428992";"";"None";"1917.26";"None";"None";"24";"CC(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCN=C(N)N)CN[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O)C(C)C";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL755164";"Affinity against Neuropeptide Y receptor Y2 in SK-N-BE2 cell line";"B";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133640";"1";"Scientific Literature";"J Med Chem";"2000";"None";"";"";""
"CHEMBL1201117";"METHOCARBAMOL";"4.0";"241.24";"0";"0.53";"METHOCARBAMOL";"COc1ccccc1OCC(O)COC(N)=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1308845";"";"None";"458.74";"0";"4.97";"SID17414745";"Cc1cc(Cl)c(OCCCNCc2ccccc2)c(Br)c1.O=C(O)C(=O)O";"IC50";"'='";"5147.0";"nM";"5.29";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614345";"PUBCHEM_BIOASSAY: Dose response cell-based screening assay for antagonists of neuropeptide Y receptor Y2 (NPY-Y2). (Class of assay: confirmatory) [Related pubchem assays: 793, 1257, 1256 ]";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1446166";"";"None";"314.80";"0";"4.72";"SID17410323";"O=C(Nc1ccc(Cl)cc1)c1csc(-c2ccccc2)n1";"IC50";"'='";"10090.0";"nM";"5.00";"";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614345";"PUBCHEM_BIOASSAY: Dose response cell-based screening assay for antagonists of neuropeptide Y receptor Y2 (NPY-Y2). (Class of assay: confirmatory) [Related pubchem assays: 793, 1257, 1256 ]";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1351633";"";"None";"349.88";"0";"4.08";"SID17506323";"Cc1cccc(CSCCNC(=O)COc2ccc(Cl)cc2)c1";"IC50";"'<'";"35000.0";"nM";"";"";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614345";"PUBCHEM_BIOASSAY: Dose response cell-based screening assay for antagonists of neuropeptide Y receptor Y2 (NPY-Y2). (Class of assay: confirmatory) [Related pubchem assays: 793, 1257, 1256 ]";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL412698";"";"None";"2004.29";"None";"None";"18";"CC(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O)C(C)C";"IC50";"'='";"0.98";"nM";"9.01";"";"";"UO_0000065";"4.49";"None";"None";"None";"0";"CHEMBL755164";"Affinity against Neuropeptide Y receptor Y2 in SK-N-BE2 cell line";"B";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133640";"1";"Scientific Literature";"J Med Chem";"2000";"None";"";"";""
"CHEMBL4090092";"";"None";"1851.24";"None";"None";"8";"CC(=O)N[C@@H](CO)C(=O)N1CCC[C@@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](CC1CCCCC1)C(=O)N[C@@H](CC1CCCCC1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCN)C(=O)NC(C)(C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC1CCCCC1)C(N)=O)[C@@H](C)O";"IC50";"'='";"1.2";"nM";"8.92";"";"";"UO_0000065";"4.82";"None";"None";"None";"0";"CHEMBL4056968";"Displacement of [125I]peptide YY from human Y2 receptor expressed in CHO cell membranes after 60 mins by TopCount scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4052740";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";""
"CHEMBL439904";"";"None";"4049.53";"None";"None";"PYY3-36";"CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O)C(C)C";"IC50";"'='";"0.57";"nM";"9.24";"";"";"UO_0000065";"2.28";"None";"None";"None";"0";"CHEMBL4056968";"Displacement of [125I]peptide YY from human Y2 receptor expressed in CHO cell membranes after 60 mins by TopCount scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4052740";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";""
"CHEMBL1592";"QUINAPRIL";"4.0";"438.52";"0";"2.57";"QUINAPRIL";"CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N1Cc2ccccc2C[C@H]1C(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL20549";"";"None";"451.61";"1";"5.39";"11";"CN1CCc2ccc(N(C(=O)/C=C/c3ccccc3)C3CCN(Cc4ccccc4)CC3)cc21";"IC50";"'='";"5300.0";"nM";"5.28";"";"";"UO_0000065";"11.68";"0.21";"-0.11";"19.69";"0";"CHEMBL750768";"Binding affinity towards the NPY Y2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147599";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2004";"None";"";"";""
"CHEMBL1159650";"CLOBETASOL PROPIONATE";"4.0";"466.98";"0";"4.10";"CLOBETASOL PROPIONATE";"CCC(=O)O[C@]1(C(=O)CCl)[C@@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1619";"CLADRIBINE";"4.0";"285.69";"0";"-0.30";"CLADRIBINE";"Nc1nc(Cl)nc2c1ncn2[C@H]1C[C@H](O)[C@@H](CO)O1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL21728";"";"None";"485.67";"1";"5.69";"49";"CC(=O)N1CCc2ccc(N(C(=O)/C=C/c3ccccc3)C3CCN(CC4CCCCC4)CC3)cc21";"IC50";"'='";"1100.0";"nM";"5.96";"";"";"UO_0000065";"12.27";"0.23";"0.27";"13.59";"0";"CHEMBL750768";"Binding affinity towards the NPY Y2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147599";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2004";"None";"";"";""
"CHEMBL283106";"";"None";"558.52";"2";"6.07";"37";"CC(=O)N1CCc2ccc(N(C(=O)/C=C/c3cccc(Br)c3)C3CCN(Cc4ccccc4)CC3)cc21";"IC50";"'='";"3300.0";"nM";"5.48";"";"";"UO_0000065";"9.81";"0.20";"-0.59";"12.50";"0";"CHEMBL750768";"Binding affinity towards the NPY Y2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147599";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2004";"None";"";"";""
"CHEMBL316153";"";"None";"399.56";"0";"4.36";"70";"Cc1ccc2c(c1)-c1nc(NCC3CCN(C(=O)C(C)C)CC3)sc1CCO2";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL750763";"In vitro binding affinity against rat neuropeptide Y2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1146725";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2004";"None";"";"";""
"CHEMBL4281479";"";"None";"4310.81";"None";"None";"PYY(1-36)";"CC[C@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)C(C)C";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL4713465";"Agonist activity at human NPY2R expressed in HEK293 cells assessed as inhibition of adenosine-induced stimulation of cAMP accumulation by FRET assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4706662";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"";""
"CHEMBL279044";"";"None";"465.64";"1";"5.78";"20";"CC(=O)N1CCc2ccc(N(C/C=C/c3ccccc3)C3CCN(Cc4ccccc4)CC3)cc21";"IC50";"'='";"30000.0";"nM";"4.52";"";"";"UO_0000065";"9.71";"0.18";"-1.26";"16.88";"0";"CHEMBL750768";"Binding affinity towards the NPY Y2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147599";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2004";"None";"";"";""
"CHEMBL311506";"";"None";"394.45";"1";"5.20";"44a";"C[C@H]([C@@H](O)c1ccccc1)N(C)C(=O)Nc1ccc(Oc2ccc(F)cc2)cc1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL749564";"Inhibitory activity tested against Human Neuropeptide Y2 Receptor.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1134441";"1";"Scientific Literature";"J Med Chem";"2001";"None";"";"";""
"CHEMBL1200709";"CROTAMITON";"4.0";"203.28";"0";"2.92";"CROTAMITON";"C/C=C/C(=O)N(CC)c1ccccc1C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL267044";"LEVOSULPIRIDE";"2.0";"341.43";"0";"0.56";"LEVOSULPIRIDE";"CCN1CCC[C@H]1CNC(=O)c1cc(S(N)(=O)=O)ccc1OC";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1453832";"";"None";"429.51";"0";"4.91";"SID14739446";"O=C(O)C(=O)O.c1ccc(COc2ccc(OCCCCN3CCCCC3)cc2)cc1";"IC50";"'>'";"35000.0";"nM";"";"";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614345";"PUBCHEM_BIOASSAY: Dose response cell-based screening assay for antagonists of neuropeptide Y receptor Y2 (NPY-Y2). (Class of assay: confirmatory) [Related pubchem assays: 793, 1257, 1256 ]";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1386511";"";"None";"313.47";"0";"3.68";"SID17505233";"CN(C)CCCSc1nc(-c2ccccc2)nc2c1CCC2";"IC50";"'='";"18180.0";"nM";"4.74";"";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614345";"PUBCHEM_BIOASSAY: Dose response cell-based screening assay for antagonists of neuropeptide Y receptor Y2 (NPY-Y2). (Class of assay: confirmatory) [Related pubchem assays: 793, 1257, 1256 ]";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL267744";"TICRYNAFEN";"4.0";"331.18";"0";"3.75";"TICRYNAFEN";"O=C(O)COc1ccc(C(=O)c2cccs2)c(Cl)c1Cl";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1603366";"";"None";"314.41";"0";"3.93";"SID17432103";"Cc1ccc(NC(S)=NCc2ccc3c(c2)OCO3)cc1C";"IC50";"'='";"10030.0";"nM";"5.00";"";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614345";"PUBCHEM_BIOASSAY: Dose response cell-based screening assay for antagonists of neuropeptide Y receptor Y2 (NPY-Y2). (Class of assay: confirmatory) [Related pubchem assays: 793, 1257, 1256 ]";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1487131";"";"None";"335.44";"0";"4.12";"SID845226";"CC(C)c1ccc(-c2nnn(Cc3nc4ccccc4s3)n2)cc1";"IC50";"'='";"4607.0";"nM";"5.34";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614345";"PUBCHEM_BIOASSAY: Dose response cell-based screening assay for antagonists of neuropeptide Y receptor Y2 (NPY-Y2). (Class of assay: confirmatory) [Related pubchem assays: 793, 1257, 1256 ]";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL497359";"";"None";"387.36";"0";"4.25";"5k";"O=C1OC2(CCN(c3nc4cc(C(F)(F)F)ccc4[nH]3)CC2)c2ccccc21";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1001159";"Binding affinity to NPY Y2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141687";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"None";"";"";""
"CHEMBL429";"LABETALOL";"4.0";"328.41";"0";"2.14";"LABETALOL";"CC(CCc1ccccc1)NCC(O)c1ccc(O)c(C(N)=O)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1419096";"";"None";"392.38";"0";"2.09";"SID4254597";"COC(=O)c1ccccc1NC(=O)Cn1c(-c2nonc2N)nc2ccccc21";"IC50";"'='";"15000.0";"nM";"4.82";"";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614345";"PUBCHEM_BIOASSAY: Dose response cell-based screening assay for antagonists of neuropeptide Y receptor Y2 (NPY-Y2). (Class of assay: confirmatory) [Related pubchem assays: 793, 1257, 1256 ]";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1319576";"";"None";"286.44";"0";"4.42";"SID22401155";"Nc1c2c(nc3sc4c(c13)CCCC4)CCCCCC2";"IC50";"'>'";"35000.0";"nM";"";"";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614345";"PUBCHEM_BIOASSAY: Dose response cell-based screening assay for antagonists of neuropeptide Y receptor Y2 (NPY-Y2). (Class of assay: confirmatory) [Related pubchem assays: 793, 1257, 1256 ]";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL282667";"";"None";"437.59";"1";"5.37";"12";"O=C(/C=C/c1ccccc1)N(c1ccc2c(c1)NCC2)C1CCN(Cc2ccccc2)CC1";"IC50";"'='";"22000.0";"nM";"4.66";"";"";"UO_0000065";"10.64";"0.19";"-0.71";"13.09";"0";"CHEMBL750768";"Binding affinity towards the NPY Y2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147599";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2004";"None";"";"";""
"CHEMBL1528149";"";"None";"563.68";"2";"3.99";"SID14724432";"COC(=O)C1=C(C(=O)OC)SC2(S1)C(C(=O)OC)=C(C(=O)OC)SC1=C2c2cccc(C)c2NC1(C)C";"IC50";"'>'";"35000.0";"nM";"";"";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614345";"PUBCHEM_BIOASSAY: Dose response cell-based screening assay for antagonists of neuropeptide Y receptor Y2 (NPY-Y2). (Class of assay: confirmatory) [Related pubchem assays: 793, 1257, 1256 ]";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1383592";"";"None";"346.81";"0";"3.09";"SID17506366";"Cc1ccc(NC(=O)C(=O)NCCOc2ccc(Cl)cc2)c(C)c1";"IC50";"'='";"7407.0";"nM";"5.13";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614345";"PUBCHEM_BIOASSAY: Dose response cell-based screening assay for antagonists of neuropeptide Y receptor Y2 (NPY-Y2). (Class of assay: confirmatory) [Related pubchem assays: 793, 1257, 1256 ]";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1335124";"";"None";"391.85";"1";"5.20";"SID17516454";"O=C(COC(=O)/C=C/c1ccc(Cl)cc1)Nc1ccccc1-c1ccccc1";"IC50";"'='";"8058.0";"nM";"5.09";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614345";"PUBCHEM_BIOASSAY: Dose response cell-based screening assay for antagonists of neuropeptide Y receptor Y2 (NPY-Y2). (Class of assay: confirmatory) [Related pubchem assays: 793, 1257, 1256 ]";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1385608";"";"None";"528.61";"2";"7.75";"SID17386306";"O=P(CCCCCCCCCP(=O)(c1ccccc1)c1ccccc1)(c1ccccc1)c1ccccc1";"IC50";"'='";"1647.0";"nM";"5.78";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614345";"PUBCHEM_BIOASSAY: Dose response cell-based screening assay for antagonists of neuropeptide Y receptor Y2 (NPY-Y2). (Class of assay: confirmatory) [Related pubchem assays: 793, 1257, 1256 ]";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1455508";"";"None";"392.50";"0";"4.00";"SID14718687";"Cc1ccccc1N1CCN(CCCOc2ccc3c(C)cc(=O)oc3c2)CC1";"IC50";"'>'";"35000.0";"nM";"";"";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614345";"PUBCHEM_BIOASSAY: Dose response cell-based screening assay for antagonists of neuropeptide Y receptor Y2 (NPY-Y2). (Class of assay: confirmatory) [Related pubchem assays: 793, 1257, 1256 ]";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1387309";"";"None";"328.76";"0";"4.74";"SID17409452";"O=C(Nc1ccccc1)OCc1cc(-c2ccccc2Cl)on1";"IC50";"'='";"14730.0";"nM";"4.83";"";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614345";"PUBCHEM_BIOASSAY: Dose response cell-based screening assay for antagonists of neuropeptide Y receptor Y2 (NPY-Y2). (Class of assay: confirmatory) [Related pubchem assays: 793, 1257, 1256 ]";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1366620";"";"None";"343.29";"0";"4.15";"SID22404149";"CCCCCC(=O)NC(=S)Nc1ccc(Br)cc1C";"IC50";"'='";"6110.0";"nM";"5.21";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614345";"PUBCHEM_BIOASSAY: Dose response cell-based screening assay for antagonists of neuropeptide Y receptor Y2 (NPY-Y2). (Class of assay: confirmatory) [Related pubchem assays: 793, 1257, 1256 ]";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL3197426";"";"None";"378.43";"0";"3.84";"SID17516081";"CCOc1ccc(Oc2c(/C=N/NC(C)=O)c(C)nn2-c2ccccc2)cc1";"IC50";"'='";"4533.0";"nM";"5.34";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614345";"PUBCHEM_BIOASSAY: Dose response cell-based screening assay for antagonists of neuropeptide Y receptor Y2 (NPY-Y2). (Class of assay: confirmatory) [Related pubchem assays: 793, 1257, 1256 ]";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL3214137";"";"None";"387.72";"1";"5.03";"SID17508441";"O=C(CSCc1ccc(Cl)cc1)N/N=C/c1c(Cl)cccc1Cl";"IC50";"'='";"6469.0";"nM";"5.19";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614345";"PUBCHEM_BIOASSAY: Dose response cell-based screening assay for antagonists of neuropeptide Y receptor Y2 (NPY-Y2). (Class of assay: confirmatory) [Related pubchem assays: 793, 1257, 1256 ]";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1312713";"";"None";"394.52";"0";"4.22";"SID14720874";"CCN(CC)CC(O)COc1ccc2c(c1)c(C(C)=O)c(C)n2-c1ccccc1";"IC50";"'='";"6947.0";"nM";"5.16";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614345";"PUBCHEM_BIOASSAY: Dose response cell-based screening assay for antagonists of neuropeptide Y receptor Y2 (NPY-Y2). (Class of assay: confirmatory) [Related pubchem assays: 793, 1257, 1256 ]";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1353075";"";"None";"354.47";"0";"2.66";"SID22412085";"CCCCCCNS(=O)(=O)c1ccc(NC(=O)C2CCCO2)cc1";"IC50";"'='";"7943.0";"nM";"5.10";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614345";"PUBCHEM_BIOASSAY: Dose response cell-based screening assay for antagonists of neuropeptide Y receptor Y2 (NPY-Y2). (Class of assay: confirmatory) [Related pubchem assays: 793, 1257, 1256 ]";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL266021";"";"None";"1931.24";"None";"None";"40";"CCCC[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(C)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCC)C(=O)N[C@@H](CCC)C(=O)N[C@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O";"IC50";"'='";"57.0";"nM";"7.24";"";"";"UO_0000065";"3.75";"None";"None";"None";"0";"CHEMBL755164";"Affinity against Neuropeptide Y receptor Y2 in SK-N-BE2 cell line";"B";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133640";"1";"Scientific Literature";"J Med Chem";"2000";"None";"";"";""
"CHEMBL4209661";"";"None";"1796.16";"None";"None";"8";"CC[C@@](C)(NC(=O)[C@H](CC1CCCCC1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H]1CCCN1C(=O)[C@H](CO)NC(C)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)NC(C)(C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC1CCCCC1)C(N)=O)[C@@H](C)O";"IC50";"'='";"3.3";"nM";"8.48";"";"";"UO_0000065";"4.72";"None";"None";"None";"0";"CHEMBL4179032";"Displacement of [125I]-PYY from human neuropeptide Y2 receptor expressed in CHO cell membranes incubated for 60 mins by TopCount based method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4177573";"1";"Scientific Literature";"Bioorg Med Chem";"2017";"None";"";"";""
"CHEMBL4073010";"";"None";"1850.25";"None";"None";"3";"CC(=O)N[C@@H](CO)C(=O)N1CCC[C@@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](CC1CCCCC1)C(=O)N[C@@H](CC1CCCCC1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)NC(C)(C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC1CCCCC1)C(N)=O)[C@@H](C)O";"IC50";"'='";"1.5";"nM";"8.82";"";"";"UO_0000065";"4.77";"None";"None";"None";"1";"CHEMBL4179032";"Displacement of [125I]-PYY from human neuropeptide Y2 receptor expressed in CHO cell membranes incubated for 60 mins by TopCount based method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4177573";"1";"Scientific Literature";"Bioorg Med Chem";"2017";"None";"";"";""
"CHEMBL4211953";"";"None";"1796.16";"None";"None";"17";"CC(=O)N[C@@H](CO)C(=O)NC(C)(C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccncc1)C(=O)N[C@@H](CC1CCCCC1)C(=O)NC(C)(C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)NC(C)(C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC1CCCCC1)C(N)=O)[C@@H](C)O";"IC50";"'='";"0.41";"nM";"9.39";"";"";"UO_0000065";"5.23";"None";"None";"None";"0";"CHEMBL4179032";"Displacement of [125I]-PYY from human neuropeptide Y2 receptor expressed in CHO cell membranes incubated for 60 mins by TopCount based method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4177573";"1";"Scientific Literature";"Bioorg Med Chem";"2017";"None";"";"";""
"CHEMBL450895";"NYSTATIN";"4.0";"926.11";"3";"0.94";"NYSTATIN";"C[C@@H]1[C@H](O)[C@@H](C)/C=C/C=C/CC/C=C/C=C/C=C/C=C/[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)C[C@@H](O)CC(=O)O[C@H]1C)C[C@H](O)[C@H]2C(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1400945";"PREGNENOLONE CARBONITRILE ";"None";"341.50";"0";"4.26";"PREGNENOLONE-16ALPHA-CARBONITRILE";"CC(=O)[C@H]1[C@H](C#N)C[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1909072";"PIPAMAZINE";"4.0";"401.96";"0";"4.53";"PIPAMAZINE";"NC(=O)C1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1404069";"";"None";"415.45";"0";"4.60";"SF-31";"COc1cccc(-c2nc(-c3ccc(NC(=O)Cc4ccccc4OC)cc3)no2)c1";"IC50";"'='";"1200.0";"nM";"5.92";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2032840";"Antagonist activity at neuropeptide Y receptor Y2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2029318";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";"";""
"CHEMBL2030145";"";"None";"444.64";"1";"5.98";"5";"CCCc1ccc(NC(=S)N2CCC(C(O)(c3ccccc3)c3ccccc3)CC2)cc1";"IC50";"'='";"777.0";"nM";"6.11";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2032840";"Antagonist activity at neuropeptide Y receptor Y2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2029318";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";"";""
"CHEMBL123292";"CYCLOHEXIMIDE";"2.0";"281.35";"0";"1.04";"SID17389082";"C[C@@H]1C[C@@H]([C@H](O)CC2CC(=O)NC(=O)C2)C(=O)[C@@H](C)C1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1687";"TUBOCURARINE CHLORIDE";"None";"645.20";"2";"6.70";"D-TUBOCURARINE CHLORIDE";"COc1cc2c3cc1Oc1cc(ccc1O)C[C@@H]1c4c(cc(OC)c(O)c4Oc4ccc(cc4)C[C@@H]3N(C)CC2)CC[N+]1(C)C.[Cl-]";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1042";"CHOLECALCIFEROL";"4.0";"384.65";"1";"7.62";"CHOLECALCIFEROL";"C=C1CC[C@H](O)C/C1=C/C=C1\CCC[C@]2(C)[C@@H]([C@H](C)CCCC(C)C)CC[C@@H]12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL714";"ALBUTEROL";"4.0";"239.31";"0";"1.31";"SALBUTAMOL";"CC(C)(C)NCC(O)c1ccc(O)c(CO)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL3104179";"";"None";"461.59";"0";"4.90";"118";"CCC(CC)C(=O)Nc1ccc(N2CCN(C(c3ccccc3)c3ncccn3)CC2)c(F)c1";"IC50";"'='";"33.0";"nM";"7.48";"";"";"UO_0000065";"16.21";"0.30";"2.58";"12.19";"0";"CHEMBL3107076";"Displacement of [125I]-PYY from human NPYY2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3102719";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL20549";"";"None";"451.61";"1";"5.39";"12";"CN1CCc2ccc(N(C(=O)/C=C/c3ccccc3)C3CCN(Cc4ccccc4)CC3)cc21";"IC50";"'='";"5300.0";"nM";"5.28";"";"";"UO_0000065";"11.68";"0.21";"-0.11";"19.69";"1";"CHEMBL3107076";"Displacement of [125I]-PYY from human NPYY2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3102719";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL263350";"";"None";"1927.25";"None";"None";"8";"CC(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N1Cc2ccccc2CC1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O)C(C)C";"IC50";"'='";"186.0";"nM";"6.73";"";"";"UO_0000065";"3.49";"None";"None";"None";"0";"CHEMBL755164";"Affinity against Neuropeptide Y receptor Y2 in SK-N-BE2 cell line";"B";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133640";"1";"Scientific Literature";"J Med Chem";"2000";"None";"";"";""
"CHEMBL77273";"";"None";"360.46";"1";"5.57";"40c";"C[C@H](Cc1ccccc1)N(C)C(=O)Nc1ccc(Oc2ccccc2)cc1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL749564";"Inhibitory activity tested against Human Neuropeptide Y2 Receptor.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1134441";"1";"Scientific Literature";"J Med Chem";"2001";"None";"";"";""
"CHEMBL311159";"";"None";"421.45";"0";"4.97";"44c";"C[C@H]([C@@H](O)c1ccccc1)N(C)C(=O)Nc1ccc(Oc2cccc([N+](=O)[O-])c2)cc1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL749564";"Inhibitory activity tested against Human Neuropeptide Y2 Receptor.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1134441";"1";"Scientific Literature";"J Med Chem";"2001";"None";"";"";""
"CHEMBL4063520";"";"None";"1885.34";"None";"None";"6";"CCC(NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(C)=O)C(=O)NC(CC1CCCCC1)C(=O)NC(CC1CCCCC1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)NC(C)(C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NC(CC1CCCCC1)C(N)=O)[C@@H](C)O";"IC50";"'='";"6.8";"nM";"8.17";"";"";"UO_0000065";"4.33";"None";"None";"None";"0";"CHEMBL4036757";"Displacement of [125I]-PYY from human Y2R expressed in CHO cell membranes after 60 mins by liquid scintillation method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4033754";"1";"Scientific Literature";"ACS Med Chem Lett";"2017";"None";"";"";""
"CHEMBL4073606";"";"None";"1810.19";"None";"None";"16";"CC(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)NC(CC1CCCCC1)C(=O)NC(CC1CCCCC1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)NC(C)(C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NC(CC1CCCCC1)C(N)=O)[C@@H](C)O";"IC50";"'='";"4.8";"nM";"8.32";"";"";"UO_0000065";"4.60";"None";"None";"None";"0";"CHEMBL4036757";"Displacement of [125I]-PYY from human Y2R expressed in CHO cell membranes after 60 mins by liquid scintillation method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4033754";"1";"Scientific Literature";"ACS Med Chem Lett";"2017";"None";"";"";""
"CHEMBL472";"GLYBURIDE";"4.0";"494.01";"0";"3.64";"GLYBURIDE";"COc1ccc(Cl)cc1C(=O)NCCc1ccc(S(=O)(=O)NC(=O)NC2CCCCC2)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL661";"ALPRAZOLAM";"4.0";"308.77";"0";"3.58";"ALPRAZOLAM";"Cc1nnc2n1-c1ccc(Cl)cc1C(c1ccccc1)=NC2";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL488";"AMINOGLUTETHIMIDE";"4.0";"232.28";"0";"1.35";"AMINOGLUTETHIMIDE";"CCC1(c2ccc(N)cc2)CCC(=O)NC1=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL558551";"";"None";"258.23";"0";"0.09";"(+)-THALIDOMIDE";"O=C1CC[C@@H](N2C(=O)c3ccccc3C2=O)C(=O)N1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1751";"DIGOXIN";"4.0";"780.95";"3";"2.22";"DIGOXIN";"C[C@H]1O[C@@H](O[C@H]2[C@@H](O)C[C@H](O[C@H]3[C@@H](O)C[C@H](O[C@H]4CC[C@@]5(C)[C@H](CC[C@@H]6[C@@H]5C[C@@H](O)[C@]5(C)[C@@H](C7=CC(=O)OC7)CC[C@]65O)C4)O[C@@H]3C)O[C@@H]2C)C[C@H](O)[C@@H]1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL6273";"FLEROXACIN";"2.0";"369.34";"0";"1.70";"FLEROXACIN";"CN1CCN(c2c(F)cc3c(=O)c(C(=O)O)cn(CCF)c3c2F)CC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1073";"GLIPIZIDE";"4.0";"445.55";"0";"2.08";"GLIPIZIDE";"Cc1cnc(C(=O)NCCc2ccc(S(=O)(=O)NC(=O)NC3CCCCC3)cc2)cn1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL434063";"";"None";"495.58";"0";"4.94";"GW-1929";"CN(CCOc1ccc(C[C@H](Nc2ccccc2C(=O)c2ccccc2)C(=O)O)cc1)c1ccccn1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL157548";"DANOFLOXACIN";"-1.0";"357.39";"0";"2.07";"DANOFLOXACIN";"CN1C[C@@H]2C[C@H]1CN2c1cc2c(cc1F)c(=O)c(C(=O)O)cn2C1CC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1123";"DICYCLOMINE";"4.0";"309.49";"0";"4.40";"DICYCLOMINE";"CCN(CC)CCOC(=O)C1(C2CCCCC2)CCCCC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1512";"FLUNISOLIDE";"4.0";"434.50";"0";"2.27";"FLUNISOLIDE";"CC1(C)O[C@@H]2C[C@H]3[C@@H]4C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO)O1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL31";"GATIFLOXACIN";"4.0";"375.40";"0";"1.98";"GATIFLOXACIN";"COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1103";"FURAZOLIDONE";"4.0";"225.16";"0";"0.97";"FURAZOLIDONE";"O=C1OCCN1/N=C/c1ccc([N+](=O)[O-])o1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1359694";"";"None";"294.35";"0";"3.56";"SID22404799";"CCCCOc1nc2ccccc2c(=O)n1-c1ccccc1";"IC50";"'='";"8151.0";"nM";"5.09";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614345";"PUBCHEM_BIOASSAY: Dose response cell-based screening assay for antagonists of neuropeptide Y receptor Y2 (NPY-Y2). (Class of assay: confirmatory) [Related pubchem assays: 793, 1257, 1256 ]";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1499276";"";"None";"396.45";"1";"5.23";"SID17412710";"Cc1ccc(-c2cc(C(=O)Nc3ccc4c(c3)OCCO4)c3ccccc3n2)cc1";"IC50";"'='";"5354.0";"nM";"5.27";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614345";"PUBCHEM_BIOASSAY: Dose response cell-based screening assay for antagonists of neuropeptide Y receptor Y2 (NPY-Y2). (Class of assay: confirmatory) [Related pubchem assays: 793, 1257, 1256 ]";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1342128";"";"None";"327.36";"0";"3.57";"SID4261856";"O=C(CSc1nc2ccccc2o1)c1ccc2c(c1)OCCO2";"IC50";"'='";"18280.0";"nM";"4.74";"";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614345";"PUBCHEM_BIOASSAY: Dose response cell-based screening assay for antagonists of neuropeptide Y receptor Y2 (NPY-Y2). (Class of assay: confirmatory) [Related pubchem assays: 793, 1257, 1256 ]";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1439981";"";"None";"349.39";"0";"4.40";"SID863565";"COc1ccc(-c2nc(C#N)c(NC(C)c3ccccc3)o2)cc1OC";"IC50";"'='";"3546.0";"nM";"5.45";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614345";"PUBCHEM_BIOASSAY: Dose response cell-based screening assay for antagonists of neuropeptide Y receptor Y2 (NPY-Y2). (Class of assay: confirmatory) [Related pubchem assays: 793, 1257, 1256 ]";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1608982";"";"None";"341.43";"0";"4.16";"SID22413249";"Cc1ccc(S(=O)(=O)C(c2ccccc2)c2c(C)noc2C)cc1";"IC50";"'='";"3917.0";"nM";"5.41";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614345";"PUBCHEM_BIOASSAY: Dose response cell-based screening assay for antagonists of neuropeptide Y receptor Y2 (NPY-Y2). (Class of assay: confirmatory) [Related pubchem assays: 793, 1257, 1256 ]";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1423382";"";"None";"444.48";"1";"5.37";"SID17506930";"CCC(Oc1ccc2c(=O)c(-c3ccccc3OC)coc2c1)C(=O)OCc1ccccc1";"IC50";"'='";"4120.0";"nM";"5.38";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614345";"PUBCHEM_BIOASSAY: Dose response cell-based screening assay for antagonists of neuropeptide Y receptor Y2 (NPY-Y2). (Class of assay: confirmatory) [Related pubchem assays: 793, 1257, 1256 ]";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1402158";"";"None";"366.46";"1";"5.12";"SID17432207";"Cc1ccccc1/C=C/c1nc2ccccc2c(=O)n1CCc1ccccc1";"IC50";"'='";"5516.0";"nM";"5.26";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614345";"PUBCHEM_BIOASSAY: Dose response cell-based screening assay for antagonists of neuropeptide Y receptor Y2 (NPY-Y2). (Class of assay: confirmatory) [Related pubchem assays: 793, 1257, 1256 ]";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1345334";"";"None";"340.43";"1";"5.26";"SID17402173";"COc1ccc(Cn2c(/C=C/c3ccccc3)nc3ccccc32)cc1";"IC50";"'='";"5505.0";"nM";"5.26";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614345";"PUBCHEM_BIOASSAY: Dose response cell-based screening assay for antagonists of neuropeptide Y receptor Y2 (NPY-Y2). (Class of assay: confirmatory) [Related pubchem assays: 793, 1257, 1256 ]";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL407";"FLUMAZENIL";"4.0";"303.29";"0";"1.77";"FLUMAZENIL";"CCOC(=O)c1ncn2c1CN(C)C(=O)c1cc(F)ccc1-2";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1599610";"";"None";"282.73";"0";"4.11";"SID17406965";"O=C(/C=C/c1cccc(Cl)c1)c1nc2ccccc2[nH]1";"IC50";"'='";"5083.0";"nM";"5.29";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614345";"PUBCHEM_BIOASSAY: Dose response cell-based screening assay for antagonists of neuropeptide Y receptor Y2 (NPY-Y2). (Class of assay: confirmatory) [Related pubchem assays: 793, 1257, 1256 ]";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1427745";"";"None";"405.50";"0";"3.51";"SID17512961";"CCC(NCCC(c1ccccc1)c1ccccc1)=C1C(=O)N(C)C(=O)N(C)C1=O";"IC50";"'='";"5256.0";"nM";"5.28";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614345";"PUBCHEM_BIOASSAY: Dose response cell-based screening assay for antagonists of neuropeptide Y receptor Y2 (NPY-Y2). (Class of assay: confirmatory) [Related pubchem assays: 793, 1257, 1256 ]";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1427860";"";"None";"470.59";"1";"6.33";"SID17413034";"Cc1ccc(C)c(NS(=O)(=O)c2cc(C(=O)Nc3ccccc3-c3ccccc3)ccc2C)c1";"IC50";"'='";"298.0";"nM";"6.53";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614345";"PUBCHEM_BIOASSAY: Dose response cell-based screening assay for antagonists of neuropeptide Y receptor Y2 (NPY-Y2). (Class of assay: confirmatory) [Related pubchem assays: 793, 1257, 1256 ]";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL941";"IMATINIB";"4.0";"493.62";"0";"4.59";"IMATINIB";"Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1089";"PHENELZINE";"4.0";"136.20";"0";"0.69";"PHENELZINE";"NNCCc1ccccc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL5314360";"ACONITINE";"-1.0";"645.75";"2";"0.65";"ACONITINE";"CCN1C[C@]2(COC)[C@H](O)C[C@H](OC)[C@@]34[C@@H]5C[C@@]6(O)[C@H](OC(=O)c7ccccc7)[C@@H]5[C@@](OC(C)=O)([C@@H]([C@H](OC)[C@H]23)[C@@H]14)[C@@H](O)[C@@H]6OC";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL936";"DIPHENIDOL";"4.0";"309.45";"0";"4.19";"DIPHENIDOL";"OC(CCCN1CCCCC1)(c1ccccc1)c1ccccc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1873703";"DIELDRIN";"2.0";"380.91";"0";"4.48";"DIELDRIN";"ClC1=C(Cl)[C@]2(Cl)[C@@H]3[C@@H]4C[C@@H]([C@H]5O[C@@H]45)[C@@H]3[C@@]1(Cl)C2(Cl)Cl";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1167";"SPECTINOMYCIN";"4.0";"332.35";"0";"-2.93";"SPECTINOMYCIN";"CN[C@@H]1[C@H](O)[C@H](NC)[C@H]2O[C@@]3(O)C(=O)C[C@@H](C)O[C@H]3O[C@@H]2[C@H]1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL311350";"PIROMIDIC ACID";"2.0";"288.31";"0";"1.11";"PIROMIDIC ACID";"CCn1cc(C(=O)O)c(=O)c2cnc(N3CCCC3)nc21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL316561";"PROGLUMIDE";"4.0";"334.42";"0";"2.30";"PROGLUMIDE";"CCCN(CCC)C(=O)C(CCC(=O)O)NC(=O)c1ccccc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL21019";"";"None";"547.62";"2";"6.33";"35";"CC(=O)N1CCc2ccc(N(C(=O)/C=C/c3cccc(C(F)(F)F)c3)C3CCN(Cc4ccccc4)CC3)cc21";"IC50";"'='";"8900.0";"nM";"5.05";"";"";"UO_0000065";"9.22";"0.17";"-1.28";"11.52";"0";"CHEMBL750768";"Binding affinity towards the NPY Y2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147599";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2004";"None";"";"";""
"CHEMBL317075";"";"None";"414.57";"1";"6.17";"23";"CN(C)CCCN(C(=O)c1cc2ccccc2s1)c1ccccc1-c1ccccc1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL747054";"Binding affinity against SMS-KAN cell membranes endogenously expressing Neuropeptide Y receptor type 2 using [125I]PYY as radioligand";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"SMS-KAN";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1136181";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2003";"None";"";"";""
"CHEMBL1210154";"";"None";"336.42";"1";"5.39";"10i";"C/C(=N\OC(=O)Nc1ccccc1)c1cccc(-c2cccs2)c1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1212489";"Displacement of [125I]peptide YY from human recombinant Y2 receptor expressed in KAN-TS cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"KAN-TS";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1208724";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL10";"SB-203580";"None";"377.44";"0";"4.68";"SB-203580";"C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL325372";"METHYLPARABEN";"-1.0";"152.15";"0";"1.18";"METHYLPARABEN";"COC(=O)c1ccc(O)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL460291";"LACIDIPINE";"4.0";"455.55";"0";"4.40";"LACIDIPINE";"CCOC(=O)C1=C(C)NC(C)=C(C(=O)OCC)C1c1ccccc1/C=C/C(=O)OC(C)(C)C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL2103774";"TIBOLONE";"4.0";"312.45";"0";"3.88";"TIBOLONE";"C#C[C@]1(O)CC[C@H]2[C@@H]3[C@H](C)CC4=C(CCC(=O)C4)[C@H]3CC[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL438945";"HUMAN NEUROPEPTIDE Y";"1.0";"4271.75";"None";"None";"NPY";"CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O)[C@@H](C)CC";"IC50";"'='";"0.028";"nM";"10.55";"";"";"UO_0000065";"2.47";"None";"None";"None";"0";"CHEMBL3876376";"Displacement of [125I]peptide YY from Y2 receptor in human KAN-TS cells measured after 60 mins by scintillation counting method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"KAN-TS";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3875185";"1";"Scientific Literature";"Bioorg Med Chem";"2017";"None";"";"";""
"CHEMBL129";"ZIDOVUDINE";"4.0";"267.24";"0";"-0.20";"ZIDOVUDINE";"Cc1cn([C@H]2C[C@H](N=[N+]=[N-])[C@@H](CO)O2)c(=O)[nH]c1=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL844";"BRIMONIDINE";"4.0";"292.14";"0";"1.76";"BRIMONIDINE";"Brc1c(NC2=NCCN2)ccc2nccnc12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL20965";"";"None";"515.68";"2";"5.07";"21";"CC(=O)N1CCc2ccc(N(C3CCN(Cc4ccccc4)CC3)S(=O)(=O)/C=C/c3ccccc3)cc21";"IC50";"'='";"30000.0";"nM";"4.52";"";"";"UO_0000065";"8.77";"0.17";"-0.55";"7.42";"0";"CHEMBL750768";"Binding affinity towards the NPY Y2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147599";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2004";"None";"";"";""
"CHEMBL95501";"";"None";"460.67";"1";"6.79";"1, BMS";"CN(C)CCCN(C(=O)c1cc2ccccc2s1)c1ccccc1SCc1ccccc1";"IC50";"'='";"450.0";"nM";"6.35";"";"";"UO_0000065";"13.78";"0.27";"-0.44";"26.95";"1";"CHEMBL1827365";"Displacement of [125I]PYY from human NPY Y2 receptor expressed endogenously in KAN-Ts cells by scintillation counting";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"KAN-Ts";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1821563";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";"";""
"CHEMBL1823353";"";"None";"536.65";"2";"5.74";"22";"CCNC(=O)C(c1ccccc1)N1CCN(c2ccc(NC(=O)c3ccccc3-c3ccccc3)cc2F)CC1";"IC50";"'='";"35.0";"nM";"7.46";"";"";"UO_0000065";"13.89";"0.25";"1.72";"11.53";"0";"CHEMBL1827365";"Displacement of [125I]PYY from human NPY Y2 receptor expressed endogenously in KAN-Ts cells by scintillation counting";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"KAN-Ts";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1821563";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";"";""
"CHEMBL21502";"";"None";"480.61";"0";"4.70";"27";"CC(=O)N1CCc2ccc(N(C(=O)/C=C/c3ccccn3)C3CCN(Cc4ccccc4)CC3)cc21";"IC50";"'='";"30000.0";"nM";"4.52";"";"";"UO_0000065";"9.41";"0.17";"-0.18";"7.97";"0";"CHEMBL750768";"Binding affinity towards the NPY Y2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147599";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2004";"None";"";"";""
"CHEMBL3198593";"";"None";"377.83";"0";"3.91";"SID14729910";"CCOC(=O)C(/C=N/c1cc(C)nn1-c1ccc(Cl)cc1)=C(\O)OCC";"IC50";"'='";"30590.0";"nM";"4.51";"";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1613986";"PUBCHEM_BIOASSAY: Dose response counterscreen assay for neuropeptide Y receptor Y1 (NPY-Y1): Cell-based high throughput assay to measure NPY-Y2 antagonism. (Class of assay: confirmatory) [Related pubchem assays: 793, 1040, 1255, 1254 ]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1392785";"";"None";"416.54";"0";"3.83";"SID24833623";"COc1ccc(N(C)S(=O)(=O)c2cccc(C(=O)NCC3CCCCC3)c2)cc1";"IC50";"'>'";"35000.0";"nM";"";"";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1613986";"PUBCHEM_BIOASSAY: Dose response counterscreen assay for neuropeptide Y receptor Y1 (NPY-Y1): Cell-based high throughput assay to measure NPY-Y2 antagonism. (Class of assay: confirmatory) [Related pubchem assays: 793, 1040, 1255, 1254 ]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL2030163";"";"None";"508.13";"2";"6.53";"24";"CCN(CC)c1ccc(NC(=S)N2CCC(C(O)(c3ccccc3)c3ccccc3)CC2)cc1Cl";"IC50";"'='";"85.0";"nM";"7.07";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2032840";"Antagonist activity at neuropeptide Y receptor Y2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2029318";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";"";""
"CHEMBL21679";"";"None";"485.65";"1";"5.37";"26";"CC(=O)N1CCc2ccc(N(C(=O)/C=C/c3ccsc3)C3CCN(Cc4ccccc4)CC3)cc21";"IC50";"'='";"3200.0";"nM";"5.50";"";"";"UO_0000065";"11.31";"0.21";"0.12";"12.53";"0";"CHEMBL750768";"Binding affinity towards the NPY Y2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147599";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2004";"None";"";"";""
"CHEMBL49";"BUSPIRONE";"4.0";"385.51";"0";"2.09";"BUSPIRONE";"O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(c2ncccn2)CC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL4226347";"";"None";"2829.48";"None";"None";"11";"CCCCCCCCCCCCCCCC(=O)NC[C@H]1CC[C@H](C(=O)N[C@@H](CCC(=O)NCCCOCCOCCOCCCNC(=O)COCC(=O)NCCCC[C@H](N)C(=O)NCCCC[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)C(C)(C)NC(=O)[C@H](CC2CCCCC2)NC(=O)[C@H](Cc2ccncc2)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H]2C[C@H](O)CN2C(=O)[C@H](CO)NC(=O)c2c[nH]cn2)C(=O)NC(C)(C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC2CCCCC2)C(N)=O)[C@@H](C)O)C(=O)O)CC1";"IC50";"'='";"0.19";"nM";"9.72";"";"";"UO_0000065";"3.44";"None";"None";"None";"0";"CHEMBL4220285";"Displacement of [125I]-PYY from human neuropeptide Y2 receptor expressed in CHO cell membranes incubated for 60 mins by TopCount micro scintillation analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4219053";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";"";"";""
"CHEMBL4224694";"";"None";"2772.42";"None";"None";"7";"CC[C@](C)(NC(=O)[C@H]1C[C@H](O)CN1C(=O)[C@H](CO)NC(=O)c1c[nH]cn1)C(=O)N[C@@H](Cc1ccncc1)C(=O)N[C@@H](CC1CCCCC1)C(=O)N[C@@H](CC(C)(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCNC(=O)COCC(=O)NCCCOCCOCCOCCCNC(=O)CC[C@H](NC(=O)[C@H]1CC[C@H](CNC(=O)CCCCCCCCCCCCCCCCCCC(=O)O)CC1)C(=O)O)C(=O)NC(C)(C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC1CCCCC1)C(N)=O)[C@@H](C)O";"IC50";"'='";"24.0";"nM";"7.62";"";"";"UO_0000065";"2.75";"None";"None";"None";"0";"CHEMBL4220285";"Displacement of [125I]-PYY from human neuropeptide Y2 receptor expressed in CHO cell membranes incubated for 60 mins by TopCount micro scintillation analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4219053";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";"";"";""
"CHEMBL386630";"TESTOSTERONE";"4.0";"288.43";"0";"3.88";"TESTOSTERONE";"C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@@]43C)[C@@H]1CC[C@@H]2O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL38737";"THIOACETAMIDE";"None";"75.14";"0";"0.91";"THIOACETAMIDE";"CC(=N)S";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL483251";"";"None";"388.25";"0";"4.54";"5bb";"O=C1OC2(CCN(c3nc4cc(Cl)c(Cl)cc4[nH]3)CC2)c2ccccc21";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1001159";"Binding affinity to NPY Y2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141687";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"None";"";"";""
"CHEMBL497569";"";"None";"395.46";"0";"4.90";"5m";"O=C1OC2(CCN(c3nc4cc(-c5ccccc5)ccc4[nH]3)CC2)c2ccccc21";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1001159";"Binding affinity to NPY Y2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141687";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"None";"";"";""
"CHEMBL414482";"";"None";"1700.97";"None";"None";"Ac-25-36[Cha31]";"CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCN=C(N)N)NC(C)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)C1CCCCC1";"IC50";"'='";"5.0";"nM";"8.30";"";"";"UO_0000065";"4.88";"None";"None";"None";"0";"CHEMBL750762";"Compound was evaluated for its inhibitory activity against human neuropeptide Y2 receptor expressing LN319 cells";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"LN319";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1126482";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1993";"None";"";"";""
"CHEMBL41457";"";"None";"492.02";"0";"3.54";"25";"N=C(N)NCCCC(NC(=O)C(c1ccccc1)c1ccc(Cl)cc1)C(=O)NCc1ccccc1";"IC50";"'='";"97000.0";"nM";"4.01";"";"";"UO_0000065";"8.16";"0.16";"0.47";"3.34";"0";"CHEMBL747056";"Inhibition of binding of [3H]propionyl-NPY (1 nM) to Neuropeptide Y receptor type 2 in SMS-KAN cell membranes";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"SMS-KAN";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133238";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2000";"None";"";"";""
"CHEMBL153479";"AMBROXOL";"3.0";"378.11";"0";"3.19";"AMBROXOL";"Nc1c(Br)cc(Br)cc1CN[C@H]1CC[C@H](O)CC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL511";"PYRILAMINE";"4.0";"285.39";"0";"2.66";"PYRILAMINE";"COc1ccc(CN(CCN(C)C)c2ccccn2)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL101";"PHENYLBUTAZONE";"4.0";"308.38";"0";"3.79";"PHENYLBUTAZONE";"CCCCC1C(=O)N(c2ccccc2)N(c2ccccc2)C1=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL633";"AMIODARONE";"4.0";"645.32";"2";"6.94";"AMIODARONE";"CCCCc1oc2ccccc2c1C(=O)c1cc(I)c(OCCN(CC)CC)c(I)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL252557";"GLYCOLIC ACID";"2.0";"76.05";"0";"-0.94";"GLYCOLIC ACID";"O=C(O)CO";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL808";"ECONAZOLE";"4.0";"381.69";"1";"5.80";"ECONAZOLE";"Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)cc1";"IC50";"'='";"20145.0";"nM";"4.70";"";"";"UO_0000065";"12.30";"0.27";"-1.10";"17.36";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL156455";"1,1-DICHLOROETHENE";"None";"96.94";"0";"1.94";"1,1-DICHLOROETHENE";"C=C(Cl)Cl";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1612004";"";"None";"123.15";"0";"1.28";"O-ANISIDINE";"COc1ccccc1N";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1543306";"";"None";"446.62";"1";"5.43";"SF-11";"CCOc1ccc(NC(=S)N2CCC(C(O)(c3ccccc3)c3ccccc3)CC2)cc1";"IC50";"'='";"190.0";"nM";"6.72";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2032840";"Antagonist activity at neuropeptide Y receptor Y2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2029318";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";"";""
"CHEMBL2030155";"";"None";"509.70";"1";"4.28";"16, CYM 9484";"CN(C)S(=O)(=O)c1ccc(NC(=S)N2CCC(C(O)(c3ccccc3)c3ccccc3)CC2)cc1";"IC50";"'='";"19.0";"nM";"7.72";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2032840";"Antagonist activity at neuropeptide Y receptor Y2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2029318";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";"";""
"CHEMBL2030171";"";"None";"430.62";"1";"6.33";"32";"CCOc1ccc(NC(=S)N2CCC(C(c3ccccc3)c3ccccc3)CC2)cc1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2032840";"Antagonist activity at neuropeptide Y receptor Y2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2029318";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";"";""
"CHEMBL2030185";"";"None";"535.70";"1";"3.61";"46";"CN(C)S(=O)(=O)c1ccc(NC(=S)N2CCN(C3c4ccccc4NC(=O)c4ccccc43)CC2)cc1";"IC50";"'='";"67.0";"nM";"7.17";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2032840";"Antagonist activity at neuropeptide Y receptor Y2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2029318";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";"";""
"CHEMBL11359";"CISPLATIN";"4.0";"300.05";"None";"None";"SID170464726";"";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL452";"CLONAZEPAM";"4.0";"315.72";"0";"3.04";"CLONAZEPAM";"O=C1CN=C(c2ccccc2Cl)c2cc([N+](=O)[O-])ccc2N1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL757";"NANDROLONE";"3.0";"274.40";"0";"3.49";"NANDROLONE";"C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@@H]43)[C@@H]1CC[C@@H]2O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL572";"NITROFURANTOIN";"4.0";"238.16";"0";"0.07";"NITROFURANTOIN";"O=C1CN(/N=C/c2ccc([N+](=O)[O-])o2)C(=O)N1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL428320";"";"None";"1954.28";"None";"None";"13";"CC(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O)C(C)C";"IC50";"'='";"2.09";"nM";"8.68";"";"";"UO_0000065";"4.44";"None";"None";"None";"0";"CHEMBL755164";"Affinity against Neuropeptide Y receptor Y2 in SK-N-BE2 cell line";"B";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133640";"1";"Scientific Literature";"J Med Chem";"2000";"None";"";"";""
"CHEMBL540466";"";"None";"581.75";"2";"5.97";"3i";"COc1ccc([C@H](N[C@@H]2CC[C@@H](C(=O)N3CCC(C(=O)N4CCCC4)(c4ccccc4)CC3)C(C)(C)C2)C(F)F)cc1";"IC50";"'='";"1400.0";"nM";"5.85";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1053233";"Antagonist activity at human neuropeptide Y2 receptor expressed in HEK293 cells by [35S]GTPgammaS binding assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1153458";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"CHEMBL3307715";"";"";""
"CHEMBL269503";"";"None";"4241.70";"None";"None";"1";"CC(C)C[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)C(C)C";"IC50";"'='";"0.07";"nM";"10.15";"";"";"UO_0000065";"2.39";"None";"None";"None";"0";"CHEMBL755164";"Affinity against Neuropeptide Y receptor Y2 in SK-N-BE2 cell line";"B";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133640";"1";"Scientific Literature";"J Med Chem";"2000";"None";"";"";""
"CHEMBL964";"DISULFIRAM";"4.0";"296.55";"0";"3.62";"DISULFIRAM";"CCN(CC)C(=S)SSC(=S)N(CC)CC";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1463";"FLUCYTOSINE";"4.0";"129.09";"0";"-0.51";"FLUCYTOSINE";"Nc1nc(=O)[nH]cc1F";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1255837";"DIHYDROERGOCRISTINE MESYLATE";"None";"707.85";"1";"2.72";"DIHYDROERGOCRISTINE MESYLATE";"CC(C)[C@@]1(NC(=O)[C@@H]2C[C@@H]3c4cccc5[nH]cc(c45)C[C@H]3N(C)C2)O[C@@]2(O)[C@@H]3CCCN3C(=O)[C@H](Cc3ccccc3)N2C1=O.CS(=O)(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1730";"CEFOTAXIME";"4.0";"455.47";"1";"-0.62";"CTX";"CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(C)=O)CS[C@H]12)c1csc(N)n1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL642";"ACEBUTOLOL";"4.0";"336.43";"0";"2.37";"ACEBUTOLOL";"CCCC(=O)Nc1ccc(OCC(O)CNC(C)C)c(C(C)=O)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL25";"ASPIRIN";"4.0";"180.16";"0";"1.31";"ASPIRIN";"CC(=O)Oc1ccccc1C(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL21737";"";"None";"477.61";"1";"6.01";"17";"CC(=O)n1ccc2ccc(N(C(=O)/C=C/c3ccccc3)C3CCN(Cc4ccccc4)CC3)cc21";"IC50";"'='";"30000.0";"nM";"4.52";"";"";"UO_0000065";"9.47";"0.17";"-1.49";"9.93";"0";"CHEMBL750768";"Binding affinity towards the NPY Y2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147599";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2004";"None";"";"";""
"CHEMBL21545";"";"None";"547.62";"2";"6.33";"36";"CC(=O)N1CCc2ccc(N(C(=O)/C=C/c3ccccc3C(F)(F)F)C3CCN(Cc4ccccc4)CC3)cc21";"IC50";"'='";"30000.0";"nM";"4.52";"";"";"UO_0000065";"8.26";"0.15";"-1.81";"10.31";"0";"CHEMBL750768";"Binding affinity towards the NPY Y2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147599";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2004";"None";"";"";""
"CHEMBL65";"CAMPTOTHECIN";"-1.0";"348.36";"0";"2.08";"CAMPTOTHECIN";"CC[C@@]1(O)C(=O)OCc2c1cc1n(c2=O)Cc2cc3ccccc3nc2-1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL9419";"METACETAMOL";"2.0";"151.16";"0";"1.35";"3-ACETAMIDOPHENOL";"CC(=O)Nc1cccc(O)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL340978";"BENOXAPROFEN";"4.0";"301.73";"0";"4.34";"BENOXAPROFEN";"CC(C(=O)O)c1ccc2oc(-c3ccc(Cl)cc3)nc2c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL768";"ESMOLOL";"4.0";"295.38";"0";"1.53";"ESMOLOL";"COC(=O)CCc1ccc(OCC(O)CNC(C)C)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL290916";"EDARAVONE";"4.0";"174.20";"0";"1.80";"EDARAVONE";"CC1=NN(c2ccccc2)C(=O)C1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL427216";"GLICLAZIDE";"4.0";"323.42";"0";"1.63";"GLICLAZIDE";"Cc1ccc(S(=O)(=O)NC(=O)NN2CC3CCCC3C2)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1467";"ALLOPURINOL";"4.0";"136.11";"0";"0.06";"ALLOPURINOL";"Oc1ncnc2[nH]ncc12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL562";"GRISEOFULVIN";"4.0";"352.77";"0";"2.81";"GRISEOFULVIN";"COC1=CC(=O)C[C@@H](C)[C@]12Oc1c(Cl)c(OC)cc(OC)c1C2=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL728";"PROCHLORPERAZINE";"4.0";"373.95";"0";"4.58";"PROCHLORPERAZINE";"CN1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL980";"GUAIFENESIN";"4.0";"198.22";"0";"0.43";"GUAIFENESIN";"COc1ccccc1OCC(O)CO";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL914";"FEXOFENADINE";"4.0";"501.67";"2";"5.51";"FEXOFENADINE";"CC(C)(C(=O)O)c1ccc(C(O)CCCN2CCC(C(O)(c3ccccc3)c3ccccc3)CC2)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL252556";"IDEBENONE";"4.0";"338.44";"0";"3.46";"IDEBENONE";"COC1=C(OC)C(=O)C(CCCCCCCCCCO)=C(C)C1=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL578";"ENALAPRIL";"4.0";"376.45";"0";"1.60";"ENALAPRIL";"CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL106";"FLUCONAZOLE";"4.0";"306.28";"0";"0.74";"FLUCONAZOLE";"OC(Cn1cncn1)(Cn1cncn1)c1ccc(F)cc1F";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL502896";"CETRAXATE HYDROCHLORIDE";"-1.0";"341.83";"0";"2.37";"CETRAXATE";"Cl.NC[C@H]1CC[C@H](C(=O)Oc2ccc(CCC(=O)O)cc2)CC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL36715";"PIRACETAM";"4.0";"142.16";"0";"-0.91";"PIRACETAM";"NC(=O)CN1CCCC1=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL71";"CHLORPROMAZINE";"4.0";"318.87";"0";"4.89";"CHLORPROMAZINE";"CN(C)CCCN1c2ccccc2Sc2ccc(Cl)cc21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL712";"ANISINDIONE";"4.0";"252.27";"0";"2.86";"ANISINDIONE";"COc1ccc(C2C(=O)c3ccccc3C2=O)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL419086";"";"None";"376.46";"1";"5.06";"1";"C[C@H]([C@H](O)c1ccccc1)N(C)C(=O)Nc1ccc(Oc2ccccc2)cc1";"IC50";"'='";"2682.0";"nM";"5.57";"";"";"UO_0000065";"14.80";"0.27";"0.51";"9.02";"0";"CHEMBL749564";"Inhibitory activity tested against Human Neuropeptide Y2 Receptor.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1134441";"1";"Scientific Literature";"J Med Chem";"2001";"None";"";"";""
"CHEMBL4097131";"";"None";"1728.13";"None";"None";"1";"CC(C)C[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)C(CC1CCCCC1)NC(=O)C(CC1CCCCC1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)c1ccccc1)C(=O)NC(C)(C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NC(CC1CCCCC1)C(N)=O)[C@@H](C)O";"IC50";"'='";"7.4";"nM";"8.13";"";"";"UO_0000065";"4.70";"None";"None";"None";"0";"CHEMBL4036757";"Displacement of [125I]-PYY from human Y2R expressed in CHO cell membranes after 60 mins by liquid scintillation method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4033754";"1";"Scientific Literature";"ACS Med Chem Lett";"2017";"None";"";"";""
"CHEMBL954";"ENCLOMIPHENE";"3.0";"405.97";"1";"6.56";"CLOMIPHENE";"CCN(CC)CCOc1ccc(/C(=C(/Cl)c2ccccc2)c2ccccc2)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1172";"DESLORATADINE";"4.0";"310.83";"0";"4.02";"DESLORATADINE";"Clc1ccc2c(c1)CCc1cccnc1C2=C1CCNCC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL16068";"BROMOBENZENE";"None";"157.01";"0";"2.45";"BROMOBENZENE";"Brc1ccccc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL50588";"EMETINE";"2.0";"480.65";"0";"4.94";"EMETINE";"CC[C@H]1CN2CCc3cc(OC)c(OC)cc3[C@@H]2C[C@@H]1C[C@H]1NCCc2cc(OC)c(OC)cc21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL3039597";"GENTAMICIN";"4.0";"1390.73";"None";"None";"GENTAMICIN";"CNC(C)[C@@H]1CC[C@@H](N)[C@@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3OC[C@](C)(O)[C@H](NC)[C@H]3O)[C@H](N)C[C@@H]2N)O1.CN[C@@H]1[C@@H](O)[C@@H](O[C@@H]2[C@@H](O)[C@H](O[C@H]3O[C@H](C(C)N)CC[C@H]3N)[C@@H](N)C[C@H]2N)OC[C@]1(C)O.CN[C@@H]1[C@@H](O)[C@@H](O[C@@H]2[C@@H](O)[C@H](O[C@H]3O[C@H](CN)CC[C@H]3N)[C@@H](N)C[C@H]2N)OC[C@]1(C)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1108";"DROPERIDOL";"4.0";"379.44";"0";"3.68";"DROPERIDOL";"O=C(CCCN1CC=C(n2c(=O)[nH]c3ccccc32)CC1)c1ccc(F)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL13378";"(R,S)-AMPA";"None";"186.17";"0";"-0.36";"(RS)-AMPA";"Cc1onc(O)c1CC(N)C(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL420630";"";"None";"474.70";"1";"7.18";"18";"CN(C)CCCCN(C(=O)c1cc2ccccc2s1)c1ccccc1SCc1ccccc1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL747054";"Binding affinity against SMS-KAN cell membranes endogenously expressing Neuropeptide Y receptor type 2 using [125I]PYY as radioligand";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"SMS-KAN";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1136181";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2003";"None";"";"";""
"CHEMBL42747";"";"None";"513.64";"1";"3.25";"4";"N=C(N)NCCCC(NC(=O)C(c1ccccc1)c1ccccc1)C(=O)N1CCCc2cc(O)ccc2C1";"IC50";"'='";"247000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL747056";"Inhibition of binding of [3H]propionyl-NPY (1 nM) to Neuropeptide Y receptor type 2 in SMS-KAN cell membranes";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"SMS-KAN";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133238";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2000";"None";"";"";""
"CHEMBL1909049";"";"None";"309.41";"0";"3.79";"1-(2-METHOXYBENZOYL)-4-(PHENYLMETHYL)-PIPERIDINE";"COc1ccccc1C(=O)N1CCC(Cc2ccccc2)CC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL438923";"";"None";"1917.26";"None";"None";"28";"CC(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](CN[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O)C(C)C)CC(C)C";"IC50";"'='";"55.0";"nM";"7.26";"";"";"UO_0000065";"3.79";"None";"None";"None";"0";"CHEMBL755164";"Affinity against Neuropeptide Y receptor Y2 in SK-N-BE2 cell line";"B";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133640";"1";"Scientific Literature";"J Med Chem";"2000";"None";"";"";""
"CHEMBL2111764";"";"None";"2004.29";"None";"None";"19";"CC(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O)C(C)C";"IC50";"'='";"56.5";"nM";"7.25";"";"";"UO_0000065";"3.62";"None";"None";"None";"0";"CHEMBL755164";"Affinity against Neuropeptide Y receptor Y2 in SK-N-BE2 cell line";"B";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133640";"1";"Scientific Literature";"J Med Chem";"2000";"None";"";"";""
"CHEMBL1476898";"CADMIUM ACETATE";"None";"230.50";"None";"None";"CADMIUM ACETATE";"";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL277474";"ANTIPYRINE";"4.0";"188.23";"0";"1.48";"ANTIPYRINE";"Cc1cc(=O)n(-c2ccccc2)n1C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL4086266";"";"None";"1814.26";"None";"None";"9";"CCC(NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CO)NC(C)=O)C(=O)NC(CC1CCCCC1)C(=O)NC(CC1CCCCC1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)NC(C)(C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NC(CC1CCCCC1)C(N)=O)[C@@H](C)O";"IC50";"'='";"11.0";"nM";"7.96";"";"";"UO_0000065";"4.39";"None";"None";"None";"0";"CHEMBL4036757";"Displacement of [125I]-PYY from human Y2R expressed in CHO cell membranes after 60 mins by liquid scintillation method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4033754";"1";"Scientific Literature";"ACS Med Chem Lett";"2017";"None";"";"";""
"CHEMBL101168";"";"None";"134.14";"0";"0.15";"1-AMINOBENZOTRIAZOLE";"Nn1nnc2ccccc21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1586";"BECLOMETHASONE";"2.0";"408.92";"0";"2.17";"BECLOMETHASONE";"C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(Cl)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL679";"EPINEPHRINE";"4.0";"183.21";"0";"0.35";"EPINEPHRINE";"CNC[C@H](O)c1ccc(O)c(O)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1237174";"HYDRAZINE";"0.5";"32.05";"0";"-1.18";"HYDRAZINE";"NN";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL723";"CARVEDILOL";"4.0";"406.48";"0";"3.74";"CARVEDILOL";"COc1ccccc1OCCNCC(O)COc1cccc2[nH]c3ccccc3c12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL290175";"";"None";"631.82";"2";"5.38";"32";"N/C(=N/CCCC(NC(=O)Cc1ccc(-c2ccccc2)cc1)C(=O)N1CCCc2cc(O)ccc2C1)NCCCc1ccccc1";"IC50";"'='";"78000.0";"nM";"4.11";"";"";"UO_0000065";"6.50";"0.12";"-1.27";"3.42";"0";"CHEMBL747056";"Inhibition of binding of [3H]propionyl-NPY (1 nM) to Neuropeptide Y receptor type 2 in SMS-KAN cell membranes";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"SMS-KAN";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133238";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2000";"None";"";"";""
"CHEMBL34431";"CILOSTAMIDE";"2.0";"342.44";"0";"3.48";"CILOSTAMIDE";"CN(C(=O)CCCOc1ccc2[nH]c(=O)ccc2c1)C1CCCCC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1425";"MERCAPTOPURINE ANHYDROUS";"4.0";"152.18";"0";"0.64";"6-MERCAPTOPURINE";"Sc1ncnc2nc[nH]c12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL545";"ALCOHOL";"4.0";"46.07";"0";"0.00";"ETHANOL";"CCO";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL657";"DIPHENHYDRAMINE";"4.0";"255.36";"0";"3.35";"DIPHENHYDRAMINE";"CN(C)CCOC(c1ccccc1)c1ccccc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL631";"PROPAFENONE";"4.0";"341.45";"0";"3.24";"PROPAFENONE";"CCCNCC(O)COc1ccccc1C(=O)CCc1ccccc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL306043";"GOLD SODIUM THIOMALATE";"4.0";"346.11";"None";"None";"GOLD SODIUM THIOMALATE";"";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL7002";"CIGLITAZONE";"2.0";"333.45";"0";"3.93";"CIGLITAZONE";"CC1(COc2ccc(CC3SC(=O)NC3=O)cc2)CCCCC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1527608";"DOXOFYLLINE";"3.0";"266.26";"0";"-1.19";"DOXOFYLLINE";"Cn1c(=O)c2c(ncn2CC2OCCO2)n(C)c1=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1256017";"ARCAINE SULFATE";"None";"270.31";"1";"-1.27";"ARCAINE SULFATE";"N=C(N)NCCCCNC(=N)N.O=S(=O)(O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1231530";"BETAMIPRON";"2.0";"193.20";"0";"0.89";"BETAMIPRON";"O=C(O)CCNC(=O)c1ccccc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1909057";"COPPER(II) OXIDE";"None";"79.55";"None";"None";"COPPER(II) OXIDE";"";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL196";"ASCORBIC ACID";"4.0";"176.12";"0";"-1.41";"ASCORBIC ACID";"O=C1O[C@H]([C@@H](O)CO)C(O)=C1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL283196";"ALPHA-NAPHTHOFLAVONE";"None";"272.30";"0";"4.61";"ALPHA-NAPHTHOFLAVONE";"O=c1cc(-c2ccccc2)oc2c1ccc1ccccc12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL44657";"ETOPOSIDE";"4.0";"588.56";"2";"1.34";"etoposide";"COc1cc([C@@H]2c3cc4c(cc3[C@@H](O[C@@H]3O[C@@H]5CO[C@@H](C)O[C@H]5[C@H](O)[C@H]3O)[C@H]3COC(=O)[C@H]23)OCO4)cc(OC)c1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL262221";"";"None";"1991.34";"None";"None";"10";"CC(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O)C(C)C)C(c1ccccc1)c1ccccc1";"IC50";"'='";"10.0";"nM";"8.00";"";"";"UO_0000065";"4.02";"None";"None";"None";"0";"CHEMBL755164";"Affinity against Neuropeptide Y receptor Y2 in SK-N-BE2 cell line";"B";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133640";"1";"Scientific Literature";"J Med Chem";"2000";"None";"";"";""
"CHEMBL441936";"";"None";"1917.26";"None";"None";"27";"CC(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](CN[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O)C(C)C)CC(C)C";"IC50";"'>'";"3000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL755164";"Affinity against Neuropeptide Y receptor Y2 in SK-N-BE2 cell line";"B";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133640";"1";"Scientific Literature";"J Med Chem";"2000";"None";"";"";""
"CHEMBL960";"LEFLUNOMIDE";"4.0";"270.21";"0";"3.25";"leflunomide";"Cc1oncc1C(=O)Nc1ccc(C(F)(F)F)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL6966";"VERAPAMIL";"4.0";"454.61";"1";"5.09";"Verapamil";"COc1ccc(CCN(C)CCCC(C#N)(c2ccc(OC)c(OC)c2)C(C)C)cc1OC";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL137";"METRONIDAZOLE";"4.0";"171.16";"0";"0.09";"METRONIDAZOLE";"Cc1ncc([N+](=O)[O-])n1CCO";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL141343";"";"None";"520.72";"1";"4.21";"U-78517F";"Cc1c(C)c2c(c(C)c1O)CCC(C)(CN1CCN(c3cc(N4CCCC4)nc(N4CCCC4)n3)CC1)O2";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL442";"ERGOTAMINE";"4.0";"581.67";"1";"1.99";"ERGOTAMINE";"CN1C[C@H](C(=O)N[C@]2(C)O[C@@]3(O)[C@@H]4CCCN4C(=O)[C@H](Cc4ccccc4)N3C2=O)C=C2c3cccc4[nH]cc(c34)C[C@H]21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL437002";"";"None";"297.37";"0";"3.92";"1-(2-FLUOROBENZOYL)-4-(PHENYLMETHYL)-PIPERIDINE";"O=C(c1ccccc1F)N1CCC(Cc2ccccc2)CC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL45245";"";"None";"195.22";"0";"2.68";"6(5H)-PHENANTHRIDINONE";"O=c1[nH]c2ccccc2c2ccccc12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL139";"DICLOFENAC";"4.0";"296.15";"0";"4.36";"DICLOFENAC";"O=C(O)Cc1ccccc1Nc1c(Cl)cccc1Cl";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1909051";"";"None";"347.38";"0";"4.80";"4-(PHENYLMETHYL)-1-[2-(TRIFLUOROMETHYL)BENZOYL]-PIPERIDINE";"O=C(c1ccccc1C(F)(F)F)N1CCC(Cc2ccccc2)CC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL435";"HYDROCHLOROTHIAZIDE";"4.0";"297.75";"0";"-0.35";"35";"NS(=O)(=O)c1cc2c(cc1Cl)NCNS2(=O)=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL788";"IDOXURIDINE";"4.0";"354.10";"0";"-1.22";"IDOXURIDINE";"O=c1[nH]c(=O)n([C@H]2C[C@H](O)[C@@H](CO)O2)cc1I";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL29292";"UBENIMEX";"2.0";"308.38";"0";"0.53";"UBENIMEX";"CC(C)C[C@H](NC(=O)[C@@H](O)[C@H](N)Cc1ccccc1)C(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL541";"BENZOIC ACID";"4.0";"122.12";"0";"1.38";"BENZOIC ACID";"O=C(O)c1ccccc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL23";"DILTIAZEM";"4.0";"414.53";"0";"3.37";"SID90341257";"COc1ccc([C@@H]2Sc3ccccc3N(CCN(C)C)C(=O)[C@@H]2OC(C)=O)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL2220427";"ERYTHROMYCIN PROPIONATE";"4.0";"790.00";"2";"2.75";"ERYTHROMYCIN PROPIONATE";"CCC(=O)O[C@H]1[C@H](O[C@@H]2[C@@H](C)[C@H](O[C@H]3C[C@@](C)(OC)[C@@H](O)[C@H](C)O3)[C@@H](C)C(=O)O[C@H](CC)[C@@](C)(O)[C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@]2(C)O)O[C@H](C)C[C@@H]1N(C)C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL13";"METOPROLOL";"4.0";"267.37";"0";"1.61";"METOPROLOL";"COCCc1ccc(OCC(O)CNC(C)C)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL6";"INDOMETHACIN";"4.0";"357.79";"0";"3.93";"Indomethacin";"COc1ccc2c(c1)c(CC(=O)O)c(C)n2C(=O)c1ccc(Cl)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL741";"LAMOTRIGINE";"4.0";"256.10";"0";"2.01";"LAMOTRIGINE";"Nc1nnc(-c2cccc(Cl)c2Cl)c(N)n1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL45";"MELATONIN";"4.0";"232.28";"0";"1.86";"MELATONIN";"COc1ccc2[nH]cc(CCNC(C)=O)c2c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL856";"PRIMIDONE";"4.0";"218.26";"0";"0.54";"PRIMIDONE";"CCC1(c2ccccc2)C(=O)NCNC1=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL975";"MESNA";"4.0";"164.18";"0";"-0.20";"MESNA";"O=S(=O)([O-])CCS.[Na+]";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL499815";"ATRACTYLOSIDE";"None";"803.00";"2";"1.67";"ATRACTYLOSIDE";"C=C1[C@@H]2CCC3[C@@](CC[C@@H]4[C@H](C(=O)O)C[C@@H](O[C@@H]5O[C@H](CO)[C@@H](OS(=O)(=O)[O-])[C@H](OS(=O)(=O)[O-])[C@H]5OC(=O)CC(C)C)C[C@@]34C)(C2)[C@@H]1O.[K+].[K+]";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL989";"FLUOCINOLONE ACETONIDE";"4.0";"452.49";"0";"2.37";"FLUOCINOLONE ACETONIDE";"CC1(C)O[C@@H]2C[C@H]3[C@@H]4C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO)O1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL880";"FAMCICLOVIR";"4.0";"321.34";"0";"0.54";"SID170464774";"CC(=O)OCC(CCn1cnc2cnc(N)nc21)COC(C)=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1491";"AMLODIPINE";"4.0";"408.88";"0";"2.27";"AMLODIPINE";"CCOC(=O)C1=C(COCCN)NC(C)=C(C(=O)OC)C1c1ccccc1Cl";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL131";"PREDNISOLONE";"4.0";"360.45";"0";"1.56";"PREDNISOLONE";"C[C@]12C=CC(=O)C=C1CC[C@@H]1[C@@H]2[C@@H](O)C[C@@]2(C)[C@H]1CC[C@]2(O)C(=O)CO";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL286398";"PROPYLENE GLYCOL";"3.0";"76.10";"0";"-0.64";"PROPYLENE GLYCOL";"CC(O)CO";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL98350";"LY-294002";"-1.0";"307.35";"0";"3.30";"LY-294002";"O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL26";"SULPIRIDE";"4.0";"341.43";"0";"0.56";"SULPIRIDE";"CCN1CCCC1CNC(=O)c1cc(S(N)(=O)=O)ccc1OC";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL822";"TERBINAFINE";"4.0";"291.44";"0";"4.88";"TERBINAFINE";"CN(C/C=C/C#CC(C)(C)C)Cc1cccc2ccccc12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL772";"RESERPINE";"4.0";"608.69";"1";"4.17";"RESERPINE";"COC(=O)[C@H]1[C@H]2C[C@@H]3c4[nH]c5cc(OC)ccc5c4CCN3C[C@H]2C[C@@H](OC(=O)c2cc(OC)c(OC)c(OC)c2)[C@@H]1OC";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL923";"RISEDRONIC ACID";"4.0";"283.11";"0";"-0.37";"RISEDRONIC ACID";"O=P(O)(O)C(O)(Cc1cccnc1)P(=O)(O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL509";"MECLOFENAMIC ACID";"4.0";"296.15";"0";"4.74";"MECLOFENAMIC ACID";"Cc1ccc(Cl)c(Nc2ccccc2C(=O)O)c1Cl";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL24944";"TRIBROMSALAN";"4.0";"449.92";"0";"4.93";"TRIBROMSALAN";"O=C(Nc1ccc(Br)cc1)c1cc(Br)cc(Br)c1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1117";"IDARUBICIN";"4.0";"497.50";"0";"1.02";"IDARUBICIN";"CC(=O)[C@]1(O)Cc2c(O)c3c(c(O)c2[C@@H](O[C@H]2C[C@H](N)[C@H](O)[C@H](C)O2)C1)C(=O)c1ccccc1C3=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL119443";"ERGONOVINE";"4.0";"325.41";"0";"1.53";"ERGONOVINE";"C[C@@H](CO)NC(=O)[C@@H]1C=C2c3cccc4[nH]cc(c34)C[C@H]2N(C)C1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL683";"CLOFIBRIC ACID";"2.0";"214.65";"0";"2.58";"CLOFIBRIC ACID";"CC(C)(Oc1ccc(Cl)cc1)C(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1403281";"ERGOCRYPTINE";"None";"575.71";"1";"2.43";"ALPHA-ERGOCRYPTINE";"CC(C)C[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C=C4c5cccc6[nH]cc(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL926";"DOBUTAMINE";"4.0";"301.39";"0";"2.96";"DOBUTAMINE";"CC(CCc1ccc(O)cc1)NCCc1ccc(O)c(O)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1727";"CEPHALEXIN ANHYDROUS";"4.0";"347.40";"0";"0.44";"CEPHALEXIN";"CC1=C(C(=O)O)N2C(=O)[C@@H](NC(=O)[C@H](N)c3ccccc3)[C@H]2SC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL44246";"";"None";"473.58";"1";"2.59";"1";"N=C(N)NCCCC(NC(=O)C(c1ccccc1)c1ccccc1)C(=O)NCc1ccc(O)cc1";"IC50";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL747056";"Inhibition of binding of [3H]propionyl-NPY (1 nM) to Neuropeptide Y receptor type 2 in SMS-KAN cell membranes";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"SMS-KAN";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133238";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2000";"None";"";"";""
"CHEMBL496327";"";"None";"377.40";"0";"3.02";"5r";"COC(=O)c1ccc2[nH]c(N3CCC4(CC3)OC(=O)c3ccccc34)nc2c1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1001159";"Binding affinity to NPY Y2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141687";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"None";"";"";""
"CHEMBL1454946";"FLUBENDAZOLE";"2.0";"313.29";"0";"3.11";"FLUBENDAZOLE";"COC(=O)Nc1nc2cc(C(=O)c3ccc(F)cc3)ccc2[nH]1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1760";"TERBUTALINE";"4.0";"225.29";"0";"1.52";"terbutaline";"CC(C)(C)NCC(O)c1cc(O)cc(O)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL408";"TROGLITAZONE";"4.0";"441.55";"0";"4.37";"troglitazone";"Cc1c(C)c2c(c(C)c1O)CCC(C)(COc1ccc(CC3SC(=O)NC3=O)cc1)O2";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL93";"ZILEUTON";"4.0";"236.30";"0";"2.73";"ZILEUTON";"CC(c1cc2ccccc2s1)N(O)C(N)=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL2252949";"(-)-CAMPHOR";"None";"152.24";"0";"2.40";"L-CAMPHOR";"CC1(C)[C@H]2CC[C@]1(C)C(=O)C2";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1643";"RIBAVIRIN";"4.0";"244.21";"0";"-3.01";"Ribavirin";"NC(=O)c1ncn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)n1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL403";"SULBACTAM";"4.0";"233.24";"0";"-0.79";"Sulbactam (SUL)";"CC1(C)[C@H](C(=O)O)N2C(=O)C[C@H]2S1(=O)=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL2030164";"";"None";"471.63";"1";"5.30";"25";"CCOc1ccc(NC(=S)N2CCC(C(O)(c3ccccc3)c3ccccc3)CC2)cc1C#N";"IC50";"'='";"323.0";"nM";"6.49";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2032840";"Antagonist activity at neuropeptide Y receptor Y2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2029318";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";"";""
"CHEMBL2030169";"";"None";"464.61";"1";"5.57";"30";"CCOc1ccc(NC(=S)N2CCC(C(O)(c3ccccc3)c3ccccc3)CC2)c(F)c1";"IC50";"'='";"1350.0";"nM";"5.87";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2032840";"Antagonist activity at neuropeptide Y receptor Y2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2029318";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";"";""
"CHEMBL2030176";"";"None";"494.69";"0";"4.04";"37";"CN(C)S(=O)(=O)c1ccc(NC(=S)N2CCN(C(c3ccccc3)c3ccccc3)CC2)cc1";"IC50";"'='";"483.0";"nM";"6.32";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2032840";"Antagonist activity at neuropeptide Y receptor Y2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2029318";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";"";""
"CHEMBL1614641";"FLUNOXAPROFEN";"2.0";"285.27";"0";"3.82";"FLUNOXAPROFEN";"C[C@H](C(=O)O)c1ccc2oc(-c3ccc(F)cc3)nc2c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL42";"CLOZAPINE";"4.0";"326.83";"0";"3.72";"CLOZAPINE";"CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1082723";"CIPARGAMIN";"2.0";"390.24";"0";"4.34";"NITD609";"C[C@H]1Cc2c([nH]c3cc(Cl)c(F)cc23)[C@@]2(N1)C(=O)Nc1ccc(Cl)cc12";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1247904";"Binding affinity to human recombinant neuropeptide Y2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1240532";"1";"Scientific Literature";"Science";"2010";"None";"";"";""
"CHEMBL95660";"";"None";"444.64";"1";"6.07";"11";"CN(C)CCCN(C(=O)[C@@H]1C[C@H]1c1ccccc1)c1ccccc1SCc1ccccc1";"IC50";"'='";"3700.0";"nM";"5.43";"";"";"UO_0000065";"12.22";"0.23";"-0.64";"23.06";"0";"CHEMBL747054";"Binding affinity against SMS-KAN cell membranes endogenously expressing Neuropeptide Y receptor type 2 using [125I]PYY as radioligand";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"SMS-KAN";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1136181";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2003";"None";"";"";""
"CHEMBL3104123";"";"None";"451.55";"0";"4.50";"109";"CCC(CC)C(=O)Nc1ccc(N2CCN(C(c3ccccc3)c3ncno3)CC2)c(F)c1";"IC50";"'='";"240.0";"nM";"6.62";"";"";"UO_0000065";"14.66";"0.27";"2.12";"8.89";"0";"CHEMBL3107076";"Displacement of [125I]-PYY from human NPYY2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3102719";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL3104115";"";"None";"477.58";"0";"4.48";"100";"CCN(CC)C(=O)C(c1ccccc1)N1CCN(c2ccc(-c3noc(C4CC4)n3)cc2F)CC1";"IC50";"'='";"270.0";"nM";"6.57";"";"";"UO_0000065";"13.75";"0.26";"2.09";"10.00";"0";"CHEMBL3107076";"Displacement of [125I]-PYY from human NPYY2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3102719";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL3104188";"";"None";"493.63";"0";"4.30";"95";"CCN(CC)C(=O)C(c1ccccc1)N1CCN(c2ccc(-c3cc(=O)n(C(C)C)[nH]3)cc2F)CC1";"IC50";"'='";"340.0";"nM";"6.47";"";"";"UO_0000065";"13.10";"0.25";"2.17";"10.02";"0";"CHEMBL3107076";"Displacement of [125I]-PYY from human NPYY2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3102719";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL3104207";"";"None";"556.73";"2";"6.01";"63";"CCN(CC)C(=O)C(c1ccccc1)N1CCN(c2ccc(NC(=O)C3(c4ccccc4)CCCC3)cc2F)CC1";"IC50";"'='";"20.0";"nM";"7.70";"";"";"UO_0000065";"13.83";"0.26";"1.69";"13.78";"0";"CHEMBL3107076";"Displacement of [125I]-PYY from human NPYY2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3102719";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL22105";"";"None";"481.64";"1";"5.23";"19";"CC(=O)N1CCc2ccc(N(C(=O)CCc3ccccc3)C3CCN(Cc4ccccc4)CC3)cc21";"IC50";"'='";"18000.0";"nM";"4.75";"";"";"UO_0000065";"9.85";"0.18";"-0.49";"10.82";"1";"CHEMBL3107076";"Displacement of [125I]-PYY from human NPYY2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3102719";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL430532";"";"None";"493.65";"1";"5.70";"19";"CC(=O)N1CCc2ccc(N(C(=O)C/C=C/c3ccccc3)C3CCN(Cc4ccccc4)CC3)cc21";"IC50";"'='";"11000.0";"nM";"4.96";"";"";"UO_0000065";"10.04";"0.18";"-0.74";"11.31";"0";"CHEMBL750768";"Binding affinity towards the NPY Y2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147599";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2004";"None";"";"";""
"CHEMBL983";"SUCCINYLCHOLINE CHLORIDE";"4.0";"361.31";"0";"0.27";"SUXAMETHONIUM CHLORIDE";"C[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)C.[Cl-].[Cl-]";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1373";"MODAFINIL";"4.0";"273.36";"0";"2.01";"MODAFINIL";"NC(=O)C[S+]([O-])C(c1ccccc1)c1ccccc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL357995";"BOPINDOLOL";"2.0";"380.49";"0";"4.47";"BOPINDOLOL";"Cc1cc2c(OCC(CNC(C)(C)C)OC(=O)c3ccccc3)cccc2[nH]1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL439";"SULFADIAZINE";"4.0";"250.28";"0";"0.86";"SULFADIAZINE";"Nc1ccc(S(=O)(=O)Nc2ncccn2)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL865";"VALDECOXIB";"4.0";"314.37";"0";"2.96";"VALDECOXIB";"Cc1onc(-c2ccccc2)c1-c1ccc(S(N)(=O)=O)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL182";"GANCICLOVIR";"4.0";"255.23";"0";"-1.97";"GANCICLOVIR";"Nc1nc2c(ncn2COC(CO)CO)c(=O)[nH]1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL75435";"DEXKETOPROFEN";"4.0";"254.29";"0";"3.11";"DEXKETOPROFEN";"C[C@H](C(=O)O)c1cccc(C(=O)c2ccccc2)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL514";"LOMUSTINE";"4.0";"233.70";"0";"2.25";"LOMUSTINE";"O=NN(CCCl)C(=O)NC1CCCCC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1489254";"TRIACETIN";"2.0";"218.21";"0";"0.04";"TRIACETIN";"CC(=O)OCC(COC(C)=O)OC(C)=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL15511";"ENROFLOXACIN";"2.0";"359.40";"0";"2.32";"ENROFLOXACIN";"CCN1CCN(c2cc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL164290";"N-NITROSODIETHYLAMINE";"None";"102.14";"0";"1.01";"N-NITROSODIETHYLAMINE";"CCN(CC)N=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL92401";"IPRONIAZID";"4.0";"179.22";"0";"0.72";"IPRONIAZID";"CC(C)NNC(=O)c1ccncc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL2030157";"";"None";"535.74";"1";"4.82";"18";"O=S(=O)(c1ccc(NC(=S)N2CCC(C(O)(c3ccccc3)c3ccccc3)CC2)cc1)N1CCCC1";"IC50";"'='";"117.0";"nM";"6.93";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2032840";"Antagonist activity at neuropeptide Y receptor Y2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2029318";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";"";""
"CHEMBL2030190";"";"None";"520.65";"1";"4.62";"55";"O=C(Oc1ccc(S(=O)(=O)N2CCCC2)cc1)N1CCC(C(O)(c2ccccc2)c2ccccc2)CC1";"IC50";"'='";"49.0";"nM";"7.31";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2032840";"Antagonist activity at neuropeptide Y receptor Y2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2029318";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";"";""
"CHEMBL1130";"DOXIFLURIDINE";"3.0";"246.19";"0";"-1.69";"DOXIFLURIDINE";"C[C@H]1O[C@@H](n2cc(F)c(=O)[nH]c2=O)[C@H](O)[C@@H]1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL806";"FLUTAMIDE";"4.0";"276.21";"0";"3.21";"FLUTAMIDE";"CC(C)C(=O)Nc1ccc([N+](=O)[O-])c(C(F)(F)F)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL305660";"EBASTINE";"4.0";"469.67";"1";"7.22";"EBASTINE";"CC(C)(C)c1ccc(C(=O)CCCN2CCC(OC(c3ccccc3)c3ccccc3)CC2)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL433257";"HARRINGTONINE";"None";"531.60";"1";"2.19";"HARRINGTONINE";"COC(=O)C[C@](O)(CCC(C)(C)O)C(=O)O[C@@H]1C(OC)=C[C@]23CCCN2CCc2cc4c(cc2[C@H]13)OCO4";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL2030172";"";"None";"458.63";"1";"6.10";"33";"CCOC(=O)c1ccc(NC(=S)N2CCC(C(c3ccccc3)c3ccccc3)CC2)cc1";"IC50";"'='";"6760.0";"nM";"5.17";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2032840";"Antagonist activity at neuropeptide Y receptor Y2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2029318";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";"";""
"CHEMBL2030188";"";"None";"494.61";"0";"4.08";"53";"CN(C)S(=O)(=O)c1ccc(OC(=O)N2CCC(C(O)(c3ccccc3)c3ccccc3)CC2)cc1";"IC50";"'='";"61.0";"nM";"7.21";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2032840";"Antagonist activity at neuropeptide Y receptor Y2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2029318";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";"";""
"CHEMBL1371";"CHLORZOXAZONE";"4.0";"169.57";"0";"1.77";"CHLORZOXAZONE";"O=c1[nH]c2cc(Cl)ccc2o1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL457299";"MACROGOL";"4.0";"62.07";"0";"-1.03";"ETHYLENE GLYCOL";"OCCO";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL2030162";"";"None";"500.59";"2";"6.06";"23";"COc1ccc(NC(=S)N2CCC(C(O)(c3ccccc3)c3ccccc3)CC2)cc1C(F)(F)F";"IC50";"'='";"6079.0";"nM";"5.22";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2032842";"Partial antagonist activity at neuropeptide Y receptor Y2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2029318";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";"";""
"CHEMBL270299";"BAY-11-7085";"None";"249.34";"0";"2.80";"BAY-117085";"CC(C)(C)c1ccc(S(=O)(=O)/C=C/C#N)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL135";"ESTRADIOL";"4.0";"272.39";"0";"3.61";"BETA-ESTRADIOL";"C[C@]12CC[C@@H]3c4ccc(O)cc4CC[C@H]3[C@@H]1CC[C@@H]2O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1194";"PRILOCAINE";"4.0";"220.32";"0";"2.32";"PRILOCAINE";"CCCNC(C)C(=O)Nc1ccccc1C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL81";"RALOXIFENE";"4.0";"473.59";"1";"6.08";"raloxifene";"O=C(c1ccc(OCCN2CCCCC2)cc1)c1c(-c2ccc(O)cc2)sc2cc(O)ccc12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1626";"CLEMASTINE";"4.0";"343.90";"1";"5.10";"CLEMASTINE";"CN1CCC[C@@H]1CCO[C@](C)(c1ccccc1)c1ccc(Cl)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL457";"GEMFIBROZIL";"4.0";"250.34";"0";"3.57";"GEMFIBROZIL";"Cc1ccc(C)c(OCCCC(C)(C)C(=O)O)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL388590";"BENZBROMARONE";"4.0";"424.09";"1";"5.46";"BENZBROMARONE";"CCc1oc2ccccc2c1C(=O)c1cc(Br)c(O)c(Br)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1230813";"ALFADEX";"2.0";"972.85";"3";"-13.05";"ALPHA-CYCLODEXTRIN";"OC[C@H]1O[C@@H]2O[C@H]3[C@H](O)[C@@H](O)[C@@H](O[C@H]4[C@H](O)[C@@H](O)[C@@H](O[C@H]5[C@H](O)[C@@H](O)[C@@H](O[C@H]6[C@H](O)[C@@H](O)[C@@H](O[C@H]7[C@H](O)[C@@H](O)[C@@H](O[C@H]1[C@H](O)[C@H]2O)O[C@@H]7CO)O[C@@H]6CO)O[C@@H]5CO)O[C@@H]4CO)O[C@@H]3CO";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1902981";"EPERISONE";"3.0";"259.39";"0";"3.55";"EPERISONE";"CCc1ccc(C(=O)C(C)CN2CCCCC2)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL502620";"ACLARUBICIN";"3.0";"811.88";"2";"3.16";"ACLARUBICIN";"CC[C@@]1(O)C[C@H](O[C@H]2C[C@H](N(C)C)[C@H](O[C@H]3C[C@H](O)[C@H](O[C@H]4CCC(=O)[C@H](C)O4)[C@H](C)O3)[C@H](C)O2)c2c(cc3c(c2O)C(=O)c2c(O)cccc2C3=O)[C@H]1C(=O)OC";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL34139";"GENACONAZOLE";"None";"331.34";"0";"0.88";"GENACONAZOLE (RR(+) ISOMER)";"C[C@H]([C@](O)(Cn1cncn1)c1ccc(F)cc1F)S(C)(=O)=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1201353";"DEXCHLORPHENIRAMINE";"4.0";"274.80";"0";"3.82";"DEXCHLORPHENIRAMINE";"CN(C)CC[C@@H](c1ccc(Cl)cc1)c1ccccn1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL493";"BROMOCRIPTINE";"4.0";"654.61";"1";"3.19";"BROMOCRIPTINE";"CC(C)C[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C=C4c5cccc6[nH]c(Br)c(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL376180";"AMINOPTERIN";"2.0";"440.42";"1";"0.24";"AMINOPTERIN";"Nc1nc(N)c2nc(CNc3ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc3)cnc2n1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1370561";"AMINOPHYLLINE";"4.0";"420.43";"0";"-1.04";"AMINOPHYLLINE";"Cn1c(=O)c2[nH]cnc2n(C)c1=O.Cn1c(=O)c2[nH]cnc2n(C)c1=O.NCCN";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL4076542";"";"None";"1727.18";"None";"None";"4";"CCC(NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(C)=O)C(=O)NC(CC1CCCCC1)C(=O)NC(CC1CCCCC1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)NC(C)(C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NC(CC1CCCCC1)C(N)=O)[C@@H](C)O";"IC50";"'='";"17.0";"nM";"7.77";"";"";"UO_0000065";"4.50";"None";"None";"None";"0";"CHEMBL4036757";"Displacement of [125I]-PYY from human Y2R expressed in CHO cell membranes after 60 mins by liquid scintillation method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4033754";"1";"Scientific Literature";"ACS Med Chem Lett";"2017";"None";"";"";""
"CHEMBL902";"FAMOTIDINE";"4.0";"337.46";"0";"-0.77";"FAMOTIDINE";"NC(N)=Nc1nc(CSCC/C(N)=N/S(N)(=O)=O)cs1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL12089";"BERBERINE CHLORIDE";"1.0";"371.82";"0";"3.10";"BERBERINE CHLORIDE";"COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-]";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1598608";"AZASETRON";"2.0";"349.82";"0";"1.52";"AZASETRON";"CN1C(=O)COc2c(C(=O)NC3CN4CCC3CC4)cc(Cl)cc21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL77675";"";"None";"211.27";"0";"3.15";"1,3-DIPHENYLGUANIDINE";"N=C(Nc1ccccc1)Nc1ccccc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL85728";"4,4'-METHYLENEDIANILINE";"None";"198.27";"0";"2.44";"4,4'-METHYLENEDIANILINE";"Nc1ccc(Cc2ccc(N)cc2)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL917";"FLOXURIDINE";"4.0";"246.19";"0";"-1.68";"5-FLUORO-2'-DEOXYURIDINE";"O=c1[nH]c(=O)n([C@H]2C[C@H](O)[C@@H](CO)O2)cc1F";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL490";"PAROXETINE";"4.0";"329.37";"0";"3.33";"PAROXETINE";"Fc1ccc([C@@H]2CCNC[C@H]2COc2ccc3c(c2)OCO3)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1679";"LEUCOVORIN";"4.0";"473.45";"1";"-0.73";"LEUCOVORIN";"Nc1nc(=O)c2c([nH]1)NCC(CNc1ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc1)N2C=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL3104209";"";"None";"480.63";"0";"4.69";"66";"CCN(CC)C(=O)C(c1ccccc1)N1CCN(c2ccc(NC(=O)C3CCCC3)cc2F)CC1";"IC50";"'='";"80.0";"nM";"7.10";"";"";"UO_0000065";"14.77";"0.28";"2.41";"12.70";"0";"CHEMBL3107076";"Displacement of [125I]-PYY from human NPYY2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3102719";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL20400";"";"None";"480.61";"0";"4.70";"28";"CC(=O)N1CCc2ccc(N(C(=O)/C=C/c3ccncc3)C3CCN(Cc4ccccc4)CC3)cc21";"IC50";"'='";"12000.0";"nM";"4.92";"";"";"UO_0000065";"10.24";"0.19";"0.22";"8.67";"1";"CHEMBL3107076";"Displacement of [125I]-PYY from human NPYY2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3102719";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL21523";"";"None";"533.59";"2";"5.85";"15";"O=C(/C=C/c1ccccc1)N(c1ccc2c(c1)N(C(=O)C(F)(F)F)CC2)C1CCN(Cc2ccccc2)CC1";"IC50";"'='";"30000.0";"nM";"4.52";"";"";"UO_0000065";"8.48";"0.16";"-1.33";"10.31";"1";"CHEMBL3107076";"Displacement of [125I]-PYY from human NPYY2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3102719";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL1823356";"";"None";"544.66";"1";"4.87";"25";"CCNC(=O)C(c1ccccc1)N1CCN(c2ccc(NC(=O)c3ccccc3-c3cccnc3)cc2C#N)CC1";"IC50";"'='";"30.0";"nM";"7.52";"";"";"UO_0000065";"13.81";"0.25";"2.65";"7.42";"0";"CHEMBL1827365";"Displacement of [125I]PYY from human NPY Y2 receptor expressed endogenously in KAN-Ts cells by scintillation counting";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"KAN-Ts";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1821563";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";"";""
"CHEMBL440278";"";"None";"520.12";"2";"6.34";"58";"CC(=O)N1CCc2ccc(N(C(=O)/C=C/c3ccc(Cl)cc3)C3CCN(CCC4CCCC4)CC3)cc21";"IC50";"'='";"1100.0";"nM";"5.96";"";"";"UO_0000065";"11.46";"0.22";"-0.38";"13.59";"0";"CHEMBL750768";"Binding affinity towards the NPY Y2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147599";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2004";"None";"";"";""
"CHEMBL870";"ALENDRONIC ACID";"4.0";"249.10";"1";"-1.27";"ALENDRONIC ACID";"NCCCC(O)(P(=O)(O)O)P(=O)(O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL21670";"";"None";"479.62";"1";"5.31";"52";"CC(=O)N1CCc2ccc(N(C(=O)/C=C/c3ccccc3)C3CCCN(Cc4ccccc4)C3)cc21";"IC50";"'='";"16000.0";"nM";"4.80";"";"";"UO_0000065";"10.00";"0.18";"-0.51";"10.93";"0";"CHEMBL750768";"Binding affinity towards the NPY Y2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147599";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2004";"None";"";"";""
"CHEMBL56367";"NIMESULIDE";"4.0";"308.31";"0";"2.76";"NIMESULIDE";"CS(=O)(=O)Nc1ccc([N+](=O)[O-])cc1Oc1ccccc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL420";"GUANABENZ";"4.0";"231.09";"0";"1.81";"GUANABENZ";"N=C(N)N/N=C/c1c(Cl)cccc1Cl";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL192";"SILDENAFIL";"4.0";"474.59";"0";"1.61";"sildenafil";"CCCc1nn(C)c2c(=O)[nH]c(-c3cc(S(=O)(=O)N4CCN(C)CC4)ccc3OCC)nc12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1447";"LINCOMYCIN";"4.0";"406.55";"0";"-0.86";"LINCOMYCIN";"CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@@H](C)O)N(C)C1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1095699";"AZASERINE";"2.0";"173.13";"0";"-1.76";"AZASERINE";"[N-]=[N+]=CC(=O)OC[C@H](N)C(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL998";"LORATADINE";"4.0";"382.89";"0";"4.89";"LORATADINE";"CCOC(=O)N1CCC(=C2c3ccc(Cl)cc3CCc3cccnc32)CC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1909083";"ZIRCONIUM(IV) CHLORIDE";"None";"233.04";"None";"None";"ZIRCONIUM(IV) CHLORIDE";"";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1909070";"NAFENOPIN";"2.0";"310.39";"0";"4.40";"NAFENOPIN";"CC(C)(Oc1ccc(C2CCCc3ccccc32)cc1)C(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1517";"OXYTETRACYCLINE";"4.0";"460.44";"1";"-1.24";"OXYTETRACYCLINE";"CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3[C@H](O)[C@@H]12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL2106399";"KITASAMYCIN";"2.0";"785.97";"2";"2.44";"KITASAMYCIN";"CO[C@@H]1[C@@H](O[C@@H]2O[C@H](C)[C@@H](O[C@H]3C[C@@](C)(O)[C@@H](OC(=O)CC(C)C)[C@H](C)O3)[C@H](N(C)C)[C@H]2O)[C@@H](CC=O)C[C@@H](C)[C@@H](O)/C=C/C=C/C[C@@H](C)OC(=O)C[C@H]1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL221753";"BENZETHONIUM CHLORIDE";"2.0";"448.09";"1";"6.07";"BENZETHONIUM CHLORIDE";"CC(C)(C)CC(C)(C)c1ccc(OCCOCC[N+](C)(C)Cc2ccccc2)cc1.[Cl-]";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL273348";"TOSUFLOXACIN";"2.0";"404.35";"0";"2.04";"2 (Tosufloxacin)";"NC1CCN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3-c2ccc(F)cc2F)C1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL571";"KETOPROFEN";"4.0";"254.29";"0";"3.11";"Ketoprofen";"CC(C(=O)O)c1cccc(C(=O)c2ccccc2)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL79";"LIDOCAINE";"4.0";"234.34";"0";"2.58";"Lidocaine";"CCN(CC)CC(=O)Nc1c(C)cccc1C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL90555";"VINCRISTINE";"4.0";"824.97";"2";"3.52";"VINCRISTINE";"CC[C@]1(O)C[C@H]2CN(CCc3c([nH]c4ccccc34)[C@@](C(=O)OC)(c3cc4c(cc3OC)N(C=O)[C@H]3[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]5(CC)C=CCN6CC[C@]43[C@@H]65)C2)C1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL34259";"METHOTREXATE";"4.0";"454.45";"0";"0.27";"METHOTREXATE";"CN(Cc1cnc2nc(N)nc(N)c2n1)c1ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL599";"MELOXICAM";"4.0";"351.41";"0";"1.95";"MELOXICAM";"Cc1cnc(NC(=O)C2=C(O)c3ccccc3S(=O)(=O)N2C)s1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1237044";"TRAMADOL";"4.0";"263.38";"0";"2.63";"TRAMADOL";"COc1cccc(C2(O)CCCCC2CN(C)C)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1236282";"THIAMPHENICOL";"2.0";"356.23";"0";"0.40";"THIAMPHENICOL";"CS(=O)(=O)c1ccc([C@@H](O)[C@@H](CO)NC(=O)C(Cl)Cl)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL508271";"";"None";"353.81";"0";"3.88";"5i";"O=C1OC2(CCN(c3nc4cc(Cl)ccc4[nH]3)CC2)c2ccccc21";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1001159";"Binding affinity to NPY Y2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1141687";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"None";"";"";""
"CHEMBL707";"DOXAZOSIN";"4.0";"451.48";"0";"1.72";"DOXAZOSIN";"COc1cc2nc(N3CCN(C(=O)C4COc5ccccc5O4)CC3)nc(N)c2cc1OC";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1113";"AMOXAPINE";"4.0";"313.79";"0";"3.43";"AMOXAPINE";"Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL264374";"BEZAFIBRATE";"4.0";"361.83";"0";"3.55";"BEZAFIBRATE";"CC(C)(Oc1ccc(CCNC(=O)c2ccc(Cl)cc2)cc1)C(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1200993";"GALLAMINE TRIETHIODIDE";"4.0";"891.54";"2";"5.45";"GALLAMINE TRIETHIODIDE";"CC[N+](CC)(CC)CCOc1cccc(OCC[N+](CC)(CC)CC)c1OCC[N+](CC)(CC)CC.[I-].[I-].[I-]";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1200693";"MANGANESE CHLORIDE ANHYDROUS";"4.0";"125.84";"None";"None";"MANGANESE (II) CHLORIDE";"";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL27769";"STANOLONE";"2.0";"290.45";"0";"3.96";"STANOLONE";"C[C@]12CCC(=O)C[C@@H]1CC[C@@H]1[C@@H]2CC[C@]2(C)[C@@H](O)CC[C@@H]12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL328861";"";"None";"432.63";"1";"6.07";"14";"CC(C(=O)N(CCCN(C)C)c1ccccc1SCc1ccccc1)c1ccccc1";"IC50";"'='";"1000.0";"nM";"6.00";"";"";"UO_0000065";"13.87";"0.26";"-0.07";"25.48";"0";"CHEMBL747054";"Binding affinity against SMS-KAN cell membranes endogenously expressing Neuropeptide Y receptor type 2 using [125I]PYY as radioligand";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"SMS-KAN";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1136181";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2003";"None";"";"";""
"CHEMBL317554";"";"None";"495.11";"1";"7.45";"15";"CN(C)CCCN(C(=O)c1sc2ccccc2c1Cl)c1ccccc1SCc1ccccc1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL747054";"Binding affinity against SMS-KAN cell membranes endogenously expressing Neuropeptide Y receptor type 2 using [125I]PYY as radioligand";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"SMS-KAN";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1136181";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2003";"None";"";"";""
"CHEMBL2402908";"";"None";"538.46";"2";"5.98";"8d";"CCNC(=O)C(c1ccccc1)C1CCN(c2ccc(NC(=O)c3ccccc3Br)cc2F)CC1";"IC50";"'='";"665.0";"nM";"6.18";"";"";"UO_0000065";"11.47";"0.24";"0.20";"10.05";"0";"CHEMBL2404394";"Displacement of [125I]PYY from NPY-Y2 receptor in human KAN-TS cell membranes after 1 hr by scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"KAN-TS";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2401643";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"None";"";"";""
"CHEMBL2403026";"";"None";"502.63";"2";"6.22";"10b";"CCNC(=O)C(c1ccccc1)C1CCN(c2ccc(NC(=O)Nc3c(C)cccc3C)cc2F)CC1";"IC50";"'='";"162.0";"nM";"6.79";"";"";"UO_0000065";"13.51";"0.25";"0.57";"9.24";"0";"CHEMBL2404394";"Displacement of [125I]PYY from NPY-Y2 receptor in human KAN-TS cell membranes after 1 hr by scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"KAN-TS";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2401643";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"None";"";"";""
"CHEMBL2403023";"";"None";"564.71";"2";"7.01";"9a";"CCN(CC)C(=O)C(c1ccccc1)C1CCN(c2ccc(NC(=O)c3ccccc3-c3cccnc3)cc2F)CC1";"IC50";"'='";"7.0";"nM";"8.15";"";"";"UO_0000065";"14.44";"0.27";"1.14";"12.44";"0";"CHEMBL2404394";"Displacement of [125I]PYY from NPY-Y2 receptor in human KAN-TS cell membranes after 1 hr by scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"KAN-TS";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2401643";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"None";"";"";""
"CHEMBL1909054";"CARBOXYMETHYLCELLULOSE";"None";"None";"None";"None";"CARBOXYMETHYLCELLULOSE";"";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL480";"LANSOPRAZOLE";"4.0";"369.37";"0";"3.52";"LANSOPRAZOLE";"Cc1c(OCC(F)(F)F)ccnc1C[S+]([O-])c1nc2ccccc2[nH]1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1144";"PRAVASTATIN";"4.0";"424.53";"0";"2.44";"PRAVASTATIN";"CC[C@H](C)C(=O)O[C@H]1C[C@H](O)C=C2C=C[C@H](C)[C@H](CC[C@@H](O)C[C@@H](O)CC(=O)O)[C@H]21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL569";"PROCAINE";"4.0";"236.31";"0";"1.77";"PROCAINE";"CCN(CC)CCOC(=O)c1ccc(N)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL516";"CYPROHEPTADINE";"4.0";"287.41";"0";"4.70";"CYPROHEPTADINE";"CN1CCC(=C2c3ccccc3C=Cc3ccccc32)CC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL193482";"ESTRIOL";"4.0";"288.39";"0";"2.58";"ESTRIOL";"C[C@]12CC[C@@H]3c4ccc(O)cc4CC[C@H]3[C@@H]1C[C@@H](O)[C@@H]2O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL302795";"TENOXICAM";"4.0";"337.38";"0";"1.64";"TENOXICAM";"CN1C(C(=O)Nc2ccccn2)=C(O)c2sccc2S1(=O)=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL522589";"";"None";"400.44";"0";"4.64";"2s";"Cc1nc(-c2ccc3[nH]c([C@H]4CC[C@@]5(CC4)OC(=O)c4ccccc45)nc3c2)no1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL981717";"Inhibition of NPYY2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1144170";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"None";"";"";""
"CHEMBL47244";"PICROTOXININ";"None";"292.29";"0";"-0.06";"COCCULIN";"C=C(C)[C@@H]1[C@H]2OC(=O)[C@@H]1[C@]1(O)C[C@H]3O[C@]34C(=O)O[C@H]2[C@]14C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL3104206";"";"None";"565.13";"2";"6.13";"62";"CCN(CC)C(=O)C(c1ccccc1)N1CCN(c2ccc(NC(=O)C(C)(C)c3ccc(Cl)cc3)cc2F)CC1";"IC50";"'='";"72.0";"nM";"7.14";"";"";"UO_0000065";"12.64";"0.24";"1.01";"12.78";"0";"CHEMBL3107076";"Displacement of [125I]-PYY from human NPYY2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3102719";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL265065";"";"None";"485.67";"1";"5.69";"48";"CC(=O)N1CCc2ccc(N(C(=O)/C=C/c3ccccc3)C3CCN(CCC4CCCC4)CC3)cc21";"IC50";"'='";"800.0";"nM";"6.10";"";"";"UO_0000065";"12.55";"0.23";"0.41";"13.90";"1";"CHEMBL3107076";"Displacement of [125I]-PYY from human NPYY2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3102719";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL441516";"";"None";"548.51";"2";"6.61";"42";"CC(=O)N1CCc2ccc(N(C(=O)/C=C/c3cc(Cl)cc(Cl)c3)C3CCN(Cc4ccccc4)CC3)cc21";"IC50";"'='";"30000.0";"nM";"4.52";"";"";"UO_0000065";"8.25";"0.16";"-2.09";"10.31";"1";"CHEMBL3107076";"Displacement of [125I]-PYY from human NPYY2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3102719";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL21019";"";"None";"547.62";"2";"6.33";"37";"CC(=O)N1CCc2ccc(N(C(=O)/C=C/c3cccc(C(F)(F)F)c3)C3CCN(Cc4ccccc4)CC3)cc21";"IC50";"'='";"8900.0";"nM";"5.05";"";"";"UO_0000065";"9.22";"0.17";"-1.28";"11.52";"1";"CHEMBL3107076";"Displacement of [125I]-PYY from human NPYY2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3102719";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL1371937";"PANTHENOL";"3.0";"205.25";"0";"-1.14";"PANTHENOL";"CC(C)(CO)C(O)C(=O)NCCCO";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1370128";"";"None";"488.08";"1";"5.49";"SID22403138";"O=C(C1CCN(Cc2ccc(Cl)cc2)CC1)N1CCN(C(c2ccccc2)c2ccccc2)CC1";"IC50";"'>'";"35000.0";"nM";"";"";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614345";"PUBCHEM_BIOASSAY: Dose response cell-based screening assay for antagonists of neuropeptide Y receptor Y2 (NPY-Y2). (Class of assay: confirmatory) [Related pubchem assays: 793, 1257, 1256 ]";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1453776";"";"None";"390.49";"0";"3.42";"SID14736687";"CCOc1ccc2nc(NC(=O)CS(=O)(=O)c3ccc(C)cc3)sc2c1";"IC50";"'>'";"35000.0";"nM";"";"";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614345";"PUBCHEM_BIOASSAY: Dose response cell-based screening assay for antagonists of neuropeptide Y receptor Y2 (NPY-Y2). (Class of assay: confirmatory) [Related pubchem assays: 793, 1257, 1256 ]";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL2029960";"";"None";"460.64";"1";"5.82";"3";"CC(C)Oc1ccc(NC(=S)N2CCC(C(O)(c3ccccc3)c3ccccc3)CC2)cc1";"IC50";"'='";"1770.0";"nM";"5.75";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2032840";"Antagonist activity at neuropeptide Y receptor Y2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2029318";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";"";""
"CHEMBL2030156";"";"None";"537.75";"2";"5.06";"17";"CCN(CC)S(=O)(=O)c1ccc(NC(=S)N2CCC(C(O)(c3ccccc3)c3ccccc3)CC2)cc1";"IC50";"'='";"136.0";"nM";"6.87";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2032840";"Antagonist activity at neuropeptide Y receptor Y2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2029318";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";"";""
"CHEMBL2030189";"";"None";"522.67";"1";"4.86";"54, CYM 9552";"CCN(CC)S(=O)(=O)c1ccc(OC(=O)N2CCC(C(O)(c3ccccc3)c3ccccc3)CC2)cc1";"IC50";"'='";"12.0";"nM";"7.92";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2032840";"Antagonist activity at neuropeptide Y receptor Y2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2029318";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";"";""
"CHEMBL2030191";"";"None";"465.57";"0";"4.24";"56";"CS(=O)(=O)c1ccc(OC(=O)N2CCC(C(O)(c3ccccc3)c3ccccc3)CC2)cc1";"IC50";"'='";"141.0";"nM";"6.85";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2032840";"Antagonist activity at neuropeptide Y receptor Y2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2029318";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";"";""
"CHEMBL4090636";"";"None";"1843.30";"None";"None";"7";"CCC(NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](C)N)C(=O)NC(CC1CCCCC1)C(=O)NC(CC1CCCCC1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)NC(C)(C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NC(CC1CCCCC1)C(N)=O)[C@@H](C)O";"IC50";"'='";"2.7";"nM";"8.57";"";"";"UO_0000065";"4.65";"None";"None";"None";"0";"CHEMBL4036757";"Displacement of [125I]-PYY from human Y2R expressed in CHO cell membranes after 60 mins by liquid scintillation method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4033754";"1";"Scientific Literature";"ACS Med Chem Lett";"2017";"None";"";"";""
"CHEMBL27";"PROPRANOLOL";"4.0";"259.35";"0";"2.58";"PROPRANOLOL";"CC(C)NCC(O)COc1cccc2ccccc12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL21283";"";"None";"510.68";"2";"5.56";"JNJ-5207787";"CC(=O)N1CCc2ccc(N(C(=O)/C=C/c3cccc(C#N)c3)C3CCN(CCC4CCCC4)CC3)cc21";"IC50";"'='";"100.0";"nM";"7.00";"";"";"UO_0000065";"13.71";"0.25";"1.44";"10.35";"1";"CHEMBL3107081";"Displacement of [125I]-NPY from NPYY2 receptor (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3102719";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL629";"AMITRIPTYLINE";"4.0";"277.41";"0";"4.17";"AMITRIPTYLINE";"CN(C)CCC=C1c2ccccc2CCc2ccccc21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL109";"VALPROIC ACID";"4.0";"144.21";"0";"2.29";"VALPROIC ACID";"CCCC(CCC)C(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL64";"ISONIAZID";"4.0";"137.14";"0";"-0.31";"isoniazid";"NNC(=O)c1ccncc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL4059729";"";"None";"1860.20";"None";"None";"15";"CC(=O)N[C@@H](CO)C(=O)N1CCC[C@@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC1CCCCC1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)NC(C)(C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC1CCCCC1)C(N)=O)[C@@H](C)O";"IC50";"'='";"5.3";"nM";"8.28";"";"";"UO_0000065";"4.45";"None";"None";"None";"0";"CHEMBL4056968";"Displacement of [125I]peptide YY from human Y2 receptor expressed in CHO cell membranes after 60 mins by TopCount scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4052740";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";""
"CHEMBL1200633";"IVERMECTIN";"4.0";"1736.18";"None";"None";"IVERMECTIN";"CC[C@H](C)[C@H]1O[C@]2(CC[C@@H]1C)C[C@@H]1C[C@@H](C/C=C(\C)[C@@H](O[C@H]3C[C@H](OC)[C@@H](O[C@H]4C[C@H](OC)[C@@H](O)[C@H](C)O4)[C@H](C)O3)[C@@H](C)/C=C/C=C3\CO[C@@H]4[C@H](O)C(C)=C[C@@H](C(=O)O1)[C@]34O)O2.CO[C@H]1C[C@H](O[C@H]2[C@H](C)O[C@@H](O[C@@H]3/C(C)=C/C[C@@H]4C[C@@H](C[C@]5(CC[C@H](C)[C@@H](C(C)C)O5)O4)OC(=O)[C@@H]4C=C(C)[C@@H](O)[C@H]5OC/C(=C\C=C\[C@@H]3C)[C@]54O)C[C@@H]2OC)O[C@@H](C)[C@@H]1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL94";"PHYSOSTIGMINE";"4.0";"275.35";"0";"1.77";"PHYSOSTIGMINE";"CNC(=O)Oc1ccc2c(c1)[C@]1(C)CCN(C)[C@@H]1N2C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL3";"NICOTINE";"4.0";"162.24";"0";"1.85";"1";"CN1CCC[C@H]1c1cccnc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL64391";"ITRACONAZOLE";"4.0";"705.65";"3";"5.58";"ITRACONAZOLE";"CCC(C)n1ncn(-c2ccc(N3CCN(c4ccc(OCC5COC(Cn6cncn6)(c6ccc(Cl)cc6Cl)O5)cc4)CC3)cc2)c1=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL2030148";"";"None";"473.69";"1";"5.88";"8";"CCN(CC)c1ccc(NC(=S)N2CCC(C(O)(c3ccccc3)c3ccccc3)CC2)cc1";"IC50";"'='";"72.0";"nM";"7.14";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2032840";"Antagonist activity at neuropeptide Y receptor Y2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2029318";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";"";""
"CHEMBL3104176";"";"None";"479.60";"1";"5.06";"115";"CCc1nc(C(c2ccccc2)N2CCN(c3ccc(NC(=O)C(CC)CC)cc3F)CC2)no1";"IC50";"'='";"150.0";"nM";"6.82";"";"";"UO_0000065";"14.23";"0.27";"1.76";"9.16";"0";"CHEMBL3107076";"Displacement of [125I]-PYY from human NPYY2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3102719";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL21992";"";"None";"493.61";"0";"4.95";"43";"CC(=O)N1CCc2ccc(N(C(=O)/C=C/c3ccccc3)C3CCN(C(=O)c4ccccc4)CC3)cc21";"IC50";"'='";"29000.0";"nM";"4.54";"";"";"UO_0000065";"9.19";"0.17";"-0.41";"7.45";"1";"CHEMBL3107076";"Displacement of [125I]-PYY from human NPYY2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3102719";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL3104222";"";"None";"465.64";"1";"5.78";"23";"CC(=O)N1CCc2ccc(N(C/C=C\c3ccccc3)C3CCN(Cc4ccccc4)CC3)cc21";"IC50";"'='";"22000.0";"nM";"4.66";"";"";"UO_0000065";"10.00";"0.18";"-1.12";"17.39";"0";"CHEMBL3107076";"Displacement of [125I]-PYY from human NPYY2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3102719";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL438945";"HUMAN NEUROPEPTIDE Y";"1.0";"4271.75";"None";"None";"NPY";"CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O)[C@@H](C)CC";"IC50";"'='";"0.19";"nM";"9.72";"";"";"UO_0000065";"2.28";"None";"None";"None";"0";"CHEMBL2394942";"Binding affinity to human neuropeptide Y receptor type 2 by radioligand displacement assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2390830";"1";"Scientific Literature";"Eur J Med Chem";"2013";"None";"";"";""
"CHEMBL4069932";"";"None";"4049.53";"None";"None";"PYY(3-36)";"CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@H](C)O)C(C)C";"IC50";"'='";"0.57";"nM";"9.24";"";"";"UO_0000065";"2.28";"None";"None";"None";"0";"CHEMBL4036757";"Displacement of [125I]-PYY from human Y2R expressed in CHO cell membranes after 60 mins by liquid scintillation method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4033754";"1";"Scientific Literature";"ACS Med Chem Lett";"2017";"None";"";"";""
"CHEMBL313493";"METHANESULFONIC ACID METHYL ESTER";"None";"110.13";"0";"-0.41";"METHYL METHANESULFONATE";"COS(C)(=O)=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL2440185";"";"None";"1673.95";"None";"None";"8";"CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](CCCNC(=N)N)NC(C)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O)[C@@H](C)CC";"IC50";"'='";"132.0";"nM";"6.88";"";"";"UO_0000065";"4.11";"None";"None";"None";"0";"CHEMBL2447452";"Binding affinity to Y2 receptor (unknown origin) expressed in human LN319 cells by radioligand binding assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"LN319";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2439969";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";""
"CHEMBL177756";"FLUORESCEIN";"None";"332.31";"0";"3.97";"FLUORESCEIN";"O=C(O)c1ccccc1-c1c2ccc(=O)cc-2oc2cc(O)ccc12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1230333";"";"None";"170.23";"0";"2.16";"4-(2-THIENYL)BUTYRIC ACID";"O=C(O)CCCc1cccs1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL762";"OXYMETAZOLINE";"4.0";"260.38";"0";"2.85";"OXYMETAZOLINE";"Cc1cc(C(C)(C)C)c(O)c(C)c1CC1=NCCN1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1568";"FLUDARABINE";"None";"285.24";"0";"-1.84";"FLUDARABINE";"Nc1nc(F)nc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL35";"FUROSEMIDE";"4.0";"330.75";"0";"1.89";"FUROSEMIDE";"NS(=O)(=O)c1cc(C(=O)O)c(NCc2ccco2)cc1Cl";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL177";"AMIKACIN";"4.0";"585.61";"3";"-8.42";"AMIKACIN";"NCC[C@H](O)C(=O)N[C@@H]1C[C@H](N)[C@@H](O[C@H]2O[C@H](CN)[C@@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@H]1O[C@H]1O[C@H](CO)[C@@H](O)[C@H](N)[C@H]1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1539";"SULFADOXINE";"4.0";"310.34";"0";"0.88";"SULFADOXINE";"COc1ncnc(NS(=O)(=O)c2ccc(N)cc2)c1OC";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL438";"SULFAMERAZINE";"4.0";"264.31";"0";"1.17";"SULFAMERAZINE";"Cc1ccnc(NS(=O)(=O)c2ccc(N)cc2)n1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL696";"ETHOSUXIMIDE";"4.0";"141.17";"0";"0.45";"ETHOSUXIMIDE";"CCC1(C)CC(=O)NC1=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL3104183";"";"None";"479.60";"0";"4.73";"90";"CCN(CC)C(=O)C(c1ccccc1)N1CCN(c2ccc(-c3nc(C(C)C)no3)cc2F)CC1";"IC50";"'='";"41.0";"nM";"7.39";"";"";"UO_0000065";"15.40";"0.29";"2.66";"11.24";"0";"CHEMBL3107076";"Displacement of [125I]-PYY from human NPYY2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3102719";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL22046";"";"None";"505.66";"2";"5.86";"25";"CC(=O)N1CCc2ccc(N(C(=O)/C=C/C=C/c3ccccc3)C3CCN(Cc4ccccc4)CC3)cc21";"IC50";"'='";"2800.0";"nM";"5.55";"";"";"UO_0000065";"10.98";"0.20";"-0.31";"12.66";"1";"CHEMBL3107076";"Displacement of [125I]-PYY from human NPYY2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3102719";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL3104181";"";"None";"475.57";"0";"4.97";"120";"CCC(CC)C(=O)Nc1ccc(N2CCN(C(c3cccc(F)c3)c3ncco3)CC2)c(C#N)c1";"IC50";"'='";"7.0";"nM";"8.15";"";"";"UO_0000065";"17.15";"0.32";"3.18";"9.55";"0";"CHEMBL3107076";"Displacement of [125I]-PYY from human NPYY2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3102719";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL21877";"";"None";"504.63";"2";"5.18";"34";"CC(=O)N1CCc2ccc(N(C(=O)/C=C/c3cccc(C#N)c3)C3CCN(Cc4ccccc4)CC3)cc21";"IC50";"'='";"1000.0";"nM";"6.00";"";"";"UO_0000065";"11.89";"0.22";"0.82";"8.87";"1";"CHEMBL3107076";"Displacement of [125I]-PYY from human NPYY2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3102719";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL21679";"";"None";"485.65";"1";"5.37";"30";"CC(=O)N1CCc2ccc(N(C(=O)/C=C/c3ccsc3)C3CCN(Cc4ccccc4)CC3)cc21";"IC50";"'='";"3200.0";"nM";"5.50";"";"";"UO_0000065";"11.31";"0.21";"0.12";"12.53";"1";"CHEMBL3107076";"Displacement of [125I]-PYY from human NPYY2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3102719";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL3104220";"";"None";"417.55";"0";"4.17";"26";"C/C=C/C(=O)N(c1ccc2c(c1)N(C(C)=O)CC2)C1CCN(Cc2ccccc2)CC1";"IC50";"'='";"30000.0";"nM";"4.52";"";"";"UO_0000065";"10.83";"0.20";"0.35";"10.31";"0";"CHEMBL3107076";"Displacement of [125I]-PYY from human NPYY2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3102719";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL22119";"";"None";"515.68";"1";"4.72";"14";"CS(=O)(=O)N1CCc2ccc(N(C(=O)/C=C/c3ccccc3)C3CCN(Cc4ccccc4)CC3)cc21";"IC50";"'='";"15000.0";"nM";"4.82";"";"";"UO_0000065";"9.35";"0.18";"0.10";"7.92";"1";"CHEMBL3107076";"Displacement of [125I]-PYY from human NPYY2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3102719";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL2030151";"";"None";"459.62";"0";"4.39";"12";"CNC(=O)c1ccc(NC(=S)N2CCC(C(O)(c3ccccc3)c3ccccc3)CC2)cc1";"IC50";"'='";"1419.0";"nM";"5.85";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2032840";"Antagonist activity at neuropeptide Y receptor Y2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2029318";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";"";""
"CHEMBL417727";"";"None";"223.23";"0";"2.31";"SID14730721";"Nc1ccc2c(c1)C(=O)C(=O)c1ccccc1-2";"IC50";"'='";"4245.0";"nM";"5.37";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614345";"PUBCHEM_BIOASSAY: Dose response cell-based screening assay for antagonists of neuropeptide Y receptor Y2 (NPY-Y2). (Class of assay: confirmatory) [Related pubchem assays: 793, 1257, 1256 ]";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1990096";"";"None";"325.41";"0";"4.67";"SID17387203";"C/C(=N\OC(=O)c1ccc(OC(C)C)cc1)c1ccc(C)c(C)c1";"IC50";"'='";"7939.0";"nM";"5.10";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614345";"PUBCHEM_BIOASSAY: Dose response cell-based screening assay for antagonists of neuropeptide Y receptor Y2 (NPY-Y2). (Class of assay: confirmatory) [Related pubchem assays: 793, 1257, 1256 ]";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL3211272";"";"None";"317.85";"0";"3.38";"SID17515043";"S=C(NCCc1ccccc1)N/N=C/c1ccccc1Cl";"IC50";"'='";"5069.0";"nM";"5.29";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614345";"PUBCHEM_BIOASSAY: Dose response cell-based screening assay for antagonists of neuropeptide Y receptor Y2 (NPY-Y2). (Class of assay: confirmatory) [Related pubchem assays: 793, 1257, 1256 ]";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1531745";"";"None";"437.95";"0";"4.73";"SID17512984";"COc1cccc(-c2ccc(C#N)c(SCC(=O)NCCc3ccc(Cl)cc3)n2)c1";"IC50";"'='";"6452.0";"nM";"5.19";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614345";"PUBCHEM_BIOASSAY: Dose response cell-based screening assay for antagonists of neuropeptide Y receptor Y2 (NPY-Y2). (Class of assay: confirmatory) [Related pubchem assays: 793, 1257, 1256 ]";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1543306";"";"None";"446.62";"1";"5.43";"SID17507305";"CCOc1ccc(NC(=S)N2CCC(C(O)(c3ccccc3)c3ccccc3)CC2)cc1";"IC50";"'='";"220.0";"nM";"6.66";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614345";"PUBCHEM_BIOASSAY: Dose response cell-based screening assay for antagonists of neuropeptide Y receptor Y2 (NPY-Y2). (Class of assay: confirmatory) [Related pubchem assays: 793, 1257, 1256 ]";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1568243";"";"None";"259.31";"0";"4.13";"SID17432603";"O=C(/C=C/c1cccc2ccccc12)c1ccncc1";"IC50";"'='";"4953.0";"nM";"5.30";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614345";"PUBCHEM_BIOASSAY: Dose response cell-based screening assay for antagonists of neuropeptide Y receptor Y2 (NPY-Y2). (Class of assay: confirmatory) [Related pubchem assays: 793, 1257, 1256 ]";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1522356";"";"None";"373.31";"1";"5.84";"SID17410088";"Clc1ccc(CSc2cc3c(nn2)-c2ccccc2CC3)cc1Cl";"IC50";"'='";"6883.0";"nM";"5.16";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614345";"PUBCHEM_BIOASSAY: Dose response cell-based screening assay for antagonists of neuropeptide Y receptor Y2 (NPY-Y2). (Class of assay: confirmatory) [Related pubchem assays: 793, 1257, 1256 ]";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL3194054";"";"None";"538.63";"1";"3.05";"SID17508973";"COc1ccc(/C=N/NC(=O)CN(CCc2ccccc2)S(=O)(=O)c2ccc(NC(C)=O)cc2)cc1OC";"IC50";"'='";"3550.0";"nM";"5.45";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614345";"PUBCHEM_BIOASSAY: Dose response cell-based screening assay for antagonists of neuropeptide Y receptor Y2 (NPY-Y2). (Class of assay: confirmatory) [Related pubchem assays: 793, 1257, 1256 ]";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1377743";"";"None";"338.86";"0";"4.00";"SID14725303";"Clc1ccc(OCCSc2nnnn2C2CCCCC2)cc1";"IC50";"'='";"14150.0";"nM";"4.85";"";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614345";"PUBCHEM_BIOASSAY: Dose response cell-based screening assay for antagonists of neuropeptide Y receptor Y2 (NPY-Y2). (Class of assay: confirmatory) [Related pubchem assays: 793, 1257, 1256 ]";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1427504";"";"None";"402.35";"1";"6.53";"SID17433913";"O=C(CSCc1c(Cl)cccc1Cl)Nc1ccccc1-c1ccccc1";"IC50";"'='";"6065.0";"nM";"5.22";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614345";"PUBCHEM_BIOASSAY: Dose response cell-based screening assay for antagonists of neuropeptide Y receptor Y2 (NPY-Y2). (Class of assay: confirmatory) [Related pubchem assays: 793, 1257, 1256 ]";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1389702";"";"None";"378.51";"0";"4.21";"SID17505574";"Cc1ccc(N=C(S)N=C(N)Nc2nc(C)c3cc(C)ccc3n2)c(C)c1";"IC50";"'='";"22910.0";"nM";"4.64";"";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614345";"PUBCHEM_BIOASSAY: Dose response cell-based screening assay for antagonists of neuropeptide Y receptor Y2 (NPY-Y2). (Class of assay: confirmatory) [Related pubchem assays: 793, 1257, 1256 ]";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1349920";"";"None";"244.32";"0";"3.23";"SID14720926";"CCSc1nc2ccc(OC)cc2cc1C#N";"IC50";"'='";"17830.0";"nM";"4.75";"";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614345";"PUBCHEM_BIOASSAY: Dose response cell-based screening assay for antagonists of neuropeptide Y receptor Y2 (NPY-Y2). (Class of assay: confirmatory) [Related pubchem assays: 793, 1257, 1256 ]";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1311570";"";"None";"427.33";"1";"5.04";"SID862064";"Brc1ccc(CSc2nnc(-c3ccccn3)n2Cc2ccco2)cc1";"IC50";"'='";"8062.0";"nM";"5.09";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614345";"PUBCHEM_BIOASSAY: Dose response cell-based screening assay for antagonists of neuropeptide Y receptor Y2 (NPY-Y2). (Class of assay: confirmatory) [Related pubchem assays: 793, 1257, 1256 ]";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL99586";"";"None";"442.63";"1";"6.29";"6";"CN(C)CCCN(C(=O)c1cc2ccccc2s1)c1ccccc1CCc1ccccc1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"1";"CHEMBL3107075";"Displacement of [125I]-PYY from NPYY2 receptor (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3102719";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL3104200";"";"None";"481.66";"1";"6.07";"84";"CCC(CC)C(=O)Nc1ccc(N2CCC(C(C(=O)N(CC)CC)c3ccccc3)CC2)c(F)c1";"IC50";"'='";"12.0";"nM";"7.92";"";"";"UO_0000065";"16.44";"0.31";"1.85";"15.04";"0";"CHEMBL3107076";"Displacement of [125I]-PYY from human NPYY2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3102719";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL3104193";"";"None";"507.65";"1";"4.80";"76";"CCC(CC)C(=O)Nc1ccc(N2CCN(C(C(=O)N(CC)CC)c3ccc(C#N)cc3)CC2)c(F)c1";"IC50";"'='";"44.0";"nM";"7.36";"";"";"UO_0000065";"14.49";"0.27";"2.56";"9.23";"0";"CHEMBL3107076";"Displacement of [125I]-PYY from human NPYY2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3102719";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL3104192";"";"None";"517.09";"2";"5.59";"75";"CCC(CC)C(=O)Nc1ccc(N2CCN(C(C(=O)N(CC)CC)c3ccc(Cl)cc3)CC2)c(F)c1";"IC50";"'='";"100.0";"nM";"7.00";"";"";"UO_0000065";"13.54";"0.27";"1.41";"12.52";"0";"CHEMBL3107076";"Displacement of [125I]-PYY from human NPYY2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3102719";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL3104219";"";"None";"520.65";"1";"4.33";"58";"CCN(CC)C(=O)C(c1ccccc1)N1CCN(c2ccc(NC(=O)c3c(C)cnn3CC)cc2F)CC1";"IC50";"'='";"35.0";"nM";"7.46";"";"";"UO_0000065";"14.32";"0.27";"3.13";"10.12";"0";"CHEMBL3107076";"Displacement of [125I]-PYY from human NPYY2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3102719";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL4224835";"";"None";"2718.38";"None";"None";"16";"CCCCCCCCCCCCCCCC(=O)NC[C@H]1CC[C@H](C(=O)N[C@@H](CCC(=O)NCCCOCCOCCOCCCNC(=O)COCC(=O)N[C@@H](CO)C(=O)N2C[C@@H](O)C[C@@H]2C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc2ccncc2)C(=O)N[C@@H](CC2CCCCC2)C(=O)NC(C)(C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCNC(=O)C2CCNCC2)C(=O)NC(C)(C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC2CCCCC2)C(N)=O)[C@@H](C)O)C(=O)O)CC1";"IC50";"'='";"0.19";"nM";"9.72";"";"";"UO_0000065";"3.58";"None";"None";"None";"0";"CHEMBL4220285";"Displacement of [125I]-PYY from human neuropeptide Y2 receptor expressed in CHO cell membranes incubated for 60 mins by TopCount micro scintillation analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4219053";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";"";"";""
"CHEMBL2403027";"";"None";"493.58";"1";"5.21";"10c";"CCNC(=O)C(c1ccccc1)C1CCN(c2ccc(NC(=O)Nc3c(C)noc3C)cc2F)CC1";"IC50";"'='";"15.0";"nM";"7.82";"";"";"UO_0000065";"15.85";"0.30";"2.61";"7.86";"0";"CHEMBL2404394";"Displacement of [125I]PYY from NPY-Y2 receptor in human KAN-TS cell membranes after 1 hr by scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"KAN-TS";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2401643";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"None";"";"";""
"CHEMBL2403028";"";"None";"521.64";"2";"5.94";"11a";"CCN(CC)C(=O)C(c1ccccc1)C1CCN(c2ccc(NC(=O)Nc3c(C)noc3C)cc2F)CC1";"IC50";"'='";"12.0";"nM";"7.92";"";"";"UO_0000065";"15.18";"0.28";"1.98";"8.73";"0";"CHEMBL2404394";"Displacement of [125I]PYY from NPY-Y2 receptor in human KAN-TS cell membranes after 1 hr by scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"KAN-TS";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2401643";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"None";"";"";""
"CHEMBL3578015";"";"None";"2886.46";"None";"None";"4c";"CC(=O)N[C@@H](CCCCNC(=O)CCNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](Cc1cccc2ccccc12)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O";"IC50";"'='";"14.7";"nM";"7.83";"";"";"UO_0000065";"2.71";"None";"None";"None";"0";"CHEMBL3579806";"Displacement of [125I]PYY from human neuropeptide Y Y2 receptor expressed in HEK293 cells cotransfected with eYFP fusion protein after 2 hrs by competitive receptor binding assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3576822";"1";"Scientific Literature";"J Med Chem";"2015";"CHEMBL3307715";"";"";""
"CHEMBL3578017";"";"None";"2857.41";"None";"None";"5a";"CC(=O)NC(CNC(=O)CCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](Cc1cccc2ccccc12)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O";"IC50";"'='";"63.1";"nM";"7.20";"";"";"UO_0000065";"2.52";"None";"None";"None";"0";"CHEMBL3579806";"Displacement of [125I]PYY from human neuropeptide Y Y2 receptor expressed in HEK293 cells cotransfected with eYFP fusion protein after 2 hrs by competitive receptor binding assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3576822";"1";"Scientific Literature";"J Med Chem";"2015";"CHEMBL3307715";"";"";""
"CHEMBL4206417";"";"None";"1819.15";"None";"None";"29";"CC[C@](C)(NC(=O)[C@H]1C[C@H](O)CN1C(=O)[C@H](CO)NC(=O)c1c[nH]cn1)C(=O)N[C@@H](Cc1ccncc1)C(=O)N[C@@H](CC1CCCCC1)C(=O)NC(C)(C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)NC(C)(C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC1CCCCC1)C(N)=O)[C@@H](C)O";"IC50";"'='";"0.91";"nM";"9.04";"";"";"UO_0000065";"4.97";"None";"None";"None";"0";"CHEMBL4179032";"Displacement of [125I]-PYY from human neuropeptide Y2 receptor expressed in CHO cell membranes incubated for 60 mins by TopCount based method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4177573";"1";"Scientific Literature";"Bioorg Med Chem";"2017";"None";"";"";""
"CHEMBL4206938";"";"None";"1809.20";"None";"None";"28";"CC[C@](C)(NC(=O)[C@H]1C[C@H](O)CN1C(=O)[C@H](CO)NC(C)=O)C(=O)N[C@@H](Cc1ccncc1)C(=O)N[C@@H](CC1CCCCC1)C(=O)N[C@@H](CC(C)(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)NC(C)(C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC1CCCCC1)C(N)=O)[C@@H](C)O";"IC50";"'='";"0.58";"nM";"9.24";"";"";"UO_0000065";"5.11";"None";"None";"None";"0";"CHEMBL4179032";"Displacement of [125I]-PYY from human neuropeptide Y2 receptor expressed in CHO cell membranes incubated for 60 mins by TopCount based method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4177573";"1";"Scientific Literature";"Bioorg Med Chem";"2017";"None";"";"";""
"CHEMBL4202723";"";"None";"1765.14";"None";"None";"24";"CC[C@](C)(NC(=O)[C@H](CC1CCCCC1)NC(=O)[C@H](Cc1ccncc1)NC(=O)[C@](C)(CC)NC(=O)[C@H]1CCCN1C(=O)[C@H](CO)NC(C)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)NC(C)(C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC1CCCCC1)C(N)=O)[C@@H](C)O";"IC50";"'='";"0.57";"nM";"9.24";"";"";"UO_0000065";"5.24";"None";"None";"None";"0";"CHEMBL4179032";"Displacement of [125I]-PYY from human neuropeptide Y2 receptor expressed in CHO cell membranes incubated for 60 mins by TopCount based method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4177573";"1";"Scientific Literature";"Bioorg Med Chem";"2017";"None";"";"";""
"CHEMBL4210343";"";"None";"1878.31";"None";"None";"19";"CC(C)C[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC1CCCCC1)NC(=O)[C@H](CC1CCCCC1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H]1CCCN1C(=O)[C@H](CO)NC(=O)C(C)C)C(=O)NC(C)(C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC1CCCCC1)C(N)=O)[C@@H](C)O";"IC50";"'='";"1.3";"nM";"8.89";"";"";"UO_0000065";"4.73";"None";"None";"None";"0";"CHEMBL4179032";"Displacement of [125I]-PYY from human neuropeptide Y2 receptor expressed in CHO cell membranes incubated for 60 mins by TopCount based method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4177573";"1";"Scientific Literature";"Bioorg Med Chem";"2017";"None";"";"";""
"CHEMBL4213780";"";"None";"1864.28";"None";"None";"5";"CC[C@](C)(NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC1CCCCC1)NC(=O)[C@H](CC1CCCCC1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H]1CCCN1C(=O)[C@H](CO)NC(C)=O)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC1CCCCC1)C(N)=O)[C@@H](C)O";"IC50";"'='";"3.7";"nM";"8.43";"";"";"UO_0000065";"4.52";"None";"None";"None";"0";"CHEMBL4179032";"Displacement of [125I]-PYY from human neuropeptide Y2 receptor expressed in CHO cell membranes incubated for 60 mins by TopCount based method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4177573";"1";"Scientific Literature";"Bioorg Med Chem";"2017";"None";"";"";""
"CHEMBL1431";"METFORMIN";"4.0";"129.17";"0";"-1.03";"METFORMIN";"CN(C)C(=N)NC(=N)N";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL588119";"SULOCTIDIL";"None";"337.57";"1";"5.56";"SULOCTIDIL";"CCCCCCCCN[C@H](C)[C@@H](O)c1ccc(SC(C)C)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL190";"THEOPHYLLINE";"4.0";"180.17";"0";"-1.04";"THEOPHYLLINE";"Cn1c(=O)c2[nH]cnc2n(C)c1=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1608982";"";"None";"341.43";"0";"4.16";"SF-41";"Cc1ccc(S(=O)(=O)C(c2ccccc2)c2c(C)noc2C)cc1";"IC50";"'='";"4400.0";"nM";"5.36";"";"";"UO_0000065";"";"";"";"";"1";"CHEMBL3106332";"Antagonist activity at NPYY2 receptor (unknown origin) by cAMP biosensor assay";"F";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3102719";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL1328939";"";"None";"434.49";"1";"5.57";"SID24781483";"Cc1nc(N2CCCCC2)c2c(C)c(C(=O)Nc3ccccc3C(F)(F)F)sc2n1";"IC50";"'='";"6658.0";"nM";"5.18";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1613986";"PUBCHEM_BIOASSAY: Dose response counterscreen assay for neuropeptide Y receptor Y1 (NPY-Y1): Cell-based high throughput assay to measure NPY-Y2 antagonism. (Class of assay: confirmatory) [Related pubchem assays: 793, 1040, 1255, 1254 ]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1386178";"";"None";"376.20";"0";"3.56";"SID858326";"CC(NC(=O)Nc1nnc(C(F)(F)F)s1)(C(F)(F)F)C(F)(F)F";"IC50";"'>'";"35000.0";"nM";"";"";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1613986";"PUBCHEM_BIOASSAY: Dose response counterscreen assay for neuropeptide Y receptor Y1 (NPY-Y1): Cell-based high throughput assay to measure NPY-Y2 antagonism. (Class of assay: confirmatory) [Related pubchem assays: 793, 1040, 1255, 1254 ]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL364713";"NOSCAPINE";"4.0";"413.43";"0";"2.88";"NOSCAPINE";"COc1ccc2c(c1OC)C(=O)O[C@@H]2[C@H]1c2c(cc3c(c2OC)OCO3)CCN1C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL21941";"";"None";"530.67";"2";"5.59";"59";"CC(=O)N1CCc2ccc(N(C(=O)/C=C/c3cccc([N+](=O)[O-])c3)C3CCN(CCC4CCCC4)CC3)cc21";"IC50";"'='";"350.0";"nM";"6.46";"";"";"UO_0000065";"12.17";"0.23";"0.87";"7.42";"0";"CHEMBL750768";"Binding affinity towards the NPY Y2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147599";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2004";"None";"";"";""
"CHEMBL117405";"";"None";"248.33";"0";"1.91";"(S)-(-)-PINDOLOL";"CC(C)NC[C@H](O)COc1cccc2[nH]ccc12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL417";"EPIRUBICIN";"4.0";"543.53";"3";"0.00";"EPIRUBICIN";"COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@@H](O)[C@H](C)O1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL3104118";"";"None";"469.54";"0";"4.08";"103";"CCN(CC)C(=O)C(c1ccccc1)N1CCN(c2ccc(-c3noc(CF)n3)cc2F)CC1";"IC50";"'='";"160.0";"nM";"6.80";"";"";"UO_0000065";"14.47";"0.27";"2.72";"10.34";"0";"CHEMBL3107076";"Displacement of [125I]-PYY from human NPYY2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3102719";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL3104202";"";"None";"520.65";"2";"5.48";"87";"CCN(CC)C(=O)C(c1ccccc1)C1CCN(c2ccc(NC(=O)Cc3c(C)noc3C)cc2F)CC1";"IC50";"'='";"14.0";"nM";"7.85";"";"";"UO_0000065";"15.08";"0.28";"2.37";"9.98";"0";"CHEMBL3107076";"Displacement of [125I]-PYY from human NPYY2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3102719";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL3104217";"";"None";"469.59";"0";"4.03";"29";"CC(=O)N1CCc2ccc(N(C(=O)/C=C/c3ncc[nH]3)C3CCN(Cc4ccccc4)CC3)cc21";"IC50";"'='";"17000.0";"nM";"4.77";"";"";"UO_0000065";"10.16";"0.19";"0.74";"6.58";"0";"CHEMBL3107076";"Displacement of [125I]-PYY from human NPYY2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3102719";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL278795";"";"None";"480.61";"0";"4.70";"27";"CC(=O)N1CCc2ccc(N(C(=O)/C=C/c3cccnc3)C3CCN(Cc4ccccc4)CC3)cc21";"IC50";"'='";"30000.0";"nM";"4.52";"";"";"UO_0000065";"9.41";"0.17";"-0.18";"7.97";"1";"CHEMBL3107076";"Displacement of [125I]-PYY from human NPYY2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3102719";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL108";"CARBAMAZEPINE";"4.0";"236.27";"0";"3.39";"carbamazepine";"NC(=O)N1c2ccccc2C=Cc2ccccc21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1823342";"";"None";"565.69";"2";"5.87";"5, JNJ-31020028";"CCN(CC)C(=O)C(c1ccccc1)N1CCN(c2ccc(NC(=O)c3ccccc3-c3cccnc3)cc2F)CC1";"IC50";"'='";"6.0";"nM";"8.22";"";"";"UO_0000065";"14.53";"0.27";"2.35";"11.95";"0";"CHEMBL1827365";"Displacement of [125I]PYY from human NPY Y2 receptor expressed endogenously in KAN-Ts cells by scintillation counting";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"KAN-Ts";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1821563";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";"";""
"CHEMBL1823346";"";"None";"523.61";"2";"5.78";"15";"COC(=O)C(c1ccccc1)N1CCN(c2ccc(NC(=O)c3ccccc3-c3ccccc3)cc2F)CC1";"IC50";"'='";"52.0";"nM";"7.28";"";"";"UO_0000065";"13.91";"0.26";"1.50";"11.77";"0";"CHEMBL1827365";"Displacement of [125I]PYY from human NPY Y2 receptor expressed endogenously in KAN-Ts cells by scintillation counting";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"KAN-Ts";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1821563";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";"";""
"CHEMBL1823351";"";"None";"423.56";"0";"4.10";"20";"CCC(CC)C(=O)Nc1ccc(N2CCN(C(C(=O)OC)c3ccccc3)CC2)cc1";"IC50";"'='";"530.0";"nM";"6.28";"";"";"UO_0000065";"14.82";"0.28";"2.18";"10.14";"0";"CHEMBL1827365";"Displacement of [125I]PYY from human NPY Y2 receptor expressed endogenously in KAN-Ts cells by scintillation counting";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"KAN-Ts";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1821563";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";"";""
"CHEMBL1823577";"";"None";"565.69";"2";"5.87";"5R, (R)-(-)-JNJ-31020028";"CCN(CC)C(=O)[C@@H](c1ccccc1)N1CCN(c2ccc(NC(=O)c3ccccc3-c3cccnc3)cc2F)CC1";"IC50";"'='";"9.0";"nM";"8.05";"";"";"UO_0000065";"14.22";"0.26";"2.18";"11.70";"0";"CHEMBL1827365";"Displacement of [125I]PYY from human NPY Y2 receptor expressed endogenously in KAN-Ts cells by scintillation counting";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"KAN-Ts";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1821563";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";"";""
"CHEMBL1235242";"";"None";"183.18";"0";"0.78";"4-FLUORO-L-PHENYLALANINE";"N[C@@H](Cc1ccc(F)cc1)C(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL2030165";"";"None";"485.65";"1";"5.69";"26";"CC(C)Oc1ccc(NC(=S)N2CCC(C(O)(c3ccccc3)c3ccccc3)CC2)cc1C#N";"IC50";"'='";"899.0";"nM";"6.05";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2032840";"Antagonist activity at neuropeptide Y receptor Y2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2029318";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";"";""
"CHEMBL1349";"VALACYCLOVIR";"4.0";"324.34";"0";"-0.80";"VALACYCLOVIR";"CC(C)[C@H](N)C(=O)OCCOCn1cnc2c(=O)nc(N)[nH]c21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1411979";"METHAPYRILENE";"4.0";"261.39";"0";"2.71";"METHAPYRILENE";"CN(C)CCN(Cc1cccs1)c1ccccn1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1439337";"";"None";"469.51";"1";"5.83";"SID14726077";"CC(C)(C)n1nnnc1C(c1ccc(C(F)(F)F)cc1)N(Cc1ccccc1)Cc1ccco1";"IC50";"'>'";"35000.0";"nM";"";"";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1613986";"PUBCHEM_BIOASSAY: Dose response counterscreen assay for neuropeptide Y receptor Y1 (NPY-Y1): Cell-based high throughput assay to measure NPY-Y2 antagonism. (Class of assay: confirmatory) [Related pubchem assays: 793, 1040, 1255, 1254 ]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL2004475";"";"None";"528.65";"1";"3.83";"SID24841448";"C/C1=C/[C@@H](C)C/C=C/[C@H]2[C@@H]3O[C@]3(C)[C@@H](C)[C@H]3[C@H](Cc4c[nH]c5ccccc45)NC(=O)[C@]32C(=O)/C=C\C(=O)[C@@H]1O";"IC50";"'='";"4760.0";"nM";"5.32";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1613986";"PUBCHEM_BIOASSAY: Dose response counterscreen assay for neuropeptide Y receptor Y1 (NPY-Y1): Cell-based high throughput assay to measure NPY-Y2 antagonism. (Class of assay: confirmatory) [Related pubchem assays: 793, 1040, 1255, 1254 ]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1360426";"";"None";"405.44";"0";"3.22";"SID7967518";"COc1ccc(-c2nnc3sc(C(C)N4C(=O)c5ccccc5C4=O)nn23)cc1";"IC50";"'='";"6020.0";"nM";"5.22";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614345";"PUBCHEM_BIOASSAY: Dose response cell-based screening assay for antagonists of neuropeptide Y receptor Y2 (NPY-Y2). (Class of assay: confirmatory) [Related pubchem assays: 793, 1257, 1256 ]";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1342925";"";"None";"370.79";"0";"4.69";"SID22400580";"COC(=O)c1cc2occc2n1Cc1nc(-c2ccccc2Cl)oc1C";"IC50";"'='";"8202.0";"nM";"5.09";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614345";"PUBCHEM_BIOASSAY: Dose response cell-based screening assay for antagonists of neuropeptide Y receptor Y2 (NPY-Y2). (Class of assay: confirmatory) [Related pubchem assays: 793, 1257, 1256 ]";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1580409";"";"None";"430.34";"1";"5.26";"SID14729875";"CN1CCN(c2ccccc2NC(=O)c2ccc(-c3ccc(Cl)cc3Cl)o2)CC1";"IC50";"'>'";"12000.0";"nM";"";"";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614345";"PUBCHEM_BIOASSAY: Dose response cell-based screening assay for antagonists of neuropeptide Y receptor Y2 (NPY-Y2). (Class of assay: confirmatory) [Related pubchem assays: 793, 1257, 1256 ]";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1502859";"";"None";"375.43";"0";"2.14";"SID14743867";"O=c1c2ccccc2nc2c3ccccc3c(NCCN3CCOCC3)nn12";"IC50";"'>'";"35000.0";"nM";"";"";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614345";"PUBCHEM_BIOASSAY: Dose response cell-based screening assay for antagonists of neuropeptide Y receptor Y2 (NPY-Y2). (Class of assay: confirmatory) [Related pubchem assays: 793, 1257, 1256 ]";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1468490";"";"None";"331.80";"0";"2.65";"SID7967718";"O=C1C2CC=C(Cl)CC2C(=O)N1CC1Cc2ccccc2CO1";"IC50";"'='";"5722.0";"nM";"5.24";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614345";"PUBCHEM_BIOASSAY: Dose response cell-based screening assay for antagonists of neuropeptide Y receptor Y2 (NPY-Y2). (Class of assay: confirmatory) [Related pubchem assays: 793, 1257, 1256 ]";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL4090126";"";"None";"1885.26";"None";"None";"5";"CC(=O)N[C@@H](CO)C(=O)N1CCC[C@@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](CC1CCCCC1)C(=O)N[C@@H](CC1CCCCC1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1ccncc1)C(=O)NC(C)(C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC1CCCCC1)C(N)=O)[C@@H](C)O";"IC50";"'='";"3.0";"nM";"8.52";"";"";"UO_0000065";"4.52";"None";"None";"None";"0";"CHEMBL4056968";"Displacement of [125I]peptide YY from human Y2 receptor expressed in CHO cell membranes after 60 mins by TopCount scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4052740";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";""
"CHEMBL4094429";"";"None";"1866.25";"None";"None";"2";"CC(=O)N[C@@H](CO)C(=O)N1C[C@@H](O)C[C@@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](CC1CCCCC1)C(=O)N[C@@H](CC1CCCCC1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)NC(C)(C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC1CCCCC1)C(N)=O)[C@@H](C)O";"IC50";"'='";"0.7";"nM";"9.15";"";"";"UO_0000065";"4.91";"None";"None";"None";"0";"CHEMBL4056968";"Displacement of [125I]peptide YY from human Y2 receptor expressed in CHO cell membranes after 60 mins by TopCount scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4052740";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";""
"CHEMBL3104228";"";"None";"527.64";"2";"6.16";"113";"CCC(CC)C(=O)Nc1ccc(N2CCN(C(c3ccccc3)c3nc(-c4ccccc4)no3)CC2)c(F)c1";"IC50";"'='";"720.0";"nM";"6.14";"";"";"UO_0000065";"11.64";"0.22";"-0.02";"8.25";"0";"CHEMBL3107076";"Displacement of [125I]-PYY from human NPYY2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3102719";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL3104121";"";"None";"446.57";"0";"4.62";"106";"CCN(CC)C(=O)C(c1ccccc1)N1CCN(c2ccc(-c3cccnc3)cc2F)CC1";"IC50";"'='";"740.0";"nM";"6.13";"";"";"UO_0000065";"13.73";"0.25";"1.51";"15.45";"0";"CHEMBL3107076";"Displacement of [125I]-PYY from human NPYY2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3102719";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL3104116";"";"None";"493.63";"0";"4.90";"101";"CCN(CC)C(=O)C(c1ccccc1)N1CCN(c2ccc(-c3noc(C(C)(C)C)n3)cc2F)CC1";"IC50";"'='";"600.0";"nM";"6.22";"";"";"UO_0000065";"12.60";"0.24";"1.32";"9.47";"0";"CHEMBL3107076";"Displacement of [125I]-PYY from human NPYY2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3102719";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL3104113";"";"None";"467.61";"0";"4.38";"98";"CCN(CC)C(=O)C(c1ccccc1)N1CCN(c2ccc(-c3nc(C)ns3)cc2F)CC1";"IC50";"'='";"110.0";"nM";"6.96";"";"";"UO_0000065";"14.88";"0.29";"2.58";"13.24";"0";"CHEMBL3107076";"Displacement of [125I]-PYY from human NPYY2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3102719";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL3104187";"";"None";"492.64";"0";"4.48";"94";"CCN(CC)C(=O)C(c1ccccc1)N1CCN(c2ccc(-c3nc(C(C)C)n(C)n3)cc2F)CC1";"IC50";"'='";"1950.0";"nM";"5.71";"";"";"UO_0000065";"11.59";"0.22";"1.23";"9.93";"0";"CHEMBL3107076";"Displacement of [125I]-PYY from human NPYY2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3102719";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL3104186";"";"None";"478.62";"0";"4.47";"93";"CCN(CC)C(=O)C(c1ccccc1)N1CCN(c2ccc(-c3nnc(C(C)C)[nH]3)cc2F)CC1";"IC50";"'='";"830.0";"nM";"6.08";"";"";"UO_0000065";"12.71";"0.24";"1.61";"8.90";"0";"CHEMBL3107076";"Displacement of [125I]-PYY from human NPYY2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3102719";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL3104204";"";"None";"521.64";"1";"4.34";"60";"CCN(CC)C(=O)C(c1ccccc1)N1CCN(c2ccc(NC(=O)Cc3c(C)noc3C)cc2F)CC1";"IC50";"'='";"20.0";"nM";"7.70";"";"";"UO_0000065";"14.76";"0.28";"3.36";"9.40";"0";"CHEMBL3107076";"Displacement of [125I]-PYY from human NPYY2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3102719";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL21753";"";"None";"514.07";"2";"5.96";"38";"CC(=O)N1CCc2ccc(N(C(=O)/C=C/c3ccc(Cl)cc3)C3CCN(Cc4ccccc4)CC3)cc21";"IC50";"'='";"3600.0";"nM";"5.44";"";"";"UO_0000065";"10.59";"0.20";"-0.52";"12.41";"1";"CHEMBL3107076";"Displacement of [125I]-PYY from human NPYY2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3102719";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL21907";"";"None";"497.61";"1";"5.45";"31";"CC(=O)N1CCc2ccc(N(C(=O)/C=C/c3cccc(F)c3)C3CCN(Cc4ccccc4)CC3)cc21";"IC50";"'='";"3600.0";"nM";"5.44";"";"";"UO_0000065";"10.94";"0.20";"-0.01";"12.41";"1";"CHEMBL3107076";"Displacement of [125I]-PYY from human NPYY2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3102719";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL3104223";"";"None";"463.63";"1";"5.12";"24";"CC(=O)N1CCc2ccc(N(CC#Cc3ccccc3)C3CCN(Cc4ccccc4)CC3)cc21";"IC50";"'='";"9200.0";"nM";"5.04";"";"";"UO_0000065";"10.86";"0.20";"-0.08";"18.80";"0";"CHEMBL3107076";"Displacement of [125I]-PYY from human NPYY2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3102719";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL1543306";"";"None";"446.62";"1";"5.43";"SF-11";"CCOc1ccc(NC(=S)N2CCC(C(O)(c3ccccc3)c3ccccc3)CC2)cc1";"IC50";"'='";"190.0";"nM";"6.72";"";"";"UO_0000065";"";"";"";"";"1";"CHEMBL3106332";"Antagonist activity at NPYY2 receptor (unknown origin) by cAMP biosensor assay";"F";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3102719";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL1289";"HALOPROGIN";"4.0";"361.39";"0";"4.42";"HALOPROGIN";"Clc1cc(Cl)c(OCC#CI)cc1Cl";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL3545252";"DOCETAXEL";"4.0";"861.94";"2";"3.26";"Docetaxel";"CC(=O)O[C@@]12CO[C@@H]1C[C@H](O)[C@@]1(C)C(=O)[C@H](O)C3=C(C)[C@@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)c4ccccc4)C[C@@](O)([C@@H](OC(=O)c4ccccc4)[C@H]21)C3(C)C.O.O.O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL54";"HALOPERIDOL";"4.0";"375.87";"0";"4.43";"HALOPERIDOL";"O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL293492";"CINNAMALDEHYDE";"-1.0";"132.16";"0";"1.90";"CINNAMALDEHYDE";"O=C/C=C/c1ccccc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL44884";"ETHAMBUTOL";"4.0";"204.31";"0";"-0.29";"ETHAMBUTOL";"CC[C@@H](CO)NCCN[C@@H](CC)CO";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL521589";"BAMBUTEROL";"3.0";"367.45";"0";"2.23";"BAMBUTEROL";"CN(C)C(=O)Oc1cc(OC(=O)N(C)C)cc(C(O)CNC(C)(C)C)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1729";"CISAPRIDE";"4.0";"465.95";"0";"3.36";"1";"COc1cc(N)c(Cl)cc1C(=O)NC1CCN(CCCOc2ccc(F)cc2)CC1OC";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL56337";"EPALRESTAT";"4.0";"319.41";"0";"2.92";"EPALRESTAT";"CC(/C=C1\SC(=S)N(CC(=O)O)C1=O)=C\c1ccccc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL52440";"DEXTROMETHORPHAN";"4.0";"271.40";"0";"3.38";"DEXTROMETHORPHAN";"COc1ccc2c(c1)[C@]13CCCC[C@@H]1[C@H](C2)N(C)CC3";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1364371";"";"None";"389.47";"0";"4.31";"SID22413191";"CN1CCC(Oc2ccccc2Sc2ccccc2)CC1.O=C(O)C(=O)O";"IC50";"'='";"17490.0";"nM";"4.76";"";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614345";"PUBCHEM_BIOASSAY: Dose response cell-based screening assay for antagonists of neuropeptide Y receptor Y2 (NPY-Y2). (Class of assay: confirmatory) [Related pubchem assays: 793, 1257, 1256 ]";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL438411";"";"None";"4224.71";"None";"None";"3";"CC(C)C[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O";"IC50";"'='";"261.0";"nM";"6.58";"";"";"UO_0000065";"1.56";"None";"None";"None";"0";"CHEMBL755164";"Affinity against Neuropeptide Y receptor Y2 in SK-N-BE2 cell line";"B";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133640";"1";"Scientific Literature";"J Med Chem";"2000";"None";"";"";""
"CHEMBL413612";"";"None";"1915.24";"None";"None";"5";"CC(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O)C(C)C";"IC50";"'='";"1.83";"nM";"8.74";"";"";"UO_0000065";"4.56";"None";"None";"None";"0";"CHEMBL755164";"Affinity against Neuropeptide Y receptor Y2 in SK-N-BE2 cell line";"B";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133640";"1";"Scientific Literature";"J Med Chem";"2000";"None";"";"";""
"CHEMBL1432676";"";"None";"341.93";"0";"4.73";"SID17403654";"CCN(CC)CC#CCC(C)(c1ccccc1)c1ccccc1.Cl";"IC50";"'='";"6166.0";"nM";"5.21";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614345";"PUBCHEM_BIOASSAY: Dose response cell-based screening assay for antagonists of neuropeptide Y receptor Y2 (NPY-Y2). (Class of assay: confirmatory) [Related pubchem assays: 793, 1257, 1256 ]";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1381600";"";"None";"431.38";"1";"5.14";"SID24829477";"Cc1ccc(-[n+]2c(-c3ccccc3)cn3c2CCc2ccccc2-3)c(C)c1.[Br-]";"IC50";"'='";"5902.0";"nM";"5.23";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1613986";"PUBCHEM_BIOASSAY: Dose response counterscreen assay for neuropeptide Y receptor Y1 (NPY-Y1): Cell-based high throughput assay to measure NPY-Y2 antagonism. (Class of assay: confirmatory) [Related pubchem assays: 793, 1040, 1255, 1254 ]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1370218";"";"None";"432.59";"1";"5.04";"2";"COc1ccc(NC(=S)N2CCC(C(O)(c3ccccc3)c3ccccc3)CC2)cc1";"IC50";"'='";"1100.0";"nM";"5.96";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2032840";"Antagonist activity at neuropeptide Y receptor Y2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2029318";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";"";""
"CHEMBL2030175";"";"None";"431.61";"1";"5.19";"36";"CCOc1ccc(NC(=S)N2CCN(C(c3ccccc3)c3ccccc3)CC2)cc1";"IC50";"'='";"371.0";"nM";"6.43";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2032840";"Antagonist activity at neuropeptide Y receptor Y2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2029318";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";"";""
"CHEMBL2030186";"";"None";"417.51";"0";"4.84";"51";"COc1ccc(OC(=O)N2CCC(C(O)(c3ccccc3)c3ccccc3)CC2)cc1";"IC50";"'='";"2680.0";"nM";"5.57";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2032840";"Antagonist activity at neuropeptide Y receptor Y2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2029318";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";"";""
"CHEMBL1383077";"";"None";"388.53";"0";"4.14";"SID14732614";"CCC(C)(C(=O)NC1CCCC1)N(Cc1ccco1)C(=O)Cc1cccs1";"IC50";"'>'";"35000.0";"nM";"";"";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1613986";"PUBCHEM_BIOASSAY: Dose response counterscreen assay for neuropeptide Y receptor Y1 (NPY-Y1): Cell-based high throughput assay to measure NPY-Y2 antagonism. (Class of assay: confirmatory) [Related pubchem assays: 793, 1040, 1255, 1254 ]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1452153";"";"None";"425.37";"0";"4.36";"SID17412522";"Cc1ccc(C(=O)C[n+]2cc(-c3ccccc3)n3c2CCCCC3)cc1.[Br-]";"IC50";"'='";"8010.0";"nM";"5.10";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1613986";"PUBCHEM_BIOASSAY: Dose response counterscreen assay for neuropeptide Y receptor Y1 (NPY-Y1): Cell-based high throughput assay to measure NPY-Y2 antagonism. (Class of assay: confirmatory) [Related pubchem assays: 793, 1040, 1255, 1254 ]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1370771";"";"None";"400.87";"0";"3.47";"SID24783064";"COc1ccc(C2N(c3ccc(Cl)cc3)N=C(C(C)=O)N(C)N2C(C)=O)cc1";"IC50";"'>'";"35000.0";"nM";"";"";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1613986";"PUBCHEM_BIOASSAY: Dose response counterscreen assay for neuropeptide Y receptor Y1 (NPY-Y1): Cell-based high throughput assay to measure NPY-Y2 antagonism. (Class of assay: confirmatory) [Related pubchem assays: 793, 1040, 1255, 1254 ]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1336318";"";"None";"335.79";"1";"5.17";"SID14737419";"O=C(c1ccco1)c1cn(Cc2ccc(Cl)cc2)c2ccccc12";"IC50";"'='";"9223.0";"nM";"5.04";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1613986";"PUBCHEM_BIOASSAY: Dose response counterscreen assay for neuropeptide Y receptor Y1 (NPY-Y1): Cell-based high throughput assay to measure NPY-Y2 antagonism. (Class of assay: confirmatory) [Related pubchem assays: 793, 1040, 1255, 1254 ]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1562842";"";"None";"412.53";"0";"4.60";"SID24797338";"COc1ccccc1N(CC(=O)NC1CCCC1)C(=O)c1oc(C(C)(C)C)cc1C";"IC50";"'>'";"35000.0";"nM";"";"";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1613986";"PUBCHEM_BIOASSAY: Dose response counterscreen assay for neuropeptide Y receptor Y1 (NPY-Y1): Cell-based high throughput assay to measure NPY-Y2 antagonism. (Class of assay: confirmatory) [Related pubchem assays: 793, 1040, 1255, 1254 ]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1352348";"";"None";"369.49";"0";"4.14";"SID14745989";"Cc1cc(C(=O)CSc2nc3ccccc3[nH]2)c(C)n1CC1CCCO1";"IC50";"'>'";"35000.0";"nM";"";"";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1613986";"PUBCHEM_BIOASSAY: Dose response counterscreen assay for neuropeptide Y receptor Y1 (NPY-Y1): Cell-based high throughput assay to measure NPY-Y2 antagonism. (Class of assay: confirmatory) [Related pubchem assays: 793, 1040, 1255, 1254 ]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL429389";"";"None";"537.66";"1";"4.85";"10";"CCOC(=O)C(=O)N1CCc2ccc(N(C(=O)/C=C/c3ccccc3)C3CCN(Cc4ccccc4)CC3)cc21";"IC50";"'='";"4800.0";"nM";"5.32";"";"";"UO_0000065";"9.89";"0.18";"0.47";"7.58";"0";"CHEMBL750768";"Binding affinity towards the NPY Y2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147599";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2004";"None";"";"";""
"CHEMBL603";"ZAFIRLUKAST";"4.0";"575.69";"2";"5.70";"ZAFIRLUKAST";"COc1cc(C(=O)NS(=O)(=O)c2ccccc2C)ccc1Cc1cn(C)c2ccc(NC(=O)OC3CCCC3)cc12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL12948";"SEMUSTINE";"3.0";"247.73";"0";"2.50";"SEMUSTINE";"CC1CCC(NC(=O)N(CCCl)N=O)CC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL54440";"MEVASTATIN";"2.0";"390.52";"0";"3.95";"MEVASTATIN";"CC[C@H](C)C(=O)O[C@H]1CCC=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@H]21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL95501";"";"None";"460.67";"1";"6.79";"3";"CN(C)CCCN(C(=O)c1cc2ccccc2s1)c1ccccc1SCc1ccccc1";"IC50";"'='";"1000.0";"nM";"6.00";"";"";"UO_0000065";"13.02";"0.26";"-0.79";"25.48";"1";"CHEMBL3107075";"Displacement of [125I]-PYY from NPYY2 receptor (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3102719";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL3104175";"";"None";"493.63";"1";"5.62";"114";"CCC(CC)C(=O)Nc1ccc(N2CCN(C(c3ccccc3)c3nnc(C(C)C)o3)CC2)c(F)c1";"IC50";"'='";"290.0";"nM";"6.54";"";"";"UO_0000065";"13.24";"0.25";"0.92";"8.78";"0";"CHEMBL3107076";"Displacement of [125I]-PYY from human NPYY2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3102719";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL1201193";"LEVOBUPIVACAINE";"4.0";"288.44";"0";"3.90";"LEVOBUPIVACAINE";"CCCCN1CCCC[C@H]1C(=O)Nc1c(C)cccc1C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1430";"PENICILLAMINE";"4.0";"149.21";"0";"0.11";"PENICILLAMINE";"CC(C)(S)[C@@H](N)C(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL490427";"";"None";"400.44";"0";"4.64";"2r";"Cc1nnc(-c2ccc3[nH]c([C@H]4CC[C@@]5(CC4)OC(=O)c4ccccc45)nc3c2)o1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL981717";"Inhibition of NPYY2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1144170";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"None";"";"";""
"CHEMBL3104189";"";"None";"464.59";"0";"4.77";"96";"CCc1cnc(-c2ccc(N3CCN(C(C(=O)N(CC)CC)c4ccccc4)CC3)c(F)c2)o1";"IC50";"'='";"460.0";"nM";"6.34";"";"";"UO_0000065";"13.64";"0.25";"1.57";"12.00";"0";"CHEMBL3107076";"Displacement of [125I]-PYY from human NPYY2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3102719";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL283106";"";"None";"558.52";"2";"6.07";"35";"CC(=O)N1CCc2ccc(N(C(=O)/C=C/c3cccc(Br)c3)C3CCN(Cc4ccccc4)CC3)cc21";"IC50";"'='";"3300.0";"nM";"5.48";"";"";"UO_0000065";"9.81";"0.20";"-0.59";"12.50";"1";"CHEMBL3107076";"Displacement of [125I]-PYY from human NPYY2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3102719";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL83668";"TOLNAFTATE";"4.0";"307.42";"0";"4.95";"TOLNAFTATE";"Cc1cccc(N(C)C(=S)Oc2ccc3ccccc3c2)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1366";"AURANOFIN";"4.0";"678.49";"None";"None";"AURANOFIN";"";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL3578015";"";"None";"2886.46";"None";"None";"4c";"CC(=O)N[C@@H](CCCCNC(=O)CCNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](Cc1cccc2ccccc12)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O";"IC50";"'='";"14.79";"nM";"7.83";"";"";"UO_0000065";"2.71";"None";"None";"None";"0";"CHEMBL3579806";"Displacement of [125I]PYY from human neuropeptide Y Y2 receptor expressed in HEK293 cells cotransfected with eYFP fusion protein after 2 hrs by competitive receptor binding assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3576822";"1";"Scientific Literature";"J Med Chem";"2015";"CHEMBL3307715";"";"";""
"CHEMBL85";"RISPERIDONE";"4.0";"410.49";"0";"3.59";"Risperidone (18)";"Cc1nc2n(c(=O)c1CCN1CCC(c3noc4cc(F)ccc34)CC1)CCCC2";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL2030161";"";"None";"474.63";"1";"5.21";"22";"CCOC(=O)c1cccc(NC(=S)N2CCC(C(O)(c3ccccc3)c3ccccc3)CC2)c1";"IC50";"'='";"238.0";"nM";"6.62";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2032842";"Partial antagonist activity at neuropeptide Y receptor Y2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2029318";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";"";""
"CHEMBL83255";"";"None";"373.50";"0";"4.11";"16";"CC(=O)N1CCC(CNc2nc3c(s2)CCCc2ccc(F)cc2-3)CC1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL750763";"In vitro binding affinity against rat neuropeptide Y2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1146725";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2004";"None";"";"";""
"CHEMBL268409";"";"None";"1991.34";"None";"None";"22";"CC(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@H](C(N)=O)C(c1ccccc1)c1ccccc1)[C@@H](C)O)C(C)C";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL755164";"Affinity against Neuropeptide Y receptor Y2 in SK-N-BE2 cell line";"B";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133640";"1";"Scientific Literature";"J Med Chem";"2000";"None";"";"";""
"CHEMBL77276";"";"None";"390.48";"1";"5.58";"40j";"COc1ccc(CC(C)N(C)C(=O)Nc2ccc(Oc3ccccc3)cc2)cc1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL749564";"Inhibitory activity tested against Human Neuropeptide Y2 Receptor.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1134441";"1";"Scientific Literature";"J Med Chem";"2001";"None";"";"";""
"CHEMBL267633";"NEUROPEPTIDE-Y";"None";"4253.71";"None";"None";"2";"CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O)[C@@H](C)CC";"IC50";"'='";"0.32";"nM";"9.49";"";"";"UO_0000065";"2.23";"None";"None";"None";"0";"CHEMBL755164";"Affinity against Neuropeptide Y receptor Y2 in SK-N-BE2 cell line";"B";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133640";"1";"Scientific Literature";"J Med Chem";"2000";"None";"";"";""
"CHEMBL428292";"";"None";"1917.26";"None";"None";"31";"CC(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@H](CN[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O)C(C)C)CC(C)C";"IC50";"'='";"59.0";"nM";"7.23";"";"";"UO_0000065";"3.77";"None";"None";"None";"0";"CHEMBL755164";"Affinity against Neuropeptide Y receptor Y2 in SK-N-BE2 cell line";"B";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133640";"1";"Scientific Literature";"J Med Chem";"2000";"None";"";"";""
"CHEMBL416005";"";"None";"479.62";"1";"5.31";"9";"CC(=O)N1CCc2ccc(N(C(=O)/C=C/c3ccccc3)C3CCN(Cc4ccccc4)CC3)cc21";"IC50";"'='";"4000.0";"nM";"5.40";"";"";"UO_0000065";"11.25";"0.20";"0.09";"12.31";"1";"CHEMBL3107076";"Displacement of [125I]-PYY from human NPYY2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3102719";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL4227359";"";"None";"2915.57";"None";"None";"10";"C[C@@H](O)[C@H](NC(=O)C(C)(C)NC(=O)[C@H](CCCCNC(=O)[C@@H](N)CCCCNC(=O)COCC(=O)NCCCOCCOCCOCCCNC(=O)CC[C@H](NC(=O)[C@H]1CC[C@H](CNC(=O)CCCCCCCCCCCCCCCCCCC(=O)O)CC1)C(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)C(C)(C)NC(=O)[C@H](CC1CCCCC1)NC(=O)[C@H](Cc1ccncc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H]1C[C@H](O)CN1C(=O)[C@H](CO)NC(=O)c1c[nH]cn1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC1CCCCC1)C(N)=O";"IC50";"'='";"8.0";"nM";"8.10";"";"";"UO_0000065";"2.78";"None";"None";"None";"0";"CHEMBL4220285";"Displacement of [125I]-PYY from human neuropeptide Y2 receptor expressed in CHO cell membranes incubated for 60 mins by TopCount micro scintillation analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4219053";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";"";"";""
"CHEMBL21507";"";"None";"499.70";"1";"6.08";"50";"CC(=O)N1CCc2ccc(N(C(=O)/C=C/c3ccccc3)C3CCN(CCC4CCCCC4)CC3)cc21";"IC50";"'='";"600.0";"nM";"6.22";"";"";"UO_0000065";"12.45";"0.23";"0.14";"14.19";"0";"CHEMBL750768";"Binding affinity towards the NPY Y2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147599";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2004";"None";"";"";""
"CHEMBL56564";"TROPISETRON";"4.0";"284.36";"0";"2.95";"TROPISETRON";"CN1[C@@H]2CC[C@H]1C[C@@H](OC(=O)c1c[nH]c3ccccc13)C2";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1513";"IRBESARTAN";"4.0";"428.54";"0";"4.78";"IRBESARTAN";"CCCCC1=NC2(CCCC2)C(=O)N1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1070";"NABUMETONE";"4.0";"228.29";"0";"3.37";"NABUMETONE";"COc1ccc2cc(CCC(C)=O)ccc2c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1200391";"TROMETHAMINE";"4.0";"121.14";"0";"-2.34";"TROMETHAMINE";"NC(CO)(CO)CO";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1556933";"";"None";"424.52";"0";"4.55";"SID24786009";"COc1ccc(N(C(=O)C2CCCCC2)S(=O)(=O)c2cccc3cccnc23)cc1";"IC50";"'>'";"35000.0";"nM";"";"";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1613986";"PUBCHEM_BIOASSAY: Dose response counterscreen assay for neuropeptide Y receptor Y1 (NPY-Y1): Cell-based high throughput assay to measure NPY-Y2 antagonism. (Class of assay: confirmatory) [Related pubchem assays: 793, 1040, 1255, 1254 ]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL95501";"";"None";"460.67";"1";"6.79";"17";"CN(C)CCCN(C(=O)c1cc2ccccc2s1)c1ccccc1SCc1ccccc1";"IC50";"'='";"1000.0";"nM";"6.00";"";"";"UO_0000065";"13.02";"0.26";"-0.79";"25.48";"0";"CHEMBL747054";"Binding affinity against SMS-KAN cell membranes endogenously expressing Neuropeptide Y receptor type 2 using [125I]PYY as radioligand";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"SMS-KAN";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1136181";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2003";"None";"";"";""
"CHEMBL372795";"STREPTOMYCIN";"4.0";"581.58";"3";"-8.16";"streptomycin";"CN[C@@H]1[C@H](O[C@H]2[C@H](O[C@H]3[C@H](O)[C@@H](O)[C@H](N=C(N)N)[C@@H](O)[C@@H]3N=C(N)N)O[C@@H](C)[C@]2(O)C=O)O[C@@H](CO)[C@H](O)[C@H]1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL4211441";"";"None";"1751.12";"None";"None";"16";"CC[C@](C)(NC(=O)[C@H]1CCCN1C(=O)[C@H](CO)NC(C)=O)C(=O)N[C@@H](Cc1ccncc1)C(=O)N[C@@H](CC1CCCCC1)C(=O)NC(C)(C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)NC(C)(C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC1CCCCC1)C(N)=O)[C@@H](C)O";"IC50";"'='";"1.8";"nM";"8.74";"";"";"UO_0000065";"4.99";"None";"None";"None";"0";"CHEMBL4179032";"Displacement of [125I]-PYY from human neuropeptide Y2 receptor expressed in CHO cell membranes incubated for 60 mins by TopCount based method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4177573";"1";"Scientific Literature";"Bioorg Med Chem";"2017";"None";"";"";""
"CHEMBL4208191";"";"None";"1822.20";"None";"None";"13";"CC[C@@](C)(NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)C(C)(C)NC(=O)[C@H](CC1CCCCC1)NC(=O)[C@H](Cc1ccncc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H]1CCCN1C(=O)[C@H](CO)NC(C)=O)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC1CCCCC1)C(N)=O)[C@@H](C)O";"IC50";"'='";"0.27";"nM";"9.57";"";"";"UO_0000065";"5.25";"None";"None";"None";"0";"CHEMBL4179032";"Displacement of [125I]-PYY from human neuropeptide Y2 receptor expressed in CHO cell membranes incubated for 60 mins by TopCount based method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4177573";"1";"Scientific Literature";"Bioorg Med Chem";"2017";"None";"";"";""
"CHEMBL1300782";"";"None";"387.28";"0";"4.47";"SID17403121";"CCC1=Nc2ccc(Br)cc2C(c2ccccc2)N1CC(=O)OC";"IC50";"'>'";"35000.0";"nM";"";"";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614345";"PUBCHEM_BIOASSAY: Dose response cell-based screening assay for antagonists of neuropeptide Y receptor Y2 (NPY-Y2). (Class of assay: confirmatory) [Related pubchem assays: 793, 1257, 1256 ]";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1537995";"";"None";"359.90";"1";"5.75";"SID17409726";"Cc1nc(-c2ccccc2)sc1C(=O)CSc1ccc(Cl)cc1";"IC50";"'='";"6989.0";"nM";"5.16";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614345";"PUBCHEM_BIOASSAY: Dose response cell-based screening assay for antagonists of neuropeptide Y receptor Y2 (NPY-Y2). (Class of assay: confirmatory) [Related pubchem assays: 793, 1257, 1256 ]";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL227934";"STRYCHNINE";"-1.0";"334.42";"0";"2.09";"STRYCHNINE";"O=C1C[C@@H]2OCC=C3CN4CC[C@]56c7ccccc7N1[C@H]5[C@H]2[C@H]3C[C@H]46";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL841";"LOPERAMIDE";"4.0";"477.05";"1";"5.09";"LOPERAMIDE";"CN(C)C(=O)C(CCN1CCC(O)(c2ccc(Cl)cc2)CC1)(c1ccccc1)c1ccccc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1384";"KANAMYCIN";"4.0";"484.50";"2";"-7.29";"KANAMYCIN";"NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1909062";"LEAD (II) ACETATE";"None";"325.29";"None";"None";"LEAD (II) ACETATE";"";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1909069";"";"None";"None";"None";"None";"MC 288769";"";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL60889";"MOSAPRIDE";"3.0";"421.90";"0";"3.09";"MOSAPRIDE";"CCOc1cc(N)c(Cl)cc1C(=O)NCC1CN(Cc2ccc(F)cc2)CCO1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1388";"MONOBENZONE";"4.0";"200.24";"0";"2.97";"MONOBENZONE";"Oc1ccc(OCc2ccccc2)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL686";"MEFENAMIC ACID";"4.0";"241.29";"0";"3.75";"MEFENAMIC ACID";"Cc1cccc(Nc2ccccc2C(=O)O)c1C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL4061266";"";"None";"1676.09";"None";"None";"2";"CCC(NC(=O)[C@H](CCCNC(=N)N)NC(=O)c1ccccc1)C(=O)NC(CC1CCCCC1)C(=O)NC(CC1CCCCC1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)NC(C)(C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NC(CC1CCCCC1)C(N)=O)[C@@H](C)O";"IC50";"'='";"5.7";"nM";"8.24";"";"";"UO_0000065";"4.92";"None";"None";"None";"0";"CHEMBL4036757";"Displacement of [125I]-PYY from human Y2R expressed in CHO cell membranes after 60 mins by liquid scintillation method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4033754";"1";"Scientific Literature";"ACS Med Chem Lett";"2017";"None";"";"";""
"CHEMBL21616";"";"None";"496.61";"0";"3.94";"30";"CC(=O)N1CCc2ccc(N(C(=O)/C=C/c3cc[n+]([O-])cc3)C3CCN(Cc4ccccc4)CC3)cc21";"IC50";"'='";"30000.0";"nM";"4.52";"";"";"UO_0000065";"9.11";"0.17";"0.58";"6.39";"0";"CHEMBL750768";"Binding affinity towards the NPY Y2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147599";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2004";"None";"";"";""
"CHEMBL411800";"";"None";"1917.26";"None";"None";"25";"CC(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](CN[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O)C(C)C";"IC50";"'='";"52.0";"nM";"7.28";"";"";"UO_0000065";"3.80";"None";"None";"None";"0";"CHEMBL755164";"Affinity against Neuropeptide Y receptor Y2 in SK-N-BE2 cell line";"B";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133640";"1";"Scientific Literature";"J Med Chem";"2000";"None";"";"";""
"CHEMBL577294";"2-HYDROXYPROPYL-BETA-CYCLODEXTRIN";"3.0";"1541.55";"None";"None";"2-HYDROXYPROPYL-BETA-CYCLODEXTRIN";"CC(O)COC[C@H]1O[C@@H]2O[C@H]3[C@H](O)[C@@H](O)[C@@H](O[C@H]4[C@H](O)[C@@H](O)[C@@H](O[C@H]5[C@H](O)[C@@H](O)[C@@H](O[C@H]6[C@H](O)[C@@H](O)[C@@H](O[C@H]7[C@H](O)[C@@H](O)[C@@H](O[C@H]8[C@H](O)[C@@H](O)[C@@H](O[C@H]1[C@H](O)[C@H]2O)O[C@@H]8COCC(C)O)O[C@@H]7COCC(C)O)O[C@@H]6COCC(C)O)O[C@@H]5COCC(C)O)O[C@@H]4COCC(C)O)O[C@@H]3COCC(C)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1464";"WARFARIN";"4.0";"308.33";"0";"3.61";"WARFARIN";"CC(=O)CC(c1ccccc1)c1c(O)c2ccccc2oc1=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1201237";"LEVOBUNOLOL";"4.0";"291.39";"0";"2.33";"LEVOBUNOLOL";"CC(C)(C)NC[C@H](O)COc1cccc2c1CCCC2=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL411200";"";"None";"2004.29";"None";"None";"41";"CCCC[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(C)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCC)C(=O)N[C@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O";"IC50";"'='";"3.73";"nM";"8.43";"";"";"UO_0000065";"4.21";"None";"None";"None";"0";"CHEMBL755164";"Affinity against Neuropeptide Y receptor Y2 in SK-N-BE2 cell line";"B";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133640";"1";"Scientific Literature";"J Med Chem";"2000";"None";"";"";""
"CHEMBL410938";"";"None";"2004.29";"None";"None";"16";"CC(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O)C(C)C";"IC50";"'='";"2.08";"nM";"8.68";"";"";"UO_0000065";"4.33";"None";"None";"None";"0";"CHEMBL755164";"Affinity against Neuropeptide Y receptor Y2 in SK-N-BE2 cell line";"B";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133640";"1";"Scientific Literature";"J Med Chem";"2000";"None";"";"";""
"CHEMBL3104216";"";"None";"512.67";"1";"4.94";"73";"CCC(CC)C(=O)Nc1ccc(N2CCN(C(C(=O)N(CC)CC)c3cccc(OC)c3)CC2)c(F)c1";"IC50";"'='";"40.0";"nM";"7.40";"";"";"UO_0000065";"14.43";"0.27";"2.46";"11.36";"0";"CHEMBL3107076";"Displacement of [125I]-PYY from human NPYY2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3102719";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL20553";"";"None";"524.62";"2";"5.21";"36";"CC(=O)N1CCc2ccc(N(C(=O)/C=C/c3cccc([N+](=O)[O-])c3)C3CCN(Cc4ccccc4)CC3)cc21";"IC50";"'='";"1900.0";"nM";"5.72";"";"";"UO_0000065";"10.91";"0.20";"0.51";"6.58";"1";"CHEMBL3107076";"Displacement of [125I]-PYY from human NPYY2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3102719";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL2403029";"";"None";"535.66";"2";"6.88";"19";"CCNC(=O)C(c1ccccc1)C1CCN(c2ccc(C(=O)Nc3ccccc3-c3ccccc3)cc2F)CC1";"IC50";"'='";"45.0";"nM";"7.35";"";"";"UO_0000065";"13.72";"0.25";"0.47";"11.96";"0";"CHEMBL2404394";"Displacement of [125I]PYY from NPY-Y2 receptor in human KAN-TS cell membranes after 1 hr by scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"KAN-TS";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2401643";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"None";"";"";""
"CHEMBL2402909";"";"None";"478.57";"0";"4.82";"8e";"CCNC(=O)C(c1ccccc1)C1CCN(c2ccc(NC(=O)c3c(C)noc3C)cc2F)CC1";"IC50";"'='";"476.0";"nM";"6.32";"";"";"UO_0000065";"13.21";"0.25";"1.50";"7.23";"0";"CHEMBL2404394";"Displacement of [125I]PYY from NPY-Y2 receptor in human KAN-TS cell membranes after 1 hr by scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"KAN-TS";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2401643";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"None";"";"";""
"CHEMBL279289";"";"None";"493.65";"1";"5.35";"47";"CC(=O)N1CCc2ccc(N(C(=O)/C=C/c3ccccc3)C3CCN(CCc4ccccc4)CC3)cc21";"IC50";"'='";"26000.0";"nM";"4.58";"";"";"UO_0000065";"9.29";"0.17";"-0.76";"10.45";"0";"CHEMBL750768";"Binding affinity towards the NPY Y2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147599";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2004";"None";"";"";""
"CHEMBL268351";"";"None";"1727.01";"None";"None";"Ac-25-36[Cha30,Cha31]";"CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCN=C(N)N)NC(C)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)C1CCCCC1)C1CCCCC1";"IC50";"'='";"8.0";"nM";"8.10";"";"";"UO_0000065";"4.69";"None";"None";"None";"0";"CHEMBL750765";"Compound was evaluated for its inhibitory activity against Y2 receptor of rabbit kidney membrane";"B";"BAO_0000019";"assay format";"Oryctolagus cuniculus";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1126482";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1993";"None";"";"";""
"CHEMBL3104120";"";"None";"449.57";"0";"3.96";"105";"CCN(CC)C(=O)C(c1ccccc1)N1CCN(c2ccc(-c3cnn(C)c3)cc2F)CC1";"IC50";"'='";"900.0";"nM";"6.05";"";"";"UO_0000065";"13.45";"0.25";"2.09";"13.55";"0";"CHEMBL3107076";"Displacement of [125I]-PYY from human NPYY2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3102719";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL3104201";"";"None";"481.61";"0";"4.67";"85";"CCN(CC)C(=O)C(c1ccccc1)C1CCN(c2ccc(NC(=O)C3CCOC3)cc2F)CC1";"IC50";"'='";"25.0";"nM";"7.60";"";"";"UO_0000065";"15.78";"0.30";"2.93";"12.29";"0";"CHEMBL3107076";"Displacement of [125I]-PYY from human NPYY2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3102719";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL281387";"";"None";"493.65";"1";"5.62";"33";"CC(=O)N1CCc2ccc(N(C(=O)/C=C/c3cccc(C)c3)C3CCN(Cc4ccccc4)CC3)cc21";"IC50";"'='";"1400.0";"nM";"5.85";"";"";"UO_0000065";"11.86";"0.22";"0.23";"13.35";"1";"CHEMBL3107076";"Displacement of [125I]-PYY from human NPYY2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3102719";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL3104180";"";"None";"486.62";"0";"4.46";"119";"CCN(CC)C(=O)C(c1ccccc1)N1CCN(c2ccc(-c3nc(C(C)C)no3)cc2C#N)CC1";"IC50";"'='";"11.0";"nM";"7.96";"";"";"UO_0000065";"16.35";"0.30";"3.50";"8.89";"0";"CHEMBL3107076";"Displacement of [125I]-PYY from human NPYY2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3102719";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL3104178";"";"None";"453.60";"1";"5.10";"117";"CCC(CC)C(=O)Nc1ccc(N2CCN(C(c3ccccc3)C3CCOC3)CC2)c(F)c1";"IC50";"'='";"34.0";"nM";"7.47";"";"";"UO_0000065";"16.46";"0.31";"2.37";"16.67";"0";"CHEMBL3107076";"Displacement of [125I]-PYY from human NPYY2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3102719";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL3102871";"";"None";"445.58";"1";"5.22";"107";"CCN(CC)C(=O)C(c1ccccc1)N1CCN(c2ccc(-c3ccccc3)cc2F)CC1";"IC50";"'='";"420.0";"nM";"6.38";"";"";"UO_0000065";"14.31";"0.26";"1.16";"23.80";"0";"CHEMBL3107076";"Displacement of [125I]-PYY from human NPYY2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3102719";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL3104184";"";"None";"479.60";"0";"4.73";"91";"CCN(CC)C(=O)C(c1ccccc1)N1CCN(c2ccc(-c3noc(C(C)C)n3)cc2F)CC1";"IC50";"'='";"130.0";"nM";"6.89";"";"";"UO_0000065";"14.36";"0.27";"2.16";"10.48";"0";"CHEMBL3107076";"Displacement of [125I]-PYY from human NPYY2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3102719";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL21071";"";"None";"493.65";"1";"5.70";"17";"CC(=O)N1CCCc2ccc(N(C(=O)/C=C/c3ccccc3)C3CCN(Cc4ccccc4)CC3)cc21";"IC50";"'='";"10000.0";"nM";"5.00";"";"";"UO_0000065";"10.13";"0.18";"-0.70";"11.40";"1";"CHEMBL3107076";"Displacement of [125I]-PYY from human NPYY2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3102719";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL282667";"";"None";"437.59";"1";"5.37";"13";"O=C(/C=C/c1ccccc1)N(c1ccc2c(c1)NCC2)C1CCN(Cc2ccccc2)CC1";"IC50";"'='";"22000.0";"nM";"4.66";"";"";"UO_0000065";"10.64";"0.19";"-0.71";"13.09";"1";"CHEMBL3107076";"Displacement of [125I]-PYY from human NPYY2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3102719";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL1419672";"";"None";"493.63";"0";"3.77";"SID17416335";"COc1ccc([N+](=O)[O-])cc1N(CC(O)CN(CC(C)C)CC(C)C)S(=O)(=O)c1ccccc1";"IC50";"'>'";"35000.0";"nM";"";"";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1613986";"PUBCHEM_BIOASSAY: Dose response counterscreen assay for neuropeptide Y receptor Y1 (NPY-Y1): Cell-based high throughput assay to measure NPY-Y2 antagonism. (Class of assay: confirmatory) [Related pubchem assays: 793, 1040, 1255, 1254 ]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL4081798";"";"None";"1814.26";"None";"None";"11";"CCC(NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CO)NC(C)=O)C(=O)NC(CC1CCCCC1)C(=O)NC(CC1CCCCC1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)NC(C)(C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NC(CC1CCCCC1)C(N)=O)[C@@H](C)O";"IC50";"'='";"12.0";"nM";"7.92";"";"";"UO_0000065";"4.37";"None";"None";"None";"0";"CHEMBL4036757";"Displacement of [125I]-PYY from human Y2R expressed in CHO cell membranes after 60 mins by liquid scintillation method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4033754";"1";"Scientific Literature";"ACS Med Chem Lett";"2017";"None";"";"";""
"CHEMBL4066409";"";"None";"1814.26";"None";"None";"10";"CCC(NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](CC(C)C)NC(=O)[C@@H](CO)NC(C)=O)C(=O)NC(CC1CCCCC1)C(=O)NC(CC1CCCCC1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)NC(C)(C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NC(CC1CCCCC1)C(N)=O)[C@@H](C)O";"IC50";"'='";"23.0";"nM";"7.64";"";"";"UO_0000065";"4.21";"None";"None";"None";"0";"CHEMBL4036757";"Displacement of [125I]-PYY from human Y2R expressed in CHO cell membranes after 60 mins by liquid scintillation method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4033754";"1";"Scientific Literature";"ACS Med Chem Lett";"2017";"None";"";"";""
"CHEMBL585";"TRIAMTERENE";"4.0";"253.27";"0";"0.83";"TRIAMTERENE";"Nc1nc(N)c2nc(-c3ccccc3)c(N)nc2n1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL21907";"";"None";"497.61";"1";"5.45";"38";"CC(=O)N1CCc2ccc(N(C(=O)/C=C/c3cccc(F)c3)C3CCN(Cc4ccccc4)CC3)cc21";"IC50";"'='";"3600.0";"nM";"5.44";"";"";"UO_0000065";"10.94";"0.20";"-0.01";"12.41";"0";"CHEMBL750768";"Binding affinity towards the NPY Y2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147599";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2004";"None";"";"";""
"CHEMBL1201146";"NORETHINDRONE ACETATE";"4.0";"340.46";"0";"4.06";"NORETHINDRONE ACETATE";"C#C[C@]1(OC(C)=O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@@H]4[C@H]3CC[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL41686";"";"None";"518.06";"1";"4.02";"27 (S)";"N=C(N)NCCCC(NC(=O)C(c1ccccc1)c1ccc(Cl)cc1)C(=O)N[C@H]1CCc2ccccc21";"IC50";"'='";"59000.0";"nM";"4.23";"";"";"UO_0000065";"8.16";"0.16";"0.21";"3.52";"0";"CHEMBL747056";"Inhibition of binding of [3H]propionyl-NPY (1 nM) to Neuropeptide Y receptor type 2 in SMS-KAN cell membranes";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"SMS-KAN";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133238";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2000";"None";"";"";""
"CHEMBL1707";"LOPERAMIDE HYDROCHLORIDE";"4.0";"513.51";"1";"5.09";"SID11533030";"CN(C)C(=O)C(CCN1CCC(O)(c2ccc(Cl)cc2)CC1)(c1ccccc1)c1ccccc1.Cl";"IC50";"'>'";"35000.0";"nM";"";"";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614345";"PUBCHEM_BIOASSAY: Dose response cell-based screening assay for antagonists of neuropeptide Y receptor Y2 (NPY-Y2). (Class of assay: confirmatory) [Related pubchem assays: 793, 1257, 1256 ]";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1573504";"";"None";"404.30";"0";"3.95";"SID857411";"Cl.N=c1n(Cc2ccc(Cl)cc2)c2ccccc2n1CC(O)c1ccco1";"IC50";"'>'";"35000.0";"nM";"";"";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614345";"PUBCHEM_BIOASSAY: Dose response cell-based screening assay for antagonists of neuropeptide Y receptor Y2 (NPY-Y2). (Class of assay: confirmatory) [Related pubchem assays: 793, 1257, 1256 ]";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL3195213";"";"None";"371.26";"0";"2.79";"SID22403229";"CCc1nnc(S)n1/N=C/c1cc(Br)c(OC)cc1OC";"IC50";"'>'";"35000.0";"nM";"";"";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614345";"PUBCHEM_BIOASSAY: Dose response cell-based screening assay for antagonists of neuropeptide Y receptor Y2 (NPY-Y2). (Class of assay: confirmatory) [Related pubchem assays: 793, 1257, 1256 ]";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1585445";"";"None";"330.77";"0";"4.29";"SID7966598";"COc1ccc(-c2noc(COc3ccc(Cl)c(C)c3)n2)cc1";"IC50";"'='";"4248.0";"nM";"5.37";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614345";"PUBCHEM_BIOASSAY: Dose response cell-based screening assay for antagonists of neuropeptide Y receptor Y2 (NPY-Y2). (Class of assay: confirmatory) [Related pubchem assays: 793, 1257, 1256 ]";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1391119";"";"None";"352.39";"0";"3.33";"SID17407403";"CCCCNC(=O)c1onc(CSc2ccccc2F)c1C(=O)O";"IC50";"'='";"13300.0";"nM";"4.88";"";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614345";"PUBCHEM_BIOASSAY: Dose response cell-based screening assay for antagonists of neuropeptide Y receptor Y2 (NPY-Y2). (Class of assay: confirmatory) [Related pubchem assays: 793, 1257, 1256 ]";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1327690";"";"None";"331.80";"0";"4.16";"SID4262635";"N#Cc1nc(COc2ccc(Cl)cc2)oc1N1CCCCCC1";"IC50";"'='";"16150.0";"nM";"4.79";"";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614345";"PUBCHEM_BIOASSAY: Dose response cell-based screening assay for antagonists of neuropeptide Y receptor Y2 (NPY-Y2). (Class of assay: confirmatory) [Related pubchem assays: 793, 1257, 1256 ]";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1312703";"";"None";"375.85";"0";"4.69";"SID17412693";"COC(=O)c1cc(Cl)c(NC(=O)c2ccc(C(C)(C)C)cc2)cc1OC";"IC50";"'='";"4321.0";"nM";"5.36";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614345";"PUBCHEM_BIOASSAY: Dose response cell-based screening assay for antagonists of neuropeptide Y receptor Y2 (NPY-Y2). (Class of assay: confirmatory) [Related pubchem assays: 793, 1257, 1256 ]";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL97046";"";"None";"444.60";"1";"6.32";"4";"CN(C)CCCN(C(=O)c1cc2ccccc2o1)c1ccccc1SCc1ccccc1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"1";"CHEMBL3107075";"Displacement of [125I]-PYY from NPYY2 receptor (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3102719";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL3104211";"";"None";"494.66";"1";"5.08";"68";"CCN(CC)C(=O)C(c1ccccc1)N1CCN(c2ccc(NC(=O)CC3CCCC3)cc2F)CC1";"IC50";"'='";"3000.0";"nM";"5.52";"";"";"UO_0000065";"11.16";"0.21";"0.44";"9.88";"0";"CHEMBL3107076";"Displacement of [125I]-PYY from human NPYY2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3102719";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL1343692";"";"None";"416.54";"0";"3.83";"SID24834434";"COc1ccc(N(C)S(=O)(=O)c2cccc(C(=O)NC3CCC(C)CC3)c2)cc1";"IC50";"'>'";"35000.0";"nM";"";"";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1613986";"PUBCHEM_BIOASSAY: Dose response counterscreen assay for neuropeptide Y receptor Y1 (NPY-Y1): Cell-based high throughput assay to measure NPY-Y2 antagonism. (Class of assay: confirmatory) [Related pubchem assays: 793, 1040, 1255, 1254 ]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1328017";"";"None";"280.20";"0";"2.86";"SID24794002";"CNCc1cc(Cl)cc(OC)c1OC(C)C.Cl";"IC50";"'>'";"35000.0";"nM";"";"";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1613986";"PUBCHEM_BIOASSAY: Dose response counterscreen assay for neuropeptide Y receptor Y1 (NPY-Y1): Cell-based high throughput assay to measure NPY-Y2 antagonism. (Class of assay: confirmatory) [Related pubchem assays: 793, 1040, 1255, 1254 ]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1326298";"";"None";"428.58";"0";"4.53";"SID17511319";"CCc1cccc(CC)c1NC(=O)C(NS(=O)(=O)c1cccs1)c1ccccc1";"IC50";"'>'";"35000.0";"nM";"";"";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1613986";"PUBCHEM_BIOASSAY: Dose response counterscreen assay for neuropeptide Y receptor Y1 (NPY-Y1): Cell-based high throughput assay to measure NPY-Y2 antagonism. (Class of assay: confirmatory) [Related pubchem assays: 793, 1040, 1255, 1254 ]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1909073";"PIPERILATE ETHOBROMIDE";"None";"448.40";"0";"3.49";"PIPERILATE ETHOBROMIDE";"CC[N+]1(CCOC(=O)C(O)(c2ccccc2)c2ccccc2)CCCCC1.[Br-]";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL95501";"";"None";"460.67";"1";"6.79";"1";"CN(C)CCCN(C(=O)c1cc2ccccc2s1)c1ccccc1SCc1ccccc1";"IC50";"'='";"450.0";"nM";"6.35";"";"";"UO_0000065";"13.78";"0.27";"-0.44";"26.95";"1";"CHEMBL1063992";"Binding affinity to neuropeptide Y2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1152417";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"None";"";"";""
"CHEMBL21523";"";"None";"533.59";"2";"5.85";"14";"O=C(/C=C/c1ccccc1)N(c1ccc2c(c1)N(C(=O)C(F)(F)F)CC2)C1CCN(Cc2ccccc2)CC1";"IC50";"'='";"30000.0";"nM";"4.52";"";"";"UO_0000065";"8.48";"0.16";"-1.33";"10.31";"0";"CHEMBL750768";"Binding affinity towards the NPY Y2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147599";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2004";"None";"";"";""
"CHEMBL41981";"";"None";"487.60";"1";"2.42";"12 (S)";"N=C(N)NCCCC(NC(=O)C(c1ccccc1)c1ccccc1)C(=O)N[C@H](CO)c1ccccc1";"IC50";"'='";"540000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL747056";"Inhibition of binding of [3H]propionyl-NPY (1 nM) to Neuropeptide Y receptor type 2 in SMS-KAN cell membranes";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"SMS-KAN";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133238";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2000";"None";"";"";""
"CHEMBL95501";"";"None";"460.67";"1";"6.79";"20";"CN(C)CCCN(C(=O)c1cc2ccccc2s1)c1ccccc1SCc1ccccc1";"IC50";"'='";"450.0";"nM";"6.35";"";"";"UO_0000065";"13.78";"0.27";"-0.44";"26.95";"0";"CHEMBL747054";"Binding affinity against SMS-KAN cell membranes endogenously expressing Neuropeptide Y receptor type 2 using [125I]PYY as radioligand";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"SMS-KAN";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1136181";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2003";"None";"";"";""
"CHEMBL438580";"";"None";"2220.62";"None";"None";"Neuropeptide Y analogue";"CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCN=C(N)N)NC(=O)CCCCCNC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O)[C@@H](C)CC";"IC50";"'='";"180.0";"nM";"6.75";"";"";"UO_0000065";"3.04";"None";"None";"None";"0";"CHEMBL750765";"Compound was evaluated for its inhibitory activity against Y2 receptor of rabbit kidney membrane";"B";"BAO_0000019";"assay format";"Oryctolagus cuniculus";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1126482";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1993";"None";"";"";""
"CHEMBL77770";"";"None";"403.53";"1";"5.43";"44h";"CCN(c1ccccc1)c1ccc(NC(=O)N(C)[C@H](C)[C@@H](O)c2ccccc2)cc1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL749564";"Inhibitory activity tested against Human Neuropeptide Y2 Receptor.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1134441";"1";"Scientific Literature";"J Med Chem";"2001";"None";"";"";""
"CHEMBL21877";"";"None";"504.63";"2";"5.18";"41";"CC(=O)N1CCc2ccc(N(C(=O)/C=C/c3cccc(C#N)c3)C3CCN(Cc4ccccc4)CC3)cc21";"IC50";"'='";"1000.0";"nM";"6.00";"";"";"UO_0000065";"11.89";"0.22";"0.82";"8.87";"0";"CHEMBL750768";"Binding affinity towards the NPY Y2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147599";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2004";"None";"";"";""
"CHEMBL585711";"";"None";"459.62";"0";"4.76";"2n";"Cc1cccc(CNc2cc(N3CCOCC3)cc(CSc3nc(CF)c(C)s3)n2)n1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1042014";"Displacement of [125I]-PYY from human NPYY2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1155324";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"None";"";"";""
"CHEMBL26260";"BETA-NAPHTHOFLAVONE";"None";"272.30";"0";"4.61";"BETA-NAPHTHOFLAVONE";"O=c1cc(-c2ccccc2)oc2ccc3ccccc3c12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1383610";"";"None";"308.34";"0";"2.51";"SID24781445";"Cc1ccc(COC(=O)c2nn(-c3ccccc3)nc2N)cc1";"IC50";"'='";"10590.0";"nM";"4.97";"";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1613986";"PUBCHEM_BIOASSAY: Dose response counterscreen assay for neuropeptide Y receptor Y1 (NPY-Y1): Cell-based high throughput assay to measure NPY-Y2 antagonism. (Class of assay: confirmatory) [Related pubchem assays: 793, 1040, 1255, 1254 ]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1823344";"";"None";"524.60";"2";"5.18";"13";"COC(=O)C(c1ccccc1)N1CCN(c2ccc(NC(=O)c3ccccc3-c3ccncc3)cc2F)CC1";"IC50";"'='";"37.0";"nM";"7.43";"";"";"UO_0000065";"14.17";"0.26";"2.25";"9.94";"0";"CHEMBL1827365";"Displacement of [125I]PYY from human NPY Y2 receptor expressed endogenously in KAN-Ts cells by scintillation counting";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"KAN-Ts";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1821563";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";"";""
"CHEMBL1608982";"";"None";"341.43";"0";"4.16";"SF-41";"Cc1ccc(S(=O)(=O)C(c2ccccc2)c2c(C)noc2C)cc1";"IC50";"'='";"4400.0";"nM";"5.36";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2032840";"Antagonist activity at neuropeptide Y receptor Y2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2029318";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";"";""
"CHEMBL2030182";"";"None";"465.62";"1";"5.04";"43";"CCOc1ccc(NC(=S)N2CCC(C(O)(c3ccccc3)c3c(C)noc3C)CC2)cc1";"IC50";"'='";"3300.0";"nM";"5.48";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2032840";"Antagonist activity at neuropeptide Y receptor Y2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2029318";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";"";""
"CHEMBL2030183";"";"None";"527.69";"1";"4.42";"44";"CN(C)S(=O)(=O)c1ccc(NC(=S)N2CCC(C(O)(c3ccccc3)c3ccc(F)cc3)CC2)cc1";"IC50";"'='";"89.0";"nM";"7.05";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2032840";"Antagonist activity at neuropeptide Y receptor Y2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2029318";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";"";""
"CHEMBL2030153";"";"None";"473.64";"0";"4.73";"14";"CN(C)C(=O)c1ccc(NC(=S)N2CCC(C(O)(c3ccccc3)c3ccccc3)CC2)cc1";"IC50";"'='";"301.0";"nM";"6.52";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2032840";"Antagonist activity at neuropeptide Y receptor Y2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2029318";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";"";""
"CHEMBL1365319";"";"None";"246.31";"0";"2.48";"SID17509493";"CCCCOc1ccc(C2=NNC(=O)CC2)cc1";"IC50";"'='";"4543.0";"nM";"5.34";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614345";"PUBCHEM_BIOASSAY: Dose response cell-based screening assay for antagonists of neuropeptide Y receptor Y2 (NPY-Y2). (Class of assay: confirmatory) [Related pubchem assays: 793, 1257, 1256 ]";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1531118";"";"None";"336.43";"0";"3.40";"SID17503911";"CCCCC(O)(CCCC)C(=O)NN(C(=O)OC)c1ccccc1";"IC50";"'>'";"35000.0";"nM";"";"";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1613986";"PUBCHEM_BIOASSAY: Dose response counterscreen assay for neuropeptide Y receptor Y1 (NPY-Y1): Cell-based high throughput assay to measure NPY-Y2 antagonism. (Class of assay: confirmatory) [Related pubchem assays: 793, 1040, 1255, 1254 ]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1377690";"";"None";"437.78";"1";"6.39";"SID24828806";"Clc1ccc(-c2csc(Nc3ccccc3)[n+]2Cc2ccco2)c(Cl)c1.[Cl-]";"IC50";"'>'";"35000.0";"nM";"";"";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1613986";"PUBCHEM_BIOASSAY: Dose response counterscreen assay for neuropeptide Y receptor Y1 (NPY-Y1): Cell-based high throughput assay to measure NPY-Y2 antagonism. (Class of assay: confirmatory) [Related pubchem assays: 793, 1040, 1255, 1254 ]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1550015";"";"None";"390.46";"0";"3.19";"SID17407200";"Cc1ccc(C)c(SCc2noc(C(=O)NCC3CCCO3)c2C(=O)O)c1";"IC50";"'='";"26360.0";"nM";"4.58";"";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1613986";"PUBCHEM_BIOASSAY: Dose response counterscreen assay for neuropeptide Y receptor Y1 (NPY-Y1): Cell-based high throughput assay to measure NPY-Y2 antagonism. (Class of assay: confirmatory) [Related pubchem assays: 793, 1040, 1255, 1254 ]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL787";"MONTELUKAST";"4.0";"586.20";"2";"8.95";"MONTELUKAST";"CC(C)(O)c1ccccc1CC[C@@H](SCC1(CC(=O)O)CC1)c1cccc(/C=C/c2ccc3ccc(Cl)cc3n2)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL650";"METHYLPREDNISOLONE";"4.0";"374.48";"0";"1.80";"METHYLPREDNISOLONE";"C[C@H]1C[C@@H]2[C@H]([C@@H](O)C[C@@]3(C)[C@H]2CC[C@]3(O)C(=O)CO)[C@@]2(C)C=CC(=O)C=C12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1440";"TETRACYCLINE";"4.0";"444.44";"1";"-0.21";"Tetracycline";"CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3C[C@@H]12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL280998";"CATECHOL";"None";"110.11";"0";"1.10";"CATECHOL";"Oc1ccccc1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL267633";"NEUROPEPTIDE-Y";"None";"4253.71";"None";"None";"NPY";"CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O)[C@@H](C)CC";"IC50";"'='";"0.2";"nM";"9.70";"";"";"UO_0000065";"2.28";"None";"None";"None";"0";"CHEMBL947366";"Displacement of radiolabeled NPY from human neuropeptide Y2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140203";"1";"Scientific Literature";"J Med Chem";"2008";"None";"";"";""
"CHEMBL1511420";"";"None";"442.50";"0";"2.77";"SID22411498";"COc1ccc(NC(=O)c2nnc(O)c3ccccc23)cc1S(=O)(=O)N1CCCCC1";"IC50";"'='";"19550.0";"nM";"4.71";"";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614345";"PUBCHEM_BIOASSAY: Dose response cell-based screening assay for antagonists of neuropeptide Y receptor Y2 (NPY-Y2). (Class of assay: confirmatory) [Related pubchem assays: 793, 1257, 1256 ]";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1570844";"";"None";"441.49";"0";"4.85";"SID14742654";"COc1ccc(-c2[nH]nc3c2C(c2ccc(OC)c(OC)c2)N(c2ccccc2)C3=O)cc1";"IC50";"'='";"4355.0";"nM";"5.36";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614345";"PUBCHEM_BIOASSAY: Dose response cell-based screening assay for antagonists of neuropeptide Y receptor Y2 (NPY-Y2). (Class of assay: confirmatory) [Related pubchem assays: 793, 1257, 1256 ]";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL54126";"NEOSTIGMINE BROMIDE";"4.0";"303.20";"0";"1.94";"NEOSTIGMINE BROMIDE";"CN(C)C(=O)Oc1cccc([N+](C)(C)C)c1.[Br-]";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1341841";"";"None";"457.56";"0";"4.60";"SID14742039";"Cc1ccc(-c2nn3c(C)nnc3c3ccccc23)cc1S(=O)(=O)NC(C)c1ccccc1";"IC50";"'='";"10420.0";"nM";"4.98";"";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614345";"PUBCHEM_BIOASSAY: Dose response cell-based screening assay for antagonists of neuropeptide Y receptor Y2 (NPY-Y2). (Class of assay: confirmatory) [Related pubchem assays: 793, 1257, 1256 ]";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1453672";"";"None";"407.47";"1";"5.82";"SID22405717";"O=C(COC(=O)c1ccc(-c2ccccc2)cc1)Nc1ccccc1-c1ccccc1";"IC50";"'='";"6973.0";"nM";"5.16";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614345";"PUBCHEM_BIOASSAY: Dose response cell-based screening assay for antagonists of neuropeptide Y receptor Y2 (NPY-Y2). (Class of assay: confirmatory) [Related pubchem assays: 793, 1257, 1256 ]";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1545971";"";"None";"383.86";"0";"4.98";"SID847358";"Cc1onc(-c2ccccc2Cl)c1C(=O)Nc1sc2c(c1C#N)CCC2";"IC50";"'='";"5862.0";"nM";"5.23";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614345";"PUBCHEM_BIOASSAY: Dose response cell-based screening assay for antagonists of neuropeptide Y receptor Y2 (NPY-Y2). (Class of assay: confirmatory) [Related pubchem assays: 793, 1257, 1256 ]";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1310577";"";"None";"329.90";"1";"5.05";"SID22411938";"CN(C)Cc1ccccc1Sc1cccc2ccccc12.Cl";"IC50";"'='";"9216.0";"nM";"5.04";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614345";"PUBCHEM_BIOASSAY: Dose response cell-based screening assay for antagonists of neuropeptide Y receptor Y2 (NPY-Y2). (Class of assay: confirmatory) [Related pubchem assays: 793, 1257, 1256 ]";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1909071";"";"None";"None";"None";"None";"NOVARTIS P-38 INHIBITOR";"";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL46";"ONDANSETRON";"4.0";"293.37";"0";"3.13";"ONDANSETRON";"Cc1nccn1CC1CCc2c(c3ccccc3n2C)C1=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL14192";"BENZYLIMIDAZOLE";"None";"158.20";"0";"1.93";"1-BENZYLIMIDAZOLE";"c1ccc(Cn2ccnc2)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL506247";"TANNIC ACID";"4.0";"1701.21";"None";"None";"TANNIC ACID";"O=C(OC[C@H]1O[C@@H](OC(=O)c2cc(O)c(O)c(OC(=O)c3cc(O)c(O)c(O)c3)c2)[C@H](OC(=O)c2cc(O)c(O)c(OC(=O)c3cc(O)c(O)c(O)c3)c2)[C@@H](OC(=O)c2cc(O)c(O)c(OC(=O)c3cc(O)c(O)c(O)c3)c2)[C@@H]1OC(=O)c1cc(O)c(O)c(OC(=O)c2cc(O)c(O)c(O)c2)c1)c1cc(O)c(O)c(OC(=O)c2cc(O)c(O)c(O)c2)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1630578";"TIRILAZAD";"3.0";"624.87";"2";"5.46";"TIRILAZAD";"C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)C3=CC[C@]2(C)[C@H]1C(=O)CN1CCN(c2cc(N3CCCC3)nc(N3CCCC3)n2)CC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL211501";"ANTIMYCIN A";"None";"548.63";"1";"3.48";"ANTIMYCIN A";"CCCCCC[C@H]1C(=O)O[C@H](C)[C@H](NC(=O)c2cccc(NC=O)c2O)C(=O)O[C@@H](C)[C@@H]1OC(=O)CC(C)C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1065";"METHYSERGIDE";"None";"353.47";"0";"1.94";"METHYSERGIDE";"CC[C@@H](CO)NC(=O)[C@@H]1C=C2c3cccc4c3c(cn4C)C[C@H]2N(C)C1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1726";"NISOLDIPINE";"4.0";"388.42";"0";"3.20";"NISOLDIPINE";"COC(=O)C1=C(C)NC(C)=C(C(=O)OCC(C)C)C1c1ccccc1[N+](=O)[O-]";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL154";"NAPROXEN";"4.0";"230.26";"0";"3.04";"NAPROXEN";"COc1ccc2cc([C@H](C)C(=O)O)ccc2c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL2107797";"NORGESTREL";"4.0";"312.45";"0";"3.88";"NORGESTREL";"C#CC1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@@H]4[C@H]3CC[C@@]21CC";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL521750";"";"None";"400.44";"0";"3.48";"2u";"Cn1nnc(-c2ccc3[nH]c([C@H]4CC[C@@]5(CC4)OC(=O)c4ccccc45)nc3c2)n1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL981717";"Inhibition of NPYY2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1144170";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"None";"";"";""
"CHEMBL1278088";"";"None";"432.57";"0";"2.53";"17m";"Nn1c(CCCCN2CCN(c3ccc4ccccc4n3)CC2)nc2c(c1=O)CCCC2";"IC50";"'>'";"1000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1286335";"Displacement of [125I]peptide YY from NPY2 receptor in human KAN-TS cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"KAN-TS";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1275331";"1";"Scientific Literature";"J Med Chem";"2010";"None";"";"";""
"CHEMBL4089420";"";"None";"1642.08";"None";"None";"3";"CCC(NC(=O)[C@H](CCCNC(=N)N)NC(=O)C(C)C)C(=O)NC(CC1CCCCC1)C(=O)NC(CC1CCCCC1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)NC(C)(C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NC(CC1CCCCC1)C(N)=O)[C@@H](C)O";"IC50";"'='";"7.3";"nM";"8.14";"";"";"UO_0000065";"4.96";"None";"None";"None";"0";"CHEMBL4036757";"Displacement of [125I]-PYY from human Y2R expressed in CHO cell membranes after 60 mins by liquid scintillation method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4033754";"1";"Scientific Literature";"ACS Med Chem Lett";"2017";"None";"";"";""
"CHEMBL21283";"";"None";"510.68";"2";"5.56";"JNJ-5207787";"CC(=O)N1CCc2ccc(N(C(=O)/C=C/c3cccc(C#N)c3)C3CCN(CCC4CCCC4)CC3)cc21";"IC50";"'='";"63.1";"nM";"7.20";"";"";"UO_0000065";"";"";"";"";"1";"CHEMBL3107074";"Antagonist activity at NPYY2 receptor (unknown origin) assessed as inhibition of PYY-induced [33S]-GTPgammaS binding";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3102719";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL3104119";"";"None";"464.59";"0";"4.83";"104";"CCN(CC)C(=O)C(c1ccccc1)N1CCN(c2ccc(-c3c(C)noc3C)cc2F)CC1";"IC50";"'='";"10000.0";"nM";"5.00";"";"";"UO_0000065";"10.76";"0.20";"0.17";"9.47";"0";"CHEMBL3107076";"Displacement of [125I]-PYY from human NPYY2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3102719";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL3104197";"";"None";"498.64";"0";"4.64";"80";"CCC(CC)C(=O)Nc1ccc(N2CCN(C(C(=O)N(CC)CC)c3ccc(O)cc3)CC2)c(F)c1";"IC50";"'='";"100.0";"nM";"7.00";"";"";"UO_0000065";"14.04";"0.27";"2.36";"9.20";"0";"CHEMBL3107076";"Displacement of [125I]-PYY from human NPYY2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3102719";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL3104205";"";"None";"522.63";"1";"4.81";"61";"CCN(CC)C(=O)C(c1ccccc1)N1CCN(c2ccc(NC(=O)Nc3c(C)noc3C)cc2F)CC1";"IC50";"'='";"16.0";"nM";"7.80";"";"";"UO_0000065";"14.92";"0.28";"2.99";"8.30";"0";"CHEMBL3107076";"Displacement of [125I]-PYY from human NPYY2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3102719";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL2030180";"";"None";"515.73";"1";"4.34";"41";"CN(C)S(=O)(=O)c1ccc(NC(=S)N2CCC(C(O)(c3ccccc3)c3ccsc3)CC2)cc1";"IC50";"'='";"248.0";"nM";"6.61";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2032840";"Antagonist activity at neuropeptide Y receptor Y2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2029318";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";"";""
"CHEMBL2030193";"";"None";"486.61";"1";"5.32";"60";"CCN(CC)C(=O)c1ccc(OC(=O)N2CCC(C(O)(c3ccccc3)c3ccccc3)CC2)cc1";"IC50";"'='";"220.0";"nM";"6.66";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2032840";"Antagonist activity at neuropeptide Y receptor Y2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2029318";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";"";""
"CHEMBL1379143";"";"None";"422.60";"0";"4.85";"SID17507889";"Cc1cccc(N=C(S)N(CCN(C)C)Cc2cc3cc(C)cc(C)c3nc2O)c1";"IC50";"'='";"14300.0";"nM";"4.84";"";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614345";"PUBCHEM_BIOASSAY: Dose response cell-based screening assay for antagonists of neuropeptide Y receptor Y2 (NPY-Y2). (Class of assay: confirmatory) [Related pubchem assays: 793, 1257, 1256 ]";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1468302";"";"None";"415.35";"1";"5.34";"SID17516282";"Nn1c(Cc2cccc3ccccc23)nnc1SCc1c(Cl)cccc1Cl";"IC50";"'='";"4297.0";"nM";"5.37";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614345";"PUBCHEM_BIOASSAY: Dose response cell-based screening assay for antagonists of neuropeptide Y receptor Y2 (NPY-Y2). (Class of assay: confirmatory) [Related pubchem assays: 793, 1257, 1256 ]";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL77589";"";"None";"374.48";"1";"5.96";"40f";"CCC(Cc1ccccc1)N(C)C(=O)Nc1ccc(Oc2ccccc2)cc1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL749564";"Inhibitory activity tested against Human Neuropeptide Y2 Receptor.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1134441";"1";"Scientific Literature";"J Med Chem";"2001";"None";"";"";""
"CHEMBL1909068";"";"None";"None";"None";"None";"MC 258717";"";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL716";"QUETIAPINE";"4.0";"383.52";"0";"2.86";"QUETIAPINE";"OCCOCCN1CCN(C2=Nc3ccccc3Sc3ccccc32)CC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL99586";"";"None";"442.63";"1";"6.29";"22";"CN(C)CCCN(C(=O)c1cc2ccccc2s1)c1ccccc1CCc1ccccc1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL747054";"Binding affinity against SMS-KAN cell membranes endogenously expressing Neuropeptide Y receptor type 2 using [125I]PYY as radioligand";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"SMS-KAN";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1136181";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2003";"None";"";"";""
"CHEMBL1219";"RABEPRAZOLE";"4.0";"359.45";"0";"2.99";"RABEPRAZOLE";"COCCCOc1ccnc(C[S+]([O-])c2nc3ccccc3[nH]2)c1C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL437";"SULFATHIAZOLE";"4.0";"255.32";"0";"1.53";"SULFATHIAZOLE";"Nc1ccc(S(=O)(=O)Nc2nccs2)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1521";"ZALEPLON";"4.0";"305.34";"0";"2.64";"zaleplon";"CCN(C(C)=O)c1cccc(-c2ccnc3c(C#N)cnn23)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL446";"SULFAMETHAZINE";"4.0";"278.34";"0";"1.48";"SULFAMETHAZINE";"Cc1cc(C)nc(NS(=O)(=O)c2ccc(N)cc2)n1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL242273";"SAFROLE";"-1.0";"162.19";"0";"2.14";"SAFROLE";"C=CCc1ccc2c(c1)OCO2";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL159";"VINBLASTINE";"4.0";"810.99";"2";"3.99";"VINBLASTINE";"CC[C@]1(O)C[C@@H]2CN(CCc3c([nH]c4ccccc34)[C@@](C(=O)OC)(c3cc4c(cc3OC)N(C)[C@H]3[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]5(CC)C=CCN6CC[C@]43[C@@H]65)C2)C1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL412378";"";"None";"1991.34";"None";"None";"9";"CC(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccc(-c2ccccc2)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O)C(C)C";"IC50";"'='";"14.2";"nM";"7.85";"";"";"UO_0000065";"3.94";"None";"None";"None";"0";"CHEMBL755164";"Affinity against Neuropeptide Y receptor Y2 in SK-N-BE2 cell line";"B";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133640";"1";"Scientific Literature";"J Med Chem";"2000";"None";"";"";""
"CHEMBL116";"AMPRENAVIR";"4.0";"505.64";"1";"2.40";"AMPRENAVIR";"CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CCOC1)S(=O)(=O)c1ccc(N)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1536";"ERGOCALCIFEROL";"4.0";"396.66";"1";"7.64";"ERGOCALCIFEROL";"C=C1CC[C@H](O)C/C1=C/C=C1\CCC[C@]2(C)[C@@H]([C@H](C)/C=C/[C@H](C)C(C)C)CC[C@@H]12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL30327";"2,3,7,8-TETRACHLORODIBENZO-P-DIOXIN";"None";"321.97";"1";"6.20";"2,3,7,8-TETRACHLORODIBENZO-P-DIOXIN";"Clc1cc2c(cc1Cl)Oc1cc(Cl)c(Cl)cc1O2";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1398754";"";"None";"491.01";"1";"6.68";"SID17413392";"Cc1ccc(C)c(NS(=O)(=O)c2cc(C(=O)Nc3ccccc3-c3ccccc3)ccc2Cl)c1";"IC50";"'='";"428.0";"nM";"6.37";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614345";"PUBCHEM_BIOASSAY: Dose response cell-based screening assay for antagonists of neuropeptide Y receptor Y2 (NPY-Y2). (Class of assay: confirmatory) [Related pubchem assays: 793, 1257, 1256 ]";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1329549";"";"None";"496.59";"0";"4.59";"SID17511337";"CCOC(=O)CCCCC(=O)c1[nH]c(O)nc1CSc1nnc2c3ccccc3n(C(C)C)c2n1";"IC50";"'='";"2949.0";"nM";"5.53";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614345";"PUBCHEM_BIOASSAY: Dose response cell-based screening assay for antagonists of neuropeptide Y receptor Y2 (NPY-Y2). (Class of assay: confirmatory) [Related pubchem assays: 793, 1257, 1256 ]";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1527817";"";"None";"391.29";"0";"3.82";"SID864669";"Clc1ccc(C2=Nn3c(nnc3-c3[nH]nc4c3CCC4)SC2)cc1Cl";"IC50";"'='";"8691.0";"nM";"5.06";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614345";"PUBCHEM_BIOASSAY: Dose response cell-based screening assay for antagonists of neuropeptide Y receptor Y2 (NPY-Y2). (Class of assay: confirmatory) [Related pubchem assays: 793, 1257, 1256 ]";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1560529";"";"None";"520.63";"1";"5.26";"SID22415380";"COc1ccccc1OCCCCN1CCN(C(c2ccccc2)c2ccccc2)CC1.O=C(O)C(=O)O";"IC50";"'>'";"35000.0";"nM";"";"";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614345";"PUBCHEM_BIOASSAY: Dose response cell-based screening assay for antagonists of neuropeptide Y receptor Y2 (NPY-Y2). (Class of assay: confirmatory) [Related pubchem assays: 793, 1257, 1256 ]";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL932";"DIPYRIDAMOLE";"4.0";"504.64";"2";"-0.02";"DIPYRIDAMOLE";"OCCN(CCO)c1nc(N2CCCCC2)c2nc(N(CCO)CCO)nc(N3CCCCC3)c2n1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL311469";"2-ACETYLAMINOFLUORENE";"None";"223.27";"0";"3.22";"2-ACETYLAMINOFLUORENE";"CC(=O)Nc1ccc2c(c1)Cc1ccccc1-2";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL30008";"FLUNARIZINE";"4.0";"404.50";"1";"5.39";"FLUNARIZINE";"Fc1ccc(C(c2ccc(F)cc2)N2CCN(C/C=C/c3ccccc3)CC2)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1020";"TOLMETIN";"4.0";"257.29";"0";"2.19";"TOLMETIN";"Cc1ccc(C(=O)c2ccc(CC(=O)O)n2C)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL407030";"";"None";"1281.13";"None";"None";"GAMMA-CYCLODEXTRIN";"OC[C@H]1OC2C3[C@@H](CO)OC(O[C@H]4[C@H](O)[C@@H](O)[C@@H](O[C@H]5[C@H](O)[C@@H](O)[C@@H](O[C@H]6[C@H](O)[C@@H](O)[C@@H](O[C@H]7[C@H](O)[C@@H](O)[C@@H](O[C@H]8[C@H](O)[C@@H](O)[C@@H](O[C@H]9[C@H](O)[C@@H](O)C(OC1[C@H](O)[C@H]2O)O[C@@H]9CO)O[C@@H]8CO)O[C@@H]7CO)O[C@@H]6CO)O[C@@H]5CO)O[C@@H]4CO)[C@H](O)[C@H]3O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL115";"INDINAVIR";"4.0";"613.80";"1";"2.87";"INDINAVIR";"CC(C)(C)NC(=O)[C@@H]1CN(Cc2cccnc2)CCN1C[C@@H](O)C[C@@H](Cc1ccccc1)C(=O)N[C@H]1c2ccccc2C[C@H]1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1261";"CITRIC ACID";"4.0";"192.12";"0";"-1.25";"CITRIC ACID";"O=C(O)CC(O)(CC(=O)O)C(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL2030150";"";"None";"474.63";"1";"5.21";"11";"CCOC(=O)c1ccc(NC(=S)N2CCC(C(O)(c3ccccc3)c3ccccc3)CC2)cc1";"IC50";"'='";"207.0";"nM";"6.68";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2032840";"Antagonist activity at neuropeptide Y receptor Y2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2029318";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";"";""
"CHEMBL2030154";"";"None";"501.70";"2";"5.51";"15";"CCN(CC)C(=O)c1ccc(NC(=S)N2CCC(C(O)(c3ccccc3)c3ccccc3)CC2)cc1";"IC50";"'='";"78.0";"nM";"7.11";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2032840";"Antagonist activity at neuropeptide Y receptor Y2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2029318";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";"";""
"CHEMBL2030159";"";"None";"432.59";"1";"5.04";"20";"COc1cccc(NC(=S)N2CCC(C(O)(c3ccccc3)c3ccccc3)CC2)c1";"IC50";"'='";"8162.0";"nM";"5.09";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2032842";"Partial antagonist activity at neuropeptide Y receptor Y2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2029318";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";"";""
"CHEMBL2030146";"";"None";"470.56";"1";"6.05";"6";"OC(c1ccccc1)(c1ccccc1)C1CCN(C(=S)Nc2ccc(C(F)(F)F)cc2)CC1";"IC50";"'='";"178.0";"nM";"6.75";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2032840";"Antagonist activity at neuropeptide Y receptor Y2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2029318";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";"";""
"CHEMBL2307889";"";"None";"896.07";"3";"3.49";"BIIE0246";"N=C(N)NCCC[C@@H](NC(=O)CC1(CC(=O)N2CCN(C3c4ccccc4NC(=O)c4ccccc43)CC2)CCCC1)C(=O)NCCn1c(=O)n(-c2ccccc2)n(-c2ccccc2)c1=O";"IC50";"'='";"3.3";"nM";"8.48";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1051546";"Antagonist activity at human neuropeptide Y2 receptor";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1152417";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"None";"";"";""
"CHEMBL21283";"";"None";"510.68";"2";"5.56";"2";"CC(=O)N1CCc2ccc(N(C(=O)/C=C/c3cccc(C#N)c3)C3CCN(CCC4CCCC4)CC3)cc21";"IC50";"'='";"63.1";"nM";"7.20";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1063993";"Antagonist activity at human neuropeptide Y2 receptor by [35]GTPgammaS assay";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1152417";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"None";"";"";""
"CHEMBL1836103";"";"None";"529.75";"2";"5.72";"11";"COc1ccc(C)cc1S(=O)(=O)NC[C@H]1CC[C@H](Nc2nc3c(s2)CCSc2ccccc2-3)CC1";"IC50";"'>'";"1000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1837822";"Antagonist activity at human NPY2 receptor assessed as calcium mobilization by FLIPR assay";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1833793";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";"";""
"CHEMBL2392022";"";"None";"2798.17";"None";"None";"porcine";"CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O";"IC50";"'='";"0.21";"nM";"9.68";"";"";"UO_0000065";"3.46";"None";"None";"None";"0";"CHEMBL2395092";"Displacement of [125I]Peptide YY from neuropeptide Y receptor type 2 in human KAN-TS cells after 2 hrs";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"KAN-TS";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2390918";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"None";"";"";""
"CHEMBL1404069";"";"None";"415.45";"0";"4.60";"SID4242079";"COc1cccc(-c2nc(-c3ccc(NC(=O)Cc4ccccc4OC)cc3)no2)c1";"IC50";"'='";"733.0";"nM";"6.13";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614345";"PUBCHEM_BIOASSAY: Dose response cell-based screening assay for antagonists of neuropeptide Y receptor Y2 (NPY-Y2). (Class of assay: confirmatory) [Related pubchem assays: 793, 1257, 1256 ]";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1426022";"";"None";"357.93";"0";"4.34";"SID17507949";"Cl.OC1(c2ccccc2)CCN(Cc2ccccc2)C2CCCCC21";"IC50";"'='";"4383.0";"nM";"5.36";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614345";"PUBCHEM_BIOASSAY: Dose response cell-based screening assay for antagonists of neuropeptide Y receptor Y2 (NPY-Y2). (Class of assay: confirmatory) [Related pubchem assays: 793, 1257, 1256 ]";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1426896";"";"None";"426.47";"0";"4.39";"SID22405491";"C/C=C(/C)C(=O)O[C@@H]1c2c(ccc3ccc(=O)oc23)O[C@@H]1C(C)(C)OC(=O)/C(C)=C\C";"IC50";"'='";"5058.0";"nM";"5.30";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614345";"PUBCHEM_BIOASSAY: Dose response cell-based screening assay for antagonists of neuropeptide Y receptor Y2 (NPY-Y2). (Class of assay: confirmatory) [Related pubchem assays: 793, 1257, 1256 ]";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1483730";"";"None";"452.35";"1";"5.05";"SID22404402";"Cc1ccc(OCCCCN(C)Cc2ccccc2)c(Br)c1.O=C(O)C(=O)O";"IC50";"'='";"12040.0";"nM";"4.92";"";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614345";"PUBCHEM_BIOASSAY: Dose response cell-based screening assay for antagonists of neuropeptide Y receptor Y2 (NPY-Y2). (Class of assay: confirmatory) [Related pubchem assays: 793, 1257, 1256 ]";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1348426";"";"None";"399.96";"0";"3.62";"SID863911";"CC(C)COc1ccc(C(=O)OC2CC(C)(C)OCC2CN(C)C)cc1.Cl";"IC50";"'='";"8009.0";"nM";"5.10";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614345";"PUBCHEM_BIOASSAY: Dose response cell-based screening assay for antagonists of neuropeptide Y receptor Y2 (NPY-Y2). (Class of assay: confirmatory) [Related pubchem assays: 793, 1257, 1256 ]";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1427860";"";"None";"470.59";"1";"6.33";"SF-21";"Cc1ccc(C)c(NS(=O)(=O)c2cc(C(=O)Nc3ccccc3-c3ccccc3)ccc2C)c1";"IC50";"'='";"440.0";"nM";"6.36";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2032840";"Antagonist activity at neuropeptide Y receptor Y2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2029318";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";"";""
"CHEMBL2029356";"";"None";"471.67";"1";"5.63";"9";"OC(c1ccccc1)(c1ccccc1)C1CCN(C(=S)Nc2ccc(N3CCCC3)cc2)CC1";"IC50";"'='";"1200.0";"nM";"5.92";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2032840";"Antagonist activity at neuropeptide Y receptor Y2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2029318";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";"";""
"CHEMBL214707";"";"None";"1990.31";"None";"None";"38";"CC(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)CN[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O)C(C)C";"IC50";"'='";"1.39";"nM";"8.86";"";"";"UO_0000065";"4.45";"None";"None";"None";"0";"CHEMBL755164";"Affinity against Neuropeptide Y receptor Y2 in SK-N-BE2 cell line";"B";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133640";"1";"Scientific Literature";"J Med Chem";"2000";"None";"";"";""
"CHEMBL1201049";"ECONAZOLE NITRATE";"4.0";"444.70";"1";"5.80";"SID855519";"Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)cc1.O=[N+]([O-])O";"IC50";"'='";"8024.0";"nM";"5.10";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614345";"PUBCHEM_BIOASSAY: Dose response cell-based screening assay for antagonists of neuropeptide Y receptor Y2 (NPY-Y2). (Class of assay: confirmatory) [Related pubchem assays: 793, 1257, 1256 ]";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL573";"NIACIN";"4.0";"123.11";"0";"0.78";"NIACIN";"O=C(O)c1cccnc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1162";"NORETHINDRONE";"4.0";"298.43";"0";"3.49";"NORETHINDRONE";"C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@@H]4[C@H]3CC[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL219916";"DOMPERIDONE";"4.0";"425.92";"0";"3.35";"DOMPERIDONE";"O=c1[nH]c2ccccc2n1CCCN1CCC(n2c(=O)[nH]c3cc(Cl)ccc32)CC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL513";"CARMUSTINE";"4.0";"214.05";"0";"1.16";"CARMUSTINE";"O=NN(CCCl)C(=O)NCCCl";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL458019";"PARAQUAT DICHLORIDE";"None";"257.16";"0";"1.00";"PARAQUAT DICHLORIDE";"C[n+]1ccc(-c2cc[n+](C)cc2)cc1.[Cl-].[Cl-]";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1628227";"DOXEPIN";"4.0";"279.38";"0";"3.96";"DOXEPIN";"CN(C)CCC=C1c2ccccc2COc2ccccc21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL3183075";"NIZATIDINE";"4.0";"331.47";"0";"1.32";"NIZATIDINE";"CNC(=C[N+](=O)[O-])NCCSCc1csc(CN(C)C)n1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1540";"PENCICLOVIR";"4.0";"253.26";"0";"-0.90";"PENCICLOVIR";"Nc1nc(O)c2ncn(CCC(CO)CO)c2n1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1771";"CLOPIDOGREL";"4.0";"321.83";"0";"3.67";"CLOPIDOGREL";"COC(=O)[C@H](c1ccccc1Cl)N1CCc2sccc2C1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL49080";"CLENBUTEROL";"4.0";"277.19";"0";"3.00";"CLENBUTEROL";"CC(C)(C)NCC(O)c1cc(Cl)c(N)c(Cl)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1054";"TRICHLORMETHIAZIDE";"4.0";"380.66";"0";"0.82";"TRICHLORMETHIAZIDE";"NS(=O)(=O)c1cc2c(cc1Cl)NC(C(Cl)Cl)NS2(=O)=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1200604";"TROPICAMIDE";"4.0";"284.36";"0";"2.21";"tropicamide";"CCN(Cc1ccncc1)C(=O)C(CO)c1ccccc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL61";"PODOFILOX";"4.0";"414.41";"0";"2.41";"PODOPHYLLOTOXIN";"COc1cc([C@@H]2c3cc4c(cc3[C@H](O)[C@H]3COC(=O)[C@H]23)OCO4)cc(OC)c1OC";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL4097195";"";"None";"1841.24";"None";"None";"19";"CC(=O)N[C@@H](CO)C(=O)N1CCC[C@@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC1CCCCC1)C(=O)N[C@@H](CC1CCCCC1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)NC(C)(C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC1CCCCC1)C(N)=O)[C@@H](C)O";"IC50";"'='";"1.1";"nM";"8.96";"";"";"UO_0000065";"4.87";"None";"None";"None";"0";"CHEMBL4056968";"Displacement of [125I]peptide YY from human Y2 receptor expressed in CHO cell membranes after 60 mins by TopCount scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4052740";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";""
"CHEMBL4065752";"";"None";"1845.19";"None";"None";"17";"CC(=O)N[C@@H](CO)C(=O)N1CCC[C@@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccncc1)C(=O)N[C@@H](CC1CCCCC1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)NC(C)(C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC1CCCCC1)C(N)=O)[C@@H](C)O";"IC50";"'='";"6.0";"nM";"8.22";"";"";"UO_0000065";"4.46";"None";"None";"None";"0";"CHEMBL4056968";"Displacement of [125I]peptide YY from human Y2 receptor expressed in CHO cell membranes after 60 mins by TopCount scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4052740";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";""
"CHEMBL4076091";"";"None";"1814.26";"None";"None";"5";"CCC(NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(C)=O)C(=O)NC(CC1CCCCC1)C(=O)NC(CC1CCCCC1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)NC(C)(C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NC(CC1CCCCC1)C(N)=O)[C@@H](C)O";"IC50";"'='";"8.8";"nM";"8.06";"";"";"UO_0000065";"4.44";"None";"None";"None";"0";"CHEMBL4036757";"Displacement of [125I]-PYY from human Y2R expressed in CHO cell membranes after 60 mins by liquid scintillation method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4033754";"1";"Scientific Literature";"ACS Med Chem Lett";"2017";"None";"";"";""
"CHEMBL160";"CYCLOSPORINE";"4.0";"1202.63";"None";"None";"CYCLOSPORIN A";"C/C=C/C[C@@H](C)[C@@H](O)[C@H]1C(=O)N[C@@H](CC)C(=O)N(C)CC(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@H](C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](C(C)C)C(=O)N1C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1554";"DACTINOMYCIN";"4.0";"1255.44";"None";"None";"DACTINOMYCIN";"Cc1c2oc3c(C)ccc(C(=O)N[C@@H]4C(=O)N[C@H](C(C)C)C(=O)N5CCC[C@H]5C(=O)N(C)CC(=O)N(C)[C@@H](C(C)C)C(=O)O[C@@H]4C)c3nc-2c(C(=O)N[C@@H]2C(=O)N[C@H](C(C)C)C(=O)N3CCC[C@H]3C(=O)N(C)CC(=O)N(C)[C@@H](C(C)C)C(=O)O[C@@H]2C)c(N)c1=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1200406";"DIMENHYDRINATE";"4.0";"469.97";"None";"None";"DIMENHYDRINATE";"CN(C)CCOC(c1ccccc1)c1ccccc1.Cn1c(=O)c2[nH]c(Cl)nc2n(C)c1=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL70927";"DEFERIPRONE";"4.0";"139.15";"0";"0.40";"DEFERIPRONE";"Cc1c(O)c(=O)ccn1C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL77776";"";"None";"404.51";"1";"5.68";"44b";"Cc1ccc(Oc2ccc(NC(=O)N(C)[C@H](C)[C@@H](O)c3ccccc3)cc2)cc1C";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL749564";"Inhibitory activity tested against Human Neuropeptide Y2 Receptor.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1134441";"1";"Scientific Literature";"J Med Chem";"2001";"None";"";"";""
"CHEMBL4211310";"";"None";"1833.18";"None";"None";"30";"CC[C@](C)(NC(=O)[C@H](CC1CCCCC1)NC(=O)[C@H](Cc1ccncc1)NC(=O)[C@](C)(CC)NC(=O)[C@H]1C[C@H](O)CN1C(=O)[C@H](CO)NC(=O)c1c[nH]cn1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)NC(C)(C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC1CCCCC1)C(N)=O)[C@@H](C)O";"IC50";"'='";"0.44";"nM";"9.36";"";"";"UO_0000065";"5.10";"None";"None";"None";"0";"CHEMBL4179032";"Displacement of [125I]-PYY from human neuropeptide Y2 receptor expressed in CHO cell membranes incubated for 60 mins by TopCount based method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4177573";"1";"Scientific Literature";"Bioorg Med Chem";"2017";"None";"";"";""
"CHEMBL441516";"";"None";"548.51";"2";"6.61";"45";"CC(=O)N1CCc2ccc(N(C(=O)/C=C/c3cc(Cl)cc(Cl)c3)C3CCN(Cc4ccccc4)CC3)cc21";"IC50";"'='";"30000.0";"nM";"4.52";"";"";"UO_0000065";"8.25";"0.16";"-2.09";"10.31";"0";"CHEMBL750768";"Binding affinity towards the NPY Y2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147599";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2004";"None";"";"";""
"CHEMBL453";"SULFISOXAZOLE";"4.0";"267.31";"0";"1.67";"SULFISOXAZOLE";"Cc1noc(NS(=O)(=O)c2ccc(N)cc2)c1C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL469";"KETOROLAC";"4.0";"255.27";"0";"2.29";"KETOROLAC";"O=C(c1ccccc1)c1ccc2n1CCC2C(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL157101";"KETOCONAZOLE";"4.0";"531.44";"1";"4.21";"KETOCONAZOLE";"CC(=O)N1CCN(c2ccc(OCC3COC(Cn4ccnc4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL269267";"";"None";"1931.24";"None";"None";"4";"CC(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O)C(C)C";"IC50";"'='";"1.3";"nM";"8.89";"";"";"UO_0000065";"4.60";"None";"None";"None";"0";"CHEMBL755164";"Affinity against Neuropeptide Y receptor Y2 in SK-N-BE2 cell line";"B";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133640";"1";"Scientific Literature";"J Med Chem";"2000";"None";"";"";""
"CHEMBL862";"GUANFACINE";"4.0";"246.10";"0";"1.55";"GUANFACINE";"N=C(N)NC(=O)Cc1c(Cl)cccc1Cl";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL4076934";"";"None";"1834.17";"None";"None";"16";"CC(=O)N[C@@H](CO)C(=O)N1CCC[C@@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](CC1CCCCC1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)NC(C)(C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC1CCCCC1)C(N)=O)[C@@H](C)O";"IC50";"'='";"11.0";"nM";"7.96";"";"";"UO_0000065";"4.34";"None";"None";"None";"0";"CHEMBL4056968";"Displacement of [125I]peptide YY from human Y2 receptor expressed in CHO cell membranes after 60 mins by TopCount scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4052740";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";""
"CHEMBL438096";"";"None";"2004.29";"None";"None";"15";"CC(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O)C(C)C";"IC50";"'='";"";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL755164";"Affinity against Neuropeptide Y receptor Y2 in SK-N-BE2 cell line";"B";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133640";"1";"Scientific Literature";"J Med Chem";"2000";"None";"";"";""
"CHEMBL4065791";"";"None";"1825.16";"None";"None";"18";"CC(=O)N[C@@H](CO)C(=O)N1CCC[C@@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC1CCCCC1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)NC(C)(C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC1CCCCC1)C(N)=O)[C@@H](C)O";"IC50";"'='";"8.7";"nM";"8.06";"";"";"UO_0000065";"4.42";"None";"None";"None";"0";"CHEMBL4056968";"Displacement of [125I]peptide YY from human Y2 receptor expressed in CHO cell membranes after 60 mins by TopCount scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4052740";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";""
"CHEMBL4069205";"";"None";"1893.28";"None";"None";"9";"CC(=O)N[C@@H](CO)C(=O)N1CCC[C@@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](CC1CCCCC1)C(=O)N[C@@H](CC1CCCCC1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NC(C)(C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC1CCCCC1)C(N)=O)[C@@H](C)O";"IC50";"'='";"0.6";"nM";"9.22";"";"";"UO_0000065";"4.87";"None";"None";"None";"0";"CHEMBL4056968";"Displacement of [125I]peptide YY from human Y2 receptor expressed in CHO cell membranes after 60 mins by TopCount scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4052740";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";""
"CHEMBL413232";"";"None";"1917.26";"None";"None";"29";"CC(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](CN[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O)C(C)C)Cc1ccc(O)cc1";"IC50";"'='";"864.0";"nM";"6.06";"";"";"UO_0000065";"3.16";"None";"None";"None";"0";"CHEMBL755164";"Affinity against Neuropeptide Y receptor Y2 in SK-N-BE2 cell line";"B";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133640";"1";"Scientific Literature";"J Med Chem";"2000";"None";"";"";""
"CHEMBL384306";"";"None";"1940.29";"None";"None";"39";"CC(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)CN[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O)C(C)C";"IC50";"'='";"1.05";"nM";"8.98";"";"";"UO_0000065";"4.63";"None";"None";"None";"0";"CHEMBL755164";"Affinity against Neuropeptide Y receptor Y2 in SK-N-BE2 cell line";"B";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133640";"1";"Scientific Literature";"J Med Chem";"2000";"None";"";"";""
"CHEMBL3195229";"";"None";"399.24";"0";"4.39";"SID17510799";"O=C(N/N=C/c1ccco1)c1ccccc1OCc1ccc(Br)cc1";"IC50";"'='";"9080.0";"nM";"5.04";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614345";"PUBCHEM_BIOASSAY: Dose response cell-based screening assay for antagonists of neuropeptide Y receptor Y2 (NPY-Y2). (Class of assay: confirmatory) [Related pubchem assays: 793, 1257, 1256 ]";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1973629";"";"None";"355.46";"0";"3.60";"SID14732975";"CCCCCCCCCS(=O)(=O)N/N=C/c1cccc([N+](=O)[O-])c1";"IC50";"'>'";"35000.0";"nM";"";"";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614345";"PUBCHEM_BIOASSAY: Dose response cell-based screening assay for antagonists of neuropeptide Y receptor Y2 (NPY-Y2). (Class of assay: confirmatory) [Related pubchem assays: 793, 1257, 1256 ]";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL564979";"";"None";"395.31";"1";"5.51";"SID17513473";"Cc1ccc(CCC(=O)Nc2ncc(Cc3cc(Cl)ccc3Cl)s2)o1";"IC50";"'='";"9880.0";"nM";"5.00";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614345";"PUBCHEM_BIOASSAY: Dose response cell-based screening assay for antagonists of neuropeptide Y receptor Y2 (NPY-Y2). (Class of assay: confirmatory) [Related pubchem assays: 793, 1257, 1256 ]";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1563162";"";"None";"481.57";"0";"4.13";"SID848177";"O=C(CN(Cc1ccc2c(c1)OCO2)C(=O)CSc1nc2ccccc2o1)NC1CCCCC1";"IC50";"'='";"13710.0";"nM";"4.86";"";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614345";"PUBCHEM_BIOASSAY: Dose response cell-based screening assay for antagonists of neuropeptide Y receptor Y2 (NPY-Y2). (Class of assay: confirmatory) [Related pubchem assays: 793, 1257, 1256 ]";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL262083";"N6-PHENYLADENOSINE";"None";"343.34";"0";"0.18";"SID855897";"OC[C@H]1O[C@@H](n2cnc3c(Nc4ccccc4)ncnc32)[C@H](O)[C@@H]1O";"IC50";"'='";"4729.0";"nM";"5.33";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614345";"PUBCHEM_BIOASSAY: Dose response cell-based screening assay for antagonists of neuropeptide Y receptor Y2 (NPY-Y2). (Class of assay: confirmatory) [Related pubchem assays: 793, 1257, 1256 ]";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1311646";"";"None";"394.52";"0";"4.49";"SID17412952";"CC(/C=C1\SC(=S)N(NC(=O)c2ccc(C)cc2)C1=O)=C\c1ccccc1";"IC50";"'='";"20550.0";"nM";"4.69";"";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614345";"PUBCHEM_BIOASSAY: Dose response cell-based screening assay for antagonists of neuropeptide Y receptor Y2 (NPY-Y2). (Class of assay: confirmatory) [Related pubchem assays: 793, 1257, 1256 ]";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1201220";"DIATRIZOIC ACID";"4.0";"613.91";"1";"3.12";"DIATRIZOIC ACID";"CC(=O)Nc1c(I)c(NC(C)=O)c(I)c(C(=O)O)c1I";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1902627";"CLORPRENALINE";"-1.0";"213.71";"0";"2.37";"CLORPRENALINE";"CC(C)NCC(O)c1ccccc1Cl";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL44618";"CHLOROFORM";"4.0";"119.38";"0";"1.99";"CHLOROFORM";"ClC(Cl)Cl";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL4092494";"";"None";"1838.24";"None";"None";"15";"CC(=O)N[C@@H](CO)C(=O)NC(C)(C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)NC(CC1CCCCC1)C(=O)NC(CC1CCCCC1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)NC(C)(C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NC(CC1CCCCC1)C(N)=O)[C@@H](C)O";"IC50";"'='";"2.0";"nM";"8.70";"";"";"UO_0000065";"4.73";"None";"None";"None";"0";"CHEMBL4036757";"Displacement of [125I]-PYY from human Y2R expressed in CHO cell membranes after 60 mins by liquid scintillation method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4033754";"1";"Scientific Literature";"ACS Med Chem Lett";"2017";"None";"";"";""
"CHEMBL405527";"";"None";"1991.34";"None";"None";"34";"CC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O)C(C)C";"IC50";"'='";"5.61";"nM";"8.25";"";"";"UO_0000065";"4.14";"None";"None";"None";"0";"CHEMBL755164";"Affinity against Neuropeptide Y receptor Y2 in SK-N-BE2 cell line";"B";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133640";"1";"Scientific Literature";"J Med Chem";"2000";"None";"";"";""
"CHEMBL3104125";"";"None";"479.60";"1";"5.06";"111";"CCc1noc(C(c2ccccc2)N2CCN(c3ccc(NC(=O)C(CC)CC)cc3F)CC2)n1";"IC50";"'='";"27.0";"nM";"7.57";"";"";"UO_0000065";"15.78";"0.30";"2.51";"10.16";"0";"CHEMBL3107076";"Displacement of [125I]-PYY from human NPYY2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3102719";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL4090700";"";"None";"1850.25";"None";"None";"17";"CC(=O)N[C@@H](CO)C(=O)N1CCC[C@@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)NC(CC1CCCCC1)C(=O)NC(CC1CCCCC1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)NC(C)(C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NC(CC1CCCCC1)C(N)=O)[C@@H](C)O";"IC50";"'='";"1.5";"nM";"8.82";"";"";"UO_0000065";"4.77";"None";"None";"None";"0";"CHEMBL4036757";"Displacement of [125I]-PYY from human Y2R expressed in CHO cell membranes after 60 mins by liquid scintillation method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4033754";"1";"Scientific Literature";"ACS Med Chem Lett";"2017";"None";"";"";""
"CHEMBL515914";"AZARIBINE";"4.0";"371.30";"1";"-1.74";"AZARIBINE";"CC(=O)OC[C@H]1O[C@@H](n2ncc(=O)[nH]c2=O)[C@H](OC(C)=O)[C@@H]1OC(C)=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL40583";"3-METHYLCHOLANTHRENE";"None";"268.36";"1";"5.55";"3-METHYLCHOLANTHRENE";"Cc1ccc2cc3c(ccc4ccccc43)c3c2c1CC3";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL19019";"NALTREXONE";"4.0";"341.41";"0";"1.53";"NALTREXONE";"O=C1CC[C@@]2(O)[C@H]3Cc4ccc(O)c5c4[C@@]2(CCN3CC2CC2)[C@H]1O5";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL691";"ETHINYL ESTRADIOL";"4.0";"296.41";"0";"3.61";"ETHINYLESTRADIOL";"C#C[C@]1(O)CC[C@H]2[C@@H]3CCc4cc(O)ccc4[C@H]3CC[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL104";"CLOTRIMAZOLE";"4.0";"344.85";"1";"5.38";"CLOTRIMAZOLE";"Clc1ccccc1C(c1ccccc1)(c1ccccc1)n1ccnc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL451";"CHLORDIAZEPOXIDE";"4.0";"299.76";"0";"2.95";"CHLORDIAZEPOXIDE";"CNC1=Nc2ccc(Cl)cc2C(c2ccccc2)=[N+]([O-])C1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1191";"SULFAMETHIZOLE";"4.0";"270.34";"0";"1.23";"SULFAMETHIZOLE";"Cc1nnc(NS(=O)(=O)c2ccc(N)cc2)s1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1747";"TOBRAMYCIN";"4.0";"467.52";"2";"-6.30";"TOBRAMYCIN";"NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1697694";"AFLATOXIN";"None";"312.28";"0";"2.28";"AFLATOXIN B1";"COc1cc2c(c3oc(=O)c4c(c13)CCC4=O)[C@@H]1C=CO[C@@H]1O2";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL553025";"VINORELBINE";"4.0";"778.95";"2";"4.75";"VINORELBINE";"CCC1=C[C@@H]2CN(C1)Cc1c([nH]c3ccccc13)[C@@](C(=O)OC)(c1cc3c(cc1OC)N(C)[C@H]1[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]4(CC)C=CCN5CC[C@]31[C@@H]54)C2";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL217692";"";"None";"1917.26";"None";"None";"26";"CC(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CN[C@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O)C(C)C";"IC50";"'='";"105.0";"nM";"6.98";"";"";"UO_0000065";"3.64";"None";"None";"None";"0";"CHEMBL755164";"Affinity against Neuropeptide Y receptor Y2 in SK-N-BE2 cell line";"B";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133640";"1";"Scientific Literature";"J Med Chem";"2000";"None";"";"";""
"CHEMBL86304";"MOCLOBEMIDE";"4.0";"268.74";"0";"1.40";"MOCLOBEMIDE";"O=C(NCCN1CCOCC1)c1ccc(Cl)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1009";"LEVODOPA";"4.0";"197.19";"0";"0.05";"LEVODOPA";"N[C@@H](Cc1ccc(O)c(O)c1)C(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1428";"NIMODIPINE";"4.0";"418.45";"0";"2.97";"NIMODIPINE";"COCCOC(=O)C1=C(C)NC(C)=C(C(=O)OC(C)C)C1c1cccc([N+](=O)[O-])c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL57";"NEVIRAPINE";"4.0";"266.30";"0";"2.65";"Nevirapine";"Cc1ccnc2c1NC(=O)c1cccnc1N2C1CC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL471";"SOTALOL";"4.0";"272.37";"0";"1.09";"SOTALOL";"CC(C)NCC(O)c1ccc(NS(C)(=O)=O)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL611";"TERAZOSIN";"4.0";"387.44";"0";"1.06";"TERAZOSIN";"COc1cc2nc(N3CCN(C(=O)C4CCCO4)CC3)nc(N)c2cc1OC";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL165";"RESVERATROL";"3.0";"228.25";"0";"2.97";"RESVERATROL";"Oc1ccc(/C=C/c2cc(O)cc(O)c2)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL2402907";"";"None";"541.69";"2";"6.94";"8c";"CCNC(=O)C(c1ccccc1)C1CCN(c2ccc(NC(=O)c3ccccc3-c3ccsc3)cc2F)CC1";"IC50";"'='";"70.0";"nM";"7.16";"";"";"UO_0000065";"13.21";"0.25";"0.21";"11.65";"0";"CHEMBL2404394";"Displacement of [125I]PYY from NPY-Y2 receptor in human KAN-TS cell membranes after 1 hr by scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"KAN-TS";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2401643";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"None";"";"";""
"CHEMBL1421312";"";"None";"353.43";"0";"3.21";"SID24798532";"COc1ccc(-c2noc(CN3CCCCC3c3nccn3C)n2)cc1";"IC50";"'>'";"35000.0";"nM";"";"";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1613986";"PUBCHEM_BIOASSAY: Dose response counterscreen assay for neuropeptide Y receptor Y1 (NPY-Y1): Cell-based high throughput assay to measure NPY-Y2 antagonism. (Class of assay: confirmatory) [Related pubchem assays: 793, 1040, 1255, 1254 ]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL412257";"";"None";"1990.31";"None";"None";"42";"CCCC[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(C)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCC)C(=O)N[C@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)CN[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O";"IC50";"'='";"1.75";"nM";"8.76";"";"";"UO_0000065";"4.40";"None";"None";"None";"0";"CHEMBL755164";"Affinity against Neuropeptide Y receptor Y2 in SK-N-BE2 cell line";"B";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133640";"1";"Scientific Literature";"J Med Chem";"2000";"None";"";"";""
"CHEMBL441007";"";"None";"3840.43";"None";"None";"43";"CC(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CSSC[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(C)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O)C(C)C";"IC50";"'='";"0.39";"nM";"9.41";"";"";"UO_0000065";"2.45";"None";"None";"None";"0";"CHEMBL755164";"Affinity against Neuropeptide Y receptor Y2 in SK-N-BE2 cell line";"B";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133640";"1";"Scientific Literature";"J Med Chem";"2000";"None";"";"";""
"CHEMBL438935";"";"None";"2003.35";"None";"None";"17";"CC(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O)C(C)C";"IC50";"'='";"158.0";"nM";"6.80";"";"";"UO_0000065";"3.39";"None";"None";"None";"0";"CHEMBL755164";"Affinity against Neuropeptide Y receptor Y2 in SK-N-BE2 cell line";"B";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133640";"1";"Scientific Literature";"J Med Chem";"2000";"None";"";"";""
"CHEMBL3213775";"";"None";"334.38";"0";"2.07";"SID22401930";"CCCCC(=O)N/N=C/c1ccc(N2CCOCC2)c([N+](=O)[O-])c1";"IC50";"'='";"16290.0";"nM";"4.79";"";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614345";"PUBCHEM_BIOASSAY: Dose response cell-based screening assay for antagonists of neuropeptide Y receptor Y2 (NPY-Y2). (Class of assay: confirmatory) [Related pubchem assays: 793, 1257, 1256 ]";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1493500";"";"None";"444.56";"1";"5.88";"SID22403379";"CCc1cccc(CC)c1NC(=O)COC(=O)c1ccccc1-c1nc2ccccc2s1";"IC50";"'='";"17330.0";"nM";"4.76";"";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614345";"PUBCHEM_BIOASSAY: Dose response cell-based screening assay for antagonists of neuropeptide Y receptor Y2 (NPY-Y2). (Class of assay: confirmatory) [Related pubchem assays: 793, 1257, 1256 ]";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL2030158";"";"None";"509.70";"1";"4.33";"19";"CCNS(=O)(=O)c1ccc(NC(=S)N2CCC(C(O)(c3ccccc3)c3ccccc3)CC2)cc1";"IC50";"'='";"121.0";"nM";"6.92";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2032840";"Antagonist activity at neuropeptide Y receptor Y2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2029318";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";"";""
"CHEMBL95963";"";"None";"428.60";"1";"6.09";"21";"CN(C)CCCN(C(=O)c1cc2ccccc2s1)c1ccccc1Cc1ccccc1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL747054";"Binding affinity against SMS-KAN cell membranes endogenously expressing Neuropeptide Y receptor type 2 using [125I]PYY as radioligand";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"SMS-KAN";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1136181";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2003";"None";"";"";""
"CHEMBL415644";"";"None";"1968.30";"None";"None";"14";"CNC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(C)=O)C(C)C)[C@@H](C)O";"IC50";"'>'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL755164";"Affinity against Neuropeptide Y receptor Y2 in SK-N-BE2 cell line";"B";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133640";"1";"Scientific Literature";"J Med Chem";"2000";"None";"";"";""
"CHEMBL510139";"CITRININ";"None";"250.25";"0";"1.72";"CITRININ";"CC1=C2C(=CO[C@H](C)[C@H]2C)C(O)=C(C(=O)O)C1=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL428647";"PACLITAXEL";"4.0";"853.92";"2";"3.74";"Taxol";"CC(=O)O[C@H]1C(=O)[C@@]2(C)[C@H]([C@H](OC(=O)c3ccccc3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c4ccccc4)c4ccccc4)C(C)=C1C3(C)C)[C@]1(OC(C)=O)CO[C@@H]1C[C@@H]2O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1515611";"BROMISOVALUM";"2.0";"223.07";"0";"0.60";"BROMISOVALUM";"CC(C)C(Br)C(=O)NC(N)=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1458880";"CADMIUM DICHLORIDE";"None";"183.32";"None";"None";"CADMIUM CHLORIDE";"";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1909063";"LEAD(IV) ACETATE";"None";"443.38";"None";"None";"LEAD(IV) ACETATE";"";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1200558";"BACITRACIN";"4.0";"1422.72";"None";"None";"BACITRACIN";"CC[C@H](C)[C@H](N)C1=N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@H]2CCCCNC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](CC(=O)O)NC(=O)[C@H](Cc3cnc[nH]3)NC(=O)[C@@H](Cc3ccccc3)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H](CCCN)NC2=O)[C@@H](C)CC)CS1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL278172";"BENZOCAINE";"4.0";"165.19";"0";"1.45";"BENZOCAINE";"CCOC(=O)c1ccc(N)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL660";"AMANTADINE";"4.0";"151.25";"0";"1.91";"AMANTADINE";"NC12CC3CC(CC(C3)C1)C2";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL711";"PHENINDIONE";"4.0";"222.24";"0";"2.85";"PHENINDIONE";"O=C1c2ccccc2C(=O)C1c1ccccc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL583";"GREPAFLOXACIN";"4.0";"359.40";"0";"2.28";"GREPAFLOXACIN";"Cc1c(F)c(N2CCNC(C)C2)cc2c1c(=O)c(C(=O)O)cn2C1CC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL416005";"";"None";"479.62";"1";"5.31";"1";"CC(=O)N1CCc2ccc(N(C(=O)/C=C/c3ccccc3)C3CCN(Cc4ccccc4)CC3)cc21";"IC50";"'='";"4000.0";"nM";"5.40";"";"";"UO_0000065";"11.25";"0.20";"0.09";"12.31";"0";"CHEMBL750768";"Binding affinity towards the NPY Y2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147599";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2004";"None";"";"";""
"CHEMBL595";"PIOGLITAZONE";"4.0";"356.45";"0";"3.16";"PIOGLITAZONE";"CCc1ccc(CCOc2ccc(CC3SC(=O)NC3=O)cc2)nc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1544103";"";"None";"402.36";"0";"3.81";"SID24830338";"CC1(C)CC(N2CCCCCC2)=CC(=[N+]2CCCC2)C1.[I-]";"IC50";"'>'";"35000.0";"nM";"";"";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1613986";"PUBCHEM_BIOASSAY: Dose response counterscreen assay for neuropeptide Y receptor Y1 (NPY-Y1): Cell-based high throughput assay to measure NPY-Y2 antagonism. (Class of assay: confirmatory) [Related pubchem assays: 793, 1040, 1255, 1254 ]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1608455";"";"None";"470.53";"0";"4.09";"SID845473";"COc1ccccc1CN(Cc1cc2cc(C)ccc2nc1O)Cc1nnnn1Cc1ccco1";"IC50";"'>'";"35000.0";"nM";"";"";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1613986";"PUBCHEM_BIOASSAY: Dose response counterscreen assay for neuropeptide Y receptor Y1 (NPY-Y1): Cell-based high throughput assay to measure NPY-Y2 antagonism. (Class of assay: confirmatory) [Related pubchem assays: 793, 1040, 1255, 1254 ]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL406128";"";"None";"1917.26";"None";"None";"30";"CC(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C(N)N)CN[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O)C(C)C";"IC50";"'='";"41.0";"nM";"7.39";"";"";"UO_0000065";"3.85";"None";"None";"None";"0";"CHEMBL755164";"Affinity against Neuropeptide Y receptor Y2 in SK-N-BE2 cell line";"B";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133640";"1";"Scientific Literature";"J Med Chem";"2000";"None";"";"";""
"CHEMBL430274";"";"None";"1921.27";"None";"None";"7";"CC(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](Cc1ccsc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O)C(C)C";"IC50";"'='";"2.63";"nM";"8.58";"";"";"UO_0000065";"4.47";"None";"None";"None";"0";"CHEMBL755164";"Affinity against Neuropeptide Y receptor Y2 in SK-N-BE2 cell line";"B";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133640";"1";"Scientific Literature";"J Med Chem";"2000";"None";"";"";""
"CHEMBL1567463";"CHOLINE ALFOSCERATE";"None";"257.22";"0";"-1.45";"CHOLINE ALFOSCERATE";"C[N+](C)(C)CCOP(=O)([O-])OC[C@H](O)CO";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL422";"TRIFLUOPERAZINE";"4.0";"407.51";"0";"4.95";"TRIFLUOPERAZINE";"CN1CCN(CCCN2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL267345";"AMPHOTERICIN B";"4.0";"924.09";"3";"0.71";"AMPHOTERICIN B";"C[C@@H]1[C@H](O)[C@@H](C)/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)CC(=O)O[C@H]1C)C[C@H](O)[C@H]2C(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL308130";"";"None";"422.53";"1";"6.93";"40g";"CN(C(=O)Nc1ccc(Oc2ccccc2)cc1)C(Cc1ccccc1)c1ccccc1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL749564";"Inhibitory activity tested against Human Neuropeptide Y2 Receptor.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1134441";"1";"Scientific Literature";"J Med Chem";"2001";"None";"";"";""
"CHEMBL765";"GUANETHIDINE";"4.0";"198.31";"0";"0.74";"GUANETHIDINE";"N=C(N)NCCN1CCCCCCC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL88";"CYCLOPHOSPHAMIDE ANHYDROUS";"4.0";"261.09";"0";"1.88";"CYCLOPHOSPHAMIDE";"O=P1(N(CCCl)CCCl)NCCCO1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1201012";"FLURANDRENOLIDE";"4.0";"436.52";"0";"2.50";"FLURANDRENOLIDE";"CC1(C)O[C@@H]2C[C@H]3[C@@H]4C[C@H](F)C5=CC(=O)CC[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO)O1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL21605";"";"None";"515.60";"2";"5.58";"43";"CC(=O)N1CCc2ccc(N(C(=O)/C=C/c3cc(F)cc(F)c3)C3CCN(Cc4ccccc4)CC3)cc21";"IC50";"'='";"2500.0";"nM";"5.60";"";"";"UO_0000065";"10.87";"0.20";"0.02";"12.77";"0";"CHEMBL750768";"Binding affinity towards the NPY Y2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147599";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2004";"None";"";"";""
"CHEMBL103";"PROGESTERONE";"4.0";"314.47";"0";"4.72";"PROGESTERONE";"CC(=O)[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL460499";"CARMOFUR";"2.0";"257.26";"0";"0.81";"CARMOFUR";"CCCCCCNC(=O)n1cc(F)c(=O)[nH]c1=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1200600";"FLUOROMETHOLONE";"4.0";"376.47";"0";"2.92";"FLUOROMETHOLONE";"CC(=O)[C@@]1(O)CC[C@H]2[C@@H]3C[C@H](C)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL41673";"";"None";"471.61";"0";"3.23";"8 (R)";"C[C@@H](NC(=O)C(CCCN=C(N)N)NC(=O)C(c1ccccc1)c1ccccc1)c1ccccc1";"IC50";"'='";"177000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL747056";"Inhibition of binding of [3H]propionyl-NPY (1 nM) to Neuropeptide Y receptor type 2 in SMS-KAN cell membranes";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"SMS-KAN";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133238";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2000";"None";"";"";""
"CHEMBL95501";"";"None";"460.67";"1";"6.79";"12";"CN(C)CCCN(C(=O)c1cc2ccccc2s1)c1ccccc1SCc1ccccc1";"IC50";"'='";"1000.0";"nM";"6.00";"";"";"UO_0000065";"13.02";"0.26";"-0.79";"25.48";"0";"CHEMBL747054";"Binding affinity against SMS-KAN cell membranes endogenously expressing Neuropeptide Y receptor type 2 using [125I]PYY as radioligand";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"SMS-KAN";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1136181";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2003";"None";"";"";""
"CHEMBL189171";"ACEMETACIN";"4.0";"415.83";"0";"3.47";"ACEMETACIN";"COc1ccc2c(c1)c(CC(=O)OCC(=O)O)c(C)n2C(=O)c1ccc(Cl)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1466";"DICUMAROL";"4.0";"336.30";"0";"2.90";"DICUMAROL";"O=c1oc2ccccc2c(O)c1Cc1c(O)c2ccccc2oc1=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL9514";"NOCODAZOLE";"2.0";"301.33";"0";"3.03";"NOCODAZOLE";"COC(=O)Nc1nc2cc(C(=O)c3cccs3)ccc2[nH]1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL564201";"6-AZAURIDINE";"None";"245.19";"0";"-3.46";"AZAURIDINE";"O=c1cnn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c(=O)[nH]1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL153062";"4-NONYLPHENOL";"None";"220.36";"0";"4.69";"4-NONYLPHENOL";"CCCCCCCCCc1ccc(O)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL222863";"OUABAIN";"4.0";"584.66";"3";"-1.51";"OUABAIN";"C[C@@H]1O[C@@H](O[C@H]2C[C@@H](O)[C@]3(CO)[C@H]4[C@H](O)C[C@]5(C)[C@@H](C6=CC(=O)OC6)CC[C@]5(O)[C@@H]4CC[C@]3(O)C2)[C@H](O)[C@H](O)[C@H]1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL63323";"NIFLUMIC ACID";"2.0";"282.22";"0";"3.54";"NIFLUMIC ACID";"O=C(O)c1cccnc1Nc1cccc(C(F)(F)F)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL3578018";"";"None";"2985.59";"None";"None";"5b";"CC(=O)NC(CNC(=O)CCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1cccc2ccccc12)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O";"IC50";"'='";"9.55";"nM";"8.02";"";"";"UO_0000065";"2.69";"None";"None";"None";"0";"CHEMBL3579806";"Displacement of [125I]PYY from human neuropeptide Y Y2 receptor expressed in HEK293 cells cotransfected with eYFP fusion protein after 2 hrs by competitive receptor binding assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3576822";"1";"Scientific Literature";"J Med Chem";"2015";"CHEMBL3307715";"";"";""
"CHEMBL6466";"COUMARIN";"4.0";"146.14";"0";"1.79";"COUMARIN";"O=c1ccc2ccccc2o1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL14060";"PHENOL";"4.0";"94.11";"0";"1.39";"PHENOL";"Oc1ccccc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1566";"ACARBOSE";"4.0";"645.61";"3";"-8.56";"ACARBOSE";"C[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@@H](O[C@H]3[C@H](O)[C@@H](O)[C@H](O)O[C@@H]3CO)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1N[C@H]1C=C(CO)[C@@H](O)[C@H](O)[C@H]1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL21283";"";"None";"510.68";"2";"5.56";"2";"CC(=O)N1CCc2ccc(N(C(=O)/C=C/c3cccc(C#N)c3)C3CCN(CCC4CCCC4)CC3)cc21";"IC50";"'='";"100.0";"nM";"7.00";"";"";"UO_0000065";"13.71";"0.25";"1.44";"10.35";"1";"CHEMBL1063992";"Binding affinity to neuropeptide Y2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1152417";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"None";"";"";""
"CHEMBL1493277";"";"None";"367.90";"1";"6.13";"SID17506246";"CC(Sc1ccc(Cl)cc1)C(=O)Nc1ccccc1-c1ccccc1";"IC50";"'='";"4768.0";"nM";"5.32";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614345";"PUBCHEM_BIOASSAY: Dose response cell-based screening assay for antagonists of neuropeptide Y receptor Y2 (NPY-Y2). (Class of assay: confirmatory) [Related pubchem assays: 793, 1257, 1256 ]";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1610409";"";"None";"328.82";"1";"5.19";"SID17409825";"Clc1ccccc1CSc1nnc(/C=C/c2ccccc2)o1";"IC50";"'='";"8088.0";"nM";"5.09";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614345";"PUBCHEM_BIOASSAY: Dose response cell-based screening assay for antagonists of neuropeptide Y receptor Y2 (NPY-Y2). (Class of assay: confirmatory) [Related pubchem assays: 793, 1257, 1256 ]";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1457093";"";"None";"382.89";"0";"3.99";"SID14732060";"Cl.O=C(COc1ccccc1CNCc1ccccc1)Nc1ccccc1";"IC50";"'='";"9671.0";"nM";"5.01";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614345";"PUBCHEM_BIOASSAY: Dose response cell-based screening assay for antagonists of neuropeptide Y receptor Y2 (NPY-Y2). (Class of assay: confirmatory) [Related pubchem assays: 793, 1257, 1256 ]";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1574689";"";"None";"390.49";"0";"3.55";"SID3712225";"COC(=O)c1ccc(CSc2nc3sc4c(c3c(=O)n2C)CCCC4)o1";"IC50";"'='";"6206.0";"nM";"5.21";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614345";"PUBCHEM_BIOASSAY: Dose response cell-based screening assay for antagonists of neuropeptide Y receptor Y2 (NPY-Y2). (Class of assay: confirmatory) [Related pubchem assays: 793, 1257, 1256 ]";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1431004";"";"None";"389.31";"0";"3.81";"SID14729548";"CCOc1nc(SCCOc2ccc(Cl)cc2Cl)nc(N(C)C)n1";"IC50";"'='";"5523.0";"nM";"5.26";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614345";"PUBCHEM_BIOASSAY: Dose response cell-based screening assay for antagonists of neuropeptide Y receptor Y2 (NPY-Y2). (Class of assay: confirmatory) [Related pubchem assays: 793, 1257, 1256 ]";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1439255";"";"None";"327.80";"0";"3.65";"SID3715989";"Clc1ccc(-c2nnn(Cc3nc4ccccc4s3)n2)cc1";"IC50";"'='";"15060.0";"nM";"4.82";"";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614345";"PUBCHEM_BIOASSAY: Dose response cell-based screening assay for antagonists of neuropeptide Y receptor Y2 (NPY-Y2). (Class of assay: confirmatory) [Related pubchem assays: 793, 1257, 1256 ]";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1539256";"";"None";"496.63";"0";"4.02";"SID14739373";"COc1ccc(NC(=O)CSc2nc3ccccc3c(=O)n2CCCN2CCCCC2)c(OC)c1";"IC50";"'='";"14740.0";"nM";"4.83";"";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614345";"PUBCHEM_BIOASSAY: Dose response cell-based screening assay for antagonists of neuropeptide Y receptor Y2 (NPY-Y2). (Class of assay: confirmatory) [Related pubchem assays: 793, 1257, 1256 ]";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1480648";"";"None";"415.41";"0";"3.38";"SID4240898";"COc1ccc(-n2nc(C(=O)Nc3ccc4c(c3)OCO4)c3ccccc3c2=O)cc1";"IC50";"'='";"7171.0";"nM";"5.14";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614345";"PUBCHEM_BIOASSAY: Dose response cell-based screening assay for antagonists of neuropeptide Y receptor Y2 (NPY-Y2). (Class of assay: confirmatory) [Related pubchem assays: 793, 1257, 1256 ]";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1559259";"";"None";"392.44";"0";"4.06";"SID14745482";"COC(=O)c1ccc(CSc2nc3ccccc3c(=O)n2-c2ccccc2)o1";"IC50";"'='";"3137.0";"nM";"5.50";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614345";"PUBCHEM_BIOASSAY: Dose response cell-based screening assay for antagonists of neuropeptide Y receptor Y2 (NPY-Y2). (Class of assay: confirmatory) [Related pubchem assays: 793, 1257, 1256 ]";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1467233";"";"None";"478.93";"1";"5.31";"SID14737781";"CCOc1ccc(-n2cc(C(=O)Nc3cccc(Cl)c3)c3cc(OC)c(OC)cc3c2=O)cc1";"IC50";"'>'";"35000.0";"nM";"";"";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614345";"PUBCHEM_BIOASSAY: Dose response cell-based screening assay for antagonists of neuropeptide Y receptor Y2 (NPY-Y2). (Class of assay: confirmatory) [Related pubchem assays: 793, 1257, 1256 ]";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1350415";"";"None";"412.49";"1";"5.05";"SID17512721";"CC(C)OC(=O)/C(=C/c1ccc2c(c1)c1ccccc1n2C)NC(=O)c1ccccc1";"IC50";"'='";"14660.0";"nM";"4.83";"";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614345";"PUBCHEM_BIOASSAY: Dose response cell-based screening assay for antagonists of neuropeptide Y receptor Y2 (NPY-Y2). (Class of assay: confirmatory) [Related pubchem assays: 793, 1257, 1256 ]";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL22119";"";"None";"515.68";"1";"4.72";"13";"CS(=O)(=O)N1CCc2ccc(N(C(=O)/C=C/c3ccccc3)C3CCN(Cc4ccccc4)CC3)cc21";"IC50";"'='";"15000.0";"nM";"4.82";"";"";"UO_0000065";"9.35";"0.18";"0.10";"7.92";"0";"CHEMBL750768";"Binding affinity towards the NPY Y2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147599";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2004";"None";"";"";""
"CHEMBL897";"PROBENECID";"4.0";"285.37";"0";"2.20";"PROBENECID";"CCCN(CCC)S(=O)(=O)c1ccc(C(=O)O)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL530291";"";"None";"339.32";"0";"3.53";"SID857902";"Br.CCCCCCn1c2c(c(=N)c3c1CCC3)CCC2";"IC50";"'='";"14570.0";"nM";"4.84";"";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1613986";"PUBCHEM_BIOASSAY: Dose response counterscreen assay for neuropeptide Y receptor Y1 (NPY-Y1): Cell-based high throughput assay to measure NPY-Y2 antagonism. (Class of assay: confirmatory) [Related pubchem assays: 793, 1040, 1255, 1254 ]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1468639";"";"None";"346.43";"0";"4.59";"SID4257335";"CCCCOc1cccc(OCCCC)c1C(=O)Nc1cc(C)on1";"IC50";"'>'";"35000.0";"nM";"";"";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1613986";"PUBCHEM_BIOASSAY: Dose response counterscreen assay for neuropeptide Y receptor Y1 (NPY-Y1): Cell-based high throughput assay to measure NPY-Y2 antagonism. (Class of assay: confirmatory) [Related pubchem assays: 793, 1040, 1255, 1254 ]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL3578017";"";"None";"2857.41";"None";"None";"5a";"CC(=O)NC(CNC(=O)CCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](Cc1cccc2ccccc12)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O";"IC50";"'='";"61.4";"nM";"7.21";"";"";"UO_0000065";"2.52";"None";"None";"None";"0";"CHEMBL3579806";"Displacement of [125I]PYY from human neuropeptide Y Y2 receptor expressed in HEK293 cells cotransfected with eYFP fusion protein after 2 hrs by competitive receptor binding assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3576822";"1";"Scientific Literature";"J Med Chem";"2015";"CHEMBL3307715";"";"";""
"CHEMBL773";"GLYCINE";"4.0";"75.07";"0";"-0.97";"GLYCINE";"NCC(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1405";"ESTRONE";"4.0";"270.37";"0";"3.82";"ESTRONE";"C[C@]12CC[C@@H]3c4ccc(O)cc4CC[C@H]3[C@@H]1CCC2=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL221886";"SISOMICIN";"3.0";"447.53";"2";"-3.85";"SISOMICIN";"CN[C@@H]1[C@@H](O)[C@@H](O[C@@H]2[C@@H](O)[C@H](O[C@H]3OC(CN)=CC[C@H]3N)[C@@H](N)C[C@H]2N)OC[C@]1(C)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL70586";"SPIRADOLINE";"None";"425.40";"0";"4.56";"SPIRADOLINE";"CN(C(=O)Cc1ccc(Cl)c(Cl)c1)[C@H]1CC[C@@]2(CCCO2)C[C@@H]1N1CCCC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1319362";"HOMATROPINE HYDROBROMIDE";"4.0";"356.26";"0";"1.89";"HOMATROPINE HYDROBROMIDE";"Br.CN1[C@@H]2CC[C@H]1C[C@@H](OC(=O)C(O)c1ccccc1)C2";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1413";"CICLOPIROX";"4.0";"207.27";"0";"2.44";"CICLOPIROX";"Cc1cc(C2CCCCC2)n(O)c(=O)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1909080";"STRONTIUM CHLORIDE HEXAHYDRATE";"None";"266.62";"None";"None";"STRONTIUM CHLORIDE HEXAHYDRATE";"O.O.O.O.O.O.[Cl-].[Cl-].[Sr+2]";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL12131";"CLOSANTEL";"2.0";"663.08";"2";"7.12";"CLOSANTEL";"Cc1cc(C(C#N)c2ccc(Cl)cc2)c(Cl)cc1NC(=O)c1cc(I)cc(I)c1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1909064";"LIPOPOLYSACCHARIDE E. COLI O55:B5";"None";"None";"None";"None";"LIPOPOLYSACCHARIDE E. COLI O55:B5";"";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL558";"MEXILETINE";"4.0";"179.26";"0";"2.03";"MEXILETINE";"Cc1cccc(C)c1OCC(C)N";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL185";"FLUOROURACIL";"4.0";"130.08";"0";"-0.80";"5-FU";"O=c1[nH]cc(F)c(=O)[nH]1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL276832";"HYDRALAZINE";"4.0";"160.18";"0";"0.92";"HYDRALAZINE";"NNc1nncc2ccccc12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1493";"FLAVOXATE";"4.0";"391.47";"0";"4.41";"FLAVOXATE";"Cc1c(-c2ccccc2)oc2c(C(=O)OCCN3CCCCC3)cccc2c1=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1069";"VALSARTAN";"4.0";"435.53";"0";"4.16";"VALSARTAN";"CCCCC(=O)N(Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1)[C@H](C(=O)O)C(C)C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL13341";"NIMETAZEPAM";"2.0";"295.30";"0";"2.41";"NIMETAZEPAM";"CN1C(=O)CN=C(c2ccccc2)c2cc([N+](=O)[O-])ccc21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL557555";"CIPROFIBRATE";"4.0";"289.16";"0";"3.59";"CIPROFIBRATE";"CC(C)(Oc1ccc(C2CC2(Cl)Cl)cc1)C(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL384467";"DEXAMETHASONE";"4.0";"392.47";"0";"1.90";"DEXAMETHASONE";"C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1148";"TORSEMIDE";"4.0";"348.43";"0";"2.53";"TORSEMIDE";"Cc1cccc(Nc2ccncc2S(=O)(=O)NC(=O)NC(C)C)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL2221249";"COLISTIN";"4.0";"2296.97";"None";"None";"COLISTIN";"CC(C)CCCCC(=O)N[C@@H](CCN)C(=O)N[C@@H](CN[C@@H](CCN)C(=O)N[C@H]1CCNC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCN)NC(=O)[C@H](CCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CCN)NC1=O)[C@@H](C)O.CCC(C)CCCCC(=O)N[C@@H](CCN)C(=O)N[C@@H](CN[C@@H](CCN)C(=O)N[C@H]1CCNC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCN)NC(=O)[C@H](CCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CCN)NC1=O)[C@@H](C)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1618305";"NALOXONAZINE";"None";"650.78";"1";"3.28";"NALOXONAZINE";"C=CCN1CC[C@]23c4c5ccc(O)c4O[C@H]2/C(=N/N=C2\CC[C@@]4(O)[C@H]6Cc7ccc(O)c8c7[C@@]4(CCN6CC=C)[C@H]2O8)CC[C@@]3(O)[C@H]1C5";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL167911";"DICHLORVOS";"2.0";"220.98";"0";"2.68";"DICHLORVOS";"COP(=O)(OC)OC=C(Cl)Cl";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL189";"MILRINONE";"4.0";"211.22";"0";"1.62";"MILRINONE";"Cc1[nH]c(=O)c(C#N)cc1-c1ccncc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1208572";"SALINOMYCIN";"2.0";"751.01";"2";"6.19";"SALINOMYCIN";"CC[C@@H](C(=O)[C@@H](C)[C@@H](O)[C@H](C)[C@@H]1O[C@@H]([C@@H](CC)C(=O)O)CC[C@@H]1C)[C@H]1O[C@]2(C=C[C@@H](O)[C@]3(CC[C@@](C)([C@H]4CC[C@](O)(CC)[C@H](C)O4)O3)O2)[C@H](C)C[C@@H]1C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL423192";"ANISOMYCIN";"None";"265.31";"0";"0.50";"ANISOMYCIN";"COc1ccc(C[C@H]2NC[C@H](O)[C@H]2OC(C)=O)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL43882";"TRICHLOROETHANE";"None";"133.41";"0";"2.03";"TRICHLOROETHANE";"ClCC(Cl)Cl";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL428017";"";"None";"1787.11";"None";"None";"2a, Ac-[L31]-PYY(24-36)";"CC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O";"IC50";"'='";"3.9";"nM";"8.41";"";"";"UO_0000065";"4.71";"None";"None";"None";"0";"CHEMBL3579819";"Agonist activity at neuropeptide Y Y2 receptor in human SMS-KAN cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"SMS-KAN";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3576822";"1";"Scientific Literature";"J Med Chem";"2015";"None";"";"";""
"CHEMBL165790";"IPRIFLAVONE";"2.0";"280.32";"0";"4.25";"IPRIFLAVONE";"CC(C)Oc1ccc2c(=O)c(-c3ccccc3)coc2c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL434";"ISOPROTERENOL";"4.0";"211.26";"0";"1.13";"ISOPRENALINE";"CC(C)NCC(O)c1ccc(O)c(O)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL614";"PYRAZINAMIDE";"4.0";"123.11";"0";"-0.42";"Pyrazinamide";"NC(=O)c1cnccn1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1501";"FLUOCINONIDE";"4.0";"494.53";"0";"2.94";"FLUOCINONIDE";"CC(=O)OCC(=O)[C@@]12OC(C)(C)O[C@@H]1C[C@H]1[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]12C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL184618";"FRAMYCETIN";"3.0";"614.65";"3";"-8.90";"NEOMYCIN";"NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1909078";"SODIUM ARSENITE";"None";"129.91";"None";"None";"SODIUM ARSENITE";"O=[As][O-].[Na+]";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL462547";"URETHANE";"4.0";"89.09";"0";"0.10";"URETHANE";"CCOC(N)=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1200679";"ZINC CHLORIDE";"4.0";"136.30";"None";"None";"ZINC CHLORIDE";"[Cl-].[Cl-].[Zn+2]";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1371125";"BENZO[E]PYRENE";"None";"252.32";"1";"5.74";"BENZO[E]PYRENE";"c1ccc2c(c1)c1cccc3ccc4cccc2c4c31";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1566956";"TROXIPIDE";"2.0";"294.35";"0";"1.19";"TROXIPIDE";"COc1cc(C(=O)NC2CCCNC2)cc(OC)c1OC";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL727";"THIOGUANINE";"4.0";"167.20";"0";"0.60";"THIOGUANINE";"Nc1nc2[nH]cnc2c(=S)[nH]1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1237";"LISINOPRIL ANHYDROUS";"4.0";"405.50";"0";"1.24";"LISINOPRIL";"NCCCC[C@H](N[C@@H](CCc1ccccc1)C(=O)O)C(=O)N1CCC[C@H]1C(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL742";"KETAMINE";"4.0";"237.73";"0";"2.90";"KETAMINE";"CNC1(c2ccccc2Cl)CCCCC1=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL91";"MICONAZOLE";"4.0";"416.13";"1";"6.45";"MICONAZOLE";"Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)c(Cl)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL134342";"THIOCTIC ACID";"None";"206.33";"0";"2.79";"THIOCTIC ACID";"O=C(O)CCCC[C@@H]1CCSS1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL809";"SERTRALINE";"4.0";"306.24";"1";"5.18";"SERTRALINE";"CN[C@H]1CC[C@@H](c2ccc(Cl)c(Cl)c2)c2ccccc21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL107";"COLCHICINE";"4.0";"399.44";"0";"2.87";"colchicine";"COc1cc2c(c(OC)c1OC)-c1ccc(OC)c(=O)cc1[C@@H](NC(C)=O)CC2";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1393";"SPIRONOLACTONE";"4.0";"416.58";"0";"4.85";"SPIRONOLACTONE";"CC(=O)S[C@@H]1CC2=CC(=O)CC[C@]2(C)[C@H]2CC[C@@]3(C)[C@@H](CC[C@@]34CCC(=O)O4)[C@H]12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL41";"FLUOXETINE";"4.0";"309.33";"0";"4.44";"FLUOXETINE";"CNCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL4203253";"";"None";"1866.25";"None";"None";"21";"CC(C)C[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC1CCCCC1)NC(=O)[C@H](CC1CCCCC1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H]1CCCN1C(=O)[C@H](CO)NC(=O)CO)C(=O)NC(C)(C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC1CCCCC1)C(N)=O)[C@@H](C)O";"IC50";"'='";"1.2";"nM";"8.92";"";"";"UO_0000065";"4.78";"None";"None";"None";"0";"CHEMBL4179032";"Displacement of [125I]-PYY from human neuropeptide Y2 receptor expressed in CHO cell membranes incubated for 60 mins by TopCount based method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4177573";"1";"Scientific Literature";"Bioorg Med Chem";"2017";"None";"";"";""
"CHEMBL456807";"PHENYLHYDRAZINE";"None";"108.14";"0";"0.97";"PHENYLHYDRAZINE";"NNc1ccccc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL19236";"MOXONIDINE";"4.0";"241.68";"0";"0.82";"MOXONIDINE";"COc1nc(C)nc(Cl)c1NC1=NCCN1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1444";"LETROZOLE";"4.0";"285.31";"0";"2.66";"LETROZOLE";"N#Cc1ccc(C(c2ccc(C#N)cc2)n2cncn2)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1201203";"BENZTROPINE";"4.0";"307.44";"0";"4.42";"BENZTROPINE";"CN1[C@@H]2CC[C@H]1C[C@@H](OC(c1ccccc1)c1ccccc1)C2";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL4225031";"";"None";"2804.47";"None";"None";"15";"C[C@@H](O)[C@H](NC(=O)C(C)(C)NC(=O)[C@H](CCCCNC(=O)C1CCNCC1)NC(=O)[C@H](CC(N)=O)NC(=O)C(C)(C)NC(=O)[C@H](CC1CCCCC1)NC(=O)[C@H](Cc1ccncc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H]1C[C@H](O)CN1C(=O)[C@H](CO)NC(=O)COCC(=O)NCCCOCCOCCOCCCNC(=O)CC[C@H](NC(=O)[C@H]1CC[C@H](CNC(=O)CCCCCCCCCCCCCCCCCCC(=O)O)CC1)C(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC1CCCCC1)C(N)=O";"IC50";"'='";"4.5";"nM";"8.35";"";"";"UO_0000065";"2.98";"None";"None";"None";"0";"CHEMBL4220285";"Displacement of [125I]-PYY from human neuropeptide Y2 receptor expressed in CHO cell membranes incubated for 60 mins by TopCount micro scintillation analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4219053";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";"";"";""
"CHEMBL36994";"ANIRACETAM";"2.0";"219.24";"0";"1.46";"ANIRACETAM";"COc1ccc(C(=O)N2CCCC2=O)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1560";"CAPTOPRIL";"4.0";"217.29";"0";"0.63";"CAPTOPRIL";"C[C@H](CS)C(=O)N1CCC[C@H]1C(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1200585";"OXYMETHOLONE";"4.0";"332.48";"0";"4.40";"OXYMETHOLONE";"C[C@]12C/C(=C/O)C(=O)C[C@@H]1CC[C@@H]1[C@@H]2CC[C@@]2(C)[C@H]1CC[C@]2(C)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL234926";"ALLYL ALCOHOL";"None";"58.08";"0";"0.16";"ALLYL ALCOHOL";"C=CCO";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL4069788";"";"None";"1861.28";"None";"None";"21";"CC(=O)N[C@@H](CO)C(=O)N1CCC[C@@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccncc1)C(=O)N[C@@H](CC1CCCCC1)C(=O)N[C@@H](CC1CCCCC1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)NC(C)(C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC1CCCCC1)C(N)=O)[C@@H](C)O";"IC50";"'='";"0.49";"nM";"9.31";"";"";"UO_0000065";"5.00";"None";"None";"None";"0";"CHEMBL4056968";"Displacement of [125I]peptide YY from human Y2 receptor expressed in CHO cell membranes after 60 mins by TopCount scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4052740";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";""
"CHEMBL128";"SUMATRIPTAN";"4.0";"295.41";"0";"1.32";"SUMATRIPTAN";"CNS(=O)(=O)Cc1ccc2[nH]cc(CCN(C)C)c2c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1024";"IFOSFAMIDE";"4.0";"261.09";"0";"1.88";"IFOSFAMIDE";"O=P1(NCCCl)OCCCN1CCCl";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL4071371";"";"None";"1728.13";"None";"None";"1";"CC(C)C[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC1CCCCC1)NC(=O)[C@H](CC1CCCCC1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)c1ccccc1)C(=O)NC(C)(C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC1CCCCC1)C(N)=O)[C@@H](C)O";"IC50";"'='";"7.4";"nM";"8.13";"";"";"UO_0000065";"4.70";"None";"None";"None";"0";"CHEMBL4056968";"Displacement of [125I]peptide YY from human Y2 receptor expressed in CHO cell membranes after 60 mins by TopCount scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4052740";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";""
"CHEMBL4081767";"";"None";"1838.24";"None";"None";"12";"CC(=O)N[C@@H](CO)C(=O)N(C)[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)NC(CC1CCCCC1)C(=O)NC(CC1CCCCC1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)NC(C)(C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NC(CC1CCCCC1)C(N)=O)[C@@H](C)O";"IC50";"'='";"5.4";"nM";"8.27";"";"";"UO_0000065";"4.50";"None";"None";"None";"0";"CHEMBL4036757";"Displacement of [125I]-PYY from human Y2R expressed in CHO cell membranes after 60 mins by liquid scintillation method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4033754";"1";"Scientific Literature";"ACS Med Chem Lett";"2017";"None";"";"";""
"CHEMBL4070864";"";"None";"1824.22";"None";"None";"14";"CC(=O)N[C@@H](CO)C(=O)N(C)CC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)NC(CC1CCCCC1)C(=O)NC(CC1CCCCC1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)NC(C)(C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NC(CC1CCCCC1)C(N)=O)[C@@H](C)O";"IC50";"'='";"2.8";"nM";"8.55";"";"";"UO_0000065";"4.69";"None";"None";"None";"0";"CHEMBL4036757";"Displacement of [125I]-PYY from human Y2R expressed in CHO cell membranes after 60 mins by liquid scintillation method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4033754";"1";"Scientific Literature";"ACS Med Chem Lett";"2017";"None";"";"";""
"CHEMBL1477";"CERIVASTATIN";"4.0";"459.56";"0";"4.88";"CERIVASTATIN";"COCc1c(C(C)C)nc(C(C)C)c(/C=C/[C@@H](O)C[C@@H](O)CC(=O)O)c1-c1ccc(F)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1372";"OXIGLUTATIONE";"4.0";"612.64";"3";"-3.88";"GLUTATHIONE, OXIDIZED FORM";"N[C@@H](CCC(=O)N[C@@H](CSSC[C@H](NC(=O)CC[C@H](N)C(=O)O)C(=O)NCC(=O)O)C(=O)NCC(=O)O)C(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL16";"PHENYTOIN";"4.0";"252.27";"0";"1.77";"PHENYTOIN";"O=C1NC(=O)C(c2ccccc2)(c2ccccc2)N1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL175";"DEXIBUPROFEN";"4.0";"206.28";"0";"3.07";"DEXIBUPROFEN";"CC(C)Cc1ccc([C@H](C)C(=O)O)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL643";"PROMETHAZINE";"4.0";"284.43";"0";"4.24";"PROMETHAZINE";"CC(CN1c2ccccc2Sc2ccccc21)N(C)C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL75880";"PERHEXILINE";"4.0";"277.50";"1";"5.30";"PERHEXILINE";"C1CCC(C(CC2CCCCN2)C2CCCCC2)CC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1479";"DANAZOL";"4.0";"337.46";"0";"4.22";"DANAZOL";"C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=Cc5oncc5C[C@]4(C)[C@H]3CC[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1518";"PROPYLTHIOURACIL";"4.0";"170.24";"0";"1.38";"PROPYLTHIOURACIL";"CCCc1cc(=O)[nH]c(=S)[nH]1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL2107687";"VALETHAMATE BROMIDE";"-1.0";"386.37";"0";"3.85";"VALETHAMATE BROMIDE";"CCC(C)C(C(=O)OCC[N+](C)(CC)CC)c1ccccc1.[Br-]";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL632";"BETAMETHASONE";"4.0";"392.47";"0";"1.90";"BETAMETHASONE";"C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1312220";"";"None";"351.43";"0";"4.14";"SID24807484";"Cc1cc2cc(C)c(NCCNC(=O)c3cccc(F)c3)nc2cc1C";"IC50";"'='";"4436.0";"nM";"5.35";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1613986";"PUBCHEM_BIOASSAY: Dose response counterscreen assay for neuropeptide Y receptor Y1 (NPY-Y1): Cell-based high throughput assay to measure NPY-Y2 antagonism. (Class of assay: confirmatory) [Related pubchem assays: 793, 1040, 1255, 1254 ]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1531251";"";"None";"515.06";"0";"3.73";"SID842834";"COc1ccc(N2CCN(C(c3cccc(OC)c3OC)c3nnnn3C3CCCC3)CC2)cc1.Cl";"IC50";"'>'";"35000.0";"nM";"";"";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1613986";"PUBCHEM_BIOASSAY: Dose response counterscreen assay for neuropeptide Y receptor Y1 (NPY-Y1): Cell-based high throughput assay to measure NPY-Y2 antagonism. (Class of assay: confirmatory) [Related pubchem assays: 793, 1040, 1255, 1254 ]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1609320";"";"None";"422.98";"0";"3.84";"SID850003";"CC(C)CC(c1nnnn1C1CCCC1)N1CCN(c2ccccc2F)CC1.Cl";"IC50";"'='";"24400.0";"nM";"4.61";"";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1613986";"PUBCHEM_BIOASSAY: Dose response counterscreen assay for neuropeptide Y receptor Y1 (NPY-Y1): Cell-based high throughput assay to measure NPY-Y2 antagonism. (Class of assay: confirmatory) [Related pubchem assays: 793, 1040, 1255, 1254 ]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1276308";"MIFEPRISTONE";"4.0";"429.60";"1";"5.41";"MIFEPRISTONE";"CC#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3[C@@H](c3ccc(N(C)C)cc3)C[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1201469";"GRAMICIDIN";"4.0";"None";"None";"None";"GRAMICIDIN";"";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL833";"TICLOPIDINE";"4.0";"263.79";"0";"3.96";"TICLOPIDINE";"Clc1ccccc1CN1CCc2sccc2C1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1390";"";"None";"344.50";"0";"4.08";"MEDROXYPROGESTERONE";"CC(=O)[C@@]1(O)CC[C@H]2[C@@H]3C[C@H](C)C4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL38";"TRETINOIN";"4.0";"300.44";"1";"5.60";"TRETINOIN";"CC1=C(/C=C/C(C)=C/C=C/C(C)=C/C(=O)O)C(C)(C)CCC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL481";"IRINOTECAN";"4.0";"586.69";"1";"4.09";"IRINOTECAN";"CCc1c2c(nc3ccc(OC(=O)N4CCC(N5CCCCC5)CC4)cc13)-c1cc3c(c(=O)n1C2)COC(=O)[C@]3(O)CC";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL98875";"";"None";"394.58";"1";"5.84";"25";"CCCCc1ccccc1N(CCCN(C)C)C(=O)c1cc2ccccc2s1";"IC50";"'='";"2200.0";"nM";"5.66";"";"";"UO_0000065";"14.34";"0.28";"-0.18";"24.02";"0";"CHEMBL747054";"Binding affinity against SMS-KAN cell membranes endogenously expressing Neuropeptide Y receptor type 2 using [125I]PYY as radioligand";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"SMS-KAN";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1136181";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2003";"None";"";"";""
"CHEMBL1499";"CORTISONE";"3.0";"360.45";"0";"1.99";"CORTISONE";"C[C@]12CCC(=O)C=C1CC[C@@H]1[C@@H]2C(=O)C[C@@]2(C)[C@H]1CC[C@]2(O)C(=O)CO";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL3559671";"POLYVINYL ALCOHOL";"4.0";"None";"None";"None";"POLYVINYL ALCOHOL";"";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL561";"LOMEFLOXACIN";"4.0";"351.35";"0";"1.80";"LOMEFLOXACIN";"CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNC(C)C3)c(F)c21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL269732";"TACROLIMUS ANHYDROUS";"4.0";"804.03";"2";"4.64";"tacrolimus";"C=CC[C@@H]1/C=C(\C)C[C@H](C)C[C@H](OC)[C@H]2O[C@@](O)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@H](/C(C)=C/[C@@H]3CC[C@@H](O)[C@H](OC)C3)[C@H](C)[C@@H](O)CC1=O)[C@H](C)C[C@@H]2OC";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL404";"TAZOBACTAM";"4.0";"300.30";"0";"-1.52";"TAZOBACTAM";"C[C@]1(Cn2ccnn2)[C@H](C(=O)O)N2C(=O)C[C@H]2S1(=O)=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL14053";"TRICHLOROACETIC ACID";"4.0";"163.39";"0";"1.44";"TRICHLOROACETIC ACID";"O=C(O)C(Cl)(Cl)Cl";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL178";"DAUNORUBICIN";"4.0";"527.53";"2";"1.03";"Dauno";"COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(C)=O)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL702";"PIPERACILLIN";"4.0";"517.56";"1";"-0.24";"PIPERACILLIN";"CCN1CCN(C(=O)N[C@@H](C(=O)N[C@@H]2C(=O)N3[C@@H]2SC(C)(C)[C@@H]3C(=O)O)c2ccccc2)C(=O)C1=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL485549";"NIFURSOL";"2.0";"365.21";"0";"1.47";"NIFURSOL";"O=C(N/N=C/c1ccc([N+](=O)[O-])o1)c1cc([N+](=O)[O-])cc([N+](=O)[O-])c1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1542";"AZATHIOPRINE";"4.0";"277.27";"0";"1.15";"AZATHIOPRINE";"Cn1cnc([N+](=O)[O-])c1Sc1ncnc2[nH]cnc12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL2403025";"";"None";"550.68";"2";"7.27";"10a";"CCNC(=O)C(c1ccccc1)C1CCN(c2ccc(NC(=O)Nc3ccccc3-c3ccccc3)cc2F)CC1";"IC50";"'='";"27.0";"nM";"7.57";"";"";"UO_0000065";"13.74";"0.25";"0.30";"10.30";"0";"CHEMBL2404394";"Displacement of [125I]PYY from NPY-Y2 receptor in human KAN-TS cell membranes after 1 hr by scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"KAN-TS";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2401643";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"None";"";"";""
"CHEMBL279236";"";"None";"465.60";"0";"4.92";"8";"O=CN1CCc2ccc(N(C(=O)/C=C/c3ccccc3)C3CCN(Cc4ccccc4)CC3)cc21";"IC50";"'='";"3500.0";"nM";"5.46";"";"";"UO_0000065";"11.72";"0.21";"0.54";"12.44";"0";"CHEMBL750768";"Binding affinity towards the NPY Y2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147599";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2004";"None";"";"";""
"CHEMBL1427860";"";"None";"470.59";"1";"6.33";"SF-21";"Cc1ccc(C)c(NS(=O)(=O)c2cc(C(=O)Nc3ccccc3-c3ccccc3)ccc2C)c1";"IC50";"'='";"440.0";"nM";"6.36";"";"";"UO_0000065";"";"";"";"";"1";"CHEMBL3106332";"Antagonist activity at NPYY2 receptor (unknown origin) by cAMP biosensor assay";"F";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3102719";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL188921";"BUFLOMEDIL";"4.0";"307.39";"0";"2.77";"BUFLOMEDIL";"COc1cc(OC)c(C(=O)CCCN2CCCC2)c(OC)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL19224";"PAPAVERINE";"4.0";"339.39";"0";"3.86";"PAPAVERINE";"COc1ccc(Cc2nccc3cc(OC)c(OC)cc23)cc1OC";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL16073";"PHENACETIN";"4.0";"179.22";"0";"2.04";"PHENACETIN";"CCOc1ccc(NC(C)=O)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1909065";"MADURAMICIN";"2.0";"917.14";"2";"4.32";"LYSERGOL";"CO[C@@H]1[C@@H](OC)[C@H](C)[C@@](O)(CC(=O)O)O[C@H]1[C@H](C)[C@H]1O[C@@]2(CC[C@@](C)([C@H]3CC[C@@](C)([C@@H]4O[C@@H]([C@H]5O[C@](C)(O)[C@H](C)C[C@@H]5C)C[C@@H]4O[C@@H]4C[C@H](OC)[C@@H](OC)[C@H](C)O4)O3)O2)C[C@H](O)[C@H]1C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL701";"BACLOFEN";"4.0";"213.66";"0";"1.86";"BACLOFEN";"NCC(CC(=O)O)c1ccc(Cl)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL526";"PROPOFOL";"4.0";"178.27";"0";"3.64";"PROPOFOL";"CC(C)c1cccc(C(C)C)c1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1297";"FENOPROFEN";"4.0";"242.27";"0";"3.67";"FENOPROFEN";"CC(C(=O)O)c1cccc(Oc2ccccc2)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL715";"OLANZAPINE";"4.0";"312.44";"0";"3.44";"OLANZAPINE";"Cc1cc2c(s1)Nc1ccccc1N=C2N1CCN(C)CC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL567495";"";"None";"418.43";"0";"3.87";"12b";"O=C1O[C@]2(CC[C@H](C(=O)Nc3ncc(-c4ccccc4F)cn3)CC2)c2ccncc21";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1037452";"Inhibition of human NPY Y2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1155978";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2009";"None";"";"";""
"CHEMBL3084803";"ASTROMICIN";"-1.0";"405.50";"1";"-3.59";"ASTROMICIN";"CO[C@H]1[C@@H](O)[C@H](N)[C@@H](O[C@H]2O[C@H]([C@H](C)N)CC[C@H]2N)[C@H](O)[C@@H]1N(C)C(=O)CN";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL600325";"PROSCILLARIDIN";"4.0";"530.66";"1";"3.01";"PROSCILLARIDIN";"C[C@@H]1O[C@@H](O[C@@H]2C=C3CC[C@@H]4[C@H](CC[C@]5(C)[C@@H](c6ccc(=O)oc6)CC[C@]45O)[C@@]3(C)CC2)[C@H](O)[C@H](O)[C@H]1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL307145";"PYROGALLOL";"4.0";"126.11";"0";"0.80";"PYROGALLOL";"Oc1cccc(O)c1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL291338";"3,3',4',5-TETRACHLOROSALICYLANILIDE";"4.0";"351.02";"1";"5.26";"3,3',4',5-TETRACHLOROSALICYLANILIDE";"O=C(Nc1ccc(Cl)c(Cl)c1)c1cc(Cl)cc(Cl)c1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1169";"AMINOSALICYLIC ACID";"4.0";"153.14";"0";"0.67";"AMINOSALICYLIC ACID";"Nc1ccc(C(=O)O)c(O)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL275742";"DEXPROPRANOLOL";"-1.0";"259.35";"0";"2.58";"R-(+)-PROPRANOLOL";"CC(C)NC[C@@H](O)COc1cccc2ccccc12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL666";"FOSCARNET";"4.0";"126.00";"0";"-0.16";"FOSCARNET";"O=C(O)P(=O)(O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1462215";"";"None";"492.45";"1";"5.49";"SID24785323";"CC[n+]1c(/C=C2\SC(c3ccccc3C)=CN2C)sc2ccccc21.[I-]";"IC50";"'='";"29590.0";"nM";"4.53";"";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1613986";"PUBCHEM_BIOASSAY: Dose response counterscreen assay for neuropeptide Y receptor Y1 (NPY-Y1): Cell-based high throughput assay to measure NPY-Y2 antagonism. (Class of assay: confirmatory) [Related pubchem assays: 793, 1040, 1255, 1254 ]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1372488";"";"None";"258.30";"0";"3.09";"SID4261075";"Cc1nn(-c2ccccc2)c2sc(C(=O)O)cc12";"IC50";"'>'";"35000.0";"nM";"";"";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1613986";"PUBCHEM_BIOASSAY: Dose response counterscreen assay for neuropeptide Y receptor Y1 (NPY-Y1): Cell-based high throughput assay to measure NPY-Y2 antagonism. (Class of assay: confirmatory) [Related pubchem assays: 793, 1040, 1255, 1254 ]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL3191634";"";"None";"336.26";"0";"4.33";"SID24828877";"Brc1ccc(-c2csc(/N=C/N3CCCC3)n2)cc1";"IC50";"'>'";"35000.0";"nM";"";"";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1613986";"PUBCHEM_BIOASSAY: Dose response counterscreen assay for neuropeptide Y receptor Y1 (NPY-Y1): Cell-based high throughput assay to measure NPY-Y2 antagonism. (Class of assay: confirmatory) [Related pubchem assays: 793, 1040, 1255, 1254 ]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1712923";"IRSOGLADINE MALEATE";"1.0";"372.17";"0";"2.01";"IRSOGLADINE MALEATE";"Nc1nc(N)nc(-c2cc(Cl)ccc2Cl)n1.O=C(O)/C=C\C(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL637";"VENLAFAXINE";"4.0";"277.41";"0";"3.04";"VENLAFAXINE";"COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL76904";"TYRPHOSTIN 23";"None";"186.17";"0";"1.53";"TYRPHOSTIN A23";"N#CC(C#N)=Cc1ccc(O)c(O)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL62193";"SULFADIMETHOXINE";"4.0";"310.34";"0";"0.88";"SULFADIMETHOXINE";"COc1cc(NS(=O)(=O)c2ccc(N)cc2)nc(OC)n1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL877";"TRANEXAMIC ACID";"4.0";"157.21";"0";"0.84";"TRANEXAMIC ACID";"NC[C@H]1CC[C@H](C(=O)O)CC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1475";"TRIOXSALEN";"4.0";"228.25";"0";"3.46";"TRIOXSALEN";"Cc1cc2cc3c(C)cc(=O)oc3c(C)c2o1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL895";"NALBUPHINE";"4.0";"357.45";"0";"1.71";"NALBUPHINE";"Oc1ccc2c3c1O[C@H]1[C@@H](O)CC[C@@]4(O)[C@@H](C2)N(CC2CCC2)CC[C@]314";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL86754";"IODOQUINOL";"2.0";"396.95";"0";"3.15";"IODOQUINOL";"Oc1c(I)cc(I)c2cccnc12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL20883";"TEGAFUR";"4.0";"200.17";"0";"-0.02";"TEGAFUR";"O=c1[nH]c(=O)n(C2CCCO2)cc1F";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL442182";"";"None";"394.90";"1";"6.23";"40l";"CC(Cc1ccc(Cl)cc1)N(C)C(=O)Nc1ccc(Oc2ccccc2)cc1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL749564";"Inhibitory activity tested against Human Neuropeptide Y2 Receptor.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1134441";"1";"Scientific Literature";"J Med Chem";"2001";"None";"";"";""
"CHEMBL438945";"HUMAN NEUROPEPTIDE Y";"1.0";"4271.75";"None";"None";"NPY";"CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O)[C@@H](C)CC";"IC50";"'='";"0.09";"nM";"10.05";"";"";"UO_0000065";"2.35";"None";"None";"None";"0";"CHEMBL2394998";"Binding affinity to human neuropeptide Y2 receptor by radioligand displacement assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2390917";"1";"Scientific Literature";"Bioorg Med Chem";"2013";"None";"";"";""
"CHEMBL942";"BISACODYL";"4.0";"361.40";"0";"4.11";"BISACODYL";"CC(=O)Oc1ccc(C(c2ccc(OC(C)=O)cc2)c2ccccn2)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL81977";"3-AMINOBENZAMIDE";"None";"136.15";"0";"0.37";"3-AMINOBENZAMIDE";"NC(=O)c1cccc(N)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL418971";"BISPHENOL A";"None";"228.29";"0";"3.42";"BISPHENOL A";"CC(C)(c1ccc(O)cc1)c1ccc(O)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL112";"ACETAMINOPHEN";"4.0";"151.16";"0";"1.35";"ACETAMINOPHEN";"CC(=O)Nc1ccc(O)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1062";"HYDROXYPROGESTERONE";"2.0";"330.47";"0";"3.84";"HYDROXYPROGESTERONE";"CC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL426123";"";"None";"258.23";"0";"0.09";"(-)-THALIDOMIDE";"O=C1CC[C@H](N2C(=O)c3ccccc3C2=O)C(=O)N1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL414827";"";"None";"521.66";"2";"5.27";"9";"CC(=O)CC(=O)N1CCc2ccc(N(C(=O)/C=C/c3ccccc3)C3CCN(Cc4ccccc4)CC3)cc21";"IC50";"'='";"4800.0";"nM";"5.32";"";"";"UO_0000065";"10.20";"0.19";"0.05";"8.73";"0";"CHEMBL750768";"Binding affinity towards the NPY Y2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147599";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2004";"None";"";"";""
"CHEMBL282057";"";"None";"469.59";"0";"3.63";"31";"CC(=O)N1CCc2ccc(N(C(=O)/C=C/C3N=CC=N3)C3CCN(Cc4ccccc4)CC3)cc21";"IC50";"'='";"17000.0";"nM";"4.77";"";"";"UO_0000065";"10.16";"0.19";"1.14";"6.95";"0";"CHEMBL750768";"Binding affinity towards the NPY Y2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147599";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2004";"None";"";"";""
"CHEMBL21997";"";"None";"465.60";"0";"4.92";"53";"CC(=O)N1CCc2ccc(N(C(=O)/C=C/c3ccccc3)C3CCN(Cc4ccccc4)C3)cc21";"IC50";"'='";"17500.0";"nM";"4.76";"";"";"UO_0000065";"10.22";"0.19";"-0.16";"10.85";"0";"CHEMBL750768";"Binding affinity towards the NPY Y2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147599";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2004";"None";"";"";""
"CHEMBL268554";"";"None";"595.69";"2";"5.93";"42";"CC(=O)N1CCc2ccc(N(C(=O)/C=C/c3cccc([S+]([O-])C(F)(F)F)c3)C3CCN(Cc4ccccc4)CC3)cc21";"IC50";"'='";"5800.0";"nM";"5.24";"";"";"UO_0000065";"8.79";"0.17";"-0.69";"7.83";"0";"CHEMBL750768";"Binding affinity towards the NPY Y2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147599";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2004";"None";"";"";""
"CHEMBL48449";"CANTHARIDIN";"4.0";"196.20";"0";"0.64";"CANTHARIDIN";"C[C@@]12C(=O)OC(=O)[C@]1(C)[C@H]1CC[C@@H]2O1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL499";"TIMOLOL";"4.0";"316.43";"0";"0.50";"TIMOLOL";"CC(C)(C)NC[C@H](O)COc1nsnc1N1CCOCC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1483";"ALBENDAZOLE";"4.0";"265.34";"0";"3.24";"ALBENDAZOLE";"CCCSc1ccc2[nH]c(NC(=O)OC)nc2c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1365675";"AMITRAZ";"2.0";"293.41";"0";"4.87";"AMITRAZ";"Cc1ccc(/N=C/N(C)/C=N/c2ccc(C)cc2C)c(C)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1201207";"BETAMETHASONE PHOSPHORIC ACID";"4.0";"472.45";"0";"2.01";"BETAMETHASONE PHOSPHATE";"C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COP(=O)(O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL4217524";"";"None";"1852.27";"None";"None";"12";"CC[C@@](C)(NC(=O)[C@H](CO)NC(C)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](CC1CCCCC1)C(=O)N[C@@H](CC1CCCCC1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)NC(C)(C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC1CCCCC1)C(N)=O)[C@@H](C)O";"IC50";"'='";"2.4";"nM";"8.62";"";"";"UO_0000065";"4.65";"None";"None";"None";"0";"CHEMBL4179032";"Displacement of [125I]-PYY from human neuropeptide Y2 receptor expressed in CHO cell membranes incubated for 60 mins by TopCount based method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4177573";"1";"Scientific Literature";"Bioorg Med Chem";"2017";"None";"";"";""
"CHEMBL4212566";"";"None";"1852.27";"None";"None";"11";"CC[C@](C)(NC(=O)[C@H](CO)NC(C)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](CC1CCCCC1)C(=O)N[C@@H](CC1CCCCC1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)NC(C)(C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC1CCCCC1)C(N)=O)[C@@H](C)O";"IC50";"'='";"1.8";"nM";"8.74";"";"";"UO_0000065";"4.72";"None";"None";"None";"0";"CHEMBL4179032";"Displacement of [125I]-PYY from human neuropeptide Y2 receptor expressed in CHO cell membranes incubated for 60 mins by TopCount based method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4177573";"1";"Scientific Literature";"Bioorg Med Chem";"2017";"None";"";"";""
"CHEMBL635";"PREDNISONE";"4.0";"358.43";"0";"1.77";"PREDNISONE";"C[C@]12C=CC(=O)C=C1CC[C@@H]1[C@@H]2C(=O)C[C@@]2(C)[C@H]1CC[C@]2(O)C(=O)CO";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL940";"GABAPENTIN";"4.0";"171.24";"0";"1.37";"GABAPENTIN";"NCC1(CC(=O)O)CCCCC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL277100";"TEMAFLOXACIN";"4.0";"417.39";"0";"2.90";"TEMAFLOXACIN";"CC1CN(c2cc3c(cc2F)c(=O)c(C(=O)O)cn3-c2ccc(F)cc2F)CCN1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1504083";"";"None";"375.58";"0";"4.55";"SID24800562";"CCOC(=O)C1(CCCc2ccccc2)CCN(C2CCSCC2)CC1";"IC50";"'>'";"35000.0";"nM";"";"";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1613986";"PUBCHEM_BIOASSAY: Dose response counterscreen assay for neuropeptide Y receptor Y1 (NPY-Y1): Cell-based high throughput assay to measure NPY-Y2 antagonism. (Class of assay: confirmatory) [Related pubchem assays: 793, 1040, 1255, 1254 ]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1533962";"";"None";"402.56";"0";"4.53";"SID14737824";"CCC(C)(C(=O)NC1CCCCC1)N(Cc1ccco1)C(=O)Cc1cccs1";"IC50";"'>'";"35000.0";"nM";"";"";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1613986";"PUBCHEM_BIOASSAY: Dose response counterscreen assay for neuropeptide Y receptor Y1 (NPY-Y1): Cell-based high throughput assay to measure NPY-Y2 antagonism. (Class of assay: confirmatory) [Related pubchem assays: 793, 1040, 1255, 1254 ]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1337101";"";"None";"356.47";"0";"2.38";"SID24826951";"CC(NC(=O)Cn1c(NCCO)nc2ccccc21)C1CC2CCC1C2";"IC50";"'>'";"35000.0";"nM";"";"";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1613986";"PUBCHEM_BIOASSAY: Dose response counterscreen assay for neuropeptide Y receptor Y1 (NPY-Y1): Cell-based high throughput assay to measure NPY-Y2 antagonism. (Class of assay: confirmatory) [Related pubchem assays: 793, 1040, 1255, 1254 ]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1546304";"";"None";"367.41";"0";"2.93";"SID24786472";"Cn1ccnc1C1CCCCN1Cc1nc(-c2ccc3c(c2)OCO3)no1";"IC50";"'>'";"35000.0";"nM";"";"";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1613986";"PUBCHEM_BIOASSAY: Dose response counterscreen assay for neuropeptide Y receptor Y1 (NPY-Y1): Cell-based high throughput assay to measure NPY-Y2 antagonism. (Class of assay: confirmatory) [Related pubchem assays: 793, 1040, 1255, 1254 ]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1407754";"";"None";"298.30";"0";"3.29";"SID863245";"COc1ccc(Oc2c[nH]nc2-c2ccc(O)cc2O)cc1";"IC50";"'>'";"35000.0";"nM";"";"";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1613986";"PUBCHEM_BIOASSAY: Dose response counterscreen assay for neuropeptide Y receptor Y1 (NPY-Y1): Cell-based high throughput assay to measure NPY-Y2 antagonism. (Class of assay: confirmatory) [Related pubchem assays: 793, 1040, 1255, 1254 ]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1550184";"";"None";"416.39";"0";"3.92";"SID24829580";"CC1CC(C)CN(C2=CC(=[N+]3CCCC3)CC(C)(C)C2)C1.[I-]";"IC50";"'>'";"35000.0";"nM";"";"";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1613986";"PUBCHEM_BIOASSAY: Dose response counterscreen assay for neuropeptide Y receptor Y1 (NPY-Y1): Cell-based high throughput assay to measure NPY-Y2 antagonism. (Class of assay: confirmatory) [Related pubchem assays: 793, 1040, 1255, 1254 ]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL531";"PERGOLIDE";"4.0";"314.50";"0";"4.27";"21";"CCCN1C[C@H](CSC)C[C@@H]2c3cccc4[nH]cc(c34)C[C@H]21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL121";"ROSIGLITAZONE";"4.0";"357.44";"0";"2.49";"rosiglitazone";"CN(CCOc1ccc(CC2SC(=O)NC2=O)cc1)c1ccccn1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL402794";"BIS(2-ETHYLHEXYL)PHTHALATE";"None";"390.56";"1";"6.43";"BIS(2-ETHYLHEXYL)PHTHALATE";"CCCC[C@@H](CC)COC(=O)c1ccccc1C(=O)OC[C@@H](CC)CCCC";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL195437";"4-OCTYLPHENOL";"None";"206.33";"0";"4.30";"4-OCTYLPHENOL";"CCCCCCCCc1ccc(O)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL245416";"L-MIMOSINE";"None";"198.18";"0";"-1.03";"L-MIMOSINE";"N[C@@H](Cn1ccc(=O)c(O)c1)C(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL157138";"LISURIDE";"4.0";"338.46";"0";"2.84";"LISURIDE";"CCN(CC)C(=O)N[C@H]1C=C2c3cccc4[nH]cc(c34)C[C@H]2N(C)C1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL9";"NORFLOXACIN";"4.0";"319.34";"0";"1.27";"NORFLOXACIN";"CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL2029961";"";"None";"486.56";"1";"5.93";"4";"OC(c1ccccc1)(c1ccccc1)C1CCN(C(=S)Nc2ccc(OC(F)(F)F)cc2)CC1";"IC50";"'='";"1047.0";"nM";"5.98";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2032840";"Antagonist activity at neuropeptide Y receptor Y2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2029318";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";"";""
"CHEMBL2030147";"";"None";"445.63";"1";"5.10";"7";"CN(C)c1ccc(NC(=S)N2CCC(C(O)(c3ccccc3)c3ccccc3)CC2)cc1";"IC50";"'='";"612.0";"nM";"6.21";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2032840";"Antagonist activity at neuropeptide Y receptor Y2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2029318";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";"";""
"CHEMBL2030187";"";"None";"431.53";"1";"5.23";"52";"CCOc1ccc(OC(=O)N2CCC(C(O)(c3ccccc3)c3ccccc3)CC2)cc1";"IC50";"'='";"1580.0";"nM";"5.80";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2032840";"Antagonist activity at neuropeptide Y receptor Y2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2029318";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";"";""
"CHEMBL1308461";"";"None";"281.36";"0";"3.92";"SID863607";"Cc1nc(N2CCC(C)CC2)c2oc3ccccc3c2n1";"IC50";"'='";"5766.0";"nM";"5.24";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614345";"PUBCHEM_BIOASSAY: Dose response cell-based screening assay for antagonists of neuropeptide Y receptor Y2 (NPY-Y2). (Class of assay: confirmatory) [Related pubchem assays: 793, 1257, 1256 ]";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1428935";"";"None";"373.80";"0";"4.84";"SID17504309";"N#CC(C#N)=C1C=CC=CN1/C(=C\c1ccco1)C(=O)c1ccc(Cl)cc1";"IC50";"'='";"3064.0";"nM";"5.51";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614345";"PUBCHEM_BIOASSAY: Dose response cell-based screening assay for antagonists of neuropeptide Y receptor Y2 (NPY-Y2). (Class of assay: confirmatory) [Related pubchem assays: 793, 1257, 1256 ]";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1507807";"";"None";"462.34";"1";"6.45";"SID14729317";"O=C(CCc1nc(-c2ccccc2)c(-c2ccccc2)o1)OCc1ccc(Br)cc1";"IC50";"'='";"15090.0";"nM";"4.82";"";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614345";"PUBCHEM_BIOASSAY: Dose response cell-based screening assay for antagonists of neuropeptide Y receptor Y2 (NPY-Y2). (Class of assay: confirmatory) [Related pubchem assays: 793, 1257, 1256 ]";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1168";"RAMIPRIL";"4.0";"416.52";"0";"2.38";"RAMIPRIL";"CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N1[C@H](C(=O)O)C[C@@H]2CCC[C@@H]21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL744";"RILUZOLE";"4.0";"234.20";"0";"2.78";"RILUZOLE";"Nc1nc2ccc(OC(F)(F)F)cc2s1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL972";"SELEGILINE";"4.0";"187.29";"0";"2.18";"SELEGILINE";"C#CCN(C)[C@H](C)Cc1ccccc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1200624";"ETHYNODIOL DIACETATE";"4.0";"384.52";"0";"4.43";"ETHYNODIOL DIACETATE";"C#C[C@]1(OC(C)=O)CC[C@H]2[C@@H]3CCC4=C[C@@H](OC(C)=O)CC[C@@H]4[C@H]3CC[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL6437";"MIANSERIN";"4.0";"264.37";"0";"3.08";"MIANSERIN";"CN1CCN2c3ccccc3Cc3ccccc3C2C1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL622";"ETODOLAC";"4.0";"287.36";"0";"3.38";"ETODOLAC";"CCc1cccc2c3c([nH]c12)C(CC)(CC(=O)O)OCC3";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL95963";"";"None";"428.60";"1";"6.09";"8";"CN(C)CCCN(C(=O)c1cc2ccccc2s1)c1ccccc1Cc1ccccc1";"IC50";"'='";"450.0";"nM";"6.35";"";"";"UO_0000065";"14.81";"0.28";"0.26";"26.95";"0";"CHEMBL3107075";"Displacement of [125I]-PYY from NPYY2 receptor (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3102719";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL3104124";"";"None";"465.57";"0";"4.80";"110";"CCC(CC)C(=O)Nc1ccc(N2CCN(C(c3ccccc3)c3nc(C)no3)CC2)c(F)c1";"IC50";"'='";"27.0";"nM";"7.57";"";"";"UO_0000065";"16.26";"0.30";"2.77";"10.16";"0";"CHEMBL3107076";"Displacement of [125I]-PYY from human NPYY2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3102719";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL3104117";"";"None";"507.65";"2";"5.51";"102";"CCC(CC)c1nc(-c2ccc(N3CCN(C(C(=O)N(CC)CC)c4ccccc4)CC3)c(F)c2)no1";"IC50";"'='";"480.0";"nM";"6.32";"";"";"UO_0000065";"12.45";"0.23";"0.81";"9.62";"0";"CHEMBL3107076";"Displacement of [125I]-PYY from human NPYY2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3102719";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL3104213";"";"None";"508.68";"2";"5.47";"70";"CCN(CC)C(=O)C(c1ccccc1)N1CCN(c2ccc(NC(=O)C3(C)CCCCC3)cc2F)CC1";"IC50";"'='";"70.0";"nM";"7.16";"";"";"UO_0000065";"14.07";"0.26";"1.68";"12.80";"0";"CHEMBL3107076";"Displacement of [125I]-PYY from human NPYY2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3102719";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL3104210";"";"None";"482.60";"0";"3.53";"67";"CCN(CC)C(=O)C(c1ccccc1)N1CCN(c2ccc(NC(=O)[C@H]3CCOC3)cc2F)CC1";"IC50";"'='";"65.0";"nM";"7.19";"";"";"UO_0000065";"14.89";"0.28";"3.66";"11.04";"0";"CHEMBL3107076";"Displacement of [125I]-PYY from human NPYY2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3102719";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL3104203";"";"None";"548.71";"2";"5.07";"59";"CCN(CC)C(=O)C(c1ccccc1)N1CCN(c2ccc(NC(=O)c3c(C)cnn3C(C)(C)C)cc2F)CC1";"IC50";"'='";"300.0";"nM";"6.52";"";"";"UO_0000065";"11.89";"0.22";"1.45";"8.85";"0";"CHEMBL3107076";"Displacement of [125I]-PYY from human NPYY2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3102719";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL417100";"";"None";"507.68";"2";"5.74";"45";"CC(=O)N1CCc2ccc(N(C(=O)/C=C/c3ccccc3)C3CCN(CCCc4ccccc4)CC3)cc21";"IC50";"'='";"2300.0";"nM";"5.64";"";"";"UO_0000065";"11.11";"0.20";"-0.10";"12.86";"1";"CHEMBL3107076";"Displacement of [125I]-PYY from human NPYY2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3102719";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL20773";"";"None";"547.62";"2";"6.33";"39";"CC(=O)N1CCc2ccc(N(C(=O)/C=C/c3ccc(C(F)(F)F)cc3)C3CCN(Cc4ccccc4)CC3)cc21";"IC50";"'='";"2800.0";"nM";"5.55";"";"";"UO_0000065";"10.14";"0.19";"-0.78";"12.66";"1";"CHEMBL3107076";"Displacement of [125I]-PYY from human NPYY2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3102719";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL429389";"";"None";"537.66";"1";"4.85";"11";"CCOC(=O)C(=O)N1CCc2ccc(N(C(=O)/C=C/c3ccccc3)C3CCN(Cc4ccccc4)CC3)cc21";"IC50";"'='";"4800.0";"nM";"5.32";"";"";"UO_0000065";"9.89";"0.18";"0.47";"7.58";"1";"CHEMBL3107076";"Displacement of [125I]-PYY from human NPYY2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3102719";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL279236";"";"None";"465.60";"0";"4.92";"10";"O=CN1CCc2ccc(N(C(=O)/C=C/c3ccccc3)C3CCN(Cc4ccccc4)CC3)cc21";"IC50";"'='";"3500.0";"nM";"5.46";"";"";"UO_0000065";"11.72";"0.21";"0.54";"12.44";"1";"CHEMBL3107076";"Displacement of [125I]-PYY from human NPYY2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3102719";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL1909067";"";"None";"None";"None";"None";"MC 258714";"";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL21731";"MAPROTILINE";"4.0";"277.41";"0";"4.21";"MAPROTILINE";"CNCCCC12CCC(c3ccccc31)c1ccccc12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL15770";"SULINDAC";"4.0";"356.42";"0";"4.37";"SULINDAC";"CC1=C(CC(=O)O)c2cc(F)ccc2/C1=C\c1ccc([S+](C)[O-])cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL820";"BUSULFAN";"4.0";"246.31";"0";"-0.28";"BUSULFAN";"CS(=O)(=O)OCCCCOS(C)(=O)=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1201216";"DAPIPRAZOLE";"4.0";"325.46";"0";"2.29";"DAPIPRAZOLE";"Cc1ccccc1N1CCN(CCc2nnc3n2CCCC3)CC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL898";"DIFLUNISAL";"4.0";"250.20";"0";"3.04";"DIFLUNISAL";"O=C(O)c1cc(-c2ccc(F)cc2F)ccc1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1460";"DIDANOSINE";"4.0";"236.23";"0";"-0.21";"DIDANOSINE";"O=c1[nH]cnc2c1ncn2[C@H]1CC[C@@H](CO)O1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL72";"DESIPRAMINE";"4.0";"266.39";"0";"3.53";"DESIPRAMINE";"CNCCCN1c2ccccc2CCc2ccccc21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1909048";"";"None";"313.83";"0";"4.43";"1-(2-CHLOROBENZOYL)-4-(PHENYLMETHYL)-PIPERIDINE";"O=C(c1ccccc1Cl)N1CCC(Cc2ccccc2)CC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL495778";"PENICILLIC ACID";"None";"170.16";"0";"0.34";"PENICILLIC ACID";"C=C(C)C1(O)OC(=O)C=C1OC";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1909056";"COBALT(II) ACETYLACETONATE";"None";"257.15";"None";"None";"COBALT(II) ACETYLACETONATE";"";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1370";"BUDESONIDE";"4.0";"430.54";"0";"2.72";"BUDESONIDE";"CCCC1O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO)O1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1255901";"HUPERZINE A";"2.0";"242.32";"0";"2.00";"HUPERZINE A";"C/C=C1\[C@H]2C=C(C)C[C@@]1(N)c1ccc(=O)[nH]c1C2";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL521";"IBUPROFEN";"4.0";"206.28";"0";"3.07";"IBUPROFEN";"CC(C)Cc1ccc(C(C)C(=O)O)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1537";"AZLOCILLIN";"4.0";"461.50";"0";"0.09";"AZLOCILLIN";"CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](NC(=O)N3CCNC3=O)c3ccccc3)C(=O)N2[C@H]1C(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL563";"FLURBIPROFEN";"4.0";"244.26";"0";"3.68";"FLURBIPROFEN";"CC(C(=O)O)c1ccc(-c2ccccc2)c(F)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1105";"6-METHOXY-2-NAPHTHYLACETIC ACID";"-1.0";"216.24";"0";"2.48";"6-METHOXY-2-NAPHTHYLACETIC ACID";"COc1ccc2cc(CC(=O)O)ccc2c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL22840";"";"None";"544.70";"2";"5.99";"57";"CC(=O)N1CCc2ccc(N(C(=O)/C=C/c3cccc([N+](=O)[O-])c3)C3CCN(CCC4CCCCC4)CC3)cc21";"IC50";"'='";"500.0";"nM";"6.30";"";"";"UO_0000065";"11.57";"0.22";"0.31";"7.24";"0";"CHEMBL750768";"Binding affinity towards the NPY Y2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147599";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2004";"None";"";"";""
"CHEMBL163";"RITONAVIR";"4.0";"720.96";"2";"5.91";"RITONAVIR";"CC(C)c1nc(CN(C)C(=O)N[C@H](C(=O)N[C@@H](Cc2ccccc2)C[C@H](O)[C@H](Cc2ccccc2)NC(=O)OCc2cncs2)C(C)C)cs1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL253376";"BROMHEXINE";"4.0";"376.14";"0";"4.56";"BROMHEXINE";"CN(Cc1cc(Br)cc(Br)c1N)C1CCCCC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL238071";"VINDESINE";"4.0";"753.94";"1";"2.73";"VINDESINE";"CC[C@]1(O)C[C@@H]2CN(CCc3c([nH]c4ccccc34)[C@@](C(=O)OC)(c3cc4c(cc3OC)N(C)[C@H]3[C@@](O)(C(N)=O)[C@H](O)[C@]5(CC)C=CCN6CC[C@]43[C@@H]65)C2)C1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL27577";"SALICYLAMIDE";"2.0";"137.14";"0";"0.49";"SALICYLAMIDE";"NC(=O)c1ccccc1O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1386";"TRANSPLATIN";"3.0";"300.05";"None";"None";"TRANS-PLATINUM(II)DIAMMINE DICHLORIDE";"";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1082";"AMOXICILLIN";"4.0";"365.41";"0";"0.02";"AMOXICILLIN";"CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](N)c3ccc(O)cc3)C(=O)N2[C@H]1C(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL42710";"EUGENOL";"0.5";"164.20";"0";"2.13";"EUGENOL";"C=CCc1ccc(O)c(OC)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL2220442";"FLUVASTATIN";"4.0";"411.47";"0";"4.63";"FLUVASTATIN";"CC(C)n1c(/C=C/C(O)CC(O)CC(=O)O)c(-c2ccc(F)cc2)c2ccccc21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1201195";"CEFMETAZOLE";"4.0";"471.55";"1";"-0.73";"CEFMETAZOLE";"CO[C@@]1(NC(=O)CSCC#N)C(=O)N2C(C(=O)O)=C(CSc3nnnn3C)CS[C@@H]21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL268291";"DIMETHYLFORMAMIDE";"None";"73.10";"0";"-0.30";"N,N-DIMETHYLFORMAMIDE";"CN(C)C=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL547";"ISOTRETINOIN";"4.0";"300.44";"1";"5.60";"ISOTRETINOIN";"CC1=C(/C=C/C(C)=C/C=C/C(C)=C\C(=O)O)C(C)(C)CCC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL40";"PHENOBARBITAL";"4.0";"232.24";"0";"0.70";"PHENOBARBITAL";"CCC1(c2ccccc2)C(=O)NC(=O)NC1=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL42686";"";"None";"500.60";"2";"1.91";"14 (R)";"N=C(N)NCCCC(NC(=O)C(c1ccccc1)c1ccccc1)C(=O)N[C@@H](C(N)=O)c1ccccc1";"IC50";"'>'";"400000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL747056";"Inhibition of binding of [3H]propionyl-NPY (1 nM) to Neuropeptide Y receptor type 2 in SMS-KAN cell membranes";"B";"BAO_0000219";"cell-based format";"None";"None";"None";"SMS-KAN";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1133238";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2000";"None";"";"";""
"CHEMBL438945";"HUMAN NEUROPEPTIDE Y";"1.0";"4271.75";"None";"None";"NPY-H";"CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O)[C@@H](C)CC";"IC50";"'='";"0.5";"nM";"9.30";"";"";"UO_0000065";"2.18";"None";"None";"None";"0";"CHEMBL750765";"Compound was evaluated for its inhibitory activity against Y2 receptor of rabbit kidney membrane";"B";"BAO_0000019";"assay format";"Oryctolagus cuniculus";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1126482";"1";"Scientific Literature";"Bioorg Med Chem Lett";"1993";"None";"";"";""
"CHEMBL1609697";"";"None";"479.56";"0";"3.49";"SID14725751";"O=C(NC1CCCCC1)C(c1ccncc1)N(Cc1ccc2c(c1)OCO2)C(=O)c1cnsn1";"IC50";"'>'";"35000.0";"nM";"";"";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1613986";"PUBCHEM_BIOASSAY: Dose response counterscreen assay for neuropeptide Y receptor Y1 (NPY-Y1): Cell-based high throughput assay to measure NPY-Y2 antagonism. (Class of assay: confirmatory) [Related pubchem assays: 793, 1040, 1255, 1254 ]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1545205";"";"None";"323.39";"0";"4.54";"SID22408684";"CC(C)(C)NC(=O)c1oc2ccccc2c1COc1ccccc1";"IC50";"'>'";"35000.0";"nM";"";"";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1613986";"PUBCHEM_BIOASSAY: Dose response counterscreen assay for neuropeptide Y receptor Y1 (NPY-Y1): Cell-based high throughput assay to measure NPY-Y2 antagonism. (Class of assay: confirmatory) [Related pubchem assays: 793, 1040, 1255, 1254 ]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1407634";"";"None";"447.22";"1";"5.58";"SID14729000";"Cc1c(OCc2c(F)cccc2Cl)c(=O)ccn1-c1ncc(C(F)(F)F)cc1Cl";"IC50";"'='";"10810.0";"nM";"4.97";"";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1613986";"PUBCHEM_BIOASSAY: Dose response counterscreen assay for neuropeptide Y receptor Y1 (NPY-Y1): Cell-based high throughput assay to measure NPY-Y2 antagonism. (Class of assay: confirmatory) [Related pubchem assays: 793, 1040, 1255, 1254 ]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL4211438";"";"None";"1912.32";"None";"None";"20";"CC(C)C[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC1CCCCC1)NC(=O)[C@H](CC1CCCCC1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H]1CCCN1C(=O)[C@H](CO)NC(=O)c1ccccc1)C(=O)NC(C)(C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC1CCCCC1)C(N)=O)[C@@H](C)O";"IC50";"'='";"1.5";"nM";"8.82";"";"";"UO_0000065";"4.61";"None";"None";"None";"0";"CHEMBL4179032";"Displacement of [125I]-PYY from human neuropeptide Y2 receptor expressed in CHO cell membranes incubated for 60 mins by TopCount based method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4177573";"1";"Scientific Literature";"Bioorg Med Chem";"2017";"None";"";"";""
"CHEMBL4208856";"";"None";"1864.28";"None";"None";"6";"CC[C@@](C)(NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC1CCCCC1)NC(=O)[C@H](CC1CCCCC1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H]1CCCN1C(=O)[C@H](CO)NC(C)=O)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC1CCCCC1)C(N)=O)[C@@H](C)O";"IC50";"'='";"0.67";"nM";"9.17";"";"";"UO_0000065";"4.92";"None";"None";"None";"0";"CHEMBL4179032";"Displacement of [125I]-PYY from human neuropeptide Y2 receptor expressed in CHO cell membranes incubated for 60 mins by TopCount based method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4177573";"1";"Scientific Literature";"Bioorg Med Chem";"2017";"None";"";"";""
"CHEMBL306277";"";"None";"390.48";"0";"4.85";"44e";"C[C@H]([C@@H](O)c1ccccc1)N(C)C(=O)Nc1ccc(OCc2ccccc2)cc1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL749564";"Inhibitory activity tested against Human Neuropeptide Y2 Receptor.";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1134441";"1";"Scientific Literature";"J Med Chem";"2001";"None";"";"";""
"CHEMBL4064467";"";"None";"1782.13";"None";"None";"14";"CC(=O)N[C@@H](CO)C(=O)N1CCC[C@@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)NC(C)(C)C(=O)N[C@@H](CC1CCCCC1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)NC(C)(C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC1CCCCC1)C(N)=O)[C@@H](C)O";"IC50";"'='";"2.6";"nM";"8.59";"";"";"UO_0000065";"4.82";"None";"None";"None";"0";"CHEMBL4056968";"Displacement of [125I]peptide YY from human Y2 receptor expressed in CHO cell membranes after 60 mins by TopCount scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4052740";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";""
"CHEMBL4075287";"";"None";"1845.19";"None";"None";"12";"CC(=O)N[C@@H](CO)C(=O)N1CCC[C@@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](CC1CCCCC1)C(=O)N[C@@H](Cc1ccncc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)NC(C)(C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC1CCCCC1)C(N)=O)[C@@H](C)O";"IC50";"'='";"2.5";"nM";"8.60";"";"";"UO_0000065";"4.66";"None";"None";"None";"0";"CHEMBL4056968";"Displacement of [125I]peptide YY from human Y2 receptor expressed in CHO cell membranes after 60 mins by TopCount scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4052740";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";""
"CHEMBL1509886";"";"None";"349.19";"1";"5.24";"SID17512715";"Cc1nc2ccc(F)cc2cc1C(=O)Nc1ccc(Cl)c(Cl)c1";"IC50";"'='";"8884.0";"nM";"5.05";"";"Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614345";"PUBCHEM_BIOASSAY: Dose response cell-based screening assay for antagonists of neuropeptide Y receptor Y2 (NPY-Y2). (Class of assay: confirmatory) [Related pubchem assays: 793, 1257, 1256 ]";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL4075597";"";"None";"1866.25";"None";"None";"18";"CC(=O)N[C@@H](CO)C(=O)N1C[C@@H](O)C[C@@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)NC(CC1CCCCC1)C(=O)NC(CC1CCCCC1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)NC(C)(C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NC(CC1CCCCC1)C(N)=O)[C@@H](C)O";"IC50";"'='";"0.7";"nM";"9.15";"";"";"UO_0000065";"4.91";"None";"None";"None";"0";"CHEMBL4036757";"Displacement of [125I]-PYY from human Y2R expressed in CHO cell membranes after 60 mins by liquid scintillation method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4033754";"1";"Scientific Literature";"ACS Med Chem Lett";"2017";"None";"";"";""
"CHEMBL1404069";"";"None";"415.45";"0";"4.60";"SF-31";"COc1cccc(-c2nc(-c3ccc(NC(=O)Cc4ccccc4OC)cc3)no2)c1";"IC50";"'='";"1200.0";"nM";"5.92";"";"";"UO_0000065";"";"";"";"";"1";"CHEMBL3106332";"Antagonist activity at NPYY2 receptor (unknown origin) by cAMP biosensor assay";"F";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3102719";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL1501390";"";"None";"298.30";"0";"3.29";"SID862846";"COc1cccc(Oc2c[nH]nc2-c2ccc(O)cc2O)c1";"IC50";"'>'";"35000.0";"nM";"";"";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1613986";"PUBCHEM_BIOASSAY: Dose response counterscreen assay for neuropeptide Y receptor Y1 (NPY-Y1): Cell-based high throughput assay to measure NPY-Y2 antagonism. (Class of assay: confirmatory) [Related pubchem assays: 793, 1040, 1255, 1254 ]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1525599";"";"None";"433.35";"0";"4.53";"SID24829750";"COc1ccccc1-n1c(-c2ccccc2)c[n+]2c1CCc1ccccc1-2.[Br-]";"IC50";"'='";"11610.0";"nM";"4.93";"";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1613986";"PUBCHEM_BIOASSAY: Dose response counterscreen assay for neuropeptide Y receptor Y1 (NPY-Y1): Cell-based high throughput assay to measure NPY-Y2 antagonism. (Class of assay: confirmatory) [Related pubchem assays: 793, 1040, 1255, 1254 ]";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL2307889";"";"None";"896.07";"3";"3.49";"BIIE0246";"N=C(N)NCCC[C@@H](NC(=O)CC1(CC(=O)N2CCN(C3c4ccccc4NC(=O)c4ccccc43)CC2)CCCC1)C(=O)NCCn1c(=O)n(-c2ccccc2)n(-c2ccccc2)c1=O";"IC50";"'='";"3.3";"nM";"8.48";"";"";"UO_0000065";"9.47";"0.18";"4.99";"3.83";"1";"CHEMBL3107081";"Displacement of [125I]-NPY from NPYY2 receptor (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3102719";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL4216997";"";"None";"1793.20";"None";"None";"9";"CC[C@@](C)(NC(=O)[C@H]1CCCN1C(=O)[C@H](CO)NC(C)=O)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](CC1CCCCC1)C(=O)N[C@@H](CC1CCCCC1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)NC(C)(C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC1CCCCC1)C(N)=O)[C@@H](C)O";"IC50";"'='";"3.8";"nM";"8.42";"";"";"UO_0000065";"4.70";"None";"None";"None";"0";"CHEMBL4179032";"Displacement of [125I]-PYY from human neuropeptide Y2 receptor expressed in CHO cell membranes incubated for 60 mins by TopCount based method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4177573";"1";"Scientific Literature";"Bioorg Med Chem";"2017";"None";"";"";""
"CHEMBL4214907";"";"None";"1908.29";"None";"None";"22";"CC(C)C[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC1CCCCC1)NC(=O)[C@H](CC1CCCCC1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H]1CCCN1C(=O)[C@H](CO)NC(=O)CCC(=O)O)C(=O)NC(C)(C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC1CCCCC1)C(N)=O)[C@@H](C)O";"IC50";"'='";"2.3";"nM";"8.64";"";"";"UO_0000065";"4.53";"None";"None";"None";"0";"CHEMBL4179032";"Displacement of [125I]-PYY from human neuropeptide Y2 receptor expressed in CHO cell membranes incubated for 60 mins by TopCount based method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4177573";"1";"Scientific Literature";"Bioorg Med Chem";"2017";"None";"";"";""
"CHEMBL3102872";"";"None";"444.64";"1";"6.07";"2";"CN(C)CCCN(C(=O)[C@H]1C[C@@H]1c1ccccc1)c1ccccc1SCc1ccccc1";"IC50";"'='";"3700.0";"nM";"5.43";"";"";"UO_0000065";"12.22";"0.23";"-0.64";"23.06";"0";"CHEMBL3107075";"Displacement of [125I]-PYY from NPYY2 receptor (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3102719";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL328860";"";"None";"430.62";"1";"5.98";"1";"CN(C)CCCN(C(=O)/C=C/c1ccccc1)c1ccccc1SCc1ccccc1";"IC50";"'='";"10000.0";"nM";"5.00";"";"";"UO_0000065";"11.61";"0.22";"-0.98";"21.23";"1";"CHEMBL3107075";"Displacement of [125I]-PYY from NPYY2 receptor (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3102719";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL3104190";"";"None";"449.57";"0";"4.26";"97";"CCN(CC)C(=O)C(c1ccccc1)N1CCN(c2ccc(-c3cc(C)n[nH]3)cc2F)CC1";"IC50";"'='";"810.0";"nM";"6.09";"";"";"UO_0000065";"13.55";"0.25";"1.83";"10.98";"0";"CHEMBL3107076";"Displacement of [125I]-PYY from human NPYY2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3102719";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL3104199";"";"None";"518.62";"2";"5.21";"82";"CCC(CC)C(=O)Nc1ccc(N2CCN(C(C(=O)N(CC)CC)c3ccc(F)cc3F)CC2)c(F)c1";"IC50";"'='";"150.0";"nM";"6.82";"";"";"UO_0000065";"13.16";"0.25";"1.61";"12.21";"0";"CHEMBL3107076";"Displacement of [125I]-PYY from human NPYY2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3102719";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL21728";"";"None";"485.67";"1";"5.69";"46";"CC(=O)N1CCc2ccc(N(C(=O)/C=C/c3ccccc3)C3CCN(CC4CCCCC4)CC3)cc21";"IC50";"'='";"1100.0";"nM";"5.96";"";"";"UO_0000065";"12.27";"0.23";"0.27";"13.59";"1";"CHEMBL3107076";"Displacement of [125I]-PYY from human NPYY2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3102719";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL3104221";"";"None";"493.65";"1";"5.40";"22";"CC(=O)N1CCc2ccc(N(C(=O)[C@H]3C[C@@H]3c3ccccc3)C3CCN(Cc4ccccc4)CC3)cc21";"IC50";"'='";"11000.0";"nM";"4.96";"";"";"UO_0000065";"10.04";"0.18";"-0.44";"11.31";"0";"CHEMBL3107076";"Displacement of [125I]-PYY from human NPYY2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3102719";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL279493";"";"None";"451.57";"0";"4.89";"18";"O=C1Cc2ccc(N(C(=O)/C=C/c3ccccc3)C3CCN(Cc4ccccc4)CC3)cc2N1";"IC50";"'='";"30000.0";"nM";"4.52";"";"";"UO_0000065";"10.02";"0.18";"-0.37";"8.59";"1";"CHEMBL3107076";"Displacement of [125I]-PYY from human NPYY2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3102719";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL3578016";"";"None";"2928.54";"None";"None";"4d";"CC(=O)N[C@@H](CCCCNC(=O)CCCCCNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](Cc1cccc2ccccc12)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O";"IC50";"'='";"9.0";"nM";"8.05";"";"";"UO_0000065";"2.75";"None";"None";"None";"0";"CHEMBL3579806";"Displacement of [125I]PYY from human neuropeptide Y Y2 receptor expressed in HEK293 cells cotransfected with eYFP fusion protein after 2 hrs by competitive receptor binding assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3576822";"1";"Scientific Literature";"J Med Chem";"2015";"CHEMBL3307715";"";"";""
"CHEMBL3578018";"";"None";"2985.59";"None";"None";"5b";"CC(=O)NC(CNC(=O)CCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1cccc2ccccc12)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O";"IC50";"'='";"9.7";"nM";"8.01";"";"";"UO_0000065";"2.68";"None";"None";"None";"0";"CHEMBL3579806";"Displacement of [125I]PYY from human neuropeptide Y Y2 receptor expressed in HEK293 cells cotransfected with eYFP fusion protein after 2 hrs by competitive receptor binding assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3576822";"1";"Scientific Literature";"J Med Chem";"2015";"CHEMBL3307715";"";"";""
"CHEMBL21652";"";"None";"507.68";"2";"5.92";"41";"CC(=O)N1CCc2ccc(N(C(=O)/C=C/c3cc(C)cc(C)c3)C3CCN(Cc4ccccc4)CC3)cc21";"IC50";"'='";"3900.0";"nM";"5.41";"";"";"UO_0000065";"10.65";"0.19";"-0.51";"12.33";"1";"CHEMBL3107076";"Displacement of [125I]-PYY from human NPYY2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3102719";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL4210786";"";"None";"1861.23";"None";"None";"31";"CC[C@](C)(NC(=O)[C@H]1C[C@H](O)CN1C(=O)[C@H](CO)NC(=O)c1c[nH]cn1)C(=O)N[C@@H](Cc1ccncc1)C(=O)N[C@@H](CC1CCCCC1)C(=O)N[C@@H](CC(C)(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)NC(C)(C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC1CCCCC1)C(N)=O)[C@@H](C)O";"IC50";"'='";"0.31";"nM";"9.51";"";"";"UO_0000065";"5.11";"None";"None";"None";"0";"CHEMBL4179032";"Displacement of [125I]-PYY from human neuropeptide Y2 receptor expressed in CHO cell membranes incubated for 60 mins by TopCount based method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4177573";"1";"Scientific Literature";"Bioorg Med Chem";"2017";"None";"";"";""
"CHEMBL4225372";"";"None";"2678.35";"None";"None";"12";"CC[C@](C)(NC(=O)[C@H]1C[C@H](O)CN1C(=O)[C@H](CO)NC(=O)COCC(=O)NCCCOCCOCCOCCCNC(=O)CC[C@H](NC(=O)[C@H]1CC[C@H](CNC(=O)CCCCCCCCCCCCCCCCCCC(=O)O)CC1)C(=O)O)C(=O)N[C@@H](Cc1ccncc1)C(=O)N[C@@H](CC1CCCCC1)C(=O)N[C@@H](CC(C)(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)NC(C)(C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC1CCCCC1)C(N)=O)[C@@H](C)O";"IC50";"'='";"13.0";"nM";"7.89";"";"";"UO_0000065";"2.94";"None";"None";"None";"0";"CHEMBL4220285";"Displacement of [125I]-PYY from human neuropeptide Y2 receptor expressed in CHO cell membranes incubated for 60 mins by TopCount micro scintillation analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4219053";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";"";"";""
"CHEMBL295416";"PIRINIXIC ACID";"2.0";"323.81";"0";"3.67";"PIRINIXIC ACID";"Cc1cccc(Nc2cc(Cl)nc(SCC(=O)O)n2)c1C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL13209";"NITRAZEPAM";"4.0";"281.27";"0";"2.38";"NITRAZEPAM";"O=C1CN=C(c2ccccc2)c2cc([N+](=O)[O-])ccc2N1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1200431";"GADOPENTETATE DIMEGLUMINE";"4.0";"742.79";"None";"None";"GADOPENTETATE DIMEGLUMINE";"";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL506";"PRIMAQUINE";"4.0";"259.35";"0";"2.78";"PRIMAQUINE";"COc1cc(NC(C)CCCN)c2ncccc2c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1201151";"MESTRANOL";"4.0";"310.44";"0";"3.92";"MESTRANOL";"C#C[C@]1(O)CC[C@H]2[C@@H]3CCc4cc(OC)ccc4[C@H]3CC[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL625";"THIABENDAZOLE";"4.0";"201.25";"0";"2.69";"thiabendazole";"c1ccc2[nH]c(-c3cscn3)nc2c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL852";"MELPHALAN";"4.0";"305.21";"0";"1.93";"MELPHALAN";"N[C@@H](Cc1ccc(N(CCCl)CCCl)cc1)C(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL427526";"(R)-IBUPROPHEN";"1.0";"206.28";"0";"3.07";"R(-)-IBUPROFEN";"CC(C)Cc1ccc([C@@H](C)C(=O)O)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL429023";"ROTENONE";"None";"394.42";"0";"3.70";"rotenone";"C=C(C)[C@H]1Cc2c(ccc3c2O[C@@H]2COc4cc(OC)c(OC)cc4[C@@H]2C3=O)O1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL2030179";"";"None";"510.69";"1";"3.68";"40";"CN(C)S(=O)(=O)c1ccc(NC(=S)N2CCC(C(O)(c3ccccc3)c3ccccn3)CC2)cc1";"IC50";"'='";"98.0";"nM";"7.01";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2032840";"Antagonist activity at neuropeptide Y receptor Y2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2029318";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";"";""
"CHEMBL2030192";"";"None";"479.60";"0";"4.63";"57";"CCS(=O)(=O)c1ccc(OC(=O)N2CCC(C(O)(c3ccccc3)c3ccccc3)CC2)cc1";"IC50";"'='";"59.0";"nM";"7.23";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2032840";"Antagonist activity at neuropeptide Y receptor Y2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2029318";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";"";""
"CHEMBL2030196";"";"None";"480.59";"0";"4.21";"63";"CS(=O)(=O)Nc1ccc(OC(=O)N2CCC(C(O)(c3ccccc3)c3ccccc3)CC2)cc1";"IC50";"'='";"394.0";"nM";"6.41";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2032840";"Antagonist activity at neuropeptide Y receptor Y2";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2029318";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";"";""
"CHEMBL1534058";"";"None";"330.48";"0";"3.68";"SID14732377";"Cc1cccc(NC(S)=NN=C(S)NCc2ccccc2)c1";"IC50";"'>'";"35000.0";"nM";"";"";"Not Active";"UO_0000065";"";"";"";"";"0";"CHEMBL1614345";"PUBCHEM_BIOASSAY: Dose response cell-based screening assay for antagonists of neuropeptide Y receptor Y2 (NPY-Y2). (Class of assay: confirmatory) [Related pubchem assays: 793, 1257, 1256 ]";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL22105";"";"None";"481.64";"1";"5.23";"18";"CC(=O)N1CCc2ccc(N(C(=O)CCc3ccccc3)C3CCN(Cc4ccccc4)CC3)cc21";"IC50";"'='";"18000.0";"nM";"4.75";"";"";"UO_0000065";"9.85";"0.18";"-0.49";"10.82";"0";"CHEMBL750768";"Binding affinity towards the NPY Y2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147599";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2004";"None";"";"";""
"CHEMBL1221512";"";"None";"559.80";"1";"1.75";"L-744832";"CC[C@H](C)[C@@H](CO[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCS(C)(=O)=O)C(=O)OC(C)C)NC[C@@H](N)CS";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL84";"TOPOTECAN";"4.0";"421.45";"0";"1.85";"TPT";"CC[C@@]1(O)C(=O)OCc2c1cc1n(c2=O)Cc2cc3c(CN(C)C)c(O)ccc3nc2-1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1200629";"VECURONIUM BROMIDE";"4.0";"637.74";"2";"5.97";"VECURONIUM BROMIDE";"CC(=O)O[C@H]1C[C@@H]2CC[C@@H]3[C@H](CC[C@@]4(C)[C@H]3C[C@H]([N+]3(C)CCCCC3)[C@@H]4OC(C)=O)[C@@]2(C)C[C@@H]1N1CCCCC1.[Br-]";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL413";"SIROLIMUS";"4.0";"914.19";"3";"6.18";"RAPAMYCIN";"CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL503";"LOVASTATIN";"4.0";"404.55";"0";"4.20";"LOVASTATIN";"CC[C@H](C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@H]21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1087";"MEPIVACAINE";"4.0";"246.35";"0";"2.73";"MEPIVACAINE";"Cc1cccc(C)c1NC(=O)C1CCCCN1C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1200559";"LACTIC ACID";"4.0";"90.08";"0";"-0.55";"LACTIC ACID";"CC(O)C(=O)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL447";"SECOBARBITAL";"4.0";"238.29";"0";"1.35";"SECOBARBITAL";"C=CCC1(C(C)CCC)C(=O)NC(=O)NC1=O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL479";"THIORIDAZINE";"4.0";"370.59";"1";"5.89";"THIORIDAZINE";"CSc1ccc2c(c1)N(CCC1CCCCN1C)c1ccccc1S2";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL130";"CHLORAMPHENICOL";"4.0";"323.13";"0";"0.91";"CHLORAMPHENICOL";"O=C(N[C@H](CO)[C@H](O)c1ccc([N+](=O)[O-])cc1)C(Cl)Cl";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1381098";"1-NAPHTHYLISOTHIOCYANATE";"None";"185.25";"0";"3.57";"1-NAPHTHYL ISOTHIOCYANATE";"S=C=Nc1cccc2ccccc12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1823341";"";"None";"465.00";"1";"5.05";"2, GSK";"COc1cccnc1C(=O)N1CCN(c2ccc(NC(C)(C)c3ccccc3)cc2Cl)CC1";"IC50";"'='";"25.0";"nM";"7.60";"";"";"UO_0000065";"16.35";"0.31";"2.55";"13.18";"0";"CHEMBL1827365";"Displacement of [125I]PYY from human NPY Y2 receptor expressed endogenously in KAN-Ts cells by scintillation counting";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"KAN-Ts";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1821563";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";"";""
"CHEMBL21283";"";"None";"510.68";"2";"5.56";"4, JNJ-5207787";"CC(=O)N1CCc2ccc(N(C(=O)/C=C/c3cccc(C#N)c3)C3CCN(CCC4CCCC4)CC3)cc21";"IC50";"'='";"100.0";"nM";"7.00";"";"";"UO_0000065";"13.71";"0.25";"1.44";"10.35";"1";"CHEMBL1827365";"Displacement of [125I]PYY from human NPY Y2 receptor expressed endogenously in KAN-Ts cells by scintillation counting";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"KAN-Ts";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1821563";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";"";""
"CHEMBL1823348";"";"None";"519.65";"2";"5.95";"17";"COC(=O)C(c1ccccc1)N1CCN(c2ccc(NC(=O)c3ccccc3-c3ccccc3)cc2C)CC1";"IC50";"'='";"100.0";"nM";"7.00";"";"";"UO_0000065";"13.47";"0.25";"1.05";"11.31";"0";"CHEMBL1827365";"Displacement of [125I]PYY from human NPY Y2 receptor expressed endogenously in KAN-Ts cells by scintillation counting";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"KAN-Ts";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1821563";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";"";""
"CHEMBL1823350";"";"None";"524.60";"2";"5.18";"19";"COC(=O)C(c1ccccc1)N1CCN(c2ccc(NC(=O)c3ccccc3-c3cccnc3)cc2F)CC1";"IC50";"'='";"40.0";"nM";"7.40";"";"";"UO_0000065";"14.10";"0.26";"2.22";"9.89";"0";"CHEMBL1827365";"Displacement of [125I]PYY from human NPY Y2 receptor expressed endogenously in KAN-Ts cells by scintillation counting";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"KAN-Ts";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1821563";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";"";""
"CHEMBL1823352";"";"None";"441.55";"0";"4.24";"21";"CCC(CC)C(=O)Nc1ccc(N2CCN(C(C(=O)OC)c3ccccc3)CC2)c(F)c1";"IC50";"'='";"165.0";"nM";"6.78";"";"";"UO_0000065";"15.36";"0.29";"2.54";"10.96";"0";"CHEMBL1827365";"Displacement of [125I]PYY from human NPY Y2 receptor expressed endogenously in KAN-Ts cells by scintillation counting";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"KAN-Ts";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1821563";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";"";""
"CHEMBL1823355";"";"None";"537.64";"2";"5.14";"24";"CCNC(=O)C(c1ccccc1)N1CCN(c2ccc(NC(=O)c3ccccc3-c3cccnc3)cc2F)CC1";"IC50";"'='";"42.0";"nM";"7.38";"";"";"UO_0000065";"13.72";"0.25";"2.24";"9.51";"0";"CHEMBL1827365";"Displacement of [125I]PYY from human NPY Y2 receptor expressed endogenously in KAN-Ts cells by scintillation counting";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"KAN-Ts";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1821563";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";"";""
"CHEMBL1823357";"";"None";"454.59";"0";"4.20";"26";"CCNC(=O)C(c1ccccc1)N1CCN(c2ccc(NC(=O)C(CC)CC)cc2F)CC1";"IC50";"'='";"370.0";"nM";"6.43";"";"";"UO_0000065";"14.15";"0.27";"2.23";"9.94";"0";"CHEMBL1827365";"Displacement of [125I]PYY from human NPY Y2 receptor expressed endogenously in KAN-Ts cells by scintillation counting";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"KAN-Ts";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1821563";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";"";""
"CHEMBL1823578";"";"None";"565.69";"2";"5.87";"5S, (S)-(+)-JNJ 31020028";"CCN(CC)C(=O)[C@H](c1ccccc1)N1CCN(c2ccc(NC(=O)c3ccccc3-c3cccnc3)cc2F)CC1";"IC50";"'='";"14.0";"nM";"7.85";"";"";"UO_0000065";"13.88";"0.26";"1.98";"11.42";"0";"CHEMBL1827365";"Displacement of [125I]PYY from human NPY Y2 receptor expressed endogenously in KAN-Ts cells by scintillation counting";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"KAN-Ts";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1821563";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";"";""
"CHEMBL17157";"TERFENADINE";"4.0";"471.69";"1";"6.45";"TERFENADINE";"CC(C)(C)c1ccc(C(O)CCCN2CCC(C(O)(c3ccccc3)c3ccccc3)CC2)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL374478";"RIFAMPIN";"4.0";"822.95";"3";"4.34";"RIFAMPIN";"CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C)c(O)c4c(O)c(c(/C=N/N5CCN(C)CC5)c(O)c4c3C2=O)NC(=O)/C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL850";"SPARFLOXACIN";"4.0";"392.41";"0";"2.08";"SPARFLOXACIN";"C[C@@H]1CN(c2c(F)c(N)c3c(=O)c(C(=O)O)cn(C4CC4)c3c2F)C[C@H](C)N1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL828";"PHENOTHIAZINE";"2.0";"199.28";"0";"3.89";"PHENOTHIAZINE";"c1ccc2c(c1)Nc1ccccc1S2";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL80";"NALOXONE";"4.0";"327.38";"0";"1.30";"NALOXONE";"C=CCN1CC[C@]23c4c5ccc(O)c4O[C@H]2C(=O)CC[C@@]3(O)[C@H]1C5";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL3350037";"";"None";"1019.26";"None";"None";"OCTREOTIDE";"C[C@@H](O)[C@H](CO)NC(=O)[C@@H]1CSSC[C@H](NC(=O)[C@H](N)Cc2ccccc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@H](Cc2c[nH]c3ccccc23)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL487894";"DIPYRONE SODIUM";"None";"333.35";"0";"0.77";"DIPYRONE";"Cc1c(N(C)CS(=O)(=O)[O-])c(=O)n(-c2ccccc2)n1C.[Na+]";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL296419";"ASTEMIZOLE";"4.0";"458.58";"1";"5.35";"ASTEMIZOLE";"COc1ccc(CCN2CCC(Nc3nc4ccccc4n3Cc3ccc(F)cc3)CC2)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL184";"ACYCLOVIR";"4.0";"225.21";"0";"-1.33";"ACYCLOVIR";"Nc1nc2c(ncn2COCCO)c(=O)[nH]1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1399";"ANASTROZOLE";"4.0";"293.37";"0";"2.93";"ANASTROZOLE";"CC(C)(C#N)c1cc(Cn2cncn2)cc(C(C)(C)C#N)c1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL310555";"OXYQUINOLINE";"-1.0";"145.16";"0";"1.94";"OXYQUINOLINE";"Oc1cccc2cccnc12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1490";"TRIHEXYPHENIDYL";"4.0";"301.47";"0";"4.33";"TRIHEXYPHENIDYL";"OC(CCN1CCCCC1)(c1ccccc1)C1CCCCC1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL416";"METHOXSALEN";"4.0";"216.19";"0";"2.55";"SID99459";"COc1c2occc2cc2ccc(=O)oc12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1068";"OXCARBAZEPINE";"4.0";"252.27";"0";"2.64";"OXCARBAZEPINE";"NC(=O)N1c2ccccc2CC(=O)c2ccccc21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1732";"DIHYDROERGOTAMINE";"4.0";"583.69";"1";"2.08";"DIHYDROERGOTAMINE";"CN1C[C@H](C(=O)N[C@]2(C)O[C@@]3(O)[C@@H]4CCCN4C(=O)[C@H](Cc4ccccc4)N3C2=O)C[C@@H]2c3cccc4[nH]cc(c34)C[C@H]21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1823349";"";"None";"506.61";"2";"5.04";"18";"COC(=O)C(c1ccccc1)N1CCN(c2ccc(NC(=O)c3ccccc3-c3cccnc3)cc2)CC1";"IC50";"'='";"220.0";"nM";"6.66";"";"";"UO_0000065";"13.14";"0.24";"1.62";"8.90";"0";"CHEMBL1827365";"Displacement of [125I]PYY from human NPY Y2 receptor expressed endogenously in KAN-Ts cells by scintillation counting";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"KAN-Ts";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1821563";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";"";""
"CHEMBL404520";"CHLORTETRACYCLINE";"4.0";"478.89";"1";"0.44";"CHLORTETRACYCLINE";"CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)ccc(Cl)c4[C@@](C)(O)[C@H]3C[C@@H]12";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1200623";"ETHYLESTRENOL";"4.0";"288.48";"1";"5.09";"ETHYLESTRENOL";"CC[C@]1(O)CC[C@H]2[C@@H]3CCC4=CCCC[C@@H]4[C@H]3CC[C@@]21C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL127516";"BUTAMBEN";"4.0";"193.25";"0";"2.23";"BUTAMBEN";"CCCCOC(=O)c1ccc(N)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL532";"ERYTHROMYCIN";"4.0";"733.94";"2";"1.79";"ERY";"CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1016";"CANDESARTAN";"3.0";"440.46";"0";"4.03";"Candesartan";"CCOc1nc2cccc(C(=O)O)c2n1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL540445";"PARTHENOLIDE";"2.0";"248.32";"0";"2.76";"PARTHENOLIDE";"C=C1C(=O)O[C@H]2[C@H]1CC/C(C)=C/CC[C@@]1(C)O[C@@H]21";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL4128926";"";"None";"583.78";"2";"5.76";"1j";"CC(C)(C)NS(=O)(=O)c1ccc(-c2sc(C(=O)N[C@H]3C[C@H](C(=O)O)C3)nc2CC2CCCCC2)c2ccccc12";"IC50";"'='";"0.28";"nM";"9.55";"";"";"UO_0000065";"16.36";"0.33";"3.79";"7.61";"0";"CHEMBL4121492";"Displacement of [125I]peptide YY from human Y2 receptor after 120 mins by scintillation counting analysis";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4118122";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2018";"None";"";"";""
"CHEMBL888";"GEMCITABINE";"4.0";"263.20";"0";"-1.29";"GEMCITABINE";"Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)C2(F)F)c(=O)n1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1502";"PANTOPRAZOLE";"4.0";"383.38";"0";"2.88";"PANTOPRAZOLE";"COc1ccnc(C[S+]([O-])c2nc3cc(OC(F)F)ccc3[nH]2)c1OC";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL389621";"HYDROCORTISONE";"4.0";"362.47";"0";"1.78";"HYDROCORTISONE";"C[C@]12CCC(=O)C=C1CC[C@@H]1[C@@H]2[C@@H](O)C[C@@]2(C)[C@H]1CC[C@]2(O)C(=O)CO";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL584";"NELFINAVIR";"4.0";"567.80";"1";"4.75";"NELFINAVIR";"Cc1c(O)cccc1C(=O)N[C@@H](CSc1ccccc1)[C@H](O)CN1C[C@H]2CCCC[C@H]2C[C@H]1C(=O)NC(C)(C)C";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL934";"METYRAPONE";"4.0";"226.28";"0";"2.64";"METYRAPONE";"CC(C)(C(=O)c1cccnc1)c1cccnc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL141";"LAMIVUDINE";"4.0";"229.26";"0";"-0.59";"Lamivudine";"Nc1ccn([C@@H]2CS[C@H](CO)O2)c(=O)n1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL4098787";"";"None";"1824.17";"None";"None";"4";"CC(=O)N[C@@H](CO)C(=O)N1CCC[C@@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](CC1CCCCC1)C(=O)N[C@@H](CC1CCCCC1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)NC(C)(C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC1CCCCC1)C(N)=O)[C@@H](C)O";"IC50";"'='";"2.3";"nM";"8.64";"";"";"UO_0000065";"4.74";"None";"None";"None";"0";"CHEMBL4056968";"Displacement of [125I]peptide YY from human Y2 receptor expressed in CHO cell membranes after 60 mins by TopCount scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4052740";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";""
"CHEMBL4073010";"";"None";"1850.25";"None";"None";"3";"CC(=O)N[C@@H](CO)C(=O)N1CCC[C@@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](CC1CCCCC1)C(=O)N[C@@H](CC1CCCCC1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)NC(C)(C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC1CCCCC1)C(N)=O)[C@@H](C)O";"IC50";"'='";"1.5";"nM";"8.82";"";"";"UO_0000065";"4.77";"None";"None";"None";"0";"CHEMBL4056968";"Displacement of [125I]peptide YY from human Y2 receptor expressed in CHO cell membranes after 60 mins by TopCount scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4052740";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";""
"CHEMBL4064778";"";"None";"1808.17";"None";"None";"4";"CC(=O)N[C@@H](CO)C(=O)N1CCC[C@@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccncc1)C(=O)N[C@@H](CC1CCCCC1)C(=O)NC(C)(C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)NC(C)(C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC1CCCCC1)C(N)=O)[C@@H](C)O";"IC50";"'='";"0.92";"nM";"9.04";"";"";"UO_0000065";"5.00";"None";"None";"None";"1";"CHEMBL4179032";"Displacement of [125I]-PYY from human neuropeptide Y2 receptor expressed in CHO cell membranes incubated for 60 mins by TopCount based method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4177573";"1";"Scientific Literature";"Bioorg Med Chem";"2017";"None";"";"";""
"CHEMBL265065";"";"None";"485.67";"1";"5.69";"51";"CC(=O)N1CCc2ccc(N(C(=O)/C=C/c3ccccc3)C3CCN(CCC4CCCC4)CC3)cc21";"IC50";"'='";"800.0";"nM";"6.10";"";"";"UO_0000065";"12.55";"0.23";"0.41";"13.90";"0";"CHEMBL750768";"Binding affinity towards the NPY Y2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147599";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2004";"None";"";"";""
"CHEMBL439904";"";"None";"4049.53";"None";"None";"PYY(3-36)";"CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O)C(C)C";"IC50";"'='";"0.57";"nM";"9.24";"";"";"UO_0000065";"2.28";"None";"None";"None";"1";"CHEMBL4179032";"Displacement of [125I]-PYY from human neuropeptide Y2 receptor expressed in CHO cell membranes incubated for 60 mins by TopCount based method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4177573";"1";"Scientific Literature";"Bioorg Med Chem";"2017";"None";"";"";""
"CHEMBL4224861";"";"None";"2900.59";"None";"None";"8";"CC[C@](C)(NC(=O)[C@H]1C[C@H](O)CN1C(=O)[C@H](CO)NC(=O)c1c[nH]cn1)C(=O)N[C@@H](Cc1ccncc1)C(=O)N[C@@H](CC1CCCCC1)C(=O)N[C@@H](CC(C)(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCNC(=O)[C@@H](N)CCCCNC(=O)COCC(=O)NCCCOCCOCCOCCCNC(=O)CC[C@H](NC(=O)[C@H]1CC[C@H](CNC(=O)CCCCCCCCCCCCCCCCCCC(=O)O)CC1)C(=O)O)C(=O)NC(C)(C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC1CCCCC1)C(N)=O)[C@@H](C)O";"IC50";"'='";"13.0";"nM";"7.89";"";"";"UO_0000065";"2.72";"None";"None";"None";"0";"CHEMBL4220285";"Displacement of [125I]-PYY from human neuropeptide Y2 receptor expressed in CHO cell membranes incubated for 60 mins by TopCount micro scintillation analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4219053";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";"";"";""
"CHEMBL1454";"LEVAMISOLE";"4.0";"204.30";"0";"2.15";"LEVAMISOLE";"c1ccc([C@H]2CN3CCSC3=N2)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL1456";"MYCOPHENOLATE MOFETIL";"4.0";"433.50";"0";"2.52";"MYCOPHENOLATE MOFETIL";"COc1c(C)c2c(c(O)c1C/C=C(\C)CCC(=O)OCCN1CCOCC1)C(=O)OC2";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL565";"CLOFIBRATE";"4.0";"242.70";"0";"3.06";"CLOFIBRATE";"CCOC(=O)C(C)(C)Oc1ccc(Cl)cc1";"IC50";"";"";"";"";"";"Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)";"";"";"";"";"";"0";"CHEMBL1909176";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"B";"BAO_0000249";"cell membrane format";"None";"None";"None";"KAN-TS";"Membrane";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909046";"15";"DrugMatrix";"";"";"None";"";"";""
"CHEMBL3578016";"";"None";"2928.54";"None";"None";"4d";"CC(=O)N[C@@H](CCCCNC(=O)CCCCCNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](Cc1cccc2ccccc12)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O";"IC50";"'='";"8.913";"nM";"8.05";"";"";"UO_0000065";"2.75";"None";"None";"None";"0";"CHEMBL3579806";"Displacement of [125I]PYY from human neuropeptide Y Y2 receptor expressed in HEK293 cells cotransfected with eYFP fusion protein after 2 hrs by competitive receptor binding assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3576822";"1";"Scientific Literature";"J Med Chem";"2015";"CHEMBL3307715";"";"";""
"CHEMBL4207076";"";"None";"1810.19";"None";"None";"18";"CC[C@@](C)(NC(=O)[C@H](CO)NC(C)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccncc1)C(=O)N[C@@H](CC1CCCCC1)C(=O)NC(C)(C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)NC(C)(C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC1CCCCC1)C(N)=O)[C@@H](C)O";"IC50";"'='";"0.3";"nM";"9.52";"";"";"UO_0000065";"5.26";"None";"None";"None";"0";"CHEMBL4179032";"Displacement of [125I]-PYY from human neuropeptide Y2 receptor expressed in CHO cell membranes incubated for 60 mins by TopCount based method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4177573";"1";"Scientific Literature";"Bioorg Med Chem";"2017";"None";"";"";""
"CHEMBL4205282";"";"None";"1793.20";"None";"None";"10";"CC[C@](C)(NC(=O)[C@H]1CCCN1C(=O)[C@H](CO)NC(C)=O)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](CC1CCCCC1)C(=O)N[C@@H](CC1CCCCC1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)NC(C)(C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC1CCCCC1)C(N)=O)[C@@H](C)O";"IC50";"'='";"16.0";"nM";"7.80";"";"";"UO_0000065";"4.35";"None";"None";"None";"0";"CHEMBL4179032";"Displacement of [125I]-PYY from human neuropeptide Y2 receptor expressed in CHO cell membranes incubated for 60 mins by TopCount based method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4177573";"1";"Scientific Literature";"Bioorg Med Chem";"2017";"None";"";"";""
"CHEMBL4204797";"";"None";"1796.16";"None";"None";"7";"CC[C@](C)(NC(=O)[C@H](CC1CCCCC1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H]1CCCN1C(=O)[C@H](CO)NC(C)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)NC(C)(C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC1CCCCC1)C(N)=O)[C@@H](C)O";"IC50";"'='";"0.45";"nM";"9.35";"";"";"UO_0000065";"5.20";"None";"None";"None";"0";"CHEMBL4179032";"Displacement of [125I]-PYY from human neuropeptide Y2 receptor expressed in CHO cell membranes incubated for 60 mins by TopCount based method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4177573";"1";"Scientific Literature";"Bioorg Med Chem";"2017";"None";"";"";""
"CHEMBL3104227";"";"None";"493.63";"1";"5.62";"112";"CCC(CC)C(=O)Nc1ccc(N2CCN(C(c3ccccc3)c3nc(C(C)C)no3)CC2)c(F)c1";"IC50";"'='";"170.0";"nM";"6.77";"";"";"UO_0000065";"13.71";"0.26";"1.15";"9.09";"0";"CHEMBL3107076";"Displacement of [125I]-PYY from human NPYY2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3102719";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL3104198";"";"None";"518.62";"2";"5.21";"81";"CCC(CC)C(=O)Nc1ccc(N2CCN(C(C(=O)N(CC)CC)c3ccc(F)c(F)c3)CC2)c(F)c1";"IC50";"'='";"330.0";"nM";"6.48";"";"";"UO_0000065";"12.50";"0.24";"1.27";"11.60";"0";"CHEMBL3107076";"Displacement of [125I]-PYY from human NPYY2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3102719";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL3104194";"";"None";"512.67";"1";"4.94";"77";"CCC(CC)C(=O)Nc1ccc(N2CCN(C(C(=O)N(CC)CC)c3ccc(OC)cc3)CC2)c(F)c1";"IC50";"'='";"18.0";"nM";"7.75";"";"";"UO_0000065";"15.11";"0.29";"2.80";"11.89";"0";"CHEMBL3107076";"Displacement of [125I]-PYY from human NPYY2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3102719";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL3104214";"";"None";"500.63";"2";"5.07";"71";"CCC(CC)C(=O)Nc1ccc(N2CCN(C(C(=O)N(CC)CC)c3cccc(F)c3)CC2)c(F)c1";"IC50";"'='";"33.0";"nM";"7.48";"";"";"UO_0000065";"14.94";"0.28";"2.41";"13.39";"0";"CHEMBL3107076";"Displacement of [125I]-PYY from human NPYY2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3102719";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL279044";"";"None";"465.64";"1";"5.78";"20";"CC(=O)N1CCc2ccc(N(C/C=C/c3ccccc3)C3CCN(Cc4ccccc4)CC3)cc21";"IC50";"'='";"30000.0";"nM";"4.52";"";"";"UO_0000065";"9.71";"0.18";"-1.26";"16.88";"1";"CHEMBL3107076";"Displacement of [125I]-PYY from human NPYY2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3102719";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL21737";"";"None";"477.61";"1";"6.01";"16";"CC(=O)n1ccc2ccc(N(C(=O)/C=C/c3ccccc3)C3CCN(Cc4ccccc4)CC3)cc21";"IC50";"'='";"30000.0";"nM";"4.52";"";"";"UO_0000065";"9.47";"0.17";"-1.49";"9.93";"1";"CHEMBL3107076";"Displacement of [125I]-PYY from human NPYY2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3102719";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL1823342";"";"None";"565.69";"2";"5.87";"56, JNJ-31020028";"CCN(CC)C(=O)C(c1ccccc1)N1CCN(c2ccc(NC(=O)c3ccccc3-c3cccnc3)cc2F)CC1";"IC50";"'='";"6.0";"nM";"8.22";"";"";"UO_0000065";"14.53";"0.27";"2.35";"11.95";"1";"CHEMBL3107081";"Displacement of [125I]-NPY from NPYY2 receptor (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3102719";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL3104191";"";"None";"500.63";"2";"5.07";"74";"CCC(CC)C(=O)Nc1ccc(N2CCN(C(C(=O)N(CC)CC)c3ccc(F)cc3)CC2)c(F)c1";"IC50";"'='";"200.0";"nM";"6.70";"";"";"UO_0000065";"13.38";"0.25";"1.63";"11.99";"0";"CHEMBL3107076";"Displacement of [125I]-PYY from human NPYY2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3102719";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL3104208";"";"None";"468.62";"0";"4.54";"65";"CC[C@H](C)C(=O)Nc1ccc(N2CCN(C(C(=O)N(CC)CC)c3ccccc3)CC2)c(F)c1";"IC50";"'='";"70.0";"nM";"7.16";"";"";"UO_0000065";"15.27";"0.29";"2.61";"12.80";"0";"CHEMBL3107076";"Displacement of [125I]-PYY from human NPYY2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3102719";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL21507";"";"None";"499.70";"1";"6.08";"47";"CC(=O)N1CCc2ccc(N(C(=O)/C=C/c3ccccc3)C3CCN(CCC4CCCCC4)CC3)cc21";"IC50";"'='";"600.0";"nM";"6.22";"";"";"UO_0000065";"12.45";"0.23";"0.14";"14.19";"1";"CHEMBL3107076";"Displacement of [125I]-PYY from human NPYY2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3102719";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL279289";"";"None";"493.65";"1";"5.35";"44";"CC(=O)N1CCc2ccc(N(C(=O)/C=C/c3ccccc3)C3CCN(CCc4ccccc4)CC3)cc21";"IC50";"'='";"26000.0";"nM";"4.58";"";"";"UO_0000065";"9.29";"0.17";"-0.76";"10.45";"1";"CHEMBL3107076";"Displacement of [125I]-PYY from human NPYY2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3102719";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL4751466";"";"None";"5197.82";"None";"None";"GEP44";"CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](CO)NC(=O)[C@@H](N)Cc1cnc[nH]1)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O)C(C)C";"IC50";"'='";"10.0";"nM";"8.00";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4713465";"Agonist activity at human NPY2R expressed in HEK293 cells assessed as inhibition of adenosine-induced stimulation of cAMP accumulation by FRET assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4706662";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"AGONIST";""
"CHEMBL4061596";"";"None";"1895.34";"None";"None";"8";"CC(C)C[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](C)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](Cc1cnc[nH]1)C(=O)NC(CC1CCCCC1)C(=O)NC(CC1CCCCC1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)NC(C)(C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NC(CC1CCCCC1)C(N)=O)[C@@H](C)O";"IC50";"'='";"1.7";"nM";"8.77";"";"";"UO_0000065";"4.63";"None";"None";"None";"0";"CHEMBL4036757";"Displacement of [125I]-PYY from human Y2R expressed in CHO cell membranes after 60 mins by liquid scintillation method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4033754";"1";"Scientific Literature";"ACS Med Chem Lett";"2017";"None";"";"";""
"CHEMBL4226974";"";"None";"2789.49";"None";"None";"14";"CC[C@](C)(NC(=O)[C@H]1C[C@H](O)CN1C(=O)[C@H](CO)NC(=O)COCC(=O)NCCCOCCOCCOCCCNC(=O)CC[C@H](NC(=O)[C@H]1CC[C@H](CNC(=O)CCCCCCCCCCCCCCCCCCC(=O)O)CC1)C(=O)O)C(=O)N[C@@H](Cc1ccncc1)C(=O)N[C@@H](CC1CCCCC1)C(=O)N[C@@H](CC(C)(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCNC(=O)C1CCNCC1)C(=O)NC(C)(C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC1CCCCC1)C(N)=O)[C@@H](C)O";"IC50";"'='";"7.6";"nM";"8.12";"";"";"UO_0000065";"2.91";"None";"None";"None";"0";"CHEMBL4220285";"Displacement of [125I]-PYY from human neuropeptide Y2 receptor expressed in CHO cell membranes incubated for 60 mins by TopCount micro scintillation analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4219053";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";"";"";""
"CHEMBL4226958";"";"None";"2957.65";"None";"None";"9";"C[C@@H](O)[C@H](NC(=O)C(C)(C)NC(=O)[C@H](CCCCNC(=O)[C@@H](N)CCCCNC(=O)COCC(=O)NCCCOCCOCCOCCCNC(=O)CC[C@H](NC(=O)[C@H]1CC[C@H](CNC(=O)CCCCCCCCCCCCCCCCCCC(=O)O)CC1)C(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)(C)C)NC(=O)[C@H](CC1CCCCC1)NC(=O)[C@H](Cc1ccncc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H]1C[C@H](O)CN1C(=O)[C@H](CO)NC(=O)c1c[nH]cn1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC1CCCCC1)C(N)=O";"IC50";"'='";"3.4";"nM";"8.47";"";"";"UO_0000065";"2.86";"None";"None";"None";"0";"CHEMBL4220285";"Displacement of [125I]-PYY from human neuropeptide Y2 receptor expressed in CHO cell membranes incubated for 60 mins by TopCount micro scintillation analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4219053";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";"";"";""
"CHEMBL439904";"";"None";"4049.53";"None";"None";"PYY3-36";"CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O)C(C)C";"IC50";"'='";"16.0";"nM";"7.80";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4713465";"Agonist activity at human NPY2R expressed in HEK293 cells assessed as inhibition of adenosine-induced stimulation of cAMP accumulation by FRET assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4706662";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"AGONIST";""
"CHEMBL414357";"EXENATIDE";"4.0";"4186.64";"None";"None";"Ex-4";"CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@@H](N)Cc1cnc[nH]1)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(N)=O";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL4713465";"Agonist activity at human NPY2R expressed in HEK293 cells assessed as inhibition of adenosine-induced stimulation of cAMP accumulation by FRET assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4706662";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"";""
"CHEMBL4796216";"";"None";"4384.87";"None";"None";"EP-38";"CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@@H](N)Cc1cnc[nH]1)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O";"IC50";"'>'";"300.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4713465";"Agonist activity at human NPY2R expressed in HEK293 cells assessed as inhibition of adenosine-induced stimulation of cAMP accumulation by FRET assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4706662";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"";""
"CHEMBL4779424";"";"None";"176.26";"0";"2.05";"Metanicotine";"CN(C)CC/C=C/c1cccnc1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4676892";"Displacement of [3H]nicotine from NPY2R (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4673260";"1";"Scientific Literature";"Bioorg Med Chem";"2020";"None";"";"";""
"CHEMBL4224865";"";"None";"2720.38";"None";"None";"13";"CC[C@](C)(NC(=O)[C@H]1C[C@H](O)CN1C(=O)[C@H](CO)NC(=O)COCC(=O)NCCCOCCOCCOCCCNC(=O)CC[C@H](NC(=O)[C@H]1CC[C@H](CNC(=O)CCCCCCCCCCCCCCCCCCC(=O)O)CC1)C(=O)O)C(=O)N[C@@H](Cc1ccncc1)C(=O)N[C@@H](CC1CCCCC1)C(=O)N[C@@H](CC(C)(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCNC(C)=O)C(=O)NC(C)(C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC1CCCCC1)C(N)=O)[C@@H](C)O";"IC50";"'='";"7.6";"nM";"8.12";"";"";"UO_0000065";"2.98";"None";"None";"None";"0";"CHEMBL4220285";"Displacement of [125I]-PYY from human neuropeptide Y2 receptor expressed in CHO cell membranes incubated for 60 mins by TopCount micro scintillation analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4219053";"1";"Scientific Literature";"Bioorg Med Chem";"2018";"None";"";"";""
"CHEMBL317554";"";"None";"495.11";"1";"7.45";"5";"CN(C)CCCN(C(=O)c1sc2ccccc2c1Cl)c1ccccc1SCc1ccccc1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"1";"CHEMBL3107075";"Displacement of [125I]-PYY from NPYY2 receptor (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3102719";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL3104177";"";"None";"464.59";"1";"5.41";"116";"CCC(CC)C(=O)Nc1ccc(N2CCN(C(c3ccccc3)c3cc(C)no3)CC2)c(F)c1";"IC50";"'='";"38.0";"nM";"7.42";"";"";"UO_0000065";"15.97";"0.30";"2.01";"12.04";"0";"CHEMBL3107076";"Displacement of [125I]-PYY from human NPYY2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3102719";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL3104122";"";"None";"475.61";"1";"5.23";"108";"CCN(CC)C(=O)C(c1ccccc1)N1CCN(c2ccc(-c3ccccc3OC)cc2F)CC1";"IC50";"'='";"78.0";"nM";"7.11";"";"";"UO_0000065";"14.94";"0.28";"1.88";"19.73";"0";"CHEMBL3107076";"Displacement of [125I]-PYY from human NPYY2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3102719";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL3104114";"";"None";"465.57";"0";"4.17";"99";"CCc1nc(-c2ccc(N3CCN(C(C(=O)N(CC)CC)c4ccccc4)CC3)c(F)c2)no1";"IC50";"'='";"240.0";"nM";"6.62";"";"";"UO_0000065";"14.22";"0.27";"2.45";"10.07";"0";"CHEMBL3107076";"Displacement of [125I]-PYY from human NPYY2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3102719";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL3104196";"";"None";"566.64";"2";"5.83";"79";"CCC(CC)C(=O)Nc1ccc(N2CCN(C(C(=O)N(CC)CC)c3ccc(OC(F)(F)F)cc3)CC2)c(F)c1";"IC50";"'='";"26.0";"nM";"7.58";"";"";"UO_0000065";"13.39";"0.26";"1.76";"11.65";"0";"CHEMBL3107076";"Displacement of [125I]-PYY from human NPYY2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3102719";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL3104195";"";"None";"526.70";"2";"5.33";"78";"CCOc1ccc(C(C(=O)N(CC)CC)N2CCN(c3ccc(NC(=O)C(CC)CC)cc3F)CC2)cc1";"IC50";"'='";"44.0";"nM";"7.36";"";"";"UO_0000065";"13.97";"0.26";"2.03";"11.30";"0";"CHEMBL3107076";"Displacement of [125I]-PYY from human NPYY2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3102719";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL3104215";"";"None";"517.09";"2";"5.59";"72";"CCC(CC)C(=O)Nc1ccc(N2CCN(C(C(=O)N(CC)CC)c3cccc(Cl)c3)CC2)c(F)c1";"IC50";"'='";"50.0";"nM";"7.30";"";"";"UO_0000065";"14.12";"0.28";"1.71";"13.06";"0";"CHEMBL3107076";"Displacement of [125I]-PYY from human NPYY2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3102719";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL3104212";"";"None";"466.60";"0";"4.30";"69";"CCN(CC)C(=O)C(c1ccccc1)N1CCN(c2ccc(NC(=O)CC3CC3)cc2F)CC1";"IC50";"'='";"300.0";"nM";"6.52";"";"";"UO_0000065";"13.98";"0.26";"2.22";"11.67";"0";"CHEMBL3107076";"Displacement of [125I]-PYY from human NPYY2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3102719";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL3104218";"";"None";"507.61";"1";"4.41";"57";"CCN(CC)C(=O)C(c1ccccc1)N1CCN(c2ccc(NC(=O)c3c(C)noc3C)cc2F)CC1";"IC50";"'='";"26.0";"nM";"7.58";"";"";"UO_0000065";"14.94";"0.28";"3.18";"9.26";"0";"CHEMBL3107076";"Displacement of [125I]-PYY from human NPYY2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3102719";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL21605";"";"None";"515.60";"2";"5.58";"40";"CC(=O)N1CCc2ccc(N(C(=O)/C=C/c3cc(F)cc(F)c3)C3CCN(Cc4ccccc4)CC3)cc21";"IC50";"'='";"2500.0";"nM";"5.60";"";"";"UO_0000065";"10.87";"0.20";"0.02";"12.77";"1";"CHEMBL3107076";"Displacement of [125I]-PYY from human NPYY2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3102719";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL22056";"";"None";"514.07";"2";"5.96";"32";"CC(=O)N1CCc2ccc(N(C(=O)/C=C/c3cccc(Cl)c3)C3CCN(Cc4ccccc4)CC3)cc21";"IC50";"'='";"3000.0";"nM";"5.52";"";"";"UO_0000065";"10.74";"0.20";"-0.44";"12.59";"1";"CHEMBL3107076";"Displacement of [125I]-PYY from human NPYY2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3102719";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL20965";"";"None";"515.68";"2";"5.07";"21";"CC(=O)N1CCc2ccc(N(C3CCN(Cc4ccccc4)CC3)S(=O)(=O)/C=C/c3ccccc3)cc21";"IC50";"'='";"30000.0";"nM";"4.52";"";"";"UO_0000065";"8.77";"0.17";"-0.55";"7.42";"1";"CHEMBL3107076";"Displacement of [125I]-PYY from human NPYY2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3102719";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL2402905";"";"None";"535.66";"2";"6.88";"8a";"CCNC(=O)C(c1ccccc1)C1CCN(c2ccc(NC(=O)c3ccccc3-c3ccccc3)cc2F)CC1";"IC50";"'='";"12.0";"nM";"7.92";"";"";"UO_0000065";"14.79";"0.27";"1.04";"12.89";"0";"CHEMBL2404394";"Displacement of [125I]PYY from NPY-Y2 receptor in human KAN-TS cell membranes after 1 hr by scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"KAN-TS";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2401643";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"None";"";"";""
"CHEMBL4208023";"";"None";"1767.12";"None";"None";"26";"CC[C@](C)(NC(=O)[C@H]1C[C@H](O)CN1C(=O)[C@H](CO)NC(C)=O)C(=O)N[C@@H](Cc1ccncc1)C(=O)N[C@@H](CC1CCCCC1)C(=O)NC(C)(C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)NC(C)(C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC1CCCCC1)C(N)=O)[C@@H](C)O";"IC50";"'='";"0.78";"nM";"9.11";"";"";"UO_0000065";"5.15";"None";"None";"None";"0";"CHEMBL4179032";"Displacement of [125I]-PYY from human neuropeptide Y2 receptor expressed in CHO cell membranes incubated for 60 mins by TopCount based method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4177573";"1";"Scientific Literature";"Bioorg Med Chem";"2017";"None";"";"";""
"CHEMBL4205712";"";"None";"1737.09";"None";"None";"15";"CC(=O)N[C@@H](CO)C(=O)N1CCC[C@@H]1C(=O)NC(C)(C)C(=O)N[C@@H](Cc1ccncc1)C(=O)N[C@@H](CC1CCCCC1)C(=O)NC(C)(C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)NC(C)(C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC1CCCCC1)C(N)=O)[C@@H](C)O";"IC50";"'='";"4.5";"nM";"8.35";"";"";"UO_0000065";"4.81";"None";"None";"None";"0";"CHEMBL4179032";"Displacement of [125I]-PYY from human neuropeptide Y2 receptor expressed in CHO cell membranes incubated for 60 mins by TopCount based method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4177573";"1";"Scientific Literature";"Bioorg Med Chem";"2017";"None";"";"";""
"CHEMBL4103628";"";"None";"1834.17";"None";"None";"11";"CC(=O)N[C@@H](CO)C(=O)N1CCC[C@@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](CC1CCCCC1)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)NC(C)(C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC1CCCCC1)C(N)=O)[C@@H](C)O";"IC50";"'='";"2.8";"nM";"8.55";"";"";"UO_0000065";"4.66";"None";"None";"None";"0";"CHEMBL4056968";"Displacement of [125I]peptide YY from human Y2 receptor expressed in CHO cell membranes after 60 mins by TopCount scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4052740";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";""
"CHEMBL4065281";"";"None";"1850.25";"None";"None";"6";"CCCC[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC1CCCCC1)NC(=O)[C@H](CC1CCCCC1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H]1CCCN1C(=O)[C@H](CO)NC(C)=O)C(=O)NC(C)(C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC1CCCCC1)C(N)=O)[C@@H](C)O";"IC50";"'='";"1.3";"nM";"8.89";"";"";"UO_0000065";"4.80";"None";"None";"None";"0";"CHEMBL4056968";"Displacement of [125I]peptide YY from human Y2 receptor expressed in CHO cell membranes after 60 mins by TopCount scintillation counting analysis";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4052740";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";""
"CHEMBL4216864";"";"None";"1781.14";"None";"None";"27";"CC[C@](C)(NC(=O)[C@H](CC1CCCCC1)NC(=O)[C@H](Cc1ccncc1)NC(=O)[C@](C)(CC)NC(=O)[C@H]1C[C@H](O)CN1C(=O)[C@H](CO)NC(C)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)NC(C)(C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC1CCCCC1)C(N)=O)[C@@H](C)O";"IC50";"'='";"0.46";"nM";"9.34";"";"";"UO_0000065";"5.24";"None";"None";"None";"0";"CHEMBL4179032";"Displacement of [125I]-PYY from human neuropeptide Y2 receptor expressed in CHO cell membranes incubated for 60 mins by TopCount based method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4177573";"1";"Scientific Literature";"Bioorg Med Chem";"2017";"None";"";"";""
"CHEMBL3104185";"";"None";"479.60";"0";"4.73";"92";"CCN(CC)C(=O)C(c1ccccc1)N1CCN(c2ccc(-c3nnc(C(C)C)o3)cc2F)CC1";"IC50";"'='";"220.0";"nM";"6.66";"";"";"UO_0000065";"13.88";"0.26";"1.93";"10.13";"0";"CHEMBL3107076";"Displacement of [125I]-PYY from human NPYY2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3102719";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL3104182";"";"None";"451.55";"0";"3.92";"89";"CCN(CC)C(=O)C(c1ccccc1)N1CCN(c2ccc(-c3nc(C)no3)cc2F)CC1";"IC50";"'='";"85.0";"nM";"7.07";"";"";"UO_0000065";"15.66";"0.29";"3.15";"10.76";"0";"CHEMBL3107076";"Displacement of [125I]-PYY from human NPYY2 receptor";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3102719";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL4741000";"";"None";"4925.58";"None";"None";"EP40";"CC[C@H](C)[C@H](NC(=O)C(Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)Cc1cnc[nH]1)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)C(C)C";"IC50";"'='";"61.0";"nM";"7.21";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4713465";"Agonist activity at human NPY2R expressed in HEK293 cells assessed as inhibition of adenosine-induced stimulation of cAMP accumulation by FRET assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4706662";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"AGONIST";""
"CHEMBL4749279";"";"None";"5223.88";"None";"None";"EP44";"CC[C@H](C)[C@H](NC(=O)C(Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)Cc1cnc[nH]1)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)NCC(=O)N1CCC[C@@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)C(C)C";"IC50";"'='";"32.0";"nM";"7.50";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4713465";"Agonist activity at human NPY2R expressed in HEK293 cells assessed as inhibition of adenosine-induced stimulation of cAMP accumulation by FRET assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4706662";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"AGONIST";""
"CHEMBL4752195";"";"None";"6190.04";"None";"None";"EP50";"CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)Cc1cnc[nH]1)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O)C(C)C";"IC50";"'='";"25.0";"nM";"7.60";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4713465";"Agonist activity at human NPY2R expressed in HEK293 cells assessed as inhibition of adenosine-induced stimulation of cAMP accumulation by FRET assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4706662";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"AGONIST";""
"CHEMBL4212927";"";"None";"1793.20";"None";"None";"25";"CC[C@](C)(NC(=O)[C@H]1CCCN1C(=O)[C@H](CO)NC(C)=O)C(=O)N[C@@H](Cc1ccncc1)C(=O)N[C@@H](CC1CCCCC1)C(=O)N[C@@H](CC(C)(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)NC(C)(C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC1CCCCC1)C(N)=O)[C@@H](C)O";"IC50";"'='";"0.4";"nM";"9.40";"";"";"UO_0000065";"5.24";"None";"None";"None";"0";"CHEMBL4179032";"Displacement of [125I]-PYY from human neuropeptide Y2 receptor expressed in CHO cell membranes incubated for 60 mins by TopCount based method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4177573";"1";"Scientific Literature";"Bioorg Med Chem";"2017";"None";"";"";""
"CHEMBL4759334";"";"None";"5834.64";"None";"None";"EP46";"CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)Cc1cnc[nH]1)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O)C(C)C";"IC50";"'='";"18.0";"nM";"7.75";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4713465";"Agonist activity at human NPY2R expressed in HEK293 cells assessed as inhibition of adenosine-induced stimulation of cAMP accumulation by FRET assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4706662";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"AGONIST";""
"CHEMBL4748874";"";"None";"5280.93";"None";"None";"EP45";"CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@@H](N)Cc1cnc[nH]1)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O)C(C)C";"IC50";"'='";"47.0";"nM";"7.33";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4713465";"Agonist activity at human NPY2R expressed in HEK293 cells assessed as inhibition of adenosine-induced stimulation of cAMP accumulation by FRET assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4706662";"1";"Scientific Literature";"J Med Chem";"2021";"None";"";"AGONIST";""
"CHEMBL4207590";"";"None";"1902.29";"None";"None";"23";"CC(C)C[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC1CCCCC1)NC(=O)[C@H](CC1CCCCC1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H]1CCCN1C(=O)[C@H](CO)NC(=O)c1c[nH]cn1)C(=O)NC(C)(C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC1CCCCC1)C(N)=O)[C@@H](C)O";"IC50";"'='";"0.51";"nM";"9.29";"";"";"UO_0000065";"4.88";"None";"None";"None";"0";"CHEMBL4179032";"Displacement of [125I]-PYY from human neuropeptide Y2 receptor expressed in CHO cell membranes incubated for 60 mins by TopCount based method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4177573";"1";"Scientific Literature";"Bioorg Med Chem";"2017";"None";"";"";""
"CHEMBL4216889";"";"None";"1822.20";"None";"None";"14";"CC[C@](C)(NC(=O)[C@H](CC1CCCCC1)NC(=O)[C@H](Cc1ccncc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H]1CCCN1C(=O)[C@H](CO)NC(C)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)NC(C)(C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC1CCCCC1)C(N)=O)[C@@H](C)O";"IC50";"'='";"0.16";"nM";"9.80";"";"";"UO_0000065";"5.38";"None";"None";"None";"0";"CHEMBL4179032";"Displacement of [125I]-PYY from human neuropeptide Y2 receptor expressed in CHO cell membranes incubated for 60 mins by TopCount based method";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4018";"Neuropeptide Y receptor type 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4177573";"1";"Scientific Literature";"Bioorg Med Chem";"2017";"None";"";"";""
